Annual Report • Mar 22, 2024
Annual Report
Open in ViewerOpens in native device viewer



The official document containing the 2023 Consolidated Financial Statements, accompanied by the Management Report, prepared according to the technical requirements of Regulation (EU) 815/2019 (European Single Electronic Reporting Format - ESEF), is available, in accordance with the law, on the company's website (www.unipolsai.com).
This document in PDF format provides the text of the 2023 Consolidated Financial Statements, accompanied by the related Management Report, for ease of reading.
Translation from the Italian original solely for the convenience of international readers
bianco





| Introduction | 8 |
|---|---|
| Macroeconomic background and market performance | 8 |
| Main regulatory developments | 12 |
| 1.Management Report | 19 |
|---|---|
| Group highlights | 20 |
| Management Report | 22 |
| Salient aspects of business operations | 31 |
| Insurance Sector | 34 |
| Other Businesses Sector | 46 |
| Asset and financial management | 47 |
| Shareholders' equity | 50 |
| Insurance and financial liabilities | 52 |
| Other Information | 53 |
| Sustainability | 53 |
| Human Resources | 55 |
| Group sales network | 55 |
| IT services | 56 |
| Transactions with related parties | 56 |
| Report on corporate governance and ownership structures |
pursuant to Art. 123-bis of Italian Legislative Decree 58 of 24 February 1998 57
Statement pursuant to Art. 2.6.2, paragraph 8 of the Regulation governing markets organised and managed by Borsa Italiana SpA 58
Significant events after the reporting period and business outlook 59
| Statement of financial position | 66 |
|---|---|
| Income statement | 68 |
| Comprehensive income statement | 69 |
| Statement of changes in shareholders' equity | 70 |
| Statement of cash flows (indirect method) | 71 |
| 3.Notes to the Financial Statements | 73 |
|---|---|
| 1. Basis of presentation | 74 |
| 2. Notes to the Financial Statements | 121 |
| Notes to the Statement of Financial Position | 134 |
| Notes to the Income Statement | 184 |
| 3. Other information | 195 |
| 3.rmation relating to the actual or potential effects of netting agreements |
195 |
| 3.2 Earnings/(loss) per share | 196 |
| 3.3 Dividends | 196 |
| 3.4 Non-current assets or assets of a disposal group held for sale and discontinued operations |
196 |
| 3.5 Transactions with related parties | 197 |
| 3.6 Information on public funds received | 203 |
| 3.7 Information on personnel | 203 |
| 3.8 Non-recurring significant transactions and events | 205 |
| 3.9 Atypical and/or unusual positions or transactions | 205 |
| 3.10 Analysis of recoverability of goodwill with indefinite useful life (impairment test) |
205 |
| 3.11 Details of other consolidated comprehensive income | 209 |
| 3.12 Information by operating segment | 212 |
| 3.13 Risk Report | 216 |
4.Statement on the Consolidated Financial Statements Art.81-ter, Consob Regulation no.11971/1999 241
5.Summary of fees for the year for services provided by the Independent Auditors 245


| BOARD OF DIRECTORS | CHAIRMAN | Carlo Cimbri | |
|---|---|---|---|
| VICE CHAIRMAN | Fabio Cerchiai | ||
| CHIEF EXECUTIVE OFFICER | Matteo Laterza | ||
| DIRECTORS | Bernabò Bocca | Jean Francois Mossino | |
| Stefano Caselli | Milo Pacchioni | ||
| Mara Anna Rita Caverni | Paolo Pietro Silvio Peveraro | ||
| Giusella Dolores Finocchiaro | Daniela Preite | ||
| Rossella Locatelli | Elisabetta Righini | ||
| Maria Paola Merloni | Antonio Rizzi | ||
| SECRETARY OF THE BOARD OF DIRECTORS |
Alessandro Nerdi | ||
| BOARD OF STATUTORY AUDITORS |
CHAIRMAN | Cesare Conti | |
| STATUTORY AUDITORS | Silvia Bocci | ||
| Angelo Mario Giudici | |||
| ALTERNATE AUDITORS | Sara Fornasiero | ||
| Luciana Ravicini | |||
| Roberto Tieghi | |||
| MANAGER IN CHARGE OF FINANCIAL REPORTING |
Luca Zaccherini | ||
| INDEPENDENT AUDITORS | EYSpA |

2023
In 2023, global GDP growth continued, estimated at +2.7%, despite slowing compared to +3.1% in 2022. The slower pace of global economic growth depends, firstly, on the restrictive monetary policies implemented by the main international central banks and, secondly, on economic growth rates in China which are still below the pre-pandemic average and in turn penalised the evolution of global trade.
In the United States, GDP increased by 2.5% in 2023 (+1.9% in 2022). GDP growth was mainly supported by the good performance of private consumption and public spending, which offset the reduction in private investments, in turn penalised by high interest rates. The trend in consumption was supported by the positive labour market results, with an unemployment rate remaining at very low values in 2023 (3.6% on average). Growth was also accompanied by a gradual reduction in the inflation rate, which on average stood at 4.2% compared to 8.0% in 2022.
In China, GDP rose by 5.2% (+3% in 2022) thanks to the recovery in domestic demand assisted by the end of the restrictive "Zero-Covid" policies of 2022. However, growth remains below the pre-pandemic average due to tensions in the real estate market and lower exports, not fully offset by the expansion in domestic demand. In this context, the average unemployment rate in 2023 was 5.2%, while the average inflation rate was 0.2%, with deflation on average in the last quarter. In 2023, China resumed growing more rapidly than emerging countries. The estimated growth in 2023 for the block of Emerging Countries as a whole is 4.2%.
In Japan, it is estimated that GDP will close 2023 with growth of 2% (+0.9% in 2022). Despite the slowdown in the third quarter (-0.7% compared to the previous quarter), Japanese growth was supported by the improvement in foreign trade, which offset a low growth in domestic demand. The labour market continued to record a low unemployment rate, averaging 2.6% per year, while the inflation rate rose to 3.3% compared to 2.5% in 2022.
In the Euro Area, GDP rose by 0.5% in 2023 (+3.4% in 2022). Growth was essentially stagnant throughout 2023 due to the effects of the ECB's restrictive monetary policy. In addition, the reduced demand for goods from China penalised economies more dependent on exports such as Germany, whose slowdown in turn negatively affected economic growth throughout the Euro Area. Despite the slowdown in economic growth, the unemployment rate fell slightly and on average was 6.5% in 2023 compared to 6.7% in 2022, while the inflation rate fell on average to 5.5% compared to 8.4% in 2022, with the December figure down further to 2.9%.
In 2023, Italian GDP increased by 0.7% (+3.9% in 2022). In particular, in the second quarter the GDP trend was negative (-0.3% compared to the first quarter) due to the decline in both final consumption and investments. The recovery in final domestic consumption led to a return to growth in the third quarter (+0.1% on the second quarter), while in the fourth quarter growth mainly benefited (+0.2% on the third quarter) from the improved net foreign component. The average annual inflation rate was 6% (8.7% in 2022). The labour market remains resilient with respect to the slowdown in growth, with the annual average unemployment rate down to 7.6% (+8.1% in 2022).
In 2023, the Fed raised the Fed funds rate by 100 basis points, also continuing the process of downsizing the portfolio of securities purchased during the various quantitative easing programmes. Similarly, the ECB also maintained a restrictive monetary policy, increasing the two main monetary policy rates (refi and deposit rate) by 200 basis points. At the end of 2023, the deposit rate stood at 4% from 2% at the end of 2022 while the refi rate stood at 4.5% at the end of 2023, from 2.5% at the end of 2022. The ECB also continued its process of reducing the amount of securities purchased for monetary policy purposes.
Declining inflation rates and expectations of a less restrictive monetary policy by the Fed as well as the ECB led to a reduction in interest rates, particularly on long maturities.

The 3-month Euribor rate closed 2023 with an increase to 3.91%, up by around 177 basis points compared to figures at the end of 2022, while the 10-year Swap rate decreased during the same period by roughly 70 basis points, closing 2023 at 2.49%.
In Germany, the 10-year Bund closed 2023 at 2.03%, down by around 50 basis points on the values at the end of 2022, whilst in Italy the 10-year BTP closed 2023 at 3.68%, down 96 basis points. The 10-year spread between Italian and German rates was therefore 166 basis points at the end of 2023, down 46 basis points from its value at the end of 2022.
2023 ended favourably for international stock markets. The Eurostoxx 50 index, which refers to the Euro Area indexes, showed an increase of 19.2% in 2023 compared to the end of 2022. The FTSE Mib index, referring to Italian listed companies, recorded an increase of 28% in the same period. The DAX index, referring to German listed companies, finally closed 2023 up 20.3% compared to December 2022.
In the United States, the S&P 500 index instead closed 2023 ahead by 24.2% compared to the values at the end of 2022. International stock markets also saw a sharp rise in 2023: the Nikkei stock index, referring to listed companies in Japan, closed 2023 with growth of 28.2% compared to December 2022, while the Morgan Stanley Emerging Markets index, referring to emerging markets, recorded a more limited increase in 2023 of 7.0%.
The narrowing of interest rate spreads between the United States and the Euro Area favoured the depreciation of 3% of the US dollar against the Euro, with the Euro/USD exchange rate closing 2023 at USD 1.10 to the Euro against USD 1.07 at the end of 2022.
At the end of the third quarter of 2023, final figures show premiums in the Italian and non-EU direct business insurance market as close to €93.9bn, down 1% compared to the third quarter of 2022. In particular, total Non-Life premiums written increased by 6.6% compared to the same period of 2022 and therefore a year-end growth of approximately 7% is expected, for premium values in excess of €38bn.
From the latest ANIA surveys for the third quarter of 2023 in the MV sector, the total premiums of the classes MV TPL, Marine Vessels TPL and Land Vehicle Hulls grew by 5.2% compared to the same period of the previous year, driven by the positive trend in premiums written for the MV TPL and Marine Vessels TPL component (+3.4%) and the Land Vehicle Hulls component (+11.1%). The increase in MV TPL premiums benefited from tariff increases, translating into an increase in the average premium, which stood at €357 in December 2023 compared to €336 in December 2022, in line with ISTAT surveys on list values (up by 4.3%). With regard to the Non-Life Non-MV business, at the end of September 2023 segment premiums reached €14.9bn, up by 7.4% (Health +12.7%, Property +8.0% and General TPL +8.2%) compared to the same period of 2022.
With regard to distribution channels, the first nine months of 2023 showed a reduction in the share of the agency channel, confirming the trend already emerging early in the year, with premiums up by about 4.7% compared to the third quarter of 2022 and a total weight of approximately 83.3%. Direct channel premiums were also up (+4.0%), as were the broker and banking channels at 4.3% and 3.9%, respectively. In the Non-MV segment, the most significant increase in premiums was achieved by the broker channel (+13.5%), while the agency channel recorded an increase in premiums of 6.6%.
With regard to Italian and Non-EU direct Life business premiums, for 2023 Ania estimates total premiums of roughly €91bn, down by around 4.0% compared to the end of 2022, due to the decline in Class III premiums (-31%) and partly offset by the Class I trend (+9%). Vice versa, premiums in Class VI are expected to increase (+21%), while Class V (-28%) and Class IV (-4.3%) are expected to see a decline.
The estimated breakdown of premiums across Life distribution channels at the end of 2023 should remain strongly biased towards the banking channel, with an estimated share of total premiums of 60.4%, while the share of the financial advisors channel and the Direct and broker channels declined to around 12.1% and 11.8%, respectively, in favour of the agents channel, which is expected to account for roughly 15.8% of premiums.

In 2023, on the basis of Assogestioni data, net deposits of assets under management (mutual funds, individual asset management, collective and individual pension plans) amounted to -€47.8bn, of which -€16bn referring to collective management (open and closed funds) and -€31.7bn in net deposits for portfolio management.
The management of pension assets, with net deposits of roughly €4bn at 30 September 2023, was up sharply compared to the €1.7bn of net deposits recorded in the same period of the previous year. Asset management referring to pension funds (pension funds and individual pension plans) therefore amounted to €105.2bn at 30 September 2023, equal to 4.7% of total assets under management.
In 2023, existing positions with supplementary pension schemes, reported by Covip, increased by 410 thousand units compared to the end of 2022. The 4% increase recorded at the end of the year confirms the upward trend observed in recent periods. In December 2023, there were therefore 10.7m existing positions, of which 7.9m held by employees (73.6%).
In line with the sector trend, in December 2023 occupational funds recorded growth of 5.5% compared to December 2022, with 211k more positions, for a total of 4m positions at the end of the year, and contributions up by 7.7%. The main growth driver was linked to the contribution of contractual enrolments, particularly in the construction sector fund (for about 88k positions), where workers join through the payment of a modest contribution from the employer, and, in the public sector, the activation of automatic registration for new public employees (for approximately 16k positions). Market pension schemes were also up compared to the end of 2022, with an increase in existing positions of open funds (+5.9%) and "new" Personal Pension Funds (PiPs) (+2.2%) and an increase in contributions of 7.4% and 2.3%, respectively. The latest data available for pre-existing pension funds, updated as at September 2023, showed an increase in the number of positions of 1.2% compared to December 2022, corresponding to roughly 8k.
In December 2023, the resources allocated to supplementary pension benefits were up by 8.2% compared to December 2022, i.e. equal to approximately €223bn compared to €206bn recorded in December 2022, due to stock price increases linked to the performance of the financial markets and the overall increase in contributions. The recovery in share prices had a positive impact on the returns of all types of pension schemes with higher values for portfolios with more equity exposure. The net return over a 10-year horizon was 2.4% for occupational funds, 2.5% for open funds, 2.7% for "new" unit-linked PiPs and 1.8% as regards the segregated fund component of "new" PiPs. All returns with a 10-year horizon were in line with or slightly higher than the revaluation threshold of post-employment benefits, equal to approximately 2.4%.
In 2023, the residential real estate market continued to show solid demand. Nevertheless, according to the Real Estate Market Observatory of the Revenue Agency, in 2023 house sales fell by a total of 9.2% compared to 2022, due to the reshaping of state incentives for renovations and repeal of the option to sell tax credits related to works that began after 31 March 2023, in addition to the restriction of offer conditions on mortgages.
In 2023, on average for the 13 major cities, house prices recorded growth of 1.5%, although the property devaluation phase in real terms continued (net of inflation, prices were down by around 4%). The decline in sales and the reduced availability of household spending is holding back price growth. Amongst the large cities, Bari (-1.5%), Venice (-1.4%) and Catania (-0.4%) still showed a drop in prices, while the strongest growth continued to be recorded in Milan (+3.4%). On the other hand, demand for leases remained high, with an average increase in rents of 3.3%, and spread across all cities (between +1.2% in Naples and +6.9% in Bologna). In terms of returns, in 2023 the residential market had an average cap rate of 5.26%, up from 5.16% in 2022, and a total return of 6.7%.
In 2023, sales in the non-residential sector also recorded a decrease, but to a lesser extent than the residential sector (-4.2%). In fact, in the face of a more marked deterioration in the conditions of access to credit for businesses than for households, the sharp increase in public investments in the NRRP continues to support private non-residential investment. The decline was greater in the production sector (-10.5%), followed by offices (-3.5%), which were affected by the sharp drop in corporate investments, and stores (-2.2%), which in the first half of the year benefited from the period of expansion of tourist services.

The decline in sales of non-residential properties had more marked effects on store and office price trends than those observed for homes. Indeed, on average in the 13 major cities store prices increased by 1.0% and office prices by 0.2%. Moreover, the growth in rents was still modest, but for offices (+0.9%) it was higher than that of prices, leading to a rise in yields (with cap rates at 5.2% and a total return of 5.4%), while for stores it was lower than prices (+0.8%) leading to a fall in yields (cap rates at 7.3% and total returns at 8.3%).

In 2023, the reference regulatory framework for the sectors in which the Group carries on business saw numerous innovations.
Provisions of particular importance to the insurance sector are contained in Law no. 213/2023 (Budget Law), which envisages the establishment of a Life insurance Guarantee Fund (the "Fund"). The Fund represents an association between insurance companies and intermediaries with the task of intervening to protect those entitled to insurance benefits (up to €100k each) against member companies subject to compulsory liquidation. When fully operational, the Fund will have a financial endowment of at least 0.4% of the total Life business technical provisions (approximately €3bn). This level of financial endowment will have to be reached gradually, by the end of 2035. The percentage contributions to the Fund by the insurance companies will be calculated in proportion to the Life technical provisions and the contributions may take the form of irrevocable payment commitments, for an amount not exceeding 50% of the Fund's financial endowment (raised to 60% when fully operational). Establishment of the Fund represents a strong guarantee for policyholders and should limit the involvement of taxpayers to extreme cases through transfers of public resources in situations of Life insurance company insolvency. The contribution to be paid by the insurance companies will be due from 2024.
Another important change in the Budget Law consists in the introduction of the obligation for all companies, except agricultural companies, to take out an insurance policy against damage to property, plant and equipment (land and buildings, plant and machinery, industrial and commercial equipment) caused by catastrophic events, such as earthquakes, floods, landslides, inundations and overflows. A form of public-private partnership is also introduced in that SACE S.p.A. is authorised to grant coverage under market conditions of up to 50% of indemnities due from the companies in the event of catastrophic events envisaged in the contract. Against an increase in the frequency and severity of catastrophic events recorded in recent years, the new insurance obligation, which will have to be fulfilled by the end of 2024, represents a concrete initiative to increase the resilience of companies to catastrophic events and to fill the current protection gap, in particular affecting small businesses: only 15% of these companies (10-49 employees) have catastrophe insurance coverage.
At EU level, on 16 January 2023 Regulation (EU) 2022/2554 on digital operational resilience for the financial sector (DORA) entered into force, which introduces harmonised requirements for companies operating in the financial sector (including insurance companies) in terms of the management of ICT (Information and Communication Technologies) risk, ICT system resilience testing and management, classification and reporting of ICT incidents. DORA enhances the ICT risk management requirements already established by certain sector regulations and extends them to a broad range of entities, including larger insurance intermediaries, institutions for occupational retirement provision and alternative investment fund managers. One of DORA's main innovations concerns the introduction of supervisory and sanctioning powers also with respect to critical third-party providers of ICT services, obliged to comply with the provisions of DORA and have a permanent presence in the European Union. DORA will apply from 17 January 2025.
Among the new initiatives, note that on 24 May 2023 the European Commission presented a legislative package relating to retail investor protection, known as the Retail Investment Strategy (RIS), with the aim of encouraging retail investors' participation in the capital market, through new rules to mitigate conflicts of interest, combat misleading marketing communications, and increase transparency and Value for Money of the investment products offered to retail customers. The legislative package consists of a proposed Omnibus Directive containing amendments to MIFID II, IDD, Solvency II, AIFMD and the UCITS Directive, and a proposed regulation amending the PRIIPs Regulation. The main provisions contain stricter rules on inducements, including the introduction of a ban on paying/receiving inducements for sales of investment products (including IBIPs) in the absence of advisory services. It is also envisaged that, in the future, Member States and the European Commission will introduce stricter rules on inducements, including a total ban which, if actually adopted, could change the market structure of financial and insurance brokerage. Furthermore, to increase the Value for Money for customers, the RIS requires that ESMA and EIOPA publish benchmarks on the costs of investment products, preventing companies and distributors from marketing investment products that show significant deviations from these benchmarks.

With regard to secondary legislation, on 12 July 2023 IVASS published a consultation paper on Draft requirements and criteria of suitability of corporate officers and key function managers, in order to adapt the IVASS Regulation to the contents of Ministry of Economic Development Decree 88/2022. Following the consultation process, on 5 March 2024 IVASS adopted the definitive version of this measure (n. 142/2024). The main changes concern the establishment of a minimum quota of independent directors for insurance companies and ultimate Italian parent companies (listed and unlisted), set at 25% of members of the administrative body. In addition, corporate officers and key function managers will be required to complete standardised questionnaires that allow the competent body to conduct more specific and detailed suitability assessments than those compliant with previous regulations. In addition, IVASS may require assessed corporate officers to be interviewed in order to assess their actual suitability and compliance with the limits on the total number of offices. The new measure aims to strengthen the quality of the corporate governance system of insurance companies, achieving alignment with the analogous banking regulations.
It should be noted that on 25 September 2023, IVASS issued Measure 138/2023 amending IVASS Regulation no. 52 of 30 August 2022 containing the implementation methods regarding the right to value trading securities based on the book value in the financial statements of the previous year rather than the realisable value (if lower than the purchase cost). This option, introduced by Decree Law no. 73 of 21 June 2022, was also extended to the entire 2023 financial year by MEF decree of 14 September 2023. Specifically, for the insurance sector, the allocation of an undistributable profit reserve is required in an amount corresponding to the difference between the values recorded and the market values recorded at the end of the reference period, net of the related tax charge. In particular, Measure 138/2023 modified Art. 5 of IVASS Regulation 52/2022, which governs undistributable reserve functioning procedures and also requires adequate reporting on them in the notes to the financial statements. Note that no Group company availed itself of the option envisaged in the aforementioned Regulation with reference to the 2023 financial statements.
In this respect, also note that on 12 March 2024 the Supervisory Authority issued Measure 143/2024 containing "Amendments and additions to IVASS Regulation no. 52/2022 for the implementation of provisions on the temporary suspension of capital losses for short-term securities introduced by Decree Law no. 73 of 21 June 2022". In essence, this document reintroduces the right to determine the amount of the Undistributable Reserve to be established, also taking into account the effect on existing commitments to policyholders for the financial year and up to five subsequent years, thus deducting the portion attributable to the policyholders.
Lastly, on 6 October 2023 IVASS published a Draft letter to the market on insurance product oversight and governance (POG) for consultation, clarifying IVASS regulatory expectations in terms of POG and Value for Money (V4M) with particular reference, in a first phase, to the assessment of value for the customer arising from the product testing phase for insurance-based investment products (IBIPs). IVASS adopts and provides a more detailed breakdown of the EIOPA guidelines on V4M assessment, taking into account evidence acquired through inspections and investigations. IVASS expects a strengthening of the POG policies by insurance companies, an increase in the granular identification of the reference market and allocation of a greater weight to product profitability for the customer in the product evaluation and testing phase. At the date of this report, the consultation periods have concluded and publication of the final measures by IVASS is now pending.
In 2023, the following regulatory measures were issued:

to other parties, including financial intermediaries and insurance companies. Extensions are also established as well as some updates, including in the criminal tax arena, to the Tax Peace regulations pursuant to Law no. 197/2022.
On 31 July 2023, the European Commission adopted Delegated Regulation (EU) 2023/2772, which introduces the first set of European sustainability standards (European Sustainability Reporting Standard - ESRS), in implementation of Directive (EU) 2022/2464 (CSRD), which requires large companies and listed companies to publish information on the risks and opportunities deriving from social and environmental factors, as well as the impact of their activities on people and the environment ("double materiality"). The ESRSs will constitute mandatory standards for corporate sustainability reporting, with the aim of ensuring greater availability and comparability of this information, and will apply to financial years beginning on or after 1 January 2024.
Lastly, note that on 22 December 2023 Regulation (EU) 2023/2854 on harmonised rules on fair access to and use of data (Data Act) was published in the Official Journal of the European Union. The Data Act governs access to and the sharing, portability and use of all data, personal and non-personal, introducing the right of users (businesses or consumers) that generate data through IoT (Internet of Things) products or related services that they own, rent or lease, to access promptly and free of charge the data generated by the use of such related products or services. Furthermore, users are afforded the right to authorise the data controller (e.g. IoT device manufacturer) to provide data access to third-party service providers: for example, the owner of a vehicle may wish to share the data generated through the use of the car with an insurance company. The objective of the Data Act is to improve data availability for companies, boost competition and create the conditions for the development of a data-driven economy, while protecting the industrial secrets and intellectual property rights of companies.

The Consolidated financial statements of UnipolSai Assicurazioni SpA are subject to audit by the independent auditors EY SpA, the company tasked with performing the legally-required audit of the consolidated financial statements for the 2021/2029 period.
With respect to the obligations laid out by Italian Legislative Decree no. 254 of 30 December 2016, on the communication of non-financial and diversity information by certain large undertakings and groups, please note that the UnipolSai Group is not subject to this obligation as one of the cases of exemption and equivalence laid out in Art. 6, paragraph 2 applies to it, given that it is a subsidiary company included within the Consolidated Non-Financial Statement prepared by the Unipol Group.


For more details see the chapter "Consolidation Scope"




| Amounts in €m | ||
|---|---|---|
| 31/12/2023 | 31/12/2022 | |
| Non-Life direct insurance premiums | 8,651 | 8,304 |
| % variation | 4.2 | 10.3 |
| Life direct insurance premiums | 6,409 | 5,341 |
| % variation | 20.0 | (6.5) |
| of which Life investment products | 2,237 | 2,170 |
| % variation | 3.1 | 84.3 |
| Direct insurance premiums | 15,060 | 13,645 |
| % variation | 10.4 | 2.4 |
| Result of insurance services | 407 | 1,074 |
| % variation | (62.1) | n.a. |
| Net financial result | 592 | (53) |
| % variation | n.s. | n.a. |
| Consolidated profit (loss) | 766 | 466 |
| % variation | 64.4 | n.a. |
| Balance on the statement of comprehensive income | 1,080 | 11 |
| Investments and cash and cash equivalents | 64,443 | 59,941 |
| % variation | 7.5 | n.a. |
| Insurance liabilities | 51,200 | 47,327 |
| % variation | 8.2 | n.a. |
| CSM Life business | 2,295 | 2,265 |
| % variation | 1.3 | n.a. |
| Financial liabilities | 13,571 | 10,894 |
| % variation | 24.6 | n.a. |
| Non-current assets or assets of a disposal group held for salea | 133 | 514 |
| Liabilities associated with disposal groups held for sale | 360 | |
| Shareholders' Equity attributable to the owners of the Parent | 7,026 | 6,458 |
| variazione % | 8.8 | n.a. |
| Solvency ratio | 313 | 288 |
| No. Staff | 12,387 | 12,315 |

| Alternative performance indicators | classes | 31/12/2023 |
|---|---|---|
| Loss ratio | Non-Life | 71.5% |
| Expense ratio | Non-Life | 26.7% |
| Combined ratio | Non-Life | 98.2% |
| Premium retention ratio | Non-Life | 94.4% |
| Premium retention ratio | Life | 99.5% |
| Premium retention ratio | Total | 96.0% |
| Life New business CSM | Life | 248 |
1 Indicator that measures the balance of overall Non-Life technical management. As of 2023, with the introduction of the new income statement formats following the entry into force of IFRS 17, the ratio is calculated using the following formula: 1 - (insurance service result/revenue from insurance contracts).

As provided for in the 2022-2024 Strategic Plan, at the beginning of 2023, after a pilot phase, the "UniSalute 2.0" project was definitively launched. With the launch of this project, the Group decided to transform UniSalute into the only product factory for the Health class. During 2023, the possibility of acquiring new UnipolSai brand business was progressively restricted, and the existing portfolio was progressively replaced with new UniSalute products. The project was also extended to the banking channel: after the pilot phase carried out on the Banco di Sardegna branches (BPER Group), starting from 9 January 2023 the offer of ACUORE health policies under the UniSalute brand was also made available at all branches of BPER Banca and Banca Popolare di Sondrio. In this way, UniSalute takes over from Arca Assicurazioni with the aim of becoming the only carrier of the Group in the healthcare sector across all sales channels.
In early 2023, "Stammi bene" ("Stay Healthy") was launched, the first podcast of UniSalute that aims to expose fake news on health, conducted in collaboration with medical professionals and different health sector specialists. In the same period, UniSalute continued, through national and local press releases, as well as on its social channels, to disseminate the contents of the Osservatorio Sanità UniSalute (UniSalute Health Observatory), which was created in collaboration with the Nomisma research institute, dealing in particular with chronic conditions and prevention.
On 16 December 2022, UnipolSai signed the contract to acquire the entire share capital of Società e Salute SpA, a company operating in the private healthcare sector under the brand name "Centro Medico Santagostino", from the L-GAM investment fund. The company holds a 100% interest in Santagostino Servizi e Prodotti, specialised in the sale of sanitary items such as eyewear and hearing aids. The acquisition was finalised on 3 April 2023 for a consideration of €105,422k, of which €5,000k deposited in an escrow account in the name of UnipolSai with a lien in favour of the sellers. This amount constitutes a guarantee in favour of UnipolSai for the indemnities laid out in the purchase agreement in relation to the obligations and warranties of the sellers.
In December 2023, the subsidiary opened a new 3-floor health centre in Rome's Garbatella district, with 6 clinics and 36 specialties, to offer quality clinical and specialist services ranging from gynaecology to dermatology, from ophthalmology to otolaryngology, physiatry, nutrition and diagnostic imaging. At the end of 2023, Santagostino health centres are present locally with 38 locations in Milan, Sesto San Giovanni, Buccinasco, Rho, Monza, Nembro, Bologna, Brescia and Rome, and are part of the development roadmap outlined with the Beyond Insurance Enrichment Strategic Guideline of the Opening New Ways Strategic Plan.
The network of Dyadea healthcare facilities was enriched during June 2023 with two new Medical Centres: the first at the Interporto Bologna hub and the second in Monza (MB). The positioning of the Unipol Group in the private healthcare sector is therefore expanded, in line with the Beyond Insurance Enrichment guideline of the "Opening New Ways" 2022-2024 Strategic Plan.
On 21 September 2023, the Boards of Directors of Dyadea Srl and Società e Salute SpA approved the merger by incorporation into Società e Salute SpA of Centri Medici Dyadea Srl. The merger is part of a broader industrial and strategic project for the reorganisation of the Unipol Group to simplify the Group's corporate structure so that all healthcare facilities can be brought together under a single corporate vehicle in order to standardise processes and business procedures and, also, create economies of scale and industrial synergies. The merger plan was approved by the Shareholders' Meetings of the two companies on 10 October 2023.

At its meeting on 23 March 2023, the Board of Directors of UnipolSai Assicurazioni SpA approved an industrial project in the long-term rental business with BPER Banca SpA (the "Framework Agreement") which, inter alia, calls for the integration via merger by incorporation of SIFÀ - Società Italiana Flotte Aziendali SpA (a company belonging to the BPER Group) into UnipolRental SpA. This project, developed as part of the "Beyond Insurance Enrichment" strategic guideline, more specifically the "Mobility" ecosystem of the "Opening New Ways" 2022-2024 Strategic Plan, aimed to create an operator of national significance in the long-term rental sector. Following the approval of the merger deed by the respective Shareholders' Meetings and its subsequent filing with the register of companies, the merger became effective for legal, accounting and tax purposes on 1 July 2023. For the merger, the share capital of the incorporating company was increased from €25,000,000 to €31,244,899, with the assignment of the newly issued shares to BPER Banca, formerly the 100% parent company of SIFÀ. With the completion of the merger, BPER acquired a stake in UnipolRental corresponding to 19.987% of the share capital and UnipolSai, formerly the sole shareholder of UnipolRental, holds the residual shareholding equal to 80.013% of the share capital.
It should also be noted that, on the UnipolRental shares held by BPER, UnipolSai and BPER have mutually granted an option, by virtue of which: (i) BPER will have the right to sell to UnipolSai its entire investment in UnipolRental, exercising the related right within 60 days of the approval of the financial statements of UnipolRental at 31 December 2025; (ii) UnipolSai will have the right to purchase the entire investment held by BPER, being able to exercise the relevant option within 60 days following the expiry of the deadline granted in favour of BPER for the exercise of the relevant put option. The exercise price of the options will be determined on the basis of a multiple of UnipolRental's profit for the year at 31 December 2025, normalised if necessary to neutralise any impact on the profit for the year arising from the indemnity scheme.
Lastly, it should be noted that, in relation to the Framework Agreement, guarantees have been provided for the benefit of UnipolRental to indemnify the company resulting from the merger in connection with any inaccuracy or untruthfulness of the representations and warranties set forth in the executed Framework Agreement.
SIAT and BPER signed an agreement on 27 July 2023 that provides for the distribution of SIAT products in the Marine and Aviation sector through the BPER banking channels. The transaction is part of the Bancassurance Boosting guideline of the Opening New Ways 2022-2024 Strategic Plan, with the aim of strengthening the bancassurance business model, and represents an important step forward for the expansion of synergies between the Unipol Group and BPER. The new agreement aims to offer the distinctive services of SIAT, specialised in transport insurance, to meet the shipping insurance needs of BPER's business customers, through its network and bank branches. The agreement began with a pilot phase involving the geographical areas of Liguria and Emilia Romagna, to test the interest of potential customers.
On 22 June 2023, a single-member limited liability company was established by Compagnia Assicuratrice Linear SpA with the company name LinearNext Srl, which has as its object the performance of agency mandates granted by insurance companies for insurance distribution activities in the Non-Life and Life business.
On 7 July 2023, the contract relating to the sale to Unicredit SpA of the equity investment held by UnipolSai in Incontra Assicurazioni, equal to 51% of the share capital, was executed. The transaction, which was planned as part of the 2022-2024 Strategic Plan, the projections of which already took this sale into account, was completed on 30 November 2023, with the sale by UnipolSai of all shares held for an equivalent value of €58,532,700: taking into account the net proceeds from the sale, equal to €23m, and the final profit recorded prior to the sale, the contribution of Incontra to the consolidated economic result for 2023 was €48m. There are no price adjustment mechanisms. At the same time, UnipolSai acquired shares of UnipolAssistance Scrl from Incontra Assicurazioni for a nominal amount of €774, corresponding to 0.15% of the share capital, for an equivalent value of €3,963.87.
The Boards of Directors of UnipolRe DAC and UnipolSai Assicurazioni SpA, which met on 20 March and 23 March 2023, respectively, approved the plan for the merger by incorporation of UnipolRe DAC into UnipolSai Assicurazioni, in order to (i) simplify the organisational structure of the Unipol Group; (ii) strengthen governance by Unipol Group structures; (iii) optimise the allocation of investments; (iv) pursue cost synergies; and (v) optimise fungibility and capital absorption.
The deed of merger, signed on 14 December 2023, was entered in the Register of Companies held by the Bologna Chamber of Commerce on 20 December 2023 and effective from 31 December 2023. The completion of this transaction has no accounting effects on the consolidated financial statements as UnipolRe is a wholly-owned subsidiary of the incorporating company UnipolSai.
On 17 May 2023, UnipolSai launched a structured and integrated plan of actions in favour of populations affected by the May floods in the Emilia Romagna region, with the aim of supporting customers and agencies resident in areas affected by the flood.
In a context of difficulty and suffering, UnipolSai committed to facilitating claims management, granting significant extensions and deferrals and providing adequate and timely responses by activating a dedicated toll-free number. In addition to the aforementioned interventions in favour of customers, the Company, with the collaboration of the US entrepreneur Elon Musk, through his company SpaceX, purchased the Starlink terminals which enabled rescue workers, essential and strategic services (e.g. hospitals) and the flood-affected population to have access to the Internet. In June 2023, the purchased terminals were distributed and installed throughout the country so as to ensure continuity of activities.
On 7 November 2023, UnipolSai also launched a structured and integrated plan of actions in favour of populations affected by the November floods in Tuscany, with the aim of supporting customers and agencies resident in areas affected by the flood. In a context of difficulty and suffering, UnipolSai committed to facilitating claims management, granting significant extensions and deferrals and providing adequate and timely responses by activating a dedicated toll-free number.
On 29 June 2023, the Board of Directors of UnipolSai Assicurazioni approved the Company's participation in the rescue operation scheme to protect Eurovita policyholders, together with Allianz, Assicurazioni Generali, Intesa Sanpaolo Vita and Poste Vita (jointly, the "Companies").
On 3 August 2023, the Companies established the NewCo Cronos Vita SpA. Following the receipt of IVASS authorisation to carry out insurance activities, the NewCo was renamed Cronos Vita Assicurazioni SpA ("Cronos Vita"). At 31 December 2023, the share capital of Cronos Vita amounted to €60m and was subscribed in equal shares of 22.5% by UnipolSai, Generali Italia, Intesa Sanpaolo Vita and Poste Vita, with Allianz subscribing the remaining 10%. The total payments made by UnipolSai in the form of share capital in favour of Cronos Vita amounted to €49.5m. With effect from 30 October 2023, Eurovita SpA transferred a company complex to Cronos Vita comprising the entire portfolio of Eurovita policies, placed under compulsory administrative liquidation on 27 October 2023. Cronos Vita is managing the run-off of this portfolio for the time strictly necessary (i) for the precise identification of the distinct business units making up the company complex to be assigned to the Companies and (ii) the subsequent transfer of these units to them (or, subject to the approval of the banks involved in the transaction, their subsidiaries).
The deadline established for completing the transfer of the business units to the Companies is 24 months from the above-mentioned effective date of the transfer to Cronos Vita of the business unit, without prejudice to any delays caused by objective technical or authorisation issues. It is expected, however, that the Companies will define the agreements aimed at identifying the complex to be transferred and the related conditions by the 2024 financial year, so as to be able to start the authorization process and the detailed technical activities functional to the migration of the portfolios.
As of 31 October 2023, IVASS Measure of 6 February 2023, which had temporarily suspended the right of Eurovita policyholders to exercise their right to Redemptions, stopped being effective. To ensure the success of the transaction and a balancing of the respective risks and charges between the parties involved, 30 banks, including the banks distributing Eurovita products and certain system banks, have indicated their willingness, subject to the issue of specific guarantees by part of Eurovita and, alternatively, its shareholders, to grant loans to the company to cover part of the early redemptions relating to the policies linked to segregated funds distributed by the banks and included in the company complex.

On 24 July 2023, UnipolSai fully repaid the Mediobanca Tier 1 subordinated loan with an original nominal value of €400m, through repayment of the fifth and final tranche of €80m as indicated in the contractually envisaged repayment plan.
On 22 November 2023, the rating agency Moody's Investor Service confirmed the Insurance Financial Strength Rating of UnipolSai as "Baa2", i.e. one notch above the Italy rating (Baa3/Stable Outlook), improving the outlook from "Negative" to "Stable" after similar action taken on the country rating. In its decision, the Moody's Committee considered the high exposure of UnipolSai's assets and liabilities to the country.
At the meeting of 7 February 2023, the Board of Directors of UnipolReC SpA, in acknowledging that, following the sale en bloc without recourse of the entire loan portfolio in favour of AMCO – Asset Management Company SpA, completed pursuant to Art. 58 of the Consolidated Law on Banking on 14 December 2022, the continuation of financial intermediation activities pursuant to Art. 106 of the Consolidated Law on Banking no longer satisfies the interests of the Unipol Group, resolved, among other things, on the proposal to adopt a new corporate purpose with consequent waiver of exercise of the activity reserved to it pursuant to Art. 106 of the Consolidated Law on Banking. This proposal was submitted for approval to the Shareholders' Meeting of UnipolReC, subject to the issue by the Bank of Italy of the authorisation required pursuant to Bank of Italy Circular no. 288 of 3 April 2015. The company was struck off from the Register of financial intermediaries on 11 December 2023.
As part of the 2022-2024 Strategic Plan implementation activities, on 18 October 2022 and 25 October 2022 trade union agreements were signed (for the companies UnipolSai, UniSalute, Arca Assicurazioni and Siat) which - as concerns voluntary pre-retirement arrangements for employees meeting pension requirements by the end of 2027 are divided into three types:
In this regard, note that the mutually agreed termination of employment relationships of the abovementioned employees took place with access to the extraordinary benefits of the Solidarity Fund as of:
1 July 2023 (termination/last day of work on 30 June 2023) for those who will accrue pension between 1 January 2026 and 31 December 2027, for a total of 445 employees.
employees who have already accrued or will accrue the pension with the "quota 102": the mutually agreed termination of the employment relationship was set by 31 December 2022, for a total of 2 employees.
Therefore, a total of 912 employees were involved in the mutually agreed termination of their employment relationship.
The trade union agreement in question envisaged the early termination of 800 employees (in addition to a higher number of participants up to a maximum 10% more than the number indicated), and therefore the objectives of the Strategic Plan were achieved with regard to this action considered strategic in terms of generational renewal and cost reduction.
In addition, in December 2022, a trade union agreement was signed on pre-retirement arrangements for executive personnel who will meet pension requirements due to either the number of years of contributions or old age by 31 December 2027. This agreement refers to the provisions of the system governed by Art. 4, paragraphs 1 to 7-ter, of Law no. 92 of 28 June 2012 ("Fornero" law), as amended by Art. 34, paragraph 54, of Law no. 221 of 17 December 2012 and Art. 1, paragraph 160, of Law no. 205 of 27 December 2017.
Senior executives who intend to participate in the plan, subject to mutually agreed termination of the employment relationship, will be paid the "isopensione", i.e. an allowance equal to the pension accrued at the time of termination, until the disbursement of the pension benefit. Payments of the relative contribution also continue until the first pension requirement is met.
To date, 9 UnipolSai executives and 1 Una Group executive have subscribed to the plan.
In terms of policies and projects, in relation to the Group Supplementary Corporate Agreement of 13 May 2016 amended on 8 June 2021 and expired on 31 December 2021 - please note that on 28 February 2024, a draft bridge agreement was signed with the Trade Unions, subject to the approval of workers in the insurance sector by means of a referendum and by the Board of Directors on 21 March 2024. The aim of this agreement was to improve company welfare benefits (supplementary pension and welfare credit, the latter valid for 2024), while also recognising an improvement in the Variable Company Bonus, in correlation with the use of holidays and mandatory training, and a one-off amount for the years 2022 and 2023.

On 23 January 2023, during the official presentation of Ducati for the 2023 season of the MotoGP World Championship, the partnership between UnipolSai and the Borgo Panigale team was renewed, for the seventh consecutive year confirming the common path of two Italian excellences united in the sharing of values, passion and approach to innovation.
In 2023, UnipolSai was back on air with the multimedia advertising campaign "Sempre un passo avanti" (Always One Step Ahead), aimed at highlighting the possibility for customers to "truly choose the future" through UnipolSai, a leader in MV insurance in Italy, with over 10 million customers and around 4 million connected cars. At the same time, the creative concept underlines the authority, reliability and innovative vocation of UnipolSai, thanks to the offer of insurance solutions combined with cutting-edge technological services.
On 8 June 2023, as part of the Finals 2023 presentation event, UnipolSai announced renewal of its partnership with the Serie A basketball league for the 2023/2024 and 2024/2025 seasons. A renewal that leverages on the remarkable synergy generated in the first three years of the 2020-2023 collaboration with effective results, in terms of visibility, brand equity and engagement, generated by the Title Sponsorship on the various media channels and "on field" in all the championship venues.
At the Aquatics World Championships, which ended on 31 July 2023 in Japan, the Italian athletes of the Italian Swimming Federation, of which UnipolSai is the main sponsor, won 14 medals; this is one of the most significant results achieved at a world championship by the Italian national team, although it did not meet the record set in Budapest 2022. Indeed, in this twentieth edition of the world championships, the Italian Swimming Federation is the only delegation that managed to place a swimmer on the podium in every discipline, with eight also qualifying for the 2024 Paris Olympics.
In August 2023, the Dominate the Water swimming event circuit was held, for which UnipolSai is the main partner. This is a two-day open water competition aimed at raising awareness around sea protection, with competition formats for all ages and degrees of preparation. DTW was founded with the desire to safeguard the marine environment by promoting open water swimming, which is still not very popular in Italy, combining sport, sea protection and the promotion of local areas with the development of a real green economy.
UnipolSai is the strongest insurance brand in the Brand Finance 2023 ranking, published in January 2023, with a Brand Strength Index score of 86.3 out of 100, which earned it an AAA brand rating. The award is determined by a balanced scorecard of metrics that assess marketing investments, stakeholder equity and company performance. UnipolSai is credited with being "one of the insurance brands most appreciated by Italians for the range of its offer and its responsiveness to its customers in difficult financial times".
On 7 February 2023, the Chief Executive Officer of UnipolSai received the Insurer of the Year award at the Milano Finanza 2023 Insurance Awards, the recognition reserved for excellence in the insurance sector.
In June 2023, UnipolTech, with UnipolMove and BeRebel, were the protagonists at the NC Awards 2023, winning several prizes, including first place for UnipolTech in the "Travel, Transport and Tourism - Entertainment and Leisure" and "Best Company 2023" categories and first place for BeRebel's holistic advertising campaign in the "Banking and Insurance" category.

For sixteen years, the NC Awards have been a point of reference for the entire panorama of integrated communication in Italy, with a jury consisting of around 30 managers from companies from all sectors and top communication spenders.
In June 2023, UnipolSai obtained two important awards with the Digital Green Index project, testifying to the Company's commitment to promoting sustainability and innovation in the insurance sector.
The Digital Green Index project has demonstrated how it is possible to create eco-sustainable and certified digital channels, through the application of a "green" methodology of design, planning and implementation that leads to a reduction in energy scoring. The innovative methodology was used for the first time in the development of the GlassX site for UnipolGlass which, from an energy point of view, produces only 0.75 tonnes of CO₂ per year, which corresponds to a reduction of 29% compared to the world average of digital channels. The project won first place in the "Best ESG Project" category at the Italy Insurance Forum Awards 2023. This event is sponsored by Insurance Club, the community of IKN Italy, which evaluates best practices in the insurance world in Italy.
This was followed by third place in the "Social, Sustainable & Responsible" category at The Qorus-Accenture Innovation in Insurance Awards 2023, which evaluates the most innovative projects and initiatives in the global insurance sector, in which 223 companies participated from 43 countries.
In August 2023, UnipolSai was recognised by Standard Ethics as one of the best examples of social and environmental sustainability at international level. The recognition came with confirmation of the "EE+" (or "very strong") SER (Corporate Standard Ethics Rating) and the transition from "stable" to "positive" of its outlook. The Company was recognised for having undergone corporate transformations, structural streamlining, organisational and technological innovations in line with the voluntary ESG policies of the European Union, the United Nations and the OECD.
On 13 September 2023, the Think Awards 2023 were held, an IBM initiative that celebrates the best projects in the categories Environmental Sustainability, Business Sustainability and Social Sustainability for their outstanding innovativeness of technological solutions and importance of the results achieved. UnipolSai won the award in the Business Sustainability category, for having modernised the technological infrastructure and adopted innovative software solutions to support the integrated customer service platform, which plays a central role in the Unipol Group's business model.
On 3 October 2023, as part of the third edition of the Health Insurance Summit Awards, the event that celebrates the operators in the welfare, supplementary healthcare and health TPL sectors who have distinguished themselves in their fields, two Unisalute products were rewarded: "Unisalute al tuo fianco", for innovation in the offer of health protection solutions dedicated to the different phases of people's lives and "Unisalute studente", for innovation of the bancassurance offer through a health policy dedicated to young people.
UnipolSai is among the top insurance companies in the world and the fourth among European multi-segment companies in terms of Total Shareholder Return (TSR) in the five-year period 2018-2022, according to findings of the study "The 2023 Insurance Value Creators Report" prepared by Boston Consulting Group in November 2023. TSR is a measure widely used in the financial sector to assess the overall return on investment in the shares of a listed company over time. It is a full representation of the economic benefits that can be obtained by shareholders and includes two key components: on one hand, the change in the share price in a given time window (capital gain) and, on the other, the amount of dividends distributed by the company in the same time interval (dividend yield). In the case of UnipolSai, the average annual return calculated in this way was 11% over the 5 years, significantly higher than the global average in the sector (4%). A particularly significant contribution to performance was the sustained ability to distribute dividends during the period analysed.

The income statement and statement of financial position values referring to 2023 were prepared by applying IFRS 9 on financial instruments and IFRS 17 on insurance contracts to the entire group scope, replacing IFRS 4 and IAS 39 previously in force. The new accounting standards, in force as of 1 January 2023, were also applied retroactively to the data presented for comparative purposes for the year 2022, to allow for a like-for-like comparison. Please refer to the New accounting standards section of the Notes to the financial statements for information on the effects of the transition on the Group's statement of financial position, income statement and shareholders' equity.
It should also be noted that, in order to provide a better representation of the actual contribution to the consolidated results and also taking into account the significance of this activity on the overall Group, the economic and financial results previously attributed to the Real Estate business have been allocated to the Life business, if referring to assets whose returns affect the services to be provided to subscribers of revaluable products, and to Other Businesses for the residual portion. The different representation of the information by segment was applied retroactively to the figures for previous years, presented for comparative purposes.
The UnipolSai Group closed 2023 with a consolidated net profit of €766m. In 2022, the Group recorded a consolidated net profit of €651m, determined according to the previous accounting standards, which reflected extraordinary expenses of approximately €137m after taxes (normalised profit of €789m).
The 2022 results were negatively affected by the allocation of the solidarity fund for employees for a pre-tax value of €199m, of which Non-Life €178m and Life €20m. The final balance for 2022, restated for comparative purposes in application of the new standards, would have been €466m (normalised result of €604m).
At 31 December 2023, direct insurance premiums, gross of reinsurance, stood at €15,060m, up (+10.4%) compared to €13,645m at 31 December 2022.
Non-Life direct premiums, amounting to €8,651m, recorded growth of 4.2% compared to €8,304m at 31 December 2022. UnipolSai Assicurazioni, which recorded Non-Life premiums of €6,952m (+1.0%), and the other main Group companies contributed to this amount. These included the following:
The MV segment was up by 3.0% compared to the previous year, recording premiums of €4,006m. Premiums were positively affected by the tariff increases made necessary due to the rising cost of claims caused by the significant recovery in inflation recorded over the last two years, which impacted both vehicle repair costs and regulatory adjustments of the reference values of losses for minor injuries and family member losses. Moreover, the growth in premiums was mitigated by the effects of the success of the offer to UnipolSai customers of the possibility of monthly premium instalments without additional charges. In addition, the accessory guarantees included in the Land Vehicle Hulls class, which recorded growth of 6.0% compared to 2022, are also continuously developing.
Premiums in the Non-MV segment continued to record positive performance, amounting to €4,645m, with growth of 5.2% compared to 31 December 2022, thanks to the contribution of all of the main business lines and sales channels of the Group.
All Ecosystem business lines posted positive performance.
The Mobility Ecosystem recorded €4,365m in insurance premiums (+3.0%). In this ecosystem, the growth of UnipolRental was further consolidated, reaching a stock of 136k contracts acquired against 78k at the end of 2022, benefitting from the merger by incorporation of the company SIFÀ (Società Italiana Flotte Aziendali) starting from the second half of the year. The total number of vehicles registered at 31 December 2023 was 38,061, compared to 23,377 in the same period of last year.
In 2023, the Welfare Ecosystem reported €1,772m in premiums (+7.4%), with a significant increase in the Health Class (+13.5%), while the Property Ecosystem, with insurance premiums of €2,514m, grew by 4.0%.

The combined ratio at 31 December 2023 was 98.2%. The loss ratio was 71.5%, while the expense ratio stood at 26.7%. The 2023 loss ratio was affected by atmospheric events linked to the flood that struck Emilia-Romagna in May and the wind and hail storms in Northern Italy at the end of July. These were exceptional events that demonstrate the danger of ongoing climate change that the insurance sector will have to face more and more.
As of 2023, with the introduction of the new income statement formats following the entry into force of IFRS 17, the ratio is calculated using the following formula: 1 - (insurance service result/revenue from insurance contracts).
The Non-Life pre-tax profit was €671m, compared to €711m in 2022 determined using the previous accounting standards (normalised profit of €889m), and the 2022 profit of €596m recalculated according to the new accounting standards (normalised profit of €775m).
In the Life business, the Group achieved direct premiums of €6,409m, up sharply (+20.0%) compared to €5,341m in 2022, despite a still difficult market context due to the generalised increase in interest rates and the climate of uncertainty also created by the Eurovita crisis, the resolution of which also benefited from a contribution from the Unipol Group. The sales networks focused on traditional and multi-segment products, with a view to optimising the net flows of segregated funds, which made it possible to achieve positive net inflows.
Premiums were very strong in the bancassurance channel, which with Arca Vita, together with the subsidiary Arca Vita International, recorded an increase of 34.8% compared to 2022 (€2,554m).
The parent UnipolSai recorded growth, with direct premiums of €3,811m, +12.3% over 2022, in part thanks to the acquisition of new pension fund contracts.
The Life pre-tax profit was €333m, compared to €275m in 2022 determined using the previous accounting standards (normalised profit of €295m), or €138m recalculated according to the new accounting standards (normalised profit of €158m).
In 2023, the Other Businesses sector benefited from the positive performance of the hotel sector represented by the UNA Group, which crowns a year of recovery in tourist flows, and the MICE segment (conferences, business trips, etc.), achieving turnover of over €200m and a net profit of €25m.
The pre-tax profit of the Other Businesses sector came to €16m compared to a pre-tax loss of -€65m at 31 December 2022 according to the previous accounting standards and -€42m recalculated with the new accounting standards.
The management of financial investments benefited from the increase in the profitability of new investments, focusing on investment grade securities, with a simultaneous improvement in terms of diversification and the overall risk-return profile.
The gross profitability of the Group's insurance financial investments portfolio achieved a return of 3.8% on invested assets, of which 3.4% from coupons and dividends and 0.4% from sales and valuations. The same figure at 31 December 2022, calculated with the IAS 39 accounting standard in force at the time, was 3.2%, of which 3.3% linked to the coupons and dividends component.
At 31 December 2023, consolidated shareholders' equity amounted to €7,307m (€6,733m at 31/12/2022, recalculated according to the accounting standards currently in force), of which €7,026m pertaining to the Group. The change during the period benefited not only from the positive result for the period, but also from the financial market recovery.
The individual solvency ratio at 31 December 2023 was 313% (288% at 31/12/2022), net of expected dividends.

The Consolidated Financial Statements of the UnipolSai Group at 31 December 2023 closed with a net profit of €766m (profit of €466m at 31/12/2022: please recall that the result was negatively affected by the allocation of the solidarity fund for employees in the amount, net of the related tax effect, of €137m, of which €123m in the Non-Life business and €14m in the Life business), net of taxes for the period of €253m.
The Insurance sector contributed €754m to consolidated net profit (€500m at 31/12/2022), of which €514m related to Non-Life business (€416m at 31/12/2022), and €239m related to Life business (€84m at 31/12/2022). The Other Businesses sector recorded a profit of €13m (loss of -€34m at 31/12/2022).
Other important factors that marked the economic performance of the Group included the following:
the loss ratio in the Non-Life segment was 71.5%;
the expense ratio in the Non-Life segment was 26.7%;
A summary of the Consolidated Operating Income Statement at 31 December 2023 is illustrated below, broken down by business segment: Insurance (Non-Life and Life) and Other Businesses, compared with the data at 31 December 2022.

| Non-Life Business | Life Business | Insurance Sector | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | var. % | 31/12/2023 | 31/12/2022 | var. % | 31/12/2023 | 31/12/2022 | var. % | |
| Insurance revenues from insurance contracts issued |
8,947 | 8,000 | 11.8 | 623 | 549 | 13.6 | 9,571 | 8,549 | 12.0 |
| Insurance service expenses from insurance contracts issued |
(9,029) | (6,985) | 29.3 | (376) | (322) | 16.5 | (9,405) | (7,307) | 28.7 |
| Reinsurance contracts held result | 247 | (162) | n.s. | (6) | (7) | (6.7) | 240 | (168) | n.s. |
| Result of insurance services | 165 | 854 | (80.7) | 241 | 220 | 9.8 | 406 | 1,074 | (62.2) |
| Balance on investments* | 680 | (38) | n.s. | 1,311 | 923 | 42.1 | 1,991 | 885 | 125.1 |
| Net financial costs/revenues relating to insurance contracts |
(97) | 71 | n.s. | (1,191) | (910) | 30.9 | (1,289) | (840) | 53.5 |
| Net financial result (excluding interest expense on financial liabilities) |
583 | 33 | n.s. | 120 | 13 | n.s. | 702 | 45 | n.s. |
| Other revenue/costs | 9 | (244) | n.s. | 6 | (64) | n.s. | 16 | (308) | n.s. |
| Profit(Loss) before tax and interest expense on financial liabilities |
757 | 643 | 17.7 | 367 | 168 | 118.5 | 1,124 | 811 | 38.6 |
| interest expense on financial liabilities | (86) | (46) | 85.4 | (34) | (30) | 12.8 | (120) | (77) | 56.7 |
| Pre-tax Profit/(Loss)for the period | 671 | 596 | 12.5 | 333 | 138 | 141.6 | 1,004 | 734 | 36.7 |
| Income taxes | (157) | (181) | (13.3) | (94) | (53) | 75.5 | (250) | (234) | 7.0 |
| Profit (Loss) from discontinued operations |
|||||||||
| Consolidated Profit (Loss) | 514 | 416 | 23.7 | 239 | 84 | 183.4 | 754 | 500 | 50.7 |
| Consolidated Profit (Loss) attributable to the owners of the Parent |
|||||||||
| Consolidated Profit (Loss) attributable to non-controlling interests |
* excluding interest expense on financial liabilities

| Other Businesses | Intersegment eliminations | Total | ||||||
|---|---|---|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | var. % | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | var. % | |
| 9,571 | 8,549 | 12.0 | ||||||
| (9,405) | (7,307) | 28.7 | ||||||
| 241 | (168) | n.s. | ||||||
| 407 | 1,074 | (62.1) | ||||||
| 62 | 21 | n.s. | (46) | (44) | 2,007 | 863 | 132.6 | |
| (1,289) | (840) | 53.5 | ||||||
| 62 | 21 | n.s. | (46) | (44) | 718 | 23 | n.s. | |
| (36) | (60) | (39.2) | 42 | 40 | 20 | (329) | n.s. | |
| 26 | (39) | n.s. | (4) | (3) | 1,145 | 768 | 49.1 | |
| (10) | (2) | n.s. | 4 | 3 | (126) | (76) | 66.4 | |
| 16 | (42) | n.s. | 1,019 | 692 | 47.3 | |||
| (3) | 8 | n.s. | (253) | (226) | 11.9 | |||
| 13 | (34) | n.s. | 766 | 466 | 64.4 | |||
| 700 | 418 | |||||||
| 66 | 48 |

The Group's insurance business closed the period with a pre-tax profit of €754m (profit of €500m at 31/12/2022), of which €514m relating to Non-Life business (€416m at 31/12/2022) and €239m relating to the Life business (€84m at 31/12/2022). It should be noted that the result at 31 December 2022 was negatively affected by the allocation of the solidarity fund for employees on the amount, net of the related tax effect, of €137m (of which Non-Life €123m and Life €14m).
Investments and cash and cash equivalents of the Insurance sector, including properties for own use, totalled €62,507m at 31 December 2023 (€58,152m at 31/12/2022), of which €13,654m in the Non-Life business (€14,390m at 31/12/2022) and €48,853m in the Life business (€43,762m at 31/12/2022).
Insurance liabilities amounted to €51,200m (€47,327m at 31/12/2022), of which €13,585m in the Non-Life business (€12,772m at 31/12/2022) and €37,615m in the Life business (€34,556m at 31/12/2022).
Financial liabilities amounted to €13,489m (€10,870m at 31/12/2022), of which €2,301m in the Non-Life business (€1,477m at 31/12/2022) and €11,188m in the Life business (€9,392m at 31/12/2022).
Total premiums (direct and indirect premiums and investment products) at 31 December 2023 amounted to €15,205m (€13,843m at 31/12/2022, +9.8%). Non-Life premiums amounted to €8,796m (€8,502m at 31/12/2022, +3.5%) and Life premiums amounted to €6,410m (€5,341m at 31/12/2022, +20%), of which €2,237m related to investment products (€2,170m at 31/12/2022, +3.1%).
| Total premiums |
|---|
| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| 31/12/2023 | % comp. | 31/12/2022 | % comp. | % var. | ||
| Non-Life direct premiums | 8,651 | 8,304 | 4.2 | |||
| Non-Life indirect premiums | 145 | 198 | (26.8) | |||
| Total Non-Life premiums | 8,796 | 57.8 | 8,502 | 61.4 | 3.5 | |
| Life direct premiums | 4,172 | 3,170 | 31.6 | |||
| Life indirect premiums | 6.5 | |||||
| Total Life premiums | 4,172 | 27.4 | 3,171 | 22.9 | 31.6 | |
| Total Life investment products | 2,237 | 14.7 | 2,170 | 15.7 | 3.1 | |
| Total Life premium income | 6,410 | 42.2 | 5,341 | 38.6 | 20.0 | |
| Overall premium income | 15,205 | 100.0 | 13,843 | 100.0 | 9.8 |

Amounts in €m
Direct premiums amounted to €15,060m (€13,645m at 31/12/2022, +10.4%), of which Non-Life premiums totalled €8,651m (+4.2%) and Life premiums €6,409m (+20%).
| Amounts in €m | |||||
|---|---|---|---|---|---|
| 31/12/2023 | % comp. | 31/12/2022 | % comp. | % var. | |
| Non-Life direct premiums | 8,651 | 57.4 | 8,304 | 60.9 | 4.2 |
| Life direct premiums | 6,409 | 42.6 | 5,341 | 39.1 | 20.0 |
| Total direct premium income | 15,060 | 100.0 | 13,645 | 100.0 | 10.4 |
Indirect premiums from Non-Life and Life businesses at 31 December 2023 amounted to a total of €145m (€199m at 31/12/2022, -26.8%), almost entirely made up of Non-Life business.
| Amounts in €m | |||||
|---|---|---|---|---|---|
| 31/12/2023 | comp. % | 31/12/2022 | % comp. | % var. | |
| Non-Life indirect premiums | 145 | 99.8 | 198 | 99.9 | (26.8) |
| Life indirect premiums | 0.2 | 0.1 | 6.5 | ||
| Total indirect premiums | 145 | 100.0 | 199 | 100.0 | (26.8) |
Group premiums ceded totalled €515m (€543m at 31/12/2022), of which €494m in premiums ceded in Non-Life business (€524m at 31/12/2022) and €21m in Life business (€19m at 31/12/2022). Retention ratios remained essentially stable in both Non-Life and Life businesses.
| 31/12/2023 | comp. % | 31/12/2022 | % comp. | % var. | |
|---|---|---|---|---|---|
| Non-Life ceded premiums | 494 | 95.9 | 524 | 96.5 | (5.8) |
| Retention ratio - Non-Life business (%) | 94.4% | 93.8% | |||
| Life ceded premiums | 21 | 4.1 | 19 | 3.5 | 9.9 |
| Retention ratio - Life business (%) | 99.5% | 99.4% | |||
| Total premiums ceded | 515 | 100.0 | 543 | 100.0 | (5.3) |
| Overall retention ratio (%) | 96.0% | 95.3% |
Retention ratio is the ratio of premiums retained (total direct and indirect premiums net of premiums ceded) to total direct and indirect premiums. Investment products are not included in calculating this ratio.

Total Non-Life premiums (direct and indirect) at 31 December 2023 were €8,796m (€8,502m at 31/12/2022, +3.5%). Direct business premiums alone amounted to €8,651m (€8,304m at 31/12/2022, +4.2%).
The breakdown of direct business for the main classes and the changes with respect to 31 December 2022 are shown in the following table:
| Amounts in €m | |||||
|---|---|---|---|---|---|
| 31/12/2023 | comp. % | 31/12/2022 | % comp. | % var. | |
| Land, sea, lake and river motor vehicles TPL (classes 10 and 12) | 3,059 | 35.4 | 2,994 | 36.1 | 2.2 |
| Land Vehicle Hulls (class 3) | 947 | 10.9 | 894 | 10.8 | 6.0 |
| Total premiums - Motor Vehicles | 4,006 | 46.3 | 3,888 | 46.8 | 3.0 |
| Accident and Health (classes 1 and 2) | 1,772 | 20.5 | 1,650 | 19.9 | 7.4 |
| Fire and Other damage to property (classes 8 and 9) | 1,392 | 16.1 | 1,322 | 15.9 | 5.3 |
| General TPL (class 13) | 807 | 9.3 | 771 | 9.3 | 4.6 |
| Other classes | 674 | 7.8 | 674 | 8.1 | (0.0) |
| Total premiums - Non-M-V | 4,645 | 53.7 | 4,416 | 53.2 | 5.2 |
| Total Non-Life direct premiums | 8,651 | 100.0 | 8,304 | 100.0 | 4.2 |

In 2023, the direct premiums of the UnipolSai Group amounted to €8,651m (+4.2%). Premiums in the MV TPL class amounted to €3,059m (+2.2%). The Land Vehicle Hulls class was also up, with premiums equal to €947m; income in the Non-MV segment was up, with premiums totalling €4,645m (+5.2%).

The loss ratio net of reinsurance was 71.5%.
As mentioned previously, the 2023 loss ratio was affected by atmospheric events linked to the flood that struck Emilia-Romagna in May and the wind and hail storms in Northern Italy at the end of July. These were exceptional events that demonstrate the danger of ongoing climate change that the insurance sector will have to face more and more.
The number of claims reported, without considering the MV TPL class, recorded an increase of 40.5%, mainly due to the significant growth in claims reported relating to the Health class. The table with the changes by class is provided below.
| 31/12/2023 | 31/12/2022 | % var. | |
|---|---|---|---|
| Land Vehicle Hulls (class 3) | 446,992 | 353,804 | 26.3 |
| Accident (class 1) | 112,542 | 103,128 | 9.1 |
| Health (class 2) | 6,287,983 | 4,235,328 | 48.5 |
| Fire and Other damage to property (classes 8 and 9) | 378,542 | 282,821 | 33.8 |
| General TPL (class 13) | 90,737 | 86,476 | 4.9 |
| Other classes | 524,060 | 518,298 | 1.1 |
| Total | 7,840,856 | 5,579,855 | 40.5 |
As regards the MV TPL class, where the CARD agreement2 is applied, in 2023, 534,844 "fault" claims (Non-Card, Debtor Card or Natural Card) were managed, a decline of 1.6% (543,525 at 31/12/2022).
Claims reported that present at least a Debtor Card claims handling numbered 328,326, up by 4.5% compared to the same period in the previous year.
Handler Card claims were 401,325 (including 81,620 Natural Card claims, claims between policyholders at the same company), up by 3.4%. The settlement rate in 2023 was 77.9%% versus 78.7% in the same period of the previous year. The weight of cases to which the Card agreement may be applied (both Handler Card and Debtor Card claims) out of the total cases (Non-Card + Handler Card + Debtor Card) in 2023 was equal to 85.4% (82.7% at 31/12/2022).
The change is largely due to the entry into the CARD regime as of 1 January 2023 of some foreign companies that previously did not participate in the direct compensation scheme. The different management of claims involves a reassignment between Non-Card and Card claims.
The expense ratio in the Non-Life segment was 26.7%.
The combined ratio at 31 December 2023 was 98.2%.
2 Below is a brief description of the terms used:
- Non-Card claims: claims governed by the ordinary regime, to which CARD is not applied;
- Debtor Card claims: claims governed by CARD where "our" policyholder is fully or partially liable, which are settled by the counterparty's insurance companies, to which "our" insurance company must pay a flat rate pay-out ("Debtor Flat Rate");
- Handler Card claims: claims governed by CARD where "our" policyholder is fully or partially not liable, which are settled by "our" insurance company, to which the counterparty's insurance companies must pay a flat rate pay-out ("Handler Flat Rate").
However, it must be noted that this classification is a simplified representation because, in reality, each individual claim may contain damages included in each of the three above-indicated cases.

The performance of the main Group companies at 31 December 2023 is summarised in the following table:
| Amounts in €m | |||||
|---|---|---|---|---|---|
| Premiums written |
% Var. | Investments | Insurance Liabilities | ||
| NON-LIFE INSURANCE SECTOR | |||||
| UNIPOLSAI ASSICURAZIONI SpA | 7,440 | 3.3 | 14,781 | 12,140 | |
| ARCA ASSICURAZIONI SpA | 272 | 10.9 | 455 | 307 | |
| DDOR NOVI SAD ADO | 114 | 10.6 | 102 | 81 | |
| COMPAGNIA ASSICURATRICE LINEAR SpA | 216 | 12.2 | 382 | 317 | |
| UNISALUTE SpA | 796 | 29.6 | 668 | 503 | |
| SIAT SpA | 192 | 11.3 | 162 | 303 |
The direct premiums of UnipolSai, the Group's main company, stood at €6,952m (€6,883m at 31/12/2022, +1.0%), of which €3,701m in MV business (€3,621m at 31/12/2022, +2.2%) and €3,250m in Non-MV business (€3,263m at 31/12/2022, roughly -0.4%).
Also considering indirect business, premiums acquired at 31 December 2023 amounted to €7,440m (+3.3%).
In the MV segment, the measures to recover the margins of the MV TPL business, applied from the end of 2022, have allowed for a significant reversal of the downward trend in the average premium that has characterised the business over the last 10 years. The rise in the average premium, which accelerated in the second half of 2023, guaranteed an increase in premiums which, net of the effect of monthly instalments, would have reached a higher value of growth. The growth in premiums concerns both the individual policies segment, due to the increase in the average premium, and the fleet segment, where the increase in the insured fleet of some major customers had an effect. The gradual return to post-pandemic normality has maintained a certain advantage in terms of claims frequency, which marked a reduction compared to 2022, with an ensuing decrease in the number and cost of claims, despite the higher average cost deriving from inflationary pressures and recent case law guidelines on minor injuries and the quantification of family member losses on claims with fatalities. The recovery in the average premium and the improvement in the claims frequency have caused the technical result of the class to improve.
As concerns the Land Vehicle Hulls class, premiums for 2023 were significantly impacted by the effect of the new monthly splitting. Furthermore, the increase in premiums was significantly caused by the higher average premium of some significant guarantees, including Natural Events, Kasko (Comprehensive cover), Collision and Socio-Political Events. The number of claims and costs is up in part due to a gradual recovery in the claims frequency, accompanied by an increase in the average cost that is involving certain guarantees but, above all, due to weather, flood and hail events, which have heavily affected the class and resulted in a negative technical balance.
Among the actions carried out in 2023 aimed at making settlement processes more efficient, the Telematica project was launched in collaboration with UnipolTech, aimed at improving the effectiveness of boxes and expanding the set of available data. With a view to the evolution of the electronic settlement process and the innovative use of the information provided by the black box for MV claims, from the end of June 2023 information from the electronic data present in the Unico platform was also integrated in Liquido, in order to provide the adjuster with more information available directly on the settlement instrument, for each applicable claim. Claim liability predictive models are also constantly improving in order to improve the verification by the adjuster of consistency between statements made and the actual dynamics of the event; as of the end of 2023, these models were further refined with the introduction of geospatial features that further boost prediction accuracy. The optimisation of the Real Time claims management process continued, which envisages the opening of a claim from the moment of a crash detected in black box data, at the same time triggering initial contact with the policyholder and anticipating the information collection stage.
In 2023, the "Lorentz" tool for detecting the intensity of atmospheric events was improved. It initially focused on precipitation intensity (up to hail), but has now been enhanced with additional maps that also represent the presence and intensity of wind phenomena and waterway flooding. These data, associated with telematics information, contribute to optimising claims management in terms of speed and accuracy in determining what took place and fault, as well as limiting the average cost.

At the end of 2023, CPMs and SPMs provided local coverage via 83 and 413 locations, respectively. The CPM (Medical Report Centre) is a service offered to the injured customer with non-severe injuries (MV, Accident or General TPL), who is given the option to perform the medical-legal examination directly at the offices of the Company and then to be paid promptly. The process was optimised for the booking of the visits by enhancing the customer's contract service and introducing the use of an electronic agenda. In addition to the CPMs located in the Territorial Settlement offices, covering particularly vast areas or with a high incidence of examinations, UnipolSai relies on SPM (Medical Booking Services), where the service is instead performed directly at the doctor's office of the independent expert, where the adjuster also goes. In order to improve the customer experience by offering innovative services, it is now possible to make direct CPM and SPM bookings from the UnipolSai App.
In the course of 2023, a series of actions continued to be taken to optimise the management of claims with injuries through the creation of a number of tools and procedures, which strengthened data use to identify injury type/severity and optimise the injury management and reserving process (first for MV TPL claims and as of the second half of 2023 for General TPL - Accident claims as well). The MV Territorial Settlement network was also reorganised, with the creation of a pool of adjusters specialised in the management of claims with injuries. The reorganisation of the approved representatives medical network continued in 2023, with about 100 new doctors under 40 to generate the turnover necessary to also renew procedures for the management of claims with injuries.
Activities also continued for improvement of the criteria adopted to identify fraud, guaranteeing an adequate system for combating fraudulent phenomena through the evolution of the Anti-Fraud Engine and the platform created for the management of relationship charts, which makes it possible to identify the correlation between events and parties and easily perform advanced searches in order to support investigations.
Lastly, in 2023 the model for the management of reimbursements was revised, changing the part for their identification and collection and business model evolution to guarantee a continuous improvement of results for UnipolSai.
In the Non-MV segment, the reduction in Health premiums already recorded in the first half of the year was due to the consolidation of the UniSalute 2.0 project, which called the centralisation of the health portfolio with UniSalute, the Group's specialist company. The effect of the reduction is mainly on the Agricultural Funds characterised by a significant volume of collections, while on the retail portfolio the decrease was confirmed as more gradual.
The Accident class closed the year 2023 with premiums down. This phenomenon is particularly evident in the retail sector, where the difficulties caused by the macroeconomic context, together with the high rate of inflation, caused a significant contraction in insurance spending capacity. All of this was reflected, for customers, in increasingly frequent recourse to monthly premium payments on standardised products, which slows down incoming cash flows, in addition to giving up all insurance coverage not seen as a priority, such as policies covering traffic accidents.
On the other hand, there was a slight increase in Other Damage to Property premiums, linked in particular to the Construction sector, which maintains a growth trend due to the increase in premiums of policies covering public tenders, especially within the scope of the NRRP, in addition to an increase in Other TPL premiums, widespread across the various segments with the exception of Public Entities and those sectors with activities linked to certifications for the 110% Superbonus. It should be noted that in 2023 growth was confirmed in Goods in Transit premiums, due to the positive influence of commercial development actions and synergies with other classes.
As concerns General Classes (GC) Direct Repair, the project for the creation of a network of craftsmen is under way, with the creation of UnipolHome, to favour the transition of the current GC Direct Repair model to a more structured one, with full supervision by the Company. The ultimate goal of this action is to achieve benefits in terms of cost and service on Property settlement.
The review of the Customer Journeys of customers who suffer an MV or Property claim is another of the priorities of the current Strategic Plan. Customer data and digital data collected during and after the claim using new technologies will be used to set up personalised interventions that will guarantee a multichannel, simple and rapid experience that keeps pace with the times, thus impacting average cost containment as well as UnipolSai's reputation.
Arca Assicurazioni achieved a net profit at 31 December 2023 of roughly €66m (€40.8m at 31/12/2022), recording direct premiums for €272.2m (+10.9%). Specifically, there was an increase in both the Non-MV segment (+10.3%) and the MV segment (+13.5%), while the Protection segment basically remained stable. The breakdown of the portfolio among the distribution channels is almost totally focused on the banking channel which, at 31 December 2023, recorded 99.1% of total Non-Life premiums (in line with the 2022 figure of 99%). Overall, the banking channel recorded an approximate 11% increase in premiums compared to the previous year, with premiums written totalling approximately €269.7m.
In the MV segment, in order to cope with the increase in compensation for non-financial damage relating to minor injuries, established by the MISE decree of 8 June 2022, and the growing cost of repairing vehicles due to inflationary trends that particularly affect component prices, a number of measures were implemented to increase the tariff.
Compagnia Assicuratrice Linear, a company specialised in direct sales (online and call centre) of MV products, in 2023 generated a profit of €10.8m, up compared to 31 December 2022 (€10.2m). Total gross premiums at just under €216m were up compared to 2022 (€192.6m). The partnership for the sale of Home Assistance insurance with Hera, an Italian multiutility based in Bologna, generated premiums written for around €1.5m in 2023 (€1.9m at 31/12/2022). The contribution of the product "Poste Guidare Sicuri LN", placed through the Poste Italiane network, was also positive, recording premiums of around €10.5m (€7.3m at 31/12/2022). The new product "Berebel Autovetture", in collaboration with Berebel, recorded premiums of around €7m in 2023. At the end of 2023, there were close to 684k contracts in the portfolio (-1.9%), a moderate decline compared to the portfolio development experienced in recent years.
DDOR Novi Sad recorded a total net profit (Non-Life and Life) at 31 December 2023 of around €4.2m (against a total loss at 31/12/2022 of around €0.3m), despite the negative contribution of the Non-Life business to the technical result due to the significant impact of catastrophic events and one-off events that occurred during the year. Total premiums were up and stood at €134.1m at 31 December 2023 (of which €113.9m in the Non-Life business) compared to €121.7m at 31 December 2022 (of which €103m Non-Life). The market context of the Serbian insurance sector continues to be characterised by intense competition in the Large Customers and MV segments, favoured by relative underdevelopment compared to the most advanced European insurance markets, although gradual progress is currently being made.
Incontra recorded a profit of around €25m at 31 December 2023 (profit of roughly €31m at 31/12/2022), with premiums decreasing by approximately 16% year-on-year, from €154.4m at the end of 2022 to €129.3m at 31 December 2023, mainly concentrated in the Health and Pecuniary Losses classes. Please note that on 30 November 2023, the sale to Unicredit S.p.A. by UnipolSai of the equity investment held in Incontra Assicurazioni became effective. For further information, please refer to the section "Information on significant events during the year".
The year 2023 recorded a profit of €5.8m for SIAT (€5.4m at 31/12/2022). Total gross premiums (direct and indirect) were up by roughly 11.3% to €192m (€173m at 31/12/2022). In particular, as regards the Hulls sector, the increase in business was due in part to extra premiums collected as a result of the continuing war between Russia and Ukraine and in part to the renewal of some fleets, including MSC, for a high amount. Newly acquired business was extremely limited; on the whole, the number of fleets in the portfolio was down compared to last year. The increase in premiums in the Goods segment is largely attributable to the continuation of the Russia-Ukraine conflict as well as the contribution of additional premiums relating to the risks of war and strikes for voyages departing from the Black Sea, as well as the underwriting of new business, the development of the digital world and the increase in the market value of raw materials, with the resulting increase in premiums relating to commodities policies. In addition, with the aim of greater portfolio diversification, this sector continues to seek and develop (through medium-small intermediaries) business with customers belonging to small - medium enterprises, which are normally more profitable and, therefore, with good expected profitability.
UniSalute, the insurance company specialised in the healthcare sector, confirms its leadership in the Healthcare segment, increasing direct premiums by 38.7% (10.6% at 31/12/2022). Total premiums (including indirect business) amounted to €796.2m (€614.3m at 31/12/2022), up by 29.6%. In terms of claims, in the Health class, claims paid during the year amounted to €474.7m, up compared to 2022 (+19.6%), while in the Accident class, claims paid during the year amounted to €5m (+19%). The increase is attributable to the increase in the loss ratio of the corporate portfolio as well as the incidence of claims of the retail and SME and bancassurance channels. 2023 posted a profit of €71.9m, up compared to €64.1m at the end of 2022. In this context, business in 2023 highlighted, in particular, new acquisitions including the Local Public Transport Fund, Ferservizi (Ferrovie dello Stato Group), Caspop (Banco Popolare Group Welfare Fund), Asdep (National Association for Healthcare of Public Entity employees), ENAV and ARERA, reforms on a significant number of health plans already in the portfolio, such as Fondo Sanilog, Fondo Sanedil, Fondo Fasda, Fideuram, Italo and Abbvie, and finally an increase of the insured population in the main sector Funds.

In the MV TPL and Land Vehicle Hulls segment, starting from February 2023, the new Unibox Smart Drive device was marketed, a new telematics solution that for proper operation involves interaction via Bluetooth between the device to be positioned autonomously on the windscreen and a specific App to be installed on the smartphone. In addition to in-vehicle safety services, with the detection of road accidents above a certain level and the subsequent dispatch of help, the App also provides the possibility of monitoring CO₂ levels and the fuel saved during the year by virtue of the driving style adopted. The initiative, included in the Data Driven Omnichannel Insurance guideline of the "Opening New Ways" Plan, enhances the widespread and advanced use of Data and Analytics to consolidate the technical and distribution excellence of the Company, through an extremely innovative insurance product.
In 2023, a number of tariff review measures were adopted for the MV price list, in continuity with the manoeuvre already initiated at the end of 2022, aimed at pursuing technical excellence in the Non-Life MV business and guaranteeing adequate levels of development and margins. As of September 2023, the new Customer Life Time Value (CLTV) indicator has been used to assess the prospective value of each customer by analysing both the profit margins that they generate with their policies, and their retention and propensity to purchase other policies in the future: customers with a higher CLTV will be able to take advantage of lower MV TPL rate increases.
With regard to the Non-MV segment, during 2023, UnipolSai expanded the range of products for the protection of companies. The month of January saw the launch of UnipolSai Condominio Più, the solution capable of responding flexibly to the needs of different condominium contexts thanks to a modular and scalable offer.
In January 2023, the new Scudo Cyber product was also unveiled, the first stand-alone cyber product to complete the range of digital covers aimed at small and medium-sized enterprises, professional firms and the third sector and offer the possibility of customising all cover depending on specific customer requirements. It also includes the Quick Recovery service, which makes it possible to use the intervention of the Cyber Incident Response Team to limit or avoid the aggravation of the damage, without any advance payment or deductible.
From 12 April 2023, note the new UnipolSai Focus Commercio product, intended for commercial activities and services, which offers dedicated cover for car repairers, service stations and the catering trade; insurance cover is also provided for professional and consulting firms. The main innovation of the product lies in the architecture of the individual sections, divided into a more streamlined and therefore more accessible basic offer, enriched by supplementary and additional guarantees.
As of 29 September 2023, it is also worth mentioning the new UnipolSai Focus Impresa product, intended for small and medium-sized enterprises for the risks associated with the performance of industrial and craft-trade business activities and for owners of construction companies. The main innovation of the new product lies in the architecture of the individual sections, divided into a more streamlined and more accessible basic offer, enriched by supplementary guarantees and additional conditions that make it possible to build a complete package based on the needs of the insured company. The main innovations include the introduction of the Environmental Damage Section, which makes available the know-how and advice of expert professionals in the environmental sector, such as technical consultants and reclamation and emergency service companies, to the insured party through the "Pool Ambiente" Consortium.
In the first few months of 2023, two new policies were issued on the UniSalute website, UniSalute Donna and UniSalute Uomo, in addition to the offer of online healthcare solutions specifically for individuals and families. The two new products are aimed at women and men between 14 and 80 years of age and offer numerous services: in addition to hospitalisation, reimbursement of sanitary tickets and subsidised rates, prevention packages are provided which are common to both women and men (e.g. cardiovascular, ophthalmologic, dermatological) and others, more specific, such as gynaecology and breast care preventive services for UniSalute Donna, and urology preventive services for UniSalute Uomo.
In January 2023, UniSalute's offer of individual solutions was enhanced with two new products within the range of policies proposed through this channel: UniSalute Sanicard Rinnovo Garantito and UniSalute Invalidità. The first is an innovative policy that allows you to protect your health year after year up to the age of 80, regardless of how your conditions change. The second, thanks to an indemnity combined with assistance coverage, protects the peace of mind of the insured and his/her family in the event of serious illnesses that compromise the ability to work.

With reference to the subsidiary Arca Assicurazioni, since the beginning of January the new single-premium product Ama & Proteggi - Benvenuto a casa has been made available for marketing, which offers cover of the building used as a residence against risks deriving from fire, lightning, explosion, blasts, atmospheric events and socio-political events. In addition, since May 2023 the annual premium product Ama & Proteggi - Casa a tua modo has been made available, which offers the possibility to adapt and choose insurance coverage. In addition, in order to make it more responsive to customer needs, the product makes it possible to insure up to 3 homes and to purchase the new cover against catastrophe risks from flooding, which supplements the earthquake guarantee already present in the products in the catalogue. Lastly, with reference to the Protection segment, the Salva Prestito range products were restyled as of 1 January, while Salva Mutuo products and the Arca Valore Impresa CPI product were restyled at the end of the year.
Since 21 February 2023, Compagnia Assicuratrice Linear's new Casa e Famiglia product has been on the market. It was developed in response to the need to offer cover that could meet new customer needs by expanding the product catalogue. Casa e Famiglia has a modular and highly customisable structure based on the customer's needs and provides coverage to protect: the home, assets and the person. It is sold both through the Linear website, through autonomous navigation, and through a call to the call centre, and can only be purchased by credit card.

Total Life premiums (direct and indirect) were €6,410m (€5,341m at 31/12/2022, +20%).
The direct premiums, which represent almost all of the premiums, are broken down as follows:
| Amounts in €m | |||||
|---|---|---|---|---|---|
| 31/12/2023 | comp. % | 31/12/2022 | % comp. | % var. | |
| Total premium income | |||||
| I - Whole and term Life insurance | 3,986 | 62.2 | 2,878 | 53.9 | 38.5 |
| III - Unit-linked/index-linked policies | 466 | 7.3 | 946 | 17.7 | (50.7) |
| IV - Health | 14 | 0.2 | 14 | 0.3 | 2.2 |
| V - Capitalisation insurance | 151 | 2.4 | 199 | 3.7 | (24.1) |
| VI - Pension funds | 1,792 | 28.0 | 1,304 | 24.4 | 37.4 |
| Total Life business direct premium income | 6,409 | 100.0 | 5,341 | 100.0 | 20.0 |
| of which Investment products (IAS 39) | 2,237 | 2,170 | 22.2 |
Even within the current difficult economic context, UnipolSai Assicurazioni has maintained its strong position in the supplementary pensions market.
UnipolSai managed a total of 28 Occupational Pension Fund mandates at 31 December 2023 (22 of them for accounts "with guaranteed capital and/or minimum return"). At the same date, resources under management totalled €5,834m (€5,187m of which with guaranteed capital). At 31 December 2022, UnipolSai managed a total of 23 Occupational Pension Fund mandates (18 of which "with guaranteed capital and/or minimum return"); resources under management totalled €4,390m (of which €3,811m with guaranteed capital).
As regards Open Pension Funds, at 31 December 2023 the Group managed 2 open-ended pension funds (UnipolSai Previdenza FPA and Fondo Pensione Aperto BIM Vita) which at that date amounted to a total of 41,337 members for total assets of around €953m. At 31 December 2022, those Funds had total assets of €881m and a total of 41,103 members.
The performance of the main Group companies at 31 December 2023 is summarised in the following table:
| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| Premiums written |
% Var. | Investments | Insurance Liabilities | |||
| LIFE INSURANCE SECTOR | ||||||
| UNIPOLSAI ASSICURAZIONI SpA | 3,811 | 12.3 | 34,044 | 25,587 | ||
| of which Investment products | 1,936 | 58.6 | ||||
| ARCA VITA SpA + AVI | 2,554 | 34.8 | 14,804 | 11,570 | ||
| of which Investment products | 292 | (51.0) | ||||
| BIM VITA SpA | 25 | (29.8) | 564 | 421 | ||
| of which Investment products | 9 | (35.6) |
UnipolSai collected direct premiums totalling €1,875m (€2,172m at 31/12/2022, -13.7%) in addition to financial products amounting to €1,936m (€1,221m at 31/12/2022).

The individual policies segment showed a decline of 5.1% compared to 2022, while collective policy premiums showed an increase of 27.3% compared to the same period of the previous year due to acquisition of the new Class VI pension funds (+37.6%). The growth in total premiums mainly concerns single premiums (+15.6%).
In an unfavourable market context, in addition to the excellent Class VI result, there was an increase in Class I premiums (+5.6%) and an increase in Class IV premiums (+1.9%).
The decline in first year premiums compared with the previous year (-18.8%) can be attributed primarily to the drop in premiums from Class I products (-16.7%).
BIM Vita recorded a profit of €1.7m at 31 December 2023 (€1.5m at 31/12/2022). Premiums amounted to around €15m (approximately €21m at 31/12/2022, -25.9%). The volume of investments stood at €564m (€581m at 31/12/2022).
The bancassurance channel of the Arca Group (Arca Vita and Arca Vita International) recorded direct premiums (including investment products) of €2,554m (€1,894m at 31/12/2022), up compared to the previous year, mainly due to Class I products. Considering the changed market scenarios, characterised by significantly higher rates than in previous years and the considerably increasing trend of redemptions, Arca Vita supported Class I premiums through campaigns that favoured New Business for traditional products, without establishing a placement ceiling for multisegment products for 2023. The volume of total investments reached the amount of €14,804m (€12,584m at 31/12/2022). The profit of Arca Vita, net of dividends collected from the subsidiaries, was €59.8m (down compared to €61.1m recognised at 31/12/2022), and that of Arca Vita International was approximately €0.9m (€0.5m at 31/12/2022).
In the first half of 2023, a new version of the Class I investment product, UnipolSai Investimento Garantito, was marketed. The restyling of the product includes a Basic version open to all customers and a Fidelity version dedicated to the reinvestment of amounts from settlements of benefits from other insurance contracts. The new version of the product includes an update of the cost structure on the premium, the overperformance commission and the financial guarantee, recognised only in the event of death or on maturity.
Starting from April, a campaign was launched on the product, aimed at customers who bring in new liquidity, which offers a discount on the management fee.
At the beginning of the second half of 2023, the new individual product UnipolSai Rendita was marketed in the two forms of immediate life annuity and immediate annuity with return of premiums to further supplement the offer.
In July 2023, the single-premium multi-segment product Investimento GestiMix was restyled. The new product maintains the same technical characteristics as the previous one, except the reference segregated fund is replaced with the newly established "PlusValore UnipolSai". Also for this product, together with the multi-segment product Investimento MixSostenibile, sales campaigns began in July that under certain conditions allow the application of a lower commission for the part referring only to the Segregated Fund.
Starting in October 2023, a new version of the Investimento Garantito product was marketed, in which the reference Segregated Fund was changed and the percentage costs were eliminated in the version from reinvestment. When the new version of the product was launched, a sales campaign began which, under certain conditions, allows for the application of a lower management fee.
Also as of October 2023, the Previdenza Futura product (individual pension plan) was updated, with a reduction in percentage loading on payments made starting from 18 October 2023 for enrollees up to the day before reaching the age of 26.
In October, marketing began of a new version of the capitalisation product, Investimento Capital, open to all customers. The main changes introduced concerned reduced loading, the introduction of additional payments, the revision of the management fee and the updating of redemption penalties. When the product was released, a campaign was launched that offered a reduction in the management fee for customers who bring in new liquidity.
In February 2023, the subsidiary Arca Vita launched an insurance solution consisting of two products that offer loan protection cover in the event of premature death (TCM) and cover in the event of loss of self-sufficiency (LTC). This product represents the Company's first offer in Class IV (long-term health insurance).

With regard to the risks underwritten in the Non-Life business, the Group reinsurance strategy proposed the same cover structures in place in 2022, maximising the effectiveness of the most operational of the main non-proportional treaties. The renewal for 2023 took place in continuity with those expiring. At Group level, the following cover was negotiated and acquired:
To minimise counterparty risk, reinsurance coverage continued to be spread out and placed with the major professional reinsurers that have been given a high credit rating by major rating agencies, in order to provide a comprehensive and competitive service. The risks of the Legal Expenses and part of Transport classes were instead ceded to specialised reinsurers and/or specialist Group companies.
As regards the Life business, the renewal of reinsurance covers relating to 2023 occurred fully in line with that expiring, therefore the risks underwritten are mainly covered at Group level with two proportional treaties, one for individual risks and one for collective risks in excess of the risk premium. Retention is protected with a nonproportional cover in excess of loss by event that regards the Life and/or Accident classes. There are also three proportional covers for LTC guarantees, one proportional cover for Individual Serious Illnesses and one for Weighted Risks.
The key income statement figures regarding the Other Businesses sector are provided below:
| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | var.% | ||||
| Gains/losses on investments in associates and interests in joint ventures |
5 | 5 | 11.5 | |||
| Gain/losses on other financial assets and liabilities and investment property |
47 | 13 | n.s. | |||
| Net financial result | 52 | 18 | 183.5 | |||
| Other revenue | 429 | 264 | 62.5 | |||
| Other costs (*) | (465) | (324) | 43.7 | |||
| Pre-tax Profit (Loss) for the period | 16 | (42) | n.s. |
(*) Includes Operating expenses, Net provisions for risks and charges, Net impairment losses/reversals on property, plant and equipment and intangible assets, Other operating expenses/income
The items Other revenue and Other costs include, aside from economic components characteristic of companies operating in the hotel and healthcare sector specified in more detail below, also revenue and costs for secondment of personnel and for services provided to and received from companies of the Group belonging to other sectors, eliminated during the consolidation process.
At 31 December 2023, the Investments and cash and cash equivalents of the Other Businesses sector (including properties for own use for €585m) were €2,085m (€1,977m at 31/12/2022).
Financial liabilities amounted to €271m (€212m at 31/12/2022).
With regard to the hotel sector, 2023 closed with a significant improvement over last year. Revenues of the subsidiary Gruppo UNA increased by approximately 40% compared to 31 December 2022 (from €149m to €208m). At 31 December 2023, there were 33 directly managed hotels: it should be noted the acquisition, during 2023, of the management of Hotel Galles in Milan and the first complete annual financial year for the newly opened Unahotels Trastevere. The year 2023 ended with a profit of €25.3m, above the forecasts at the beginning of the year.
In the health sector, Casa di Cura Villa Donatello closed 2023 with revenue of €44m, up by around 8.7% compared to 2022 (€40.5m). Revenue trends show a continuation of the positive performance in the core business, for hospitalisation (hospital stays and outpatient surgery) as well as clinic activities (visits and diagnostics). The company closed with a profit of €2.7m (loss of €1.5m in the previous year).
With regard to agricultural activities, on 30 May 2023 Tenute del Cerro Wines Srl was established with the aim of marketing a broader range of owned and distributed wines, with sales activities starting on 1 July. Considering the combined data of Tenute del Cerro and Tenute del Cerro Wines, packaged wine sales recorded an increase of approximately 4.5% compared to 31 December 2022, reaching €9.9m, while total revenue rose from €11.3m to €11.9m, also as a result of the excellent performance of agri-tourism businesses. The year ended with a total profit of the two companies of €0.2m.

UnipolSai Assicurazioni 2023 Consolidated Financial Statements
At 31 December 2023, the Group's Investments and cash and cash equivalents totalled €64,443m (€59,941m at 31/12/2022), with the following breakdown by business segment:
| Amounts in €m | |||||
|---|---|---|---|---|---|
| 31/12/2023 | comp.% | 31/12/2022 | comp.% | var.% | |
| Insurance sector | 62,507 | 97.0 | 58,152 | 97.0 | 7.5 |
| Other businesses sector | 2,085 | 3.2 | 1,977 | 3.3 | 5.5 |
| Intersegment eliminations | (150) | (0.2) | (188) | (0.3) | (20.2) |
| Total Investments and cash and cash equivalentsquide |
64,443 | 100.0 | 59,941 | 100.0 | 7.5 |
The breakdown by investment category is as follows:
| Amounts in €m | |||||
|---|---|---|---|---|---|
| 31/12/2023 | % comp. | 31/12/2022 | % comp. | % var. | |
| INVESTMENTS | |||||
| Property (*) | 3,869 | 6.0 | 3,852 | 6.4 | 0.4 |
| Investments in associates and interests in joint ventures |
170 | 0.3 | 162 | 0.3 | 4.9 |
| Financial assets at amortised cost | 2,149 | 3.3 | 2,076 | 3.5 | 3.5 |
| Debt securities | 1,282 | 2.0 | 1,262 | 2.1 | 1.5 |
| Other loans and receivables | 868 | 1.3 | 814 | 1.4 | 6.6 |
| Financial assets at fair value through OCI | 40,867 | 63.4 | 37,126 | 61.9 | 10.1 |
| Financial assets at fair value through profit or loss |
16,410 | 25.5 | 15,899 | 26.5 | 3.2 |
| Held-for-trading financial assets | 72 | 0.1 | 281 | 0.5 | (74.4) |
| Financial assets at fair value | 10,679 | 16.6 | 8,786 | 14.7 | 21.5 |
| Other financial assets mandatorily at fair value |
5,659 | 8.8 | 6,832 | 11.4 | (17.2) |
| Cash and cash equivalents | 978 | 1.5 | 826 | 1.4 | 18.4 |
| Total Investments and Cash and cash equivalents |
64,443 | 100.0 | 59,941 | 100.0 | 7.5 |
(*) including properties for own use


Amounts in €m
This section provides information on financial transactions referring to Group investments other than those for which the risk is borne by customers, the only exclusion being portfolios held by the foreign companies DDOR and DDOR Re, the values of which in the Group's total portfolio are of little significance.
In 2023, the investment policies adopted in the financial area continued to apply, in the medium/long term, the general criteria of prudence and preservation of asset quality, in compliance with the Guidelines defined in the Group Investment Policy.
Specifically, financial transactions were geared towards reaching profitability targets consistent with the asset return profile and with the trend in liabilities over the long term, maintaining a high-quality portfolio through a process of selecting issuers on the basis of their diversification and strength, with a particular focus on the liquidity profile.
As regards bonds, a prudent approach was maintained, assuming a positioning consistent with a context of volatile interest rates and still high inflation.
The year was characterised by a restructuring of the exposure to government bonds and a reduction in exposure to Italian government bonds.
During the year, the non-government bond component recorded an increase in the Life business and a decrease in the Non-Life business, mainly involving financial and corporate issuers in the subordinated and corporate securities categories in order to reduce the risk profile of the portfolio.
Exposure to level 2 and 3 structured bonds remained essentially unchanged during 2023.
| 31/12/2023 | 31/12/2022 | variation | ||||||
|---|---|---|---|---|---|---|---|---|
| Carrying | Market | Implied +/- | Carrying | Market | Implied +/- | Carrying | Market | |
| amount | value | amount | value | amount | value | |||
| Structured securities - Level 1 |
14 | 14 | 14 | 14 | ||||
| Structured securities - Level 2 |
222 | 218 | 3 | 227 | 229 | (1) | (6) | (10) |
| Structured securities - Level 3 |
1 | 1 | 1 | 1 | ||||
| Total structured securities |
236 | 233 | 3 | 242 | 243 | (1) | (6) | (10) |
The following table shows the Group's exposure to structured securities:
Equity exposure decreased by €401m in 2023; transactions mainly concerned the securities of issuers operating in the oil, technology and basic resources sectors. On the whole, the portfolio maintains a good dividend yield despite a 25% exposure to ETFs that have a dividend flow close to zero. During the year, exposure to emerging markets was also reduced, replaced by the purchase of call options expiring in December 2024 on China and Emerging Markets, for a nominal amount of €285m.
Exposure to alternative funds, a category that includes Private Equity Funds, Hedge Funds and investments in Real Assets, amounted to €2,753m, an increase of approximately €382m compared to 31 December 2022.
Currency operations were actively managed following the performance of currency prices with a view to managing net exposure to the currency risk of outstanding equity and bond positions.
The Group's overall portfolio duration of 5.57 years was up compared to the end of 2022 (5.28 years). With reference to the Group insurance portfolio, the Non-Life duration was 2.97 years (2.62 years at the end of 2022); the Life duration was 6.48 years (6.33 years at the end of 2022). The fixed rate and floating rate components of the bond portfolio amounted respectively to 91.8% and 8.2%. The government component accounted for approximately 63.7% of the bond portfolio whilst the corporate component accounted for the remaining 36.3%, split into 26.5% financial and 9.8% industrial credit.

92.2% of the bond portfolio was invested in securities with ratings of BBB- or higher. 10.1% of the total is positioned in rating classes AAA and AA-, while 21.3% of securities had an A rating. The exposure to securities in the BBB rating class was 60.7% and includes Italian government bonds which make up 43.1% of the total bond portfolio.
Details of the Net financial result are shown in the following table:
| Amounts in €m | |||||
|---|---|---|---|---|---|
| 31/12/2023 | comp. % | 31/12/2022 | comp. % | var.% | |
| Gains/losses on investment property | 18 | 0.9 | (3) | (0.3) | n.s. |
| Gains/losses on investments in associates and interests in joint ventures |
38 | 1.9 | 15 | 1.6 | 158.5 |
| Net gains on financial assets recognised at amortised cost | 138 | 7.1 | 61 | 6.8 | 125.7 |
| Net gains on financial assets at fair value through OCI (*) | 1,356 | 69.3 | 1,361 | 151.7 | (0.4) |
| Net gains on financial assets at fair value through profit or loss (**) | 406 | 20.8 | (537) | (59.9) | n.s. |
| Total net gains on investments | 1,955 | 100.0 | 897 | 100.0 | 118.0 |
| Net losses on other financial liabilities at amortised cost | (128) | (78) | 65.7 | ||
| Total net losses on financial liabilities | (128) | (78) | 65.7 | ||
| Total net gains (***) | 1,827 | 819 | 123.0 | ||
| Net gains on financial assets at fair value(****) | 668 | (899) | n.s. | ||
| Net losses on financial liabilities at fair value(****) | (614) | 866 | n.s. | ||
| Total net gains on financial instruments at fair value (****) | 54 | (33) | n.s. | ||
| Balance on investments | 1,881 | 786 | 139.2 | ||
| Net financial costs/revenues relating to insurance contracts issued | (1,286) | (838) | 53.5 | ||
| Net financial revenues/costs relating to reinsurance contracts held | (3) | (2) | 50.0 | ||
| Net financial result | 592 | (54) | n.s. |
(*) excluding measurement of financial instruments at fair value through OCI subject to hedge accounting
(**) excluding net gains and losses on financial instruments at fair value through profit or loss for which investment risk is borne by customers (index-and unit-linked) and arising from pension fund management; including measurement of financial instruments at fair value through OCI subject to hedge accounting
(***) excluding net gains and losses on financial instruments at fair value through profit or loss for which investment risk is borne by customers (index-and unit-linked) and arising from pension fund management
(****) net gains and losses on financial instruments at fair value through profit or loss for which investment risk is borne by customers (index-and unit-linked) and arising from pension fund management

Shareholders' equity, excluding non-controlling interests, breaks down as follows:
| Amounts in €m | |||
|---|---|---|---|
| 31/12/2023 | 31/12/2022 | var. in amount | |
| Share capital | 2,031 | 2,031 | |
| Other equity instruments | 496 | 496 | |
| Capital reserves | 347 | 347 | |
| Income-related and other equity reserves | 3,240 | 3,260 | (20) |
| Treasury shares (-) | (3) | (3) | |
| Valuation reserves | 215 | (91) | 306 |
| Profit (loss) for the year attributable to the owners of the Parent (+/-) | 700 | 418 | 282 |
| Total shareholders' equity attributable to the owners of the Parent | 7,026 | 6,458 | 568 |
Movements in shareholders' equity recognised during the year with respect to 31 December 2022 are set out in the attached statement of changes in shareholders' equity.
The main changes in the Group's shareholders' equity were as follows:
Shareholders' equity attributable to non-controlling interests amounted to €281m (€275m at 31/12/2022).
At 31 December 2023, the treasury shares held by UnipolSai and its subsidiaries totalled 1,087,879 (1,162,312 at 31/12/2022), of which 947,782 shares were directly held.
The changes during the year referred to the following transactions:
At 31 December 2023, UnipolSai held a total of 641,014 shares (651,889 at 31/12/2022) issued by the holding company Unipol Gruppo SpA, of which 556,950 directly and the remainder indirectly through the following subsidiaries: SIAT (24,443), UniSalute (19,629), Linear (14,743), UnipolRental (13,783), Leithà (7,056), Arca Vita (2,403) and UnipolAssistance (2,007).
The changes during the year referred to the following transactions:

In compliance with Consob communication no. 6064293 of 28 July 2006, the reconciliation between the Group result for the year and shareholders' equity is provided below, along with the corresponding figures for the Parent:
| Amounts in €m | Share capital and reserves |
Profit(loss) for the year |
Shareholders' equity at 31/12/2023 |
|---|---|---|---|
| Parent balances in accordance with Italian GAAP | 5,715 | 624 | 6,339 |
| IAS/IFRS adjustments to the Parent's financial statements | 1,367 | (26) | 1,341 |
| Differences between net carrying amount and shareholders'equity and profit (loss) for the year of consolidated investments, of which: - Translation reserve |
(1,068) 4 |
320 | (748) 4 |
| - Gains or losses on available-for-sale financial assets | (443) | (443) | |
| - Financial revenues or costs relating to insurance contracts issued and to reinsurance transfers |
334 | 334 | |
| - Other gains or losses recognised directly in equity | 25 | 25 | |
| Consolidation differences | 396 | 396 | |
| Companies measured using the equity method | 36 | 13 | 49 |
| Intercompany elimination of dividends | 166 | (166) | |
| Other adjustments | (70) | (70) | |
| Consolidated Shareholders' equity | 6,541 | 766 | 7,307 |
| Non-controlling interests | 215 | 66 | 281 |
| Shareholders' equity attributable to the owners of the Parent | 6,326 | 700 | 7,026 |

At 31 December 2023, Insurance liabilities amounted to €51,200m (€47,327m at 31/12/2022) and Financial liabilities amounted to €13,571m (€10,894m at 31/12/2022).
| Amounts in €m | |||
|---|---|---|---|
| 31/12/2023 | 31/12/2022 | var.% | |
| Non-Life Insurance liabilities | 13,585 | 12,772 | 6.4 |
| Life Insurance liabilities | 37,615 | 34,556 | 8.9 |
| Total Insurance liabilities | 51,200 | 47,327 | 8.2 |
| Financial liabilities at fair value | 10,507 | 8,723 | 20.5 |
| Investment contracts - insurance companies | 10,412 | 8,568 | 21.5 |
| Other | 95 | 155 | (38.7) |
| Financial liabilities at amortised cost | 3,064 | 2,171 | 41.1 |
| Subordinated liabilities | 1,287 | 1,367 | (5.8) |
| Other | 1,777 | 804 | 121.0 |
| Total financial liabilities | 13,571 | 10,894 | 24.6 |
| Total | 64,771 | 58,221 | 11.3 |
For a correct representation of the accounts under examination, information is provided below of financial debt only, which is the total amount of the financial liabilities not strictly associated with normal business operations.
The situation is summarised in the following table, which shows an increase in debt of approximately €893m.
| Amounts in €m | |||
|---|---|---|---|
| 31/12/2023 | 31/12/2022 | var. in amount | |
| Subordinated liabilities | 1,287 | 1,367 | (80) |
| Payables to banks and other lenders | 1,776 | 803 | 973 |
| Total debt | 3,063 | 2,170 | 893 |
Subordinated liabilities issued by UnipolSai Assicurazioni Spa amounted to €1,287m. The change compared to the previous year is due to the repayment of the last tranche on 24 July 2023 of the subordinated loan granted by Mediobanca in 2003.
Payables to banks and other lenders, amounting to €1,776m (€803m at 31/12/2022), are primarily related to loans taken out for the acquisition of real estate and for improvement works, by the Athens R.E. Closed Real Estate Fund for €140m and by the Tikal Closed Real Estate Fund for €99m, as well as loans taken out by UnipolRental from banks and other lenders for a total of €1,370m. The item also includes the financial liabilities deriving from the present value of future lease payments due on lease agreements accounted for on the basis of IFRS 16 for a total of €137m.

The sustainability guidance function is performed by the Board of Directors, which approves Policies that define the Group's ESG (Environmental, Social and Governance) commitments, the Integrated Three-Year Strategic Plan and the Sustainability Report. Since 2022, the Board has been supported by the Appointments, Governance and Sustainability Board Committee established within UnipolSai, which performs propositional, advisory, investigation and support functions for the Board of Directors with regard to ESG topics, coordinating – for the areas of competence – the policies, processes, initiatives and activities designed to monitor and promote the efforts of the Company for the pursuit of sustainable success. The implementation of the strategies is supported by the Sustainability Function, which reports to the Chief Executive Officer.
Sustainability is integrated within the strategies and activities of the Group, which pursues the objectives of creating shared value, support for sustainable development and the prevention and mitigation of ESG risks.
The commitments made in the Unipol Gruppo Code of Ethics are concretely expressed in the Sustainability Policy, which outlines strategies for pursuing the objectives of Sustainable Success and the management of ESG risks and impacts, in line with the overall system for the management of the risks and impacts generated by the Group as a result of its activities and business relationships. In 2023, the Policy was enhanced with two new annexes: the "Guidelines on Human Rights", which aim to define and develop a structured approach on the issue, in order to identify, monitor and manage impacts on human rights in all their forms, and the "Anti-Corruption Guidelines", which aim to organically provide the reference anti-corruption principles for the Unipol Group Companies.
ESG risk and impact monitoring is then operationally broken down into Business policies, namely:
UnipolSai believes that the opportunities and well-being of the customers and people who work with the Group on a daily basis are the necessary conditions for its market development capacity and its sustainable success. Therefore, in the "Opening New Ways" 2022-2024 Strategic Plan, in relation to each of the five strategic guidelines, ESG objectives are identified and integrated, i.e. lines of action that, starting from opportunities linked to social, environmental and governance aspects, are aimed at generating positive impacts for stakeholders and society as well and contributing to sustainable development.
The main actions implemented in 2023 to meet these objectives include:
• evolution of the Life & Health offer from a Life-Cycle perspective, offering insurance solutions and assistance services designed to meet the specific needs that arise in the different periods of life,

identifying solutions that respond to the change over time in the needs of individuals and, together, of society;
In support of this latter objective, in June 2023 the Board of Directors of the holding company Unipol Gruppo - in line with the Target Setting Protocol of the Net-Zero Asset Owner Alliance which it joined in 2022 - approved the interim sustainability targets for 2030 for its financial investments portfolio (with the commitment to reduce the carbon intensity of its directly managed portfolios of listed equities and publicly traded corporate bonds by 50% by 2030 compared to 30/09/2022).
In this manner, the Group is committed to contributing to the achievement of the UN 2030 Agenda Goals 3 (Good health and well-being), 8 (Decent work and economic growth), 11 (Sustainable cities and communities), 12 (Responsible production and consumption) and 13 (Climate action).
The sustainability indicators aimed at monitoring compliance with the commitments made include:
(i) the increase in premiums for the sale of products with a social and environmental impact, with the aim of reaching 30% of the corresponding product families at the end of 2024; the result at the end of 2023 was 27.6%;
(ii) the increase in thematic investments, from €862m to €1,300m over the course of the Plan; the target was reached and exceeded in 2023, coming to €1,439.3m;
(iii) the maintenance of reputational performance with the General Public higher than the average of the financialinsurance sector; in 2023, Unipol's reputational index was 77.6/100, almost ten points higher than the industry average.
The role of non-financial factors amongst long-term variable remuneration criteria was strengthened significantly, to support the adoption of integrated thinking in the managerial structure; in the 2022-2024 period, these factors account for 20% of the long-term variable remuneration, considering the following objectives:
During the year, social initiatives continued as well: insurance education through the UnipolEos project and with FEduf (Foundation for Financial Education and Savings) for schools, the campaigns with Legambiente ("Bellezza Italia") and the initiatives to support a widespread culture of respect for women. In the stakeholder engagement and management activities of the Unipol Regional Councils (CRU), in 2023 the new administrations of some CRUs in both the North West and Central Italy became fully operational, and the stakeholder engagement and management activities of the Councils were able to successfully involve new organisations and reactivate the participation of those already present. Also during the year, important projects launched in the previous year were completed; the CreAree project recorded a qualitative and quantitative leap in quality, committing new resources, new partners and new sustainable development objectives at local level, for internal and marginal areas, and at national level, i.e. for the entire CRU network.
At international level, the holding company Unipol has signed on to the United Nations Global Compact, the Principles for Responsible Investing (UN PRI) and, as of 2021, the Principles for Sustainable Insurance (PSI), the global framework on sustainability in the insurance sector promoted by the United Nations Environmental Programme Finance Initiative (UNEP FI).

The total number of Group employees at 31 December 2023 was 12,387 (+72 compared with 2022).
| 31/12/2023 | 31/12/2022 | variation | |
|---|---|---|---|
| Total number of UnipolSai Group employees | 12,387 | 12,315 | 72 |
| of which on a fixed-term contract | 706 | 534 | 172 |
| Full Time Equivalent – FTE | 11,884 | 11,775 | 109 |
This includes 204 seasonal staff of Gruppo UNA at 31 December 2023 (173 at 31/12/2022), and foreign company employees (1,301) include 505 agents.
The increase of 72 compared to 31 December 2022 was due, net of transfers to fixed-term contracts or changes due to seasonal work that began and ended during the year, to 1,647 entries and 1,609 departures and 34 cases of incoming intra-group mobility from a company outside the UnipolSai scope.
At 31 December 2023, 2,236 agencies were in operation, of which 1,991 of UnipolSai (at 31/12/2022, the agencies were 2,361, of which 2,117 of UnipolSai), with 3,700 agents (3,914 at 31/12/2022).
The leading bancassurance companies of the Group placed their products through the following sales networks:
In 2023, consolidation and optimisation actions continued, with the aim of building a network of agencies to manage more consistent portfolios, with highly skilled specialist structures that guarantee the development of all the business ecosystems.
The Group's commercial action in 2023 was mainly characterised by the implementation of sales campaigns, incentives and tenders aimed at supporting the rise in the average MV TPL premium, the reform aimed at improving the quality of the portfolio in the General classes and the new Health and Life business, particularly in the Protection (TCM and LTC) and Investment segments and, moreover, the consolidation of the omnichannel sales method. This sales method was developed on products to insure the home, pets and travel: existing or potential customers can calculate (on the website and app) an online quote, then directly purchase the policy remotely or choose to contact an agency for advice and finalisation of the contract. Potential customers can also sign the contract through the Contact Centre channel, active since April 2023. Lastly, please recall the further development of the UnipolSai website and App, which made it possible to manage, increase and improve the services offered to customers registered in the Reserved Area, with relative access to the Customer App, and the signing of the new UnipolSai 3.0 Agreement with the agency network, which introduces, among its main new features, an innovative system for the distribution of commissions between the channels, MV commissions linked to specific parameters and a new incentive system for Health.
On 22 December 2023, UnipolSai Assicurazioni S.p.A. submitted an application for adoption of the cooperative compliance programme pursuant to Art. 7, paragraph 2, Italian Legislative Decree no. 128 of 5 August 2015, on its own account and on behalf of Unipol Gruppo S.p.A. as the entity exercising management and control. Subsequently, on 19 January 2024, support documentation for the application was sent to the Italian Revenue Agency pursuant to point 4.5, Measure no. 54237 of 14 April 2016.
As part of the activities to verify the requirements for eligibility to access the cooperative compliance programme, on 25 January 2024 the Italian Revenue Agency issued two separate requests for information, pursuant to point 5.3 of the aforementioned Measure, effectively opening the initial assessment phase of the programme (Company Level

Assessment), to verify compliance of the governance of the Tax Control Framework and the tax risks map with the principles and requirements of the programme. Subsequently, following the response to these requests for information, the Italian Revenue Agency will launch the Activity Level Assessment phase which is expected to terminate by the end of 2024 with acceptance of UnipolSai Assicurazioni S.p.A. and Unipol Gruppo S.p.A. into the cooperative compliance programme.
During 2023, activities were structured according to the areas set forth in the Strategic Plan and, in particular, along 3 lines of action.
The development activities of the new "NEW CORE - Single Product" platform continued and as of November, as planned, the first release of the new system on the Vehicle, Home and Family protection areas was released into production on an initial group of pilot agencies, while activities continue in order to complete the platform and create the remaining areas that will be released over the coming year.
The creation of the new "Individual Life FE" was completed, which simplifies after-sales activities in the agency, and the roll-out began across the network.
As part of the Multi-channel and Hybrid Sales channel, a new sales channel was activated through the Contact Centre, the Customer Experience was optimised for the placement of Pet, Travel and Home products and new functions were integrated for the sale and management of the UnipolMove electronic toll payment service.
On the AI front, the new CHIARA chatbot was released on the APP and WEB to support the Home product, created using new "Generative AI" technologies, and a new framework began being introduced for the development and monitoring of AI projects.
The new agency infrastructure (Next Gen Agency) was rolled out, which is based on the intensive use of internet connections and devices owned by agencies to support Network digitalisation and mobility.
Technological upgrading activities were completed, which led to the replacement of IBM mainframes with new Z16 hosts and another 50 software products with new, more modern solutions that made it possible to improve the technologies used as well as reduce operating costs.
The process of extending the use of the Cloud set forth in the Strategic Plan continued, and framework agreements were signed with Google and AWS.
The new UNIPORT Platform for Bancassurance was designed and built in 9 months, to support the sale of insurance products in the branch and on digital channels (Web and App), integrated with bank systems and processes. The first digital product, UniSalute Sorriso, was released on the BPER APP.
In the Cybersecurity area, migration to the new Microsoft "extended detection and response" platform was completed: new security event detection and management functions were introduced, supported by AI algorithms.
The Procedure for related-party transactions (the "Procedure") - prepared pursuant to Art. 4 of Consob Regulation no. 17221 of 12 March 2010, as amended (the "CONSOB Regulation") − defines the rules, methods and principles that ensure the transparency and substantive and procedural fairness of the transactions with related parties carried out by UnipolSai, either directly or through its subsidiaries.
The Procedure is published in the "Corporate Governance/Related Party Transactions" section of UnipolSai 's website (www.unipolsai.com).
With regard to the execution of Transactions with Related Parties qualified as of "Major Signifigance", the Board of Directors of the Company approved, in compliance with the Procedure:

of a minority interest of 19.987% of the share capital of the company resulting from the merger (the "Combined Entity"), in exchange for the shares held in SIFÀ (the "Merger"), also with the provision of certain exit mechanisms in favour of UnipolSai and/or BPER in relation to the investment held by the latter in the Combined Entity after the completion of the Merger;
In addition, in order to meet the obligation to extinguish the outstanding debt of SIFÀ with respect to BPER at the Effective Date of the Merger, undertaken by UnipolRental as part of the Transaction, in the same context the Board of Directors of the Company approved, in accordance with the Procedure, insofar as it is responsible, two loans in favour of the Combined Entity for up to €150m and €450m from UnipolSai and Unipol Gruppo SpA ("Unipol Gruppo"), respectively, with a view to the efficient management of their respective financial situations (the "Intercompany Loans").
The Industrial Project and the Intercompany Loans were reviewed in advance by the Company's Related Party Transactions Committee (the "RPT Committee"), which issued its favourable opinion. On 30 March 2023, UnipolSai published, pursuant to Art. 5 of the CONSOB Regulation and Art. 14 of the Procedure, the relevant information document, which was made available to the public at UnipolSai's registered office, on the authorised e-Market Storage mechanism () and on UnipolSai's website (www.unipolsai.com-"Goverance/Related-Party Transactions" section).
The Transaction was finalised on 22 June 2023 with the signing of the Merger deed, with legal effect as of 1 July 2023, as a result of which the share capital of UnipolRental is 80.013% held by UnipolSai, while the remainder is held by BPER. On the same date, the Referral Agreement and the above-mentioned loan agreements were also signed, the amounts of which were disbursed in full on 4 July 2023; - on 10 August 2023:
The August 2023 Loan and the Amendment to Intercompany Loans were reviewed in advance by the RPT Committee, which issued its favourable opinion. On 11 August 2023, UnipolSai published, pursuant to Art. 5 of the CONSOB Regulation and Art. 14 of the Procedure, the relevant information document, which was made available to the public at UnipolSai's registered office, on the authorised e-Market Storage mechanism () and on UnipolSai's website (www.unipolsai.com-"Goverance/Related-Party Transactions" section).
Lastly, please note that in 2023, UnipolSai did not approve, or carry out, directly or through subsidiaries, any additional Related Party Transactions qualified as of "Major Significance", or which significantly influenced the financial position or results of the Company, pursuant to Art. 5, paragraph 8 of the CONSOB Regulation.
As regards the disclosure required by IAS 24, please refer to paragraph 3.6 - Transactions with related parties in the Notes to the financial statements.
The information required by the Art. 123-bis, Italian Legislative Decree 58 of 24 February 1998 as amended is included in the Annual Report on corporate governance and ownership structures, approved by the Board of Directors and published together with the management report.

The Annual Report on Corporate Governance and Ownership Structures is available in the "Governance/Corporate Governance System/Annual Report" Section on the Company's website (www.unipolsai.com).
Pursuant to the requirements set forth in Art. 2.6.2, paragraph 8 of the Regulation governing markets organised and managed by Borsa Italiana SpA with reference to subsidiaries subject to the management and coordination of another company, it is hereby stated that the conditions set forth in Art. 16 of Consob Regulation no. 20249/2017 exist for UnipolSai SpA.

On 16 February 2024, the Board of Directors of UnipolSai Assicurazioni approved a project for the corporate rationalisation of the Unipol Group (the "Transaction"), to be carried out through the merger by incorporation (the "Merger") of UnipolSai, as well as Unipol Finance S.r.l., UnipolPart I S.p.A. and Unipol Investment S.p.A., companies wholly owned by Unipol Gruppo that hold investments in UnipolSai (the "Intermediate Holding Companies") into the holding company Unipol Gruppo.
The Merger swap ratio, determined by the administrative bodies of Unipol Gruppo and UnipolSai, is 3 Unipol Gruppo shares for every 10 UnipolSai shares.
As part of the Transaction, Unipol Gruppo also announced a voluntary public purchase offer (the "Offer") concerning all of the ordinary shares of UnipolSai not held directly or indirectly by Unipol Gruppo. The Offer concerns a maximum of 417,386,600 UnipolSai shares, representing 14.750% of the share capital. Unipol Gruppo will pay each participant in the Offer consideration of €2.700 (cum dividend, i.e. including the coupons relating to any dividends distributed by UnipolSai) for each share for which the Offer is accepted.
The Transaction will involve the streamlining of the corporate structure of the Unipol Group, while also simplifying the group's unitary management and governance decision-making processes, allowing UnipolSai shareholders that choose not to accept the Offer to:
UnipolSai and Unipol Gruppo also signed a framework agreement (the "Framework Agreement") intended to (i) establish the main terms and conditions of the Transaction, (ii) govern the preparatory and/or functional activities for its implementation, as well as (iii) establish the relative timing, the interim management of the Group companies and the Transaction conditions and methods of execution.
Subject to finalisation of the Merger, all UnipolSai shares will be cancelled and exchanged for Unipol Gruppo shares by Unipol Gruppo, with the exception of shares held directly and indirectly through the Intermediate Holding Companies, and treasury shares held by UnipolSai, which will be cancelled with no share swap. In order to assign the swap shares, Unipol Gruppo may approve an increase in its share capital by a maximum of €299,742,415.54, by issuing up to 125,258,009 new ordinary shares with normal dividend rights. Furthermore, if, on conclusion of the Offer, Unipol Gruppo directly and indirectly holds the entire share capital of UnipolSai, it will not be necessary to issue Unipol Gruppo shares and the Merger will take place with no share swap.
The Merger will be subject to the approval of the extraordinary shareholders' meetings of, respectively, UnipolSai, Unipol Gruppo and the Intermediate Holding Companies, and its completion will be subject, inter alia, without prejudice to the waiver of the parties where permitted, to obtaining the necessary regulatory authorisations and the non-occurrence of particularly significant events such as to significantly affect the assumptions underlying the Merger.
The Extraordinary Shareholders' Meeting of Unipol Gruppo convened to approve the Merger will also be called upon to express an opinion on the amendment to the By-Laws of Unipol Gruppo made necessary, among other things, by the change in the corporate purpose. The holders of ordinary Unipol Gruppo shares who did not participate in the approval of the Merger Plan and, therefore, in the amendment of the corporate purpose, will have the right of withdrawal pursuant to Art. 2437, paragraph 1, letter a) of the Italian Civil Code (the "Right of Withdrawal").
The effectiveness of the Right of Withdrawal is subject to the finalisation of the Merger which, in turn, is subject, inter alia, to the circumstance that the total outlay of Unipol Gruppo against any exercise of the Right of Withdrawal does not exceed €100m, without prejudice to the waiver of Unipol Gruppo and UnipolSai.
Any approval of the Merger resolution will not give rise to any right of withdrawal in favour of UnipolSai shareholders, as none of the conditions in Art. 2437 of the Civil Code or in other legal provisions are satisfied.
Without prejudice to the above, the Merger is expected to be completed by the end of 2024.
The Merger qualifies as a "related party transaction" pursuant to the Regulation on Transactions with Related Parties adopted by CONSOB with resolution no. 17221 of 12 March 2010, as amended (the "RPT Regulation") and the procedures for carrying out transactions with related parties adopted by UnipolSai, by virtue of the relationship of control between Unipol Gruppo and UnipolSai, and - specifically - as a transaction with related parties "of major significance".
Therefore, the Framework Agreement was approved by the UnipolSai Board of Directors after obtaining the favourable opinion of the Related Party Transactions Committee regarding the interest of UnipolSai in the Transaction as well as the cost effectiveness and substantial fairness of the relative conditions.
The merger by incorporation of Centri Medici Dyadea Srl into Società e Salute SpA became effective from 1 January 2024.
In line with the commitment already undertaken by the Unipol Group, in January 2024 DDOR also joined the large community of Ogyre, with the aim of pursuing a sustainable development strategy by contributing to protection of the seas. DDOR purchased 1,000 Ogyre water bottles, an investment aimed at removing 1,000 kg of marine litter and contributing to the regeneration of the Mediterranean Sea. DDOR's commitment to its alignment with a high ESG (Environmental, Social and Governance) standard was recognised and awarded in 2022 by Confindustria Serbia and in 2023 by the Italian-Serbian Chamber of Commerce.
The new great challenge of Ducati Corse in the MotoGP World Championship will again see UnipolSai across the side panels of the Borgo Panigale team as Official Sponsor through a renewed partnership already for the 2024 and 2025 seasons. On 22 January 2024, the Ducati Lenovo Team was presented at the Palacampiglio in Madonna di Campiglio, unveiling the colours of the Desmosedici GP that will take part in the 2024 MotoGP World Championship.
On 28 February 2024, a draft bridge agreement was signed with the Trade Unions, subject to the approval of workers in the insurance sector by means of a referendum and by the Board of Directors on 21 March 2024. The aim of this agreement was to improve company welfare benefits (supplementary pension and welfare credit, the latter valid for 2024), while also recognising an improvement in the Variable Company Bonus, in correlation with the use of holidays and mandatory training, and a one-off amount for the years 2022 and 2023.
On 8 February 2024, during the award ceremony of the MF Insurance Awards 2024, 4 "Compagnia di Valore" awards were won by UnipolSai for the "Best technical result": "Best Technical Result in the Assistance Class", "Best Technical Result in the Land Vehicle Hulls Class", "Best Technical Result in the Legal Expenses Class" and "Best Technical Result in the General TPL Class". UnipolSai also won the Insurance Elite award ("Best ecosystem strategy") for the new business acquisition campaign for healthcare (Centro Medico Santagostino) and mobility (long-term rental) in symbiosis with the protection offer, in addition to the MF Innovazione award for the Omnichannel Evolution of the distribution model.
Siat received the "Compagnia di Valore" award for the "Best Technical Result" for the Aircraft, Rail and Marine Vessels Class, in addition to the award for average profit growth.

Major recognition also for BeRebel, with the "MF Innovazione Award" in the product/service category - Mobility and for Arca Vita with the "Lombard Superindex" award.


International macroeconomic forecasts for the year 2024 are characterised by expectations of a gradual recovery, moreover already underway towards the end of 2023, of the inflationary tensions that followed the rally in raw materials and the critical logistics issues triggered by the pandemic crises and the war between Russia and Ukraine. The financial markets therefore expect a reduction in interest rates by the main Central Banks during 2024.
However, uncertainties surrounding the global economy persist, with very low growth estimates in the Eurozone, and high concerns about growing geopolitical tensions exacerbated by the ongoing conflict in Palestine and the threat of its expansion to the Red Sea area, with repercussions on transport costs and delays in the supply chain. In Italy, despite the drives deriving from the NRRP, GDP growth is still expected to be weak after the modest increase of 0.9% recorded in 2023.
With regard to the Non-Life insurance business, the effects of ongoing climate change, which generated a peak in claims in 2023, are leading to changes in products, at both tariff and regulatory level, in addition to a revision of reinsurance treaties. As concerns MV TPL, although in a still highly competitive market context, ongoing actions are aimed at achieving positive margins by favouring portfolio selection and cost containment, also thanks to the knowhow acquired in the area of telematics and the constant increase in MV claims channelled to the UnipolService and UnipolGlass networks, allowing for excellent results in terms of limiting average repair costs.
In the Life segment, traditional Class I products will continue to be offered across all production networks in 2024 as well, to promote the profitability of segregated funds, alongside multi-segment and protection products, while maintaining leadership in the Pension Funds sector.
As set forth in our 2022-2024 Strategic Plan, after two years in which all ecosystems in which the Group is active recorded strong growth, both internally and externally, in 2024 activities will be focused on the integration and consolidation of the various businesses. In this sense, the Dyadea health centres merged as of 1 January 2024 with the Santagostino Medical Centres. Together, they have 45 facilities in different Italian cities and strengthen the offer of the Welfare ecosystem, which is one of the Group's main strategic assets.
Overall, the information currently available makes it possible to confirm, in the absence of currently unforeseeable events, also linked to the deterioration of the reference context, that its consolidated income trends for the year under way are in line with the objectives laid out in the 2022-2024 Strategic Plan.
Bologna, 21 March 2024
The Board of Directors

\63


\65
2.Consolidated Financial Statements
Consolidated Financial Statements
at 31 December 2023 Tables of
bianco

Amounts in €m
| Asset items | 31/12/2023 | 31/12/2022 | |
|---|---|---|---|
| 1. | INTANGIBLE ASSETS | 1,367 | 1,119 |
| of which: goodwill | 765 | 602 | |
| 2. | PROPERTY, PLANT AND EQUIPMENT | 4,124 | 2,791 |
| 3. | INSURANCE ASSETS | 1,123 | 980 |
| 3.1 | Insurance contracts issued that are assets | 63 | 54 |
| 3.2 | Reinsurance contracts held that are assets | 1,060 | 926 |
| 4. | INVESTMENTS | 61,960 | 57,622 |
| 4.1 | Investment property | 2,364 | 2,359 |
| 4.2 | Investments in associates and interests in joint ventures | 170 | 162 |
| 4.3 | Financial assets at amortised cost | 2,149 | 2,076 |
| 4.4 | Financial assets at fair value through OCI | 40,867 | 37,126 |
| 4.5 | Financial assets at fair value through profit or loss | 16,410 | 15,899 |
| a) Held-for-trading financial assets |
72 | 281 | |
| b) Financial assets at fair value |
10,679 | 8,786 | |
| c) Other financial assets mandatorily at fair value |
5,659 | 6,832 | |
| 5. | OTHER FINANCIAL ASSETS | 2,433 | 2,470 |
| 6. | OTHER ASSETS | 3,136 | 2,888 |
| 6.1 | Non-current assets or assets of a disposal group held for sale | 133 | 514 |
| 6.2 | Tax assets | 411 | 892 |
| a) current |
3 | 36 | |
| b) deferred |
408 | 856 | |
| 6.3 | Other assets | 2,592 | 1,482 |
| 7 | CASH AND CASH EQUIVALENTS | 978 | 826 |
| TOTAL ASSETS | 75,121 | 68,696 |

Amounts in €m
UnipolSai Assicurazioni 2023 Consolidated Financial Statements
| Items of Shareholders' Equity and Liabilities | 31/12/2023 | 31/12/2022 | |
|---|---|---|---|
| 1. | SHAREHOLDERS' EQUITY | 7,307 | 6,733 |
| 1.1 | Share capital | 2,031 | 2,031 |
| 1.2 | Other equity instruments | 496 | 496 |
| 1.3 | Capital reserves | 347 | 347 |
| 1.4 | Income-related and other equity reserves | 3,240 | 3,260 |
| 1.5 | Treasury shares (-) | (3) | (3) |
| 1.6 | Valuation reserves | 215 | (91) |
| 1.7 | Shareholders' equity attributable to non-controlling interests (+/-) | 215 | 227 |
| 1.8 | Profit (loss) for the year attributable to the owners of the Parent (+/-) | 700 | 418 |
| 1.9 | Profit (loss) for the year attributable to non-controlling interests (+/-) | 66 | 48 |
| 2. | PROVISIONS FOR RISKS AND CHARGES | 519 | 596 |
| 3. | INSURANCE LIABILITIES | 51,200 | 47,327 |
| 3.1 | Insurance contracts issued that are liabilities | 51,108 | 47,194 |
| 3.2 | Reinsurance contracts held that are liabilities | 92 | 133 |
| 4. | FINANCIAL LIABILITIES | 13,571 | 10,894 |
| 4.1 | Financial liabilities at fair value through profit or loss | 10,507 | 8,723 |
| a) Financial liabilities held-for trading |
95 | 155 | |
| b) Financial liabilities at fair value |
10,412 | 8,568 | |
| 4.2 | Financial liabilities at amortised cost | 3,064 | 2,171 |
| 5. | PAYABLES | 1,273 | 1,353 |
| 6. | OTHER LIABILITIES | 1,251 | 1,793 |
| 6.1 | Liabilities associated with disposal groups held for sale | 0 | 360 |
| 6.2 | Tax liabilities | 105 | 388 |
| a) current |
16 | 12 | |
| b) deferred |
89 | 376 | |
| 6.3 | Other liabilities | 1,146 | 1,045 |
| TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES | 75,121 | 68,696 |

Amounts in €m
| Items | 31/12/2023 | 31/12/2022 | |
|---|---|---|---|
| 1. | Insurance revenue from insurance contracts issued | 9,571 | 8,549 |
| 2. | Insurance service expenses from insurance contracts issued | (9,405) | (7,307) |
| 3. | Insurance revenue from reinsurance contracts held | 637 | 190 |
| 4. | Insurance service expenses from reinsurance contracts held | (396) | (358) |
| 5. | Result of insurance services | 407 | 1,074 |
| 6. | Gains/losses on financial assets and liabilities at fair value through profit or loss | 460 | (318) |
| 7. | Gains/losses on investments in associates and interests in joint ventures | 38 | 15 |
| 8. | Gain/losses on other financial assets and liabilities and investment property | 1,383 | 1,090 |
| 8.1 | - Interest income calculated with the effective interest method | 1,434 | 1,401 |
| 8.2 | - Interest expense | (126) | (76) |
| 8.3 | - Other income/Charges | 172 | 160 |
| 8.4 | - Realised gains/losses | 2 | (11) |
| 8.5 | - Unrealised gains/losses | (99) | (384) |
| of which: Related to impaired financial assets | (10) | (3) | |
| 9. | Balance on investments | 1,881 | 787 |
| 10. | Net finance expenses/income relating to insurance contracts issued | (1,286) | (838) |
| 11. | Net finance income/expenses relating to reinsurance contracts held | (3) | (2) |
| 12. | Net financial result | 592 | (53) |
| 13. | Other revenue/costs | 1,059 | 476 |
| 14. | Operating expenses: | (520) | (436) |
| 14.1 | - Investment management expenses | (74) | (91) |
| 14.2 | - Other administrative expenses | (446) | (345) |
| 15. | Net provisions for risks and charges | (10) | 11 |
| 16. | Net impairment losses/reversals on property, plant and equipment | (375) | (282) |
| 17. | Net impairment losses/reversals on intangible assets | (133) | (97) |
| of which: Value adjustments to goodwill | 0 | 0 | |
| 18. | Other operating expenses/income | (1) | (1) |
| 19. | Pre-tax Profit (Loss) for the period | 1,019 | 692 |
| 20. | Income taxes | (253) | (226) |
| 21. | Profit (Loss) for the year after taxes | 766 | 466 |
| 22. | Profit (Loss) from discontinued operations | 0 | 0 |
| 23. | Consolidated Profit (Loss) | 766 | 466 |
| of which: attributable to the owners of the Parent | 700 | 418 | |
| of which: attributable to non-controlling interests | 66 | 48 | |

Amounts in €m
UnipolSai Assicurazioni 2023 Consolidated Financial Statements
| Items | 31/12/2023 | 31/12/2022 | |
|---|---|---|---|
| 1 | Profit (Loss) for the period | 766 | 466 |
| 2 | Other income items net of taxes not reclassified to profit or loss | 237 | (31) |
| 2.1 | Portion of valuation reserves of equity investments valued at equity | 9 | 17 |
| 2.2 | Change in the revaluation reserve for intangible assets | 0 | 0 |
| 2.3 | Change in the revaluation reserve for property, plant and equipment | 0 | 0 |
| 2.4 | Financial revenues or costs relating to insurance contracts issued | (22) | 12 |
| 2.5 | Gains and losses on non-current assets or disposal groups held for sale | 0 | 0 |
| 2.6 | Actuarial gains and losses and adjustments relating to defined benefit plans | (6) | 11 |
| 2.7 | Gains or losses on equity instruments at fair value through OCI | 256 | (71) |
| 2.8 | Reserve deriving from variation on credit risk on financial liabilities at fair value through profit or loss | 0 | 0 |
| 2.9 | Other items | 0 | 0 |
| 3 | Other income items net of taxes reclassified to profit or loss | 77 | (425) |
| 3.1. | Change in the reserve for foreign currency translation differences | 0 | 0 |
| 3.2 | Gains or losses on financial assets (other than equity instruments) at fair value through OCI | 1,551 | (6,596) |
| 3.3 | Gains or losses on cash flow hedges | 37 | 70 |
| 3.4 | Gains or losses on hedges of a net investment in foreign operations | 0 | 0 |
| 3.5 | Portion of valuation reserves of equity investments valued at equity | 1 | (23) |
| 3.6 | Financial revenues or costs relating to insurance contracts issued | (1,526) | 6,154 |
| 3.7 | Financial revenues or costs relating to reinsurance transfers | 14 | (30) |
| 3.8 | Gains and losses on non-current assets or disposal groups held for sale | 0 | 0 |
| 3.9 | Other items | 0 | 0 |
| 4 | TOTAL OTHER COMPREHENSIVE INCOME (EXPENSE) | 314 | (456) |
| 5 | TOTAL CONSOLIDATED COMPREHENSIVE INCOME (EXPENSE) (Voce 1+4) | 1,080 | 11 |
| 5.1 | of which: attributable to the owners of the Parent | 1,006 | (16) |
| 5.2 | of which: attributable to non-controlling interests | 74 | 27 |

| Amounts in €m | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Other equity instruments |
Capital reserves |
Income related and other equity reserves |
Treasury shares |
Valuation reserves |
Profit (loss) for the year attributable to the owners of the Parent |
Equity attributable to the owners of the Parent |
Shareholders' equity attributable to non-controlling interests |
Total equity |
|
| Balance at 1.1.2022 |
2,031 | 496 | 347 | 3,396 | (1) | 358 | 723 | 7,077 | 275 | 7,352 |
| of which: Changes to opening balance |
0 | 0 | 0 | 33 | 0 | (916) | 0 | (888) | 5 | (883) |
| Allocation of profit (loss) for the year 2021 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 0 | 0 | 0 | 159 | 0 | 0 | (159) | 0 | 0 | 0 |
| Dividends and other allocations |
0 | 0 | 0 | (25) | 0 | 0 | (564) | (562) | (26) | (588) |
| Changes during the year |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Issuance of new shares |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of treasury shares |
0 | 0 | 0 | 0 | (2) | 0 | 0 | (2) | 0 | (2) |
| Changes in investments |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Comprehensive Income Statement |
0 | 0 | 0 | 0 | 0 | (455) | 466 | (16) | 27 | 11 |
| Other changes | 0 | 0 | 0 | (37) | 0 | 0 | 0 | (37) | 0 | (37) |
| Balance at 31.12.2022 |
2,031 | 496 | 347 | 3,493 | (3) | (97) | 466 | 6,458 | 275 | 6,733 |
| Balance at 1.1.2023 |
2,031 | 496 | 347 | 3,493 | (3) | (97) | 466 | 6,458 | 275 | 6,733 |
| of which: Changes to opening balance |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Allocation of profit (loss) for the year 2022 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 0 | 0 | 0 | 290 | 0 | 0 | (290) | 0 | 0 | 0 |
| Dividends and other allocations |
0 | 0 | 0 | (333) | 0 | 0 | (176) | (477) | (31) | (509) |
| Changes during | ||||||||||
| the year | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Issuance of new shares |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of | ||||||||||
| treasury shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| investments Comprehensive |
||||||||||
| Income Statement | 0 | 0 | 0 | 0 | 0 | 314 | 766 | 1,006 | 74 | 1,080 |
| Other changes | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 39 | (37) | 2 |
| Balance at | ||||||||||
| 31.12.2023 | 2,031 | 496 | 347 | 3,453 | (3) | 217 | 766 | 7,026 | 281 | 7,307 |

Amounts in €m
| Amount | |||
|---|---|---|---|
| 31/12/2023 | 31/12/2022 | ||
| Net cash flows generated by/used for: | (+/-) | (+/-) | |
| - Profit (loss) for the period (+/-) | 766 | 466 | |
| - Net revenues and costs of insurance contracts issued and reinsurance transfers (+/-) | 883 | (234) | |
| - Capital gains/losses on financial assets at fair value through profit or loss (-/+) | (1,699) | 1,831 | |
| - Other non-monetary gains and losses on financial instruments, investment property and investments (+/-) | (725) | 247 | |
| - Net provisions for risks and charges (+/-) | (77) | 174 | |
| - Interest income. dividends, interest expense. taxes (+/-) | (2,404) | (3,354) | |
| - Other adjustments (+/-) | 841 | (1,043) | |
| - interest income collected (+) | 1,013 | 984 | |
| - dividends collected (+) | 218 | 213 | |
| - interest expense paid (-) | (130) | (100) | |
| - paid taxes (-) | (97) | (156) | |
| Net cash flows generated by/used for other monetary items from operating activities | (+/-) | (+/-) | |
| - Insurance contracts classifiable as liabilities/assets (+/-) | 587 | 1,093 | |
| - Reinsurance transfers classifiable as assets/liabilities (+/-) | 68 | (147) | |
| - Liabilities from financial contracts issued by insurance companies | 1,187 | 1,287 | |
| - Receivables of banking subsidiaries (+/-) | 0 | 0 | |
| - Liabilities of banking subsidiaries (+/-) | 0 | 0 | |
| - Other financial instruments and liabilities at fair value through profit or loss (+/-) | 1,599 | 1,008 | |
| - Other financial instruments and liabilities (+/-) | 284 | 257 | |
| Total net cash flow generated by/used for operating activities | 2,314 | 2,526 | |
| Net cash flows generated by/used for: | (+/-) | (+/-) | |
| - Sale/purchase of investment property (+/-) | (24) | (266) | |
| - Sale/purchase of investments in associates and joint ventures (+/-) | (49) | (74) | |
| - Dividends collected on equity investments (+) | 166 | 167 | |
| - Sale/purchase of financial assets measured at amortised cost (+/-) | (16) | 119 | |
| - Sale/purchase of financial assets measured at fair value through other comprehensive income (+/-) | (703) | (1,441) | |
| - Sale/purchase of property, plant and equipment and intangible assets (+/-) | (1,293) | (817) | |
| - Sale/purchase of subsidiaries and business units (+/-) | (114) | (96) | |
| - Other net cash flows from investing activities (+/-) | 63 | 24 | |
| Total net cash flow generated by/used for investing activities | (1,970) | (2,384) | |
| Net cash flows generated by/used for: | (+/-) | (+/-) | |
| - Issues/purchases of equity instruments (+/-) | 0 | (25) | |
| - Issues/purchases of treasury shares (+/-) | 0 | (2) | |
| - Distribution of dividends and other purposes (-) | (509) | (564) | |
| - Sale/purchase of non-controlling interests (+/-) | 0 | 0 | |
| - Issues/purchases of subordinated liabilities and participating financial instruments (+/-) | (80) | (80) | |
| - Issues/purchases of liabilities measured at amortised cost (+/-) | 392 | 472 | |
| Total net cash flow generated by/used for financing activities (197) |
|||
| NET CASH FLOW GENERATED/USED DURING THE YEAR | 148 | (55) |
| Financial statement items | Amount | |||
|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | |||
| Cash and cash equivalents at 1 January | 830 | 885 | ||
| Total net cash flow generated/used during the year | 148 | (55) | ||
| Cash and cash equivalents: effect of exchange rate changes | 0 | 0 | ||
| Cash and cash equivalents at 30 June | 978 | 830 |
Cash and cash equivalents at the end of the year 2022 and at the beginning of the year 2023 include the cash and cash equivalents of non-current assets or assets of a disposal group held for sale (€4,4m).
Cash and cash equivalents at the beginning of the year 2022 include the cash and cash equivalents of non-current assets or assets of a disposal group held for sale (€0,2m).


3.Notes to the

The UnipolSai Group, consisting of UnipolSai SpA ("UnipolSai") and its subsidiaries, operates in all Non-Life and Life insurance and reinsurance and capitalisation business; it may issue investment contracts and may set up and manage Open Pension Funds, in compliance with the provisions of Art. 9 of Italian Legislative Decree 124 of 21 April 1993 and subsequent amendments.
To support the insurance business and the relative ecosystems, it has developed instrumental commercial activities relating in particular to vehicle repair and vehicle glass replacement, the management of black boxes and other telematic devices, the management of payments in mobility, long-term vehicle rental and the marketing of anti-theft systems for vehicles.
It also carries out real estate, and to a lesser extent, financial, hotel, agricultural, healthcare and flexible benefits activities.
The UnipolSai Group operates primarily in Italy: outside Italy, the Group operates in Serbia, through the subsidiary DDOR Novi Sad and the dedicated captive reinsurance company Ddor Re.
UnipolSai is a joint-stock company, has its registered office in Bologna (Italy) at via Stalingrado 45 and is listed on the Milan Stock Exchange.
The UnipolSai Group's Consolidated Financial Statements were drawn up in accordance with Art. 154-ter of Italian Legislative Decree 58/1998 (Consolidated Law on Finance) and of ISVAP Regulation no. 7 of 13 July 2007, as amended. They conform to the IAS/IFRS standards issued by the IASB and endorsed by the European Union, along with the interpretations issued by IFRIC, in accordance with the provisions of Regulation (EC) no. 1606/2002 in force on the closing date of the financial statements.
The Consolidated Financial Statements consist of:
• Notes to the Financial Statements.
The layout conforms to the provisions of ISVAP Regulation no. 7 of 13 July 2007, Part III as amended, relating to the layout of the Consolidated Financial Statements of insurance and reinsurance companies that must adopt international accounting standards.
The information requested by Consob Communications DEM/6064293, 28 July 2006, and DEM/11070007 of 5 August 2011 is also provided.
The Consolidated Financial Statements are drawn up on the assumption that the company will continue as a going concern, in application of the principles of accrual accounting, materiality and truthfulness of accounting information, in order to provide a true and fair view of the equity-financial position and economic result, in compliance with the principle of the prevalence of the economic substance of transactions over their legal form.
The going concern assumption is considered to be confirmed with reasonable certainty given that companies belonging to the UnipolSai Group have sufficient resources to ensure that they will continue to operate for the foreseeable future. In addition, the liquidity risk is deemed to be very remote.
The layout of the financial statements offers a comparison with the figures of the previous year. Where necessary, in the event of a change to the accounting standards, measurement or classification criteria, the comparative data are restated and reclassified in order to provide homogeneous and consistent information.
The presentation currency is the euro and all the amounts, unless otherwise indicated, are disclosed in €m. Note that, in line with the provisions of ISVAP Regulation no. 7 of 13 July 2007, with reference to the Statement of Financial Position, Income Statement, Comprehensive Income Statement, Statement of Cash Flows and Statement of Changes in Shareholders' Equity (the "Financial Statements"), the amounts of the sub-items have been rounded, disregarding fractions of amounts equal to or less than €500k and rounding fractions greater than €500k up to the nearest million. The rounded total of items is the sum of rounded sub-item amounts. The algebraic sum of the differences deriving

from the rounding carried out on the items refers to the items in each financial statement specifically indicated in the Regulation. The amounts in the Explanatory Notes are rounded according to the same criterion and are expressed in €m, ensuring that the amounts therein are aligned with those of the Financial Statements.
The Consolidated financial statements of UnipolSai are subject to audit by the independent auditors EY S.p.A., the company tasked with performing the legally-required audit of the consolidated financial statements for the years 2021-2029.
The "Transparency Directive" (2004/109/EC) requires listed companies to publish their annual financial report in the "single electronic reporting format". To this end, Regulation (EU) 2019/815 of 2018 (the "ESEF Regulation"), as supplemented by national regulations, imposed the obligation of drafting such reporting in XHTML format starting from 2021, also marking up certain information in the consolidated financial statements using XBRL specifications. In particular, the consolidated financial statements contain the mark-up of numerical data contained in the statement of financial position, income statement and comprehensive income statement, statement of changes in shareholders' equity and statement of cash flows, as well as the information elements identified in Annex II of the regulation if these are reported in the explanatory notes. It should be noted that, due to certain technical limitations recognised by ESMA in its ESEF Reporting Manual, when some information contained in the explanatory notes is extracted from the XHTML format in an iXBRL instance, it may not be reproduced in a manner identical to the corresponding information that can be viewed in the consolidated financial statements in XHTML format, which could therefore cause difficulties in the readability of such extracted information.
The reporting date of the Consolidated Financial Statements is 31 December 2023, the date the Separate Financial Statements of the Parent Unipol closed. All the consolidated companies close their financial statements at 31 December with the exception of the following:
The Consolidated Financial Statements were drawn up using restatements of the separate financial statements of the consolidated companies, adjusted to comply with IAS/IFRS standards as applied by the Parent Unipol, and approved by the Boards of Directors of the companies concerned.
This method provides for the consolidation on a line-by-line basis of the assets, liabilities, gains and losses of the consolidated companies as from the date they were acquired, with the carrying amount of the investment being offset against the corresponding amount of the shareholders' equity of each individual subsidiary and, in the case of investments not wholly owned, the separate recognition of the amount of the equity and the profit or loss for the year attributable to non-controlling interests.
The amount of equity attributable to non-controlling interests is recognised under shareholders' equity as "Share capital and reserves attributable to non-controlling interests", whilst the corresponding share of consolidated profit or loss is shown under "Profit (loss) for the year attributable to non-controlling interests".
The financial statements of the subsidiaries are consolidated on a line-by-line basis.
If the cost of acquiring investments in subsidiaries exceeds the fair value of the identifiable assets, liabilities and contingent liabilities, the excess amount is recognised as goodwill under intangible assets.
This goodwill represents a payment made in the expectation of future economic benefits arising from assets that cannot be identified individually and recognised separately.

In the years after the year of acquisition, goodwill is measured at cost, net of any impairment losses accumulated. Ancillary acquisition costs are recognised in the income statement during the year in which the costs are incurred or the services provided.
Under IFRS 10.23 changes in investments in subsidiaries that do not lead to a loss of control are recognised as equity transactions. Any positive difference between the proportion of net fair value of identifiable assets, liabilities and contingent liabilities of the subsidiary and the fair value of the price paid or received is recognised directly in profit for the period and allocated to the members of the holding company.
When this method is used the carrying amount of the investment is adjusted to the corresponding portion of shareholders' equity, including the profit/loss for the year and all the adjustments made when consolidation is on a line-by-line basis. Any difference between the portion of shareholders' equity acquired and the fair value of the price paid (goodwill) is recognised in the carrying amount of the investment. Changes in interests in an associate which do not entail the acquisition of control or the loss of significant influence are treated as purchases or sales of shares, even if due to reasons other than purchases or sales, and therefore result in income or expenses recognised in the income statement and calculated on the basis of the difference between any consideration due or received and the change in the share of the investee's shareholders' equity held by the investor.
The amounts receivable and payable between companies included in the consolidation scope, the gains and losses relating to transactions carried out between these companies and the profits and losses resulting from transactions carried out between these companies and not yet realised with parties external to the Group are eliminated during the preparation of Consolidated Financial Statements.
In the presence of put options granted by the Group on the shareholders' equity of subsidiaries held by noncontrolling shareholders, and in the absence of mechanisms for determining the exercise price that in substance already expose the Group to the risks and benefits deriving from holding such shareholders' equity, the following accounting treatment is adopted:
If, on the other hand, the above-mentioned put options granted by the Group on the shareholders' equity of subsidiaries held by non-controlling shareholders substantially already expose the Group to the risks and benefits deriving from holding such shareholders' equity, the transaction would be treated like a purchase of non-controlling interests with deferred payment.
Segment reporting is provided according to the provisions of IFRS 8 and structured on the basis of the major business segments in which the Group operated in the year reported in these consolidated financial statements and in the previous year:
It should be noted that, in order to provide a better representation of the actual contribution to the consolidated results and also taking into account the significance of this activity on the overall Group, the economic and financial results previously attributed to the Real Estate business have been allocated to the Life business, if referring to assets whose returns affect the services to be provided to subscribers of revaluable products, and to Holding and

Other Businesses for the residual portion. The different representation of the information by segment was applied retroactively to previous years presented for comparative purposes.
Segment reporting is carried out by separately consolidating the accounting items for the individual subsidiaries and associates that belong to each identified segment, eliminating intragroup balances between companies in the same segment and cancelling, where applicable, the carrying amount of the investments against the corresponding portion of shareholders' equity.
In the column "Intersegment eliminations", the intragroup balances between companies in different sectors are eliminated.
This rule does not apply in the following cases:
No segment reporting based on geographical area has been provided since the Group operates mainly at the national level and there appears to be no significant diversification of risks and benefits, for a given type of business activity, based on the economic situation of the individual regions.
The segment reporting layout conforms to the provisions of ISVAP Regulation no. 7/2007 as amended.

A summary is provided below of the amendments to the accounting standards previously in force, applied as of 1 January 2023; among the changes of greatest interest to the UnipolSai Group are the entry into force of "IFRS 17 - Insurance Contracts" and the extension of the application of "IFRS 9 - Financial Instruments" to the entire Group scope, the effects of which are presented in specific paragraphs.
As regards the other regulatory developments, no impact is worth reporting.
On 3 March 2022, Regulation (EU) 2022/357 was published, which incorporated the amendments to IAS 1 "Presentation of financial statements" and IAS 8 "Accounting policies, changes in accounting estimates and errors", published by the IASB on 12 February 2021 with a view to improving the communication of the accounting policies of companies, which should privilege information that is more relevant and effective for investors and users of financial statements. Specifically, the amendments to IAS 1 and IFRS Practice Statement 2 provide guidelines on how to apply the concept of materiality to the disclosure on the accounting policy adopted, while those to IAS 8 have the dual objective of introducing a new definition of "accounting estimate" and clarifying how entities should distinguish between changes in the accounting standards applied and changes in accounting estimates. This differentiation is of fundamental importance as the latter are applied on a prospective basis only to future transactions, while amendments to accounting standards are generally applied retroactively to past events as well.
Regulation (EU) 2022/1392 published on 12 August 2022 adopted several amendments to IAS 12 "Income taxes" to specify how to account for deferred taxes on certain transactions that may generate assets and liabilities of an equal amount, such as leases and decommissioning obligations.
On 23 May 2023, the IASB issued amendments, effective as of 1 January 2023, to IAS 12 "International Tax Reform - Pillar Two Model Rules" in which it introduces, following numerous market requests, a mandatory temporary exception to the requirements of IAS 12 to recognise and disclose information on deferred tax assets and liabilities deriving from the rules of the "Global minimum tax under Pillar 2" regulations, which will enter into force on 1 January 2024, which resulted in Directive (EU) 2022/2523, on the global minimum level of taxation of 15% ("top-up tax"), applicable to large multinational groups (and large national groups beginning from 2029). On 2 June 2023, EFRAG submitted the Endorsement Advice Letter to the EU Commission, in which it expressed a positive opinion on the amendments and on 13 July the ARC (EC Accounting Regulatory Committee) also voted in favour.
On 29 September 2023, the IASB also issued the document "International Tax Reform - Pillar Two Model Rules - Amendments to the IFRS for SMEs Standard", making the temporary exception applicable to SMEs as well.
On 9 November 2023, Regulation (EU) 2023/2468 was published, which incorporates the entire set of amendments to IAS 12.
The standards IFRS 17 and IFRS 9, both applicable to the entire scope of the Group from 1 January 2023, significantly change the accounting representation of insurance contracts and financial instruments. As mentioned in previous years, due to the strict correlation between the two standards, as from the 2018 financial year, the undertakings or groups that conduct insurance business had the option to defer the application of IFRS 9 up to the date of first-time adoption of IFRS 17. This option was also exercised by the UnipolSai Group. It is also noted that, specifically due to the close interrelation of the two standards, the Group has adopted the option set forth in Regulation (EU) 2022/1491 (so-

called "classification overlay") to ensure full representation of the joint impact of the new context of the accounting standards, therefore adopting both IFRS 9 and IFRS 17 in determining the comparative data for 2022 presented in the accounting reports for the 2023 financial year. The most significant changes introduced by the aforementioned standards and a disclosure on the main accounting policies that the Group has adopted are described below.
IFRS 17 "Insurance Contracts", applicable from 1 January 2023, establishes new criteria for measuring and accounting rules for insurance products, replacing IFRS 4, an "interim" standard issued in 2004, which provided for the application of local accounting practices, potentially different from each other, complicating the comparison of the financial results of insurance companies. The process of formation and approval of the standard was particularly complex: specifically, in the version approved by the IASB on 18 May 2017, the date of entry into force was set for 1 January 2021. With the two following interventions by the IASB, the date of entry into force was postponed to 1 January 2023, also considering the numerous requests to amend the standard proposed by the various stakeholders in the months immediately following the publication of the first version of the standard.
The amendments to the standard have been adopted by the IASB on 25 June 2020 and, downstream, the process of endorsement of the new standard in the European Union was activated, which was completed on 23 November 2021 with the publication of Regulation (EU) 2021/2036. It is noted that, in the endorsement phase, in line with that desired by the Italian and European industry, as a partial amendment to the version of the standard approved by the IASB, the possibility was also introduced via EU Regulation UE 2023/1803 of not applying the grouping into annual cohorts of Life insurance contracts characterised by intergenerational mutualisation and cash flow matching.
Very briefly, the IFRS 17 accounting standard has introduced the following changes:

the attribution to the year of a portion of the CSM based on the portion of services provided, gross of the component of acquisition charges.
B. Insurance costs, mainly comprised of:

h) qualitative and quantitative disclosure: to accompany the information reported in the Income Statement and in the Statement of Financial Position, the impact of insurance contracts on the company's cash flows and financial performance must also be reported by means of various statements showing the changes occurred during the year related to the single components making up the insurance liabilities. Please recall that, with regard to disclosure, the Supervisory Authority also intervened significantly and, with its Measure of 7 June 2022, updated IVASS Regulation 7/2007, defining, inter alia, in line with the requirements of the IFRS international standards, the minimum content of the annual disclosure and of the more limited halfyearly disclosure, and also introducing a mandatory format, with the quantitative disclosure broken down into mostly tabular forms.
A brief analysis is provided below of the main choices made by the UnipolSai Group with reference to the adoption of the new accounting standard IFRS 17 as well as the transition approach referring to the date of initial application (1/1/2022).
For a more detailed illustration of the methodological and valuation approach adopted by the Group, please refer to what is reported below in this section of the Notes to the Financial Statements, commenting on the accounting standards adopted in the recognition and measurement of Insurance Liabilities and other Statement of Financial Position and Income Statement items relating to insurance operations.
IFRS 17 is applied to all products featuring significant insurance risk and to insurance contracts with direct participation features. Based on this criterion, the scope of application has included all Non-Life insurance contracts and, with regard to the Life business, all class I, IV and V products and a limited portion of class III products, if they contain, at the date of first-time adoption of IFRS 17, significant insurance risk other than investment risk. On the basis of this approach, all class VI products were considered not insurance contracts but investment contracts.
In addition, for the determination of the scope of cash flows included in the contract boundary for the purpose of accounting for insurance contracts compared to the scope considered based on the previous accounting criteria, the following changes were made:
For the purpose of identifying the unit of account, i.e., the level of aggregation, also defined based on the level of expected profitability of the contracts, to which the accounting criteria set out in the standard are applied, the Group has included in the same UOA all contracts issued during each financial year (period 1/1 – 31/12, corresponding to the "annual cohort" concept). Accounting for charges for claims based on the "cohorts" of issue of insurance contracts, and not by the year of occurrence constitutes a significant change, especially with regard to the Non-Life business, compared to the representation criteria based on the provisions of the previous IFRS 4. Please refer to the section Method of aggregating groups of contracts for additional information on the application criteria adopted by the Group.
With regard to the aggregation criteria used under IFRS 4, the different level of granularity introduced by IFRS 17 results in a greater possibility of identifying onerous UOAs, in the initial accounting phase, resulting in the recording of the expected loss directly in the year of issue.

To determine the discount rate to apply to future cash flows, in the absence of regulatory provisions on the matter, the Group has applied a bottom-up approach. This approach provides for the identification of a "risk free" curve adjusted on the basis of a factor ("Illiquidity Premium") that expresses the illiquidity characteristics of insurance contracts. To identify the risk free curve, the Group has adopted a methodology similar to the one used in the area of prudential supervision. The Illiquidity Premium is determined using an approach analogous to that designed in the context of the revision of the Solvency II standard formula, but using the characteristics of the real asset portfolio underlying insurance liabilities. In other words, the Illiquidity Premium is differentiated based on the liquidity characteristics of the cash flows being discounted, distinguishing, for example, between flows that are dependent on the returns of a portfolio of underlying financial assets and those that are not.
The Group has adopted a method of determining the Risk Adjustment calculated using metrics derived from the Solvency II framework based on the probability distributions of the set of risks to which the cash flows are subject, and also taking into account the diversification benefits existing between the different UOAs. In particular, the diversification effect is applied between the insurance portfolios of the same entity, but not between different sectors or between legal entities. With reference to the confidence level on the basis of which the amount of the Risk Adjustment is determined, the Group has generally adopted a level equal to the 75th percentile which may be supplemented with a prudential buffer up to the 98th percentile in the event of situations of particular uncertainty in the reference context.
For insurance contracts taken out since the transition date, the Group has generally applied the following accounting models:
These accounting models were applied consistently also to contracts signed prior to the transition date, with the exception of Non-Life business, accounted for on the basis of:
The Group has adopted the options to reduce accounting mismatches deriving from the methods of valuation of liabilities and assets subject to IFRS 17 and/or IFRS 9. Specifically, the options set out in paragraphs 88, 89 and 90 of IFRS 17 allow for recognising as an offsetting entry in the Comprehensive Income Statement, rather than in the Income Statement, a portion of the finance income or expenses relating to insurance contracts. That option makes it possible:

On first-time adoption, the standard IFRS 17 requires the recalculation of the Statement of Financial Position and Income Statement balances at the transition date (which, for the UnipolSai Group, is 1 January 2022, as the 2023 Financial Statements present the previous year's Statement of Financial Position and Income Statement for comparison purposes) based on the full retrospective approach, i.e., assuming that the standard had been applied from the date of initial recognition of the insurance contracts. Based on the complexity of the provisions of the standard and the changes introduced to the existing accounting methods, the standard also provides the option, where it is not possible to retrospectively and fully apply the standard, to use two simplified approaches, as alternatives to each other, to calculate the amount of accounting items linked to insurance contracts: the modified retrospective approach or the fair value approach.
In order to verify the possibility of reconstructing the data necessary for the application of the full retrospective approach, the Group has carried out a detailed analysis in relation to the transactional flows of the years prior to the transition date (so-called "actual" flows), the cash flows (so-called "expected" data) and the values, subject to the allocation processes, not directly attributable to the contracts. On the basis of these analyses, the information relating to past years was not fully available in the portfolio or could not be found except by incurring excessive efforts, unreasonable costs with respect to the (limited) information advantage and/or adopting excessively arbitrary assumptions and simplifications, sometimes the result of derivation rules made more uncertain by changes in operations. In this context, the Group believed that there were well-founded reasons that made the full retrospective approach not applicable for the transition to IFRS 17 and, in line with the provisions of the same standard, therefore decided to apply both the fair value approach and the modified retrospective approach to net insurance liabilities outstanding at the transition date.
As a result of the above, the fair value transition approach concerned approximately 89% of the Non-Life business in place at the transition date and 47% of the Life business; while the modified retrospective approach was applied to 53% of the Life business and 11% of the Non-Life business. As already mentioned above, the transition approach, limited to the Non-Life business, also affected the choice of the accounting model to be applied to the business in place at the transition date, reserving the PAA model for the Non-Life business with transition under the modified retrospective approach and instead applying the BBA to the Non-Life business with transition under the fair value approach.
It should also be noted that, for the same reasons that do not permit the application of the full retrospective approach, the Group has decided to adopt the following simplifications in the application of the transition approaches with respect to the application of the full retrospective approach:

With reference to the methods for calculating the FV, it should be noted that this was determined as an aggregation between:
the value of the Best Estimates calculated with metrics in line with those adopted for the preparation of the MCBS and appropriately supplemented, where necessary, to take into account a better estimate of the inflationary context in place at the transition date;
an amount equal to the estimate of the additional profitability required by the market for assuming the risks underlying the portfolios (the so-called Cost Of Capital method), also defined starting from SII metrics and taking into consideration a capital endowment equal to that held on average in the Italian market with respect to the minimum regulatory capital.
The CSM at the transition date was determined, on the basis of the information available at the transition date, as the difference between the FV and the present value of the risk-adjusted expected future cash flows for each UOA.
The standard IFRS 9 - Financial Instruments was effective at the beginning of 2018. This standard was issued by the IASB at end July 2014 and was endorsed by Regulation (EU) 2016/2067, which reformed provisions envisaged by IAS 39 on the following main issues:
In particular, as regards Classification and Measurement, unlike in the IAS 39, which required mainly the analysis of the type of financial asset or liability, as well as the related holding period, the IFRS 9 standard introduced classification criteria of financial instruments based on the measurement of the related business model, as well as the analysis of the characteristics of the contractual cash flows resulting from the instruments themselves, with the application of the so-called SPPI test, aimed at verifying the position of Solely Payments of Principal and Interest. Moreover, in view of measuring what business model should be assigned to the financial instrument, the IFRS 9 envisages more objective parameters, based on various requirements such as: performance, risk, remuneration and turnover.
The new regulations also revised some guidelines on the possible reassignment of the business model that must however be very uncommon and shall meet special conditions involving significant changes, both "internal" with respect to the company and "demonstrable" with respect to external parties.
A brief examination of the activities carried out in relation to the main areas of impact is provided below.
Classification and measurement of financial assets (credits and debt securities) was defined by the UnipolSai Group based on the following elements:
As regards the first classification element of financial assets, initiatives and procedures have been performed aimed at evaluating whether the contractual cash flows of debt securities in portfolio, at the date of transition to the standard, exclusively reflect the payment of principal and interest accrued on the amount of capital to be returned (so-called SPPI Test – Solely Payment of Principle and Interest, supplemented by the so-called Benchmark Test in the absence of a perfect correspondence between the periodical redefinition of the interest rate and the related tenor).

As regards the Group's securities portfolio subject to first-time adoption of IFRS 9, the following is noted:
With reference to debt securities, IFRS 9 introduced a structured impairment model based on the concept of "expected loss" which requires the classification of financial assets into three different categories based on the evolution of credit risk, superseding the concept of "incurred loss" established by the previous IAS 39.
With reference to equities, based on the categories in which these instruments can be classified on the basis of IFRS 9 (FVOCI Equity and FVPL), the concept of impairment established by the previous IAS 39 for securities classified in the category of Available-for-sale financial assets has therefore been superseded.
As regards Hedge Accounting, the Group has exercised the faculty, afforded by IFRS 9, to maintain the accounting model as envisaged by the previous IAS 39.

The Unipol Group has been strongly committed to planning for the future application of IFRS 17 since 2017, with extensive involvement of the main corporate functions. After a thorough assessment to determine the impact of this standard and measuring the gaps in terms of processes, IT systems, accounting, actuarial calculations, business and risk, at the beginning of 2018 the IFRS 17 transition project was launched which, under the guidance of UnipolSai, has gradually also involved the other insurance companies in the Group, with a view to implementing a single data processing and management model within the Group, leveraging common policies, processes and IT applications.
With reference to IFRS 9, the Group, following a process of analysis and implementation in the management, IT and accounting systems, has activated in previous years for entities holding financial instruments (other than those not belonging to the insurance sector that have applied IFRS 9 already from the 2019 financial year) a parallel management and accounting system adapted to the requirements of IFRS 9. It should be noted that, in order to enable a more timely application of the rules provided for the VFA, it was necessary to proceed to independently identify and manage a higher number of financial asset portfolios, compared to the context of the previous IAS 39. Specifically, a portfolio of financial instruments was activated for each portfolio to which the VFA is applied.
As already mentioned above, the financial statements layouts of ISVAP Regulation 7/2007 applicable to Insurance Groups were revised in 2022 by the Supervisory Authority, albeit with effect only from the year 2023. The amendments introduced, attributable mainly, but not only, to the introduction of IFRS 17 have had significant impacts on the presentation of the Income Statement and Statement of Financial Position items and were also applied to the figures for the previous period presented for comparative purposes in these Consolidated Financial Statements.
In order to allow a clearer reconciliation between the data presented in the last approved consolidated financial statements for the year 2022 and those restated according to the new regulatory system, the effects deriving from the restatement, i.e. from the reclassification, are shown below, without any impacts from the remeasurement of assets, liabilities, costs and revenue due to the application of the new accounting standards:
accompanied by a comment on the main changes.

| 1/1/2022 (previous presentation) 1/1/2022 (new presentation) |
INTANGIBLE ASSETS | PROPERTY, PLANT AND EQUIPMENT | TECHNICAL PROVISIONS - REINSURERS' SHARE | Investment property | Investments in subsidiaries, associates and interests in joint ventures | Held-to-maturity investments | Loans and receivables | Available-for-sale financial assets | Financial assets at fair value through profit or loss | Receivables relating to direct insurance business | Receivables relating to reinsurance business | Other receivables | Non-current assets or assets of a disposal group held for sale | Deferred acquisition costs | Deferred tax assets | Current tax assets | Other assets | CASH AND CASH EQUIVALENTS | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | 2. | 3. | 4.1 | 4.2 | 4.3 | 4.4 | 4.5 | 4.6 | 5.1 | 5.2 | 5.3 | 6.1 | 6.2 | 6.3 | 6.4 | 6.5 | 7. | |||
| 1. | INTANGIBLE ASSETS | 963 - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 963 | |
| 2. | PROPERTY, PLANT AND EQUIPMENT |
- | 2,431 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5 | - | 2,436 |
| 3.1 | Insurance contracts issued that are assets |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 3.2 | Reinsurance contracts held that are assets |
- | - | 831 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 831 |
| 4.1 | Investment property | - | - | - | 2,156 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,156 |
| 4.2 | Investments in associates and interests in joint ventures |
- | - | - | - | 176 | - | - | - | - | - | - | - | - | - | - | - | - | - | 176 |
| 4.3 | Financial assets at amortised cost | - | - | - | - | - | 66 2,484 | - | - | - | - | - | - | - | - | - | - | - | 2,550 | |
| 4.4 | Financial assets at fair value through OCI |
- | - | - | - | - | 301 | 2,457 | 42,556 | 2 | - | - | - | - | - | - | - | - | - | 45,316 |
| 4.5 a) Held-for-trading assets at FVPL | - | - | - | - | - | - | - | - | 145 - | - | - | - | - | - | - | - | - | 145 | ||
| 4.5 b) Assets at FVPL | - | - | - | - | - | - | - | - | 8,345 - | - | - | - | - | - | - | - | - | 8,345 | ||
| 4.5 c) Other assets mandatorily at FVPL | - | - | - | - | - | - | 304 7,879 | 82 - | - | - | - | - | - | - | - | - | 8,265 | |||
| 5. | OTHER FINANCIAL ASSETS | - | - | - | - | - | - | - | - | - | 1,398 | 205 | 1,822 - | - | - | - | - | - | 3,425 | |
| Non-current assets or assets of a | ||||||||||||||||||||
| 6.1 | disposal group held for sale | - | - | - | - | - | - | - | - | - | - | - | - | 133 | - | - | - | - | - | 133 |
| 6.2 a) Current tax assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9 | - | - | 9 | |
| 6.2 b) Deferred tax assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 108 | - | - | - | 108 | |
| 6.3 Other assets | - | - | - | - | - | - | - | - | - | - | - | - | - | 100 | - | - | 616 - | 716 | ||
| 7. | CASH AND CASH EQUIVALENTS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 885 | 885 |
| Total | 963 | 2,431 | 831 | 2,156 | 176 | 367 | 5,245 | 50,435 | 8,574 | 1,398 | 205 | 1,822 | 133 | 100 | 108 | 9 | 621 | 885 | 76,459 |

| 1/1/2022 (previous presentation) 1/1/2022 |
GSE - Share capital | GSE - Other equity instruments | GSE - Capital reserves | GSE - Income-related and other equity reserves |
GSE - (Treasury shares) | GSE - Reserve for foreign currency translation differences |
GSE - Gains or losses on available for-sale financial assets |
recognised directly in equity GSE - Other gains or losses |
attributable to the owners of the Profit (loss) for the year Parent |
NCI - Share capital and reserves attributable to non-controlling interests |
NCI - Gains or losses recognised directly in equity |
attributable to non-controlling Profit (loss) for the year interests |
Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (new presentation) | 1.1.1 | 1.1.2 | 1.1.3 | 1.1.4 | 1.1.5 | 1.1.6 | 1.1.7 | 1.1.8 | 1.1.9 | 1.2.1 | 1.2.2 | 1.2.3 | ||
| 1.1 | Share capital | 2,031 | - | - | - | - | - | - | - | - | - | - | - 2,031 | |
| 1.2 | Other equity instruments | - | 496 | - | - | - | - | - | - | - | - | - | - | 496 |
| 1.3 | Capital reserves | - | - | 347 | - | - | - | - | - | - | - | - | - | 347 |
| 1.4 | Income-related and other equity reserves | - | - | - | 3,146 | - | - | - | - | 688 | - | - | - 3,835 | |
| 1.5 | Treasury shares (-) | - | - | - | - | (1) | - | - | - | - | - | - | - | (1) |
| 1.6 | Valuation reserves | - | - | - | - | - | 4 | 1,285 | (34) | - | - | - | - 1,256 | |
| Shareholders' Equity attributable to non-controlling | ||||||||||||||
| 1.7 | interests (+/-) | - | - | - | - | - | - | - | - | - | 217 | 18 | 35 | 270 |
| 1.8 | Profit (loss) for the year attributable to the Parent (+/-) | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Profit (loss) for the year attributable to non-controlling | ||||||||||||||
| 1.9 | interests (+/-) | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Shareholders' Equity | 2,031 | 496 | 347 | 3,146 | (1) | 4 | 1,285 | (34) | 688 | 217 | 18 | 35 8,234 | ||
| 1/1/2022 (previous presentation) 1/1/2022 (new presentation) |
PROVISIONS | TECHNICAL PROVISIONS | Financial liabilities at fair value through profit or loss |
Financial liabilities at amortised cost | Payables arising from direct insurance business |
Payables arising from reinsurance business |
Other payables | Liabilities associated with disposal groups held for sale |
Deferred tax liabilities | Current tax liabilities | Other liabilities | Total | ||
| 2. | 3. | 4.1 | 4.2 | 5.1 | 5.2 | 5.3 | 6.1 | 6.2 | 6.3 | 6.4 | ||||
| 2. | PROVISIONS FOR RISKS AND CHARGES | 422 | - | - | - | - | - | - | - | - | - | - | 422 | |
| 3.1 | Insurance contracts issued that are liabilities | - 57,128 | - | - | - | - | - | - | - | - | - | 57,128 | ||
| 3.2 | Reinsurance contracts held that are liabilities | - | - | - | - | - | - | - | - | - | - | - | - | |
| 4.1 a) Held-for-trading financial liabilities at FVPL | - | - | 445 | - | - | - | - | - | - | - | - | 445 | ||
| 4.1 b) Financial liabilities at FVPL | - | - | 5,911 | - | - | - | - | - | - | - | - | 5,911 | ||
| 4.2 | Financial liabilities at amortised cost | - | - | - | 2,055 | - | - | - | - | - | - | - | 2,055 | |
| 5. | PAYABLES | - | - | - | - | 188 | 104 | 900 | - | - | - | - | 1,192 | |
| 6.1 | Liabilities associated with disposal groups held for sale | - | - | - | - | - | - | - | 3 | - | - | - | 3 | |
| 6.2 a) Current tax liabilities | - | - | - | - | - | - | - | - | - | 39 | - | 39 | ||
| 6.2 b) Deferred tax liabilities | - | - | - | - | - | - | - | - | 108 | - | - | 108 | ||
| 6.3 | Other liabilities Total liabilities |
- | - | - 422 57,128 6,356 |
- 2,055 |
- 188 |
- 104 |
- 900 |
- 3 |
- 108 |
- 39 |
922 922 |
922 68,226 |
Total Shareholders' Equity and Liabilities 76,459

| 31/12/2022 (previous presentation) 31/12/2022 (new presentation) |
INTANGIBLE ASSETS | PROPERTY, PLANT AND EQUIPMENT | TECHNICAL PROVISIONS - REINSURERS' SHARE | Investment property | Investments in subsidiaries, associates and interests in joint ventures |
Held-to-maturity investments | Loans and receivables | Available-for-sale financial assets | Financial assets at fair value through profit or loss | Receivables relating to direct insurance business | Receivables relating to reinsurance business | Other receivables | Non-current assets or assets of a disposal group held for sale |
Deferred acquisition costs | Deferred tax assets | Current tax assets | Other assets | CASH AND CASH EQUIVALENTS | TOTAL ASSETS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | 2. | 3. | 4.1 | 4.2 | 4.3 | 4.4 | 4.5 | 4.6 | 5.1 | 5.2 | 5.3 | 6.1 | 6.2 | 6.3 | 6.4 | 6.5 | 7. | |||
| 1. | INTANGIBLE ASSETS | 1,143 - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,143 | |
| 2. | PROPERTY, PLANT AND EQUIPMENT | - | 2,784 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5 | - | 2,789 |
| 3.1 | Insurance contracts issued that are assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 3.2 | Reinsurance contracts held that are assets | - | - | 762 - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 762 | |
| 4.1 | Investment property | - | - | - | 2,359 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2,359 |
| 4.2 | Investments in associates and interests in joint ventures |
- | - | - | - | 162 | - | - | - | - | - | - | - | - | - | - | - | - | - | 162 |
| 4.3 | Financial assets at amortised cost | - | - | - | - | - | 64 2,134 | 16 | - | - | - | - | - | - | - | - | - | - | 2,213 | |
| 4.4 | Financial assets at fair value through OCI | - | - | - | - | - | 302 2,479 34,719 | - | - | - | - | - | - | - | - | - | - | 37,500 | ||
| 4.5 a) Held-for-trading assets at FVPL | - | - | - | - | - | - | - | - | 284 - | - | - | - | - | - | - | - | - | 284 | ||
| 4.5 b) Assets at FVPL | - | - | - | - | - | - | - | - | 8,786 | - | - | - | - | - | - | - | - | - | 8,786 | |
| 4.5 c) Other assets mandatorily at FVPL | - | - | - | - | - | - | 281 6,548 | 52 - | - | - | - | - | - | - | - | - | 6,881 | |||
| 5. | OTHER FINANCIAL ASSETS | - | - | - | - | - | - | - | - | - | 1,416 192 1,864 - | - | - | - | - | - | 3,472 | |||
| Non-current assets or assets of a disposal | ||||||||||||||||||||
| 6.1 | group held for sale | - | - | - | - | - | - | - | - | - | - | - | - | 533 | - | - | - | - | - | 533 |
| 6.2 a) Current tax assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 36 - | - | 36 | ||
| 6.2 b) Deferred tax assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 885 - | - | - | 885 | ||
| 6.3 | Other assets | - | - | - | - | - | - | - | - | - | - | - | - | - | 102 | - | - | 1,478 | - | 1,580 |
| 7. | CASH AND CASH EQUIVALENTS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 826 | 826 |
| Total | 1,143 2,784 762 2,359 162 | 366 4,894 41,283 9,121 | 1,416 192 1,864 533 102 885 | 36 1,483 826 70,211 |

| 31/12/2022 (previous presentation) 31/12/2022 (new presentation) |
GSE - Share capital | GSE - Other equity instruments | GSE - Capital reserves | GSE - Income-related and other equity reserves |
GSE - (Treasury shares) | GSE - Reserve for foreign currency translation differences |
GSE - Gains or losses on available-for sale financial assets |
GSE - Other gains or losses recognised directly in equity |
Profit (loss) for the year attributable to the owners of the Parent |
attributable to non-controlling interests NCI - Share capital and reserves |
NCI - Gains or losses recognised directly in equity |
Profit (loss) for the year attributable to non-controlling interests |
Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.1.1 | 1.1.2 | 1.1.3 | 1.1.4 | 1.1.5 | 1.1.6 | 1.1.7 | 1.1.8 | 1.1.9 | 1.2.1 | 1.2.2 | 1.2.3 | |||
| 1.1 | Share capital | 2,031 | - - |
- | - | - | - | - | - | - | - | - 2,031 | ||
| 1.2 | Other equity instruments | - | 496 | - | - | - | - | - | - | - | - | - | - | 496 |
| 1.3 | Capital reserves | - | - 347 |
- | - | - | - | - | - | - | - | - | 347 | |
| 1.4 | Income-related and other equity reserves | - | - | - 3,236 | - | - | - | - | - | - | - | - 3,236 | ||
| 1.5 | Treasury shares (-) | - | - - |
- | (3) | - | - | - | - | - | - | - | (3) | |
| 1.6 | Valuation reserves | - | - - |
- | - | 4 (1,129) | (11) | - | - | - | - (1,136) | |||
| Shareholders' Equity attributable to non-controlling | ||||||||||||||
| 1.7 | interests (+/-) | - | - - |
- | - | - | - | - | - | 225 | (36) | - | 189 | |
| 1.8 | Profit (loss) for the year attributable to the Parent (+/-) | - | - - |
- | - | - | - | - | 597 | - | - | - | 597 | |
| Profit (loss) for the year attributable to non-controlling | ||||||||||||||
| 1.9 | interests (+/-) | - | - - |
- | - | - | - | - | - | - | - | 55 | 55 | |
| Total Shareholders' Equity | 2,031 | 496 | 347 3,236 | (3) | 4 (1,129) | (11) | 597 | 225 | (36) | 55 5,813 | ||||
| 31/12/2022 (previous presentation) 31/12/2022 (new presentation) |
PROVISIONS | TECHNICAL PROVISIONS | Financial liabilities at fair value through profit or loss |
Financial liabilities at amortised cost |
Payables arising from direct insurance business |
Payables arising from reinsurance business |
Other payables | disposal groups held for sale Liabilities associated with |
Deferred tax liabilities | Current tax liabilities | Other liabilities | Total | ||
| 2. | 3. | 4.1 | 4.2 | 5.1 | 5.2 | 5.3 | 6.1 | 6.2 | 6.3 | 6.4 | ||||
| 2. | PROVISIONS FOR RISKS AND CHARGES | 596 | - - |
- | - | - | - | - | - | - | - | 596 | ||
| 3.1 3.2 |
Insurance contracts issued that are liabilities Reinsurance contracts held that are liabilities |
- | - 51,766 | - - - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- | - 51,766 - |
|
| 4.1 a) Held-for-trading financial liabilities at FVPL | - | - 155 |
- | - | - | - | - | - | - | - | 155 | |||
| 4.1 b) Financial liabilities at FVPL | - | - 6,685 | - | - | - | - | - | - | - | - 6,685 | ||||
| 4.2 | Financial liabilities at amortised cost | - | - | - 2,303 | - | - | - | - | - | - | - | 2,303 | ||
| 5. | PAYABLES | - | - - |
- | 198 | 144 | 1,156 | - | - | - | - | 1,498 | ||
| 6.1 | Liabilities associated with disposal groups held for sale | - | - - |
- | - | - | - | 388 | - | - | - | 388 | ||
| 6.2 a) Current tax liabilities | - | - - |
- | - | - | - | - | - | 12 | - | 12 | |||
| 6.2 b) Deferred tax liabilities | - | - - |
- | - | - | - | - | 1 | - | - | 1 | |||
| 6.3 | Other liabilities | - | - - |
- | - | - | - | - | - | - | 995 | 995 | ||
| Total liabilities | 596 51,766 6,839 2,303 | 198 | 144 | 1,156 | 388 | 1 | 12 | 995 64,398 | ||||||
Total Shareholders' Equity and Liabilities 70,211
With reference to the statement of financial position balances, it should be noted that, for the purposes of restatement, the amount of item "3. Technical provisions - Reinsurers' share" of assets and "3. Technical provisions" of liabilities, has been fully allocated respectively to item "3.2 Reinsurance contracts held that are assets" and "3.1 Insurance contracts issued that are liabilities" of the current statement of financial position format: the detailed effects arising from the recalculation of insurance assets and liabilities on the basis of IFRS 17 have been shown in the subsequent section on restatement of balances.
The most significant impact deriving from the restatement of asset items is attributable to the reclassification of financial instruments in the categories under IFRS 9. As mentioned above, the application of IFRS 9 resulted in a significant increase in financial assets at fair value through profit or loss, mainly attributable to the failure to pass the SPPI Test of a portion of the securities portfolio previously classified under Available-for-sale financial assets and, to a lesser extent, Loans and receivables.
Conversely, the amount of financial instruments reclassified under Financial assets at amortised cost is significantly lower than the corresponding accounting categories under the previous IAS 39 (Loans and receivables and Held-tomaturity investments). Similarly, the amount of FVOCI assets is lower than the corresponding IAS 39 category of Available-for-sale financial assets.

| 31/12/2022 (previous presentation) 31/12/2022 |
Gross premiums earned | Earned premiums ceded to reinsurers | Commission income | Gains and losses on financial instruments at FVPL | Gains on investments in subs. ass. and interests in JV | Interest income | Other income | Realised gains | Unrealised gains | Other revenue | Charges relating to claims - Amounts paid and chan. tech. prov. |
Charges relating to claims - Reinsurers' share | Commission expense | Losses on investments in subs. ass. and interests in JV | Interest expense | Other charges | Realised losses | Unrealised losses | Commissions and other acquisition costs | Investment management expenses | Other administrative expenses | Other costs | Taxes | Profit (Loss) from discontinued operations | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (new presentation) Insurance revenue from insurance |
1.1.1 | 1.1.2 | 1.2 | 1.3 | 1.4 | 1.5.1 | 1.5.2 | 1.5.3 | 1.5.4 | 1.6 | 2.1.1 | 2.1.2 | 2.2 | 2.3 | 2.4.1 | 2.4.2 | 2.4.3 | 2.4.4 | 2.5.1 | 2.5.2 | 2.5.3 | 2.6 | 3. | 4 | ||
| 1. | contracts issued Insurance service expenses from |
11,907 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - 11,907 | |
| 2. | insurance contracts issued | - | - | - | - | - | - | - | - | - | 22 (8,832) | - | - | - | - | - | - | - (2,071) | - | - (244) | - | - (11,124) | ||||
| 3. | Insurance revenue from reinsurance contracts held |
- | - | - | - | - | - | - | - | - | - | - 183 | - | - | - | - | - | - | 184 | - | - | - | - | - | 367 | |
| 4. | Insurance service expenses from reinsurance contracts held |
- (541) | - | - | - | - | - | - | - | 10 | - | - | - | - | - | - | - | - | - | - | - | (4) | - | - (536) | ||
| 6. | Gains/losses on financial assets and liabilities at fair value through profit or loss |
- | - | - (313) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | (313) | |
| 7. | Gains/losses on investments in associates and interests in joint ventures |
- | - | - | - 23 | - | - | - | - | - | - | - | - (8) | - | - | - | - | - | - | - | - | - | - | 15 | ||
| 8.1 | Interest income calculated with the effective interest method |
- | - | - | - | - 1,508 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - 1,508 | ||
| 8.2 | Interest expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - (80) | - | - | - | - | - | - | - | - | - | (80) | |
| 8.3 | Other gains/losses | - | - | - | - | - | - 345 | - | - | - | - | - | - | - | - (32) | - | - | - | - | - | - | - | - | 314 | ||
| 8.4 8.5 |
Realised gains/losses Unrealised gains/losses |
- - |
- - |
- - |
- - |
- - |
- - |
- | - 467 - |
- 1 |
- - |
- - |
- - |
- - |
- - |
- - |
- | - (413) | - - (347) |
- - |
- - |
- - |
- (9) |
- - |
- - |
54 (355) |
| Net finance expenses/income | ||||||||||||||||||||||||||
| 10. | relating to insurance contracts issued |
- | - | - | - | - | - | - | - | - | - | 49 | - | - | - | - | - | - | - | - | - | - | - | - | - | 49 |
| 11. | Net finance income/expenses relating to reinsurance contracts held |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 13. | Other revenue/costs | - | - 49 | - | - | 5 | - | - | - 1,112 | - | - (89) | - | - | - | - | - | - | - | - (767) | - | - | 310 | ||||
| 14.1 | Investment management expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - (135) | - | - | - | - | (135) | |
| 14.2 | Other administrative expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - (747) | - | - | - (747) | ||
| 15. | Net provisions for risks and charges | - | - | - | - | - | - | - | - | - | 10 | - | - | - | - | - | - | - | - | - | - | - | 1 | - | - | 11 |
| 16. | Net impairment losses/reversals on property, plant and equipment |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - (282) | - | - (282) | ||
| 17. | Net impairment losses/reversals on intangible assets |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | (41) | - | - | (41) |
| 18. | Other operating expenses/income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 20. 22. |
Taxes Profit (Loss) from discontinued operations |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- | - (269) - |
- | - (269) - |
| Total | 11,907 (541) 49 (313) 23 1,512 345 467 | 1 1,154 (8,783) 183 (89) (8) (80) (32) (413) (347) (1,887) (135) (747) (1,347) (269) | - | 651 |
As emerges from the reconciliation scheme, the Income Statement introduced by the current Regulation 7/2007 shows a scalar structure that provides separate evidence of the income components that constitute the insurance service result and those that make up the financial result deriving from investments and of the financial component deriving from insurance assets and liabilities. Some economic components previously grouped under Other revenue and Other costs have also been detailed and shown separately.
For the purposes of the restatement, as the discounting of technical provisions was not included in the previous IFRS 4, it should be noted that in item "10. Net finance expenses/income relating to insurance contracts issued", the only component of the change in Life technical provisions attributable to the application of the so-called shadow accounting was recognised.

| 1/1/2022 Reclassified |
IFRS 9 transition effect |
IFRS 17 transition effect |
Tax effect | 1/1/2022 Restated |
||
|---|---|---|---|---|---|---|
| 1. | INTANGIBLE ASSETS | 963 | - | (38) | - | 925 |
| 2. | PROPERTY, PLANT AND EQUIPMENT |
2,436 | - | - | - | 2,436 |
| 3. | INSURANCE ASSETS | 831 | - | 277 | - | 1,108 |
| 3.1 | Insurance contracts issued that are assets |
- | - | 79 | - | 79 |
| 3.2 | Reinsurance contracts held that are assets |
831 | - | 198 | - | 1,029 |
| 4. | INVESTMENTS | 66,953 | 457 | (124) | - | 67,286 |
| 4.1 | Investment property | 2,156 | - | - | - | 2,156 |
| 4.2 | Investments in associates and interests in joint ventures |
176 | - | - | - | 176 |
| 4.3 | Financial assets at amortised cost | 2,550 | (5) | (124) | - | 2,422 |
| 4.4 | Financial assets at fair value through OCI |
45,316 | 480 | - | - | 45,796 |
| 4.5 a) | Held-for-trading assets at FVPL | 145 | (13) | - | - | 133 |
| 4.5 b) | Assets at FVPL | 8,345 | - | - | - | 8,345 |
| 4.5 c) | Other assets mandatorily at FVPL | 8,265 | (6) | - | - | 8,259 |
| 5. | OTHER FINANCIAL ASSETS | 3,425 | - | (987) | - | 2,438 |
| 6. | OTHER ASSETS | 965 | - | (96) | 310 | 1,180 |
| 6.1 | Non-current assets or assets of a disposal group held for sale |
133 | - | - | - | 132 |
| 6.2 a) | Current tax assets | 9 | - | - | - | 9 |
| 6.2 b) | Deferred tax assets | 108 | - | - | 310 | 418 |
| 6.3 | Other assets | 716 | - | (95) | - | 620 |
| 7. | CASH AND CASH EQUIVALENTS | 885 | - | - | - | 885 |
| TOTAL ASSETS | 76,459 | 457 | (968) | 310 | 76,258 |

| 1/1/2022 Reclassified |
IFRS 9 transition effect |
IFRS 17 transition effect |
Tax effect | 1/1/2022 Restated |
||
|---|---|---|---|---|---|---|
| 1. | SHAREHOLDERS' EQUITY | 8,234 | 470 | (1,731) | 378 | 7,352 |
| 1.1 | Share capital | 2,031 | - | - | - | 2,031 |
| 1.2 | Other equity instruments | 496 | - | - | - | 496 |
| 1.3 | Capital reserves | 347 | - | - | - | 347 |
| 1.4 | Income-related and other equity reserves |
3,835 | 430 | (383) | (22) | 3,859 |
| 1.5 | Treasury shares (-) | (1) | - | - | - | (1) |
| 1.6 | Valuation reserves | 1,256 | 36 | (1,352) | 403 | 343 |
| 1.7 | Shareholders' Equity attributable to non-controlling interests (+/-) |
270 | 4 | 4 | (3) | 275 |
| 1.8 | Profit (loss) for the year attributable to the Parent (+/-) |
- | - | - | - | - |
| 1.9 | Profit (loss) for the year attributable to non-controlling interests (+/-) |
- | - | - | - | - |
| 2. | PROVISIONS FOR RISKS AND CHARGES |
422 | - | - | - | 422 |
| 3. | INSURANCE LIABILITIES | 57,128 | - | (1,267) | - | 55,862 |
| 3.1 | Insurance contracts issued that are liabilities |
57,128 | - | (1,353) | - | 55,775 |
| 3.2 | Reinsurance contracts held that are liabilities |
- | - | 87 | - | 87 |
| 4. | FINANCIAL LIABILITIES | 8,411 | (13) | 2,090 | - | 10,488 |
| 4.1 a) | Held-for-trading financial liabilities at FVPL |
445 | (13) | - | - | 432 |
| 4.1 b) | Financial liabilities at FVPL | 5,911 | - | 2,220 | - | 8,131 |
| 4.2 | Financial liabilities at amortised cost | 2,055 | - | (131) | - | 1,924 |
| 5. | PAYABLES | 1,192 | - | (113) | - | 1,079 |
| 6. | OTHER LIABILITIES | 1,072 | - | 53 | (69) | 1,056 |
| 6.1 | Liabilities associated with disposal groups held for sale |
3 | - | - | - | 3 |
| 6.2 a) | Current tax liabilities | 39 | - | - | - | 39 |
| 6.2 b) | Deferred tax liabilities | 108 | - | - | (69) | 39 |
| 6.3 | Other liabilities | 922 | - | 53 | - | 975 |
| TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES |
76,459 | 457 | (968) | 310 | 76,258 |

| 31/12/2022 Reclassified |
IFRS 9 transition effect |
IFRS 17 transition effect |
Tax effect | 31/12/2022 Restated |
||
|---|---|---|---|---|---|---|
| 1. | INTANGIBLE ASSETS | 1,143 | - | (24) | - | 1,119 |
| 2. | PROPERTY, PLANT AND EQUIPMENT |
2,789 | - | 1 | - | 2,791 |
| 3. | INSURANCE ASSETS | 762 | - | 218 | - | 980 |
| 3.1 | Insurance contracts issued that are assets |
- | - | 54 | - | 54 |
| 3.2 | Reinsurance contracts held that are assets |
762 | - | 164 | - | 926 |
| 4. | INVESTMENTS | 58,186 | (431) | (133) | - | 57,622 |
| 4.1 | Investment property | 2,359 | - | - | - | 2,359 |
| 4.2 | Investments in associates and interests in joint ventures |
162 | - | - | - | 162 |
| 4.3 | Financial assets at amortised cost | 2,213 | (4) | (133) | - | 2,076 |
| 4.4 | Financial assets at fair value through OCI |
37,500 | (374) | - | - | 37,126 |
| 4.5 a) | Held-for-trading assets at FVPL | 284 | (3) | - | - | 281 |
| 4.5 b) | Assets at FVPL | 8,786 | - | - | - | 8,786 |
| 4.5 c) | Other assets mandatorily at FVPL | 6,881 | (49) | - | - | 6,832 |
| 5. | OTHER FINANCIAL ASSETS | 3,472 | - | (1,001) | - | 2,470 |
| 6. | OTHER ASSETS | 3,034 | - | (116) | (29) | 2,888 |
| 6.1 | Non-current assets or assets of a disposal group held for sale |
533 | - | (18) | - | 514 |
| 6.2 a) | Current tax assets | 36 | - | - | - | 36 |
| 6.2 b) | Deferred tax assets | 885 | - | - | (29) | 856 |
| 6.3 | Other assets | 1,580 | - | (98) | - | 1,482 |
| 7. | CASH AND CASH EQUIVALENTS | 826 | - | - | - | 826 |
| TOTAL ASSETS | 70,211 | (431) | (1,055) | (29) | 68,696 |

| 31/12/2022 Reclassified |
IFRS 9 transition effect |
IFRS 17 transition effect |
Tax effect | 31/12/2022 Restated |
||
|---|---|---|---|---|---|---|
| 1. | SHAREHOLDERS' EQUITY | 5,813 | (426) | 1,752 | (404) | 6,733 |
| 1.1 | Share capital | 2,031 | - | - | - | 2,031 |
| 1.2 | Other equity instruments | 496 | - | - | - | 496 |
| 1.3 | Capital reserves | 347 | - | - | - | 347 |
| 1.4 | Income-related and other equity reserves |
3,236 | 427 | (383) | (20) | 3,260 |
| 1.5 | Treasury shares (-) | (3) | - | - | - | (3) |
| 1.6 | Valuation reserves | (1,136) | (132) | 1,586 | (409) | (91) |
| 1.7 | Shareholders' Equity attributable to non-controlling interests (+/-) |
189 | (23) | 80 | (18) | 227 |
| 1.8 | Profit (loss) for the year attributable to the Parent (+/-) |
597 | (686) | 468 | 40 | 418 |
| 1.9 | Profit (loss) for the year attributable to non-controlling interests (+/-) |
55 | (11) | 1 | 4 | 48 |
| 2. | PROVISIONS FOR RISKS AND CHARGES |
596 | - | - | - | 596 |
| 3. | INSURANCE LIABILITIES | 51,766 | - | (4,440) | - | 47,327 |
| 3.1 | Insurance contracts issued that are liabilities |
51,766 | - | (4,573) | - | 47,194 |
| 3.2 | Reinsurance contracts held that are liabilities |
- | - | 133 | - | 133 |
| 4. | FINANCIAL LIABILITIES | 9,142 | - | 1,752 | - | 10,894 |
| 4.1 a) | Held-for-trading financial liabilities at FVPL |
155 | - | - | - | 155 |
| 4.1 b) | Financial liabilities at FVPL | 6,685 | - | 1,884 | - | 8,568 |
| 4.2 | Financial liabilities at amortised cost |
2,303 | - | (132) | - | 2,171 |
| 5. | PAYABLES | 1,498 | - | (144) | - | 1,353 |
| 6. | OTHER LIABILITIES | 1,397 | (5) | 27 | 376 | 1,793 |
| 6.1 | Liabilities associated with disposal groups held for sale |
388 | - | (28) | - | 360 |
| 6.2 a) | Current tax liabilities | 12 | - | - | - | 12 |
| 6.2 b) | Deferred tax liabilities | 1 | - | - | 376 | 376 |
| 6.3 | Other liabilities | 995 | (5) | 55 | - | 1,045 |
| TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES |
70,211 | (431) | (1,053) | (28) | 68,696 |

| 31/12/2022 Reclassified |
IFRS 9 transition effect |
IFRS 17 transition effect |
Tax effect | 31/12/2022 Restated |
||
|---|---|---|---|---|---|---|
| 1. | Insurance revenue from insurance contracts issued | 11,907 | - | (3,358) | - | 8,549 |
| 2. | Insurance service expenses from insurance contracts issued |
(11,124) | - | 3,817 | - | (7,307) |
| 3. | Insurance revenue from reinsurance contracts held | 367 | - | (177) | - | 190 |
| 4. | Insurance service expenses from reinsurance contracts held |
(536) | - | 178 | - | (358) |
| 5. | Insurance service result | 613 | - | 460 | - | 1,074 |
| 6. | Gains/losses on financial assets and liabilities at fair value through profit or loss |
(313) | (347) | 342 | - | (318) |
| 7. | Gains/losses on investments in associates and interests in joint ventures |
15 | - | - | - | 15 |
| 8.1 | Interest income calculated with the effective interest method |
1,508 | (107) | - | - | 1,401 |
| 8.2 | Interest expense | (80) | 4 | - | - | (76) |
| 8.3 | Other gains/losses | 314 | (154) | - | - | 160 |
| 8.4 | Realised gains/losses | 54 | (65) | - | - | (11) |
| 8.5 | Unrealised gains/losses | (355) | (29) | - | - | (384) |
| 9. | Investment result | 1,142 | (697) | 342 | - | 787 |
| 10. | Net finance expenses/income relating to insurance contracts issued |
49 | - | (887) | - | (838) |
| 11. | Net finance income/expenses relating to reinsurance contracts held |
- | - | (2) | - | (2) |
| 12. | Net financial result | 1,191 | (697) | (548) | - | (53) |
| 13. | Other revenue/costs | 310 | - | 163 | - | 476 |
| 14.1 | Investment management expenses | (135) | - | 44 | - | (91) |
| 14.2 | Other administrative expenses | (747) | - | 402 | - | (345) |
| 15. | Net provisions for risks and charges | 11 | - | - | - | 11 |
| 16. | Net impairment losses/reversals on property, plant and equipment |
(282) | - | - | - | (282) |
| 17. | Net impairment losses/reversals on intangible assets |
(41) | - | (56) | - | (97) |
| 18. | Other operating expenses/income | - | - | - | - | (1) |
| 19. | Pre-tax profit (loss) for the year | 920 | (697) | 467 | - | 692 |
| 20. | Taxes | (269) | - | - | 43 | (226) |
| 21. | Profit (Loss) for the year after taxes | 651 | (697) | 467 | 43 | 466 |
| 22. | Profit (Loss) from discontinued operations | - | - | - | - | - |
| Consolidated profit (loss) | 651 | (697) | 467 | 43 | 466 | |
| 23. | of which attributable to the Parent | 597 | (686) | 465 | 39 | 418 |
| of which attributable to non-controlling interests | 55 | (11) | 1 | 3 | 48 |
In order to provide an overall representation of the effects on equity and on the economic result deriving from the transition to the new accounting standards, please note the following:
| Shareholders' Equity 1/1/2022 |
Profit for the period |
Other comprehensive income (expense) |
Other changes | Shareholders' Equity 31/12/2022 |
|
|---|---|---|---|---|---|
| Change in Shareholders' Equity as shown in the 2022 consolidated financial statements |
8,234 | 651 | (2,446) | (627) | 5,813 |
| Impact of IFRS 9 application | 470 | (697) | (198) | - | (426) |
| Impact of IFRS 17 application of which: |
(1,731) | 467 | 3,017 | - | 1,752 |
| Intangible assets and deferred acquisition costs |
(138) | (126) | |||
| Cash flows | 2,773 | 5,816 | |||
| CSM | (3,203) | (2,996) | |||
| RA | (1,162) | (942) | |||
| Tax and other minor effects | 378 | 43 | (830) | - | (404) |
| Total adjustments | (883) | (188) | 1,990 | - | 921 |
| Data restated | 7,352 | 466 | (456) | (627) | 6,733 |

Shareholders' Equity restated at the transition date in application of the new standards, equal to €7,352m, was €883m lower than the €8,234m recognised in application of the previous standards. The reduction is due to the combined effect of positive changes from the application of IFRS 9, amounting to €470m, negative changes deriving from the application of IFRS 17 equal to €1,731m, in addition to the related tax effects of €378m.
With reference to the application of IFRS 9, the positive balance is mainly due to the portion of financial instruments reclassified from HTM and L&R according to IAS 39 to FVOCI and FVPL according to IFRS 9 and, consequently, recognised at fair value rather than at amortised cost, with the emergence of implicit capital gains in a market environment at the transition date characterised by low interest rates.
The negative impact from the application of IFRS 17 is instead due to the increase in net insurance liabilities as a result of:
these increases were partly offset by the decrease of €2,773m deriving from the best estimate of the discounted cash flows to replace the technical provisions at ultimate cost.
It should be noted that, as mentioned above, during the transition phase, the fair value approach was applied with reference to a portion of the Life portfolio as well as to the insurance liabilities of the Non-Life business of UnipolSai, with the consequent application of the BBA to all Non-Life contracts in effect at that date and with a separate recognition, for the net liability component for residual coverage, of the CSM and the Risk Adjustment.
The changes in the Statement of Financial Position illustrated above were also reflected in the related deferred taxation, which resulted in a net positive effect on equity of €378m.
The result for the period restated according to the new accounting standards went from €651m to €466m, against a negative impact of €697m resulting from the application of IFRS 9, a positive impact of €467m resulting from the application of IFRS 17, and the related positive deferred tax effects of €43m. With reference to the impact of IFRS 9, this is mainly due, in a context of significant depreciation of almost all asset classes, to the increased share of financial instruments at fair value through profit or loss. This asset category, intended to increase the volatility of the Income Statement, was progressively reduced during the year 2022, also in view of the entry into force of the new standard.
The negative impact on the 2022 restated income statement arising from IFRS 9 is partially offset by the application of IFRS 17, due in particular to the adoption of the OCI option, which allows for a better control of accounting mismatches with reference to the valuation of assets and liabilities relating to revaluable Life insurance contracts, recognised using the VFA method, and to a positive contribution from the Non-Life business, which benefits from the approach adopted on transition and the net insurance liability discounting effect. In this regard, it should be noted, more generally, that the exercise of the options to mitigate accounting mismatches, relating to the Life and Non-Life insurance portfolio, also led to a marked reduction (from €2,446m to €456m net of tax effects) of the negative change in other comprehensive income.
As a result of the differences commented above, there was a positive impact of €921m on shareholders' equity at 31 December 2022 deriving from the application of the new accounting standards, deriving from a positive impact of €1,752m for the application of IFRS 17, partially offset by the negative effect of the application of IFRS 9 (€426m) and the effect on deferred taxation, also negative in the amount of €404m.
With reference to the impact of IFRS 9, this is mainly attributable to the decrease in the portion of the bond portfolio recognised at amortised cost (L&R and HTM categories according to IAS 39 and Amortised cost according to IFRS 9) and the consequent more extensive use of fair values for the measurement of financial assets in the portfolio, in a context of significantly rising interest rates during 2022 such as to negatively affect the market prices of fixed-rate bonds.
In the application of IFRS 17, the main impact resulting from the cash flow component, which increased from €2,773m to €5,816m, as discussed above, is attributable to the remeasurement of net insurance liabilities at current values, thus taking into account the discounting effect in a context of significantly higher rates than those at initial recognition of the same net insurance liabilities. It should be noted that this mechanism for adjusting net insurance liabilities was not contemplated in the application of IFRS 4 except through the application of shadow accounting

with respect to insurance contracts with direct participation features. With reference to the adjustment for the recognition of the CSM down from €3,203m to €2,996m, please note:
(i) a decrease in the component relating to the Non-Life business (from €1,071m to €731m) due to the decrease in the portfolio component of policies accounted for under the BBA method, which are gradually being replaced by newly issued policies accounted for under the PAA method, and thus without autonomous representation of the CSM;
(ii) an increase in the component linked to the Life business (from €2,132m to €2,265m) due to the positive impacts on the prospective margins of the insurance contracts accounted for using the VFA method due to the increase in market rates.
Lastly, with reference to the Risk Adjustment component, the decrease from €1,162m to €942m is mainly due to the same trends already commented on with reference to the CSM in the Non-Life business.

The documents published by the International Accounting Standards Board listed below could be significant for the Group, but are still not applicable since they have not yet been endorsed by the European Union or have not yet entered into force at the reporting date.
On 20 December 2023, Regulation (EU) 2023/2822 was published, which adopts the amendments to IAS 1 "Presentation of Financial Statements", subject to the document issued by the IASB on 23 January 2020, whereby the Board defined a more general approach for the classification of payables - and other liabilities - providing some criteria for the distinction between "current" and "non-current". Specifically, the classification should be based on the substantial right, existing at the reporting date, to defer the payment (or not) by at least twelve months. On 31 October 2022, the IASB also published the document "Non-current Liabilities with Covenants" proposing several amendments to IAS 1 "Presentation of Financial Statements", with a view to improving the information that companies provide on long-term debt with covenants. The entire set of amendments mentioned above applies as of 1 January 2024.
EU Regulation 2023/2579, published on 21 November 2023, adopted the amendments to IFRS 16 "Leases" issued by the IASB on 21 September 2022, in which the Board clarified the methods for accounting for a sale and leaseback transaction that calls for variable payments based on the performance or use of the asset involved in the transaction. The amendments entered into force on 1 January 2024.
On 20 December 2023, Regulation EU 2023/2859 was published in the Official Journal, establishing the European Single Access Point (ESAP), introducing centralised access to publicly available information on financial services, capital markets and sustainability reporting. Together with the above-mentioned Regulation, Regulation (EU) 2023/2869 and Directive (EU) 2023/2864 of 13 December 2023 were published, amending past regulations on the establishment and functioning of the European single access point. The ESAP is expected to be made available to the public starting in 2027.
On 25 May 2023, the IASB issued the document "Supplier Finance Arrangements (Proposed amendments to IAS 7 "Statement of Cash Flows" and IFRS 7 "Financial Instruments: Disclosures") in which it requires entities to provide additional information - both qualitative and quantitative - on supplier finance arrangements, in order to allow users of the financial statements to assess how these arrangements affect the company's liabilities and cash flows, as well as their exposure to liquidity risk. The EFRAG issued its positive "Endorsement Advice" on 4 October 2023.
On 21 March 2023, the IASB published the ED "Amendments to the Classification and Measurement of Financial Instruments - Proposed amendments to IFRS 9 and IFRS 7" following the Post Implementation Review (PIR) project, concluded in December 2022, on classification and measurement requirements for financial instruments, not finding any fundamental critical issues with regard to the clarity or adequacy of the objectives of the standard's requirements, without prejudice to certain issues such as financial assets with ESG-linked features and cash received via electronic transfer as settlement for a financial asset or liability. With regard to financial assets with ESG features, on 21 March 2023 the IASB issued ED 2023/2 in which it proposed some clarifications on the general principles of the applicable SPPI test and also provided some application examples. On 5 May, the EFRAG expressed its favourable Endorsement Advice, and the final version of the amendments is expected in the first half of 2024.

During 2023, the IASB also issued the "Request for Information Post-implementation Review of IFRS 9 Financial Instruments-Impairment" on 30 May, in consultation until 27 September, to gather market feedback on the provisions on expected credit loss and ED 2023/5 "Financial instruments with characteristics of equity (Amendments to IAS 32, IFRS 7 and IAS 1)" on 29 November, in consultation until March 2024, on the requirements for the classification of financial instruments.
On 21 August 2023, the IASB published the amendments to IAS 21 "The Effects of Changes in Foreign Exchange Rates". Since IAS 21 establishes the exchange rate that a company should use to convert the foreign currency transactions of an investee, without providing additional provisions on the exchange rate to be used in the absence of an exchange rate observable in the market, the amendments proposed by the IASB provide indications in this sense, and also establish the cases in which one currency cannot be converted into another, while at the same time requiring a specific additional disclosure to be provided in the notes to the financial statements. On 9 January 2024, EFRAG expressed a favourable opinion in its "Endorsement Advice". The amendments are expected to enter into force as of 1 January 2025, with the option of early application.
The accounting standards and the most significant criteria used in drawing up the Consolidated Financial Statements are set out below.
_____________________________________________________________________________________________________________________________________________________________________________
The paragraph numbers are the same as those of the corresponding items in the Statement of Financial Position and Income Statement, which are laid out in accordance with ISVAP Regulation no. 7/2007, as amended.
In accordance with the provisions of IAS 38, the only intangible assets that may be capitalised are those that can be identified and controlled by the company and from which the company will derive future financial benefits.
The following assets are recognised as intangible assets with a finite life:
Projects under development are not amortised until the year in which they are first used.
Goodwill paid when companies are acquired or merged is also included among intangible assets, as already mentioned in the previous paragraph Basis of consolidation (also provisionally, determined on the basis of IFRS 3). As this goodwill has an indefinite useful life, it is not amortised, but it is tested for impairment at least once a year, or each time there is any indication of impairment; durable impairments are recognised in the income statement and cannot be reversed in subsequent years.

The item includes properties used for business purposes, plant, other machines and equipment owned by the Group and rights of use acquired through lease contracts for the use of a tangible asset, except for contracts with a duration equal to or less than 12 months or referring to assets of a modest unit value.
For recognising and measuring this category of assets the Group has adopted the cost model, which systematically depreciates the asset's depreciable amount over its useful life. With reference to property, plant and equipment deriving from right of use recognition, as envisaged in IFRS 16, the initial recognition value corresponds with the present value of future payments to the lessor over the contractual duration of the lease, also including amounts due to the lessor for the exercise of any purchase option on the asset if such exercise is considered reasonably certain. Depreciation, which is carried out each year on a straight-line basis, begins when the asset is available and ready for use and ends when the asset has come to the end of its useful life (which in the case of property is estimated at 33.4 years). In the case of wholly-owned properties (land and buildings) depreciation is carried out only on the building.
Consolidated real estate companies include in the carrying amount the borrowing costs incurred for loans specifically for acquiring and renovating property, if this can be justified.
The costs of improvements and conversions are capitalised if they result in an increase in the useful life or the carrying amount of the assets.
Assets that suffer impairment losses are written down.
The carrying amount of property acquired as a result of business combinations is reassessed on the basis of the current value on the date of acquisition.
This item includes insurance contracts issued as defined and governed by IFRS 17 - insurance and reinsurance contracts, and investment contracts issued with discretionary participation features - belonging to groups of contracts (UoA) whose net positions at year end constitute assets. Please refer to the comments to item 3 Insurance liabilities - IFRS 17 for additional information on the recognition and measurement criteria adopted with regard to insurance contracts.
This item includes reinsurance contracts held defined and governed by IFRS 17, belonging to groups of contracts (UoA) whose net positions at year end constitute assets.
The Group generally applies the same recognition and measurement criteria used for insurance contracts issued without direct participation features to reinsurance contracts held that transfer a significant risk, as defined and governed by IFRS 17, illustrated below in the note on item 3 Insurance liabilities - IFRS 17, to which reference is made. In particular, reinsurance contracts held can be recognised in accordance with the BBA and PAA accounting models. Similarly to the underlying insurance contracts, the PAA is generally used for short-term reinsurance coverage, while contracts with long-term coverage are measured with the BBA. It should be noted that since the specific features of the treaties may influence their respective classification, each reinsurance contract is subject to a detailed analysis by the Group in order to identify the corresponding appropriate accounting treatment.
In addition, the valuation of reinsurance contracts held adopts assumptions consistent with those used to estimate the present value of future cash flows of the underlying insurance contracts, integrating an adjustment for the risk of default of the reinsurer measured at each reporting date, the effect of which is recognised in the income statement. The trend of the valuation models is the same as the underlying insurance contracts except for the concept of CSM, which is replaced by that of "net cost/net gain" which, in any case, is deferred and released to the Income Statement during the coverage period, in line with the provision of reinsurance services.

This item includes property or rights of use (IFRS 16) held either to earn rental income or for capital appreciation or for both.
Investment property is recognised by applying the cost method, as allowed by IAS 40 (an alternative to the fair value method).
If the final recoverable amount of property is estimated to be less than the carrying amount (or zero) it is depreciated annually on a straight-line basis, based on the recoverable amount and the estimated useful life (33.4 years).
If the recoverable amount of the property is estimated to exceed the carrying amount, no depreciation is applied. In the case of wholly-owned properties (land and buildings) depreciation is carried out only on the building.
The costs of improvements and conversions are capitalised if they result in an increase in the carrying amount, the useful life or the profitability of the assets.
Assets that suffer impairment losses are written down. The market value is determined at least once a year by means of expert appraisals conducted by outside companies.
The carrying amount of property acquired as a result of business combinations is reassessed on the basis of the current value on the date of acquisition.
This item includes investments in associates as defined in IAS 28, which are measured using the equity method or at cost.
The Group generally records financial transactions on the basis of the settlement date (value date), with reference to the financial instruments included in items 4. Investments and 4. Financial liabilities and on the basis of the transaction (trading) date for the financial instruments recognised in other items of the statement of financial position.
With reference to debt securities, reclassifications among other categories of financial assets are limited to cases in which there is a change to the business model for financial asset management and forward-looking recognition is applied, i.e. without adjusting any economic component recognised previously. The reclassification of equity instruments is not permitted.
Derivatives are initially recognised at the purchase cost representing the fair value and subsequently measured at fair value. Information on how the fair value is determined is provided in the section "Fair value measurement criteria – IFRS 13".
Derivatives may be acquired for "trading" or "hedging" purposes. For hedging transactions, the accounting standards envisage cumbersome and complex rules, with the preparation of specific documentation, to assess the effectiveness of the hedge from the time it is activated and throughout its entire term (hedge accounting). Please note that the Group has exercised the right, afforded by IFRS 9, to continue to recognise hedging transactions according to the accounting model envisaged by the previous IAS 39.

All derivative financial instruments are classified under "Financial assets at fair value through profit or loss - Held-fortrading financial assets" and "Financial liabilities at fair value through profit or loss - Held-for-trading financial liabilities".
The Group invests in notes issued by SPVs with rather similar purposes and management methods as those that characterise investments in structured and unstructured bonds, made as part of the ordinary financial management of resources derived from normal business. This financial management is characterised, in relation to the Group's business sector, by a special degree of complexity, which requires, under certain circumstances, the subscription of financial assets with specific characteristics (e.g. in terms of maturity, creditworthiness and payoff) that are not always easy to find on the financial markets. The investment opportunities offered via SPVs also make it possible, owing to their specific nature, to expand the range of financial investments available.
The UnipolSai Group classifies and records the bonds issued by SPVs based on the instructions provided in IFRS 9, deeming the circumstance that they have been issued by SPVs irrelevant, in consideration of the fact that the SPV is, in fact, considered merely a technical instrument through which to structure complex financial instruments whose risk/return profile is essentially evaluated by jointly taking into consideration the contracts that govern the notes issued by the SPV, the associated derivative contracts (generally swap agreements) and any other contractual clauses such as financial guarantee or similar clauses, or yet other "ancillary" clauses which may, in theory, make provision, when given conditions are satisfied, for the liquidation of the securities. The SPVs whose bonds are held by the UnipolSai Group in fact, consistently replicate, with the arranger, the positions they assume with noteholders, as the risks or returns of the transaction cannot be retained within it.
Therefore, investments in notes issued by SPVs are accounted for on the basis of IFRS 9, with the same criteria applied for investments in structured and unstructured bonds, with particular regard to the SPPI test. In fact, an entity must only consolidate an SPV in the event the entity exercises control over it pursuant to IFRS 10, paragraphs 6 and 7.
The UnipolSai Group, with regard to bonds issued by SPVs in the portfolio at 31 December 2023, does not exercise any form of control over the SPVs, in the sense that it is not able to govern the management process of the SPVs (which, in fact, is defined by the arrangers of the investment transaction in which the Group participates by subscribing the notes and other relevant contracts) and does not obtain any benefits from the SPVs other than those strictly dependent on the formally subscribed financial instrument. The Group holds the notes issued by the SPV and can only dispose of these autonomously, as it does not have the power to dispose of the financial instruments held by the vehicle. It is reasonable to infer, from this, that the Group holds no form of control of the SPVs pursuant to IFRS 10.
In cases where, through the SPV internal segments, which segregate the risks and benefits of issues, the majority of said risks and benefits are transferred to the UnipolSai Group, the consolidation of the segments would lead to the need to replace the debt securities issued by the SPV and subscribed by the Group with a financial asset which, in terms of the associated risks and returns, exactly replicates the financial profile of the notes cancelled as a result of the consolidation.
In fact, the segments consistently replicate, with the arranger, the positions the latter assume with noteholders, as the risks or benefits of the transaction cannot be retained within it. The result is that the financial asset to be recognised due to the consolidation of the segments would have, substantively speaking and therefore for the purposes of classification and measurement pursuant to IFRS 9, characteristics identical to those of the notes cancelled as a result of the consolidation of said segment; the result being that, in the case of consolidation of segments in which the risks/benefits of the asset pertain fully to the UnipolSai Group, there would be no substantive effects on the accounting representation of the transaction, essentially confirming the fact that, in effect, the SPVs are technical instruments for realising an investment in financial assets with characteristics which are, for all intents and purposes, equivalent to those of the notes issued by the SPV itself and segregated in the segment.
In order to quantify impairment, financial assets (other than those purchased or originated which, as of the initial recognition date, show objective evidence of impairment "Purchased or Originated Credit Impaired assets" or "POCI")

recognised in the categories Financial assets at amortised cost and Financial assets at fair value through other comprehensive income are classified in three stages (credit rating):
Stage 1: financial assets qualified as "performing", for which a significant increase in credit risk has not been recognised with respect to the initial recognition date;
Stage 2: financial assets qualified as "performing", for which a significant increase in credit rating has been recognised with respect to the initial recognition date;
Stage 3: impaired financial assets.
With reference to POCI, the amortised cost and the relative impairment adjustments are calculated in a specific manner on the basis of an effective interest rate adjusted for the credit risk determined by taking initial expected losses into account in estimated future flows.
The IFRS 9 impairment model is based both on objective (quantitative) and qualitative criteria to determine the significant increase of credit risk used to classify the individual financial assets in Stage 1 or Stage 2. Specifically, the UnipolSai Group recognises in Stage 2 any situations of non-payment for at least 30 days from the reporting date and any exposures whose rating assigned to the security has been specifically downgraded (in terms of the number of notches). As regards downgrading, it is noted that, in defining a significant increase in credit risk, the option is exercised to exclude a portion of the securities portfolio, which is characterised by a low credit risk (i.e., "Low credit risk exemption"). Specifically, that option is applied to debt securities with "investment grade" ratings. All exposures for which there is objective evidence of loss are classified in Stage 3.
Different modalities to measure value adjustments were defined for each Stage, based on the concept of "Expected Loss" or "Expected Credit Losses" (ECL), and, specifically:
In the risk parameters used to calculate the ECL, measurement models of expected losses include the Point-in-Time risk measures and the Forward looking risk measures on the future dynamics of macro-economic factors on which the lifetime expected loss depends.
This financial statements item includes financial assets that meet both the following conditions:
The initial recognition of these financial assets is carried out when the Group becomes a party in the contractual terms of the financial instrument, which usually coincides with the date of settlement. The value of the initial recognition is equal to the fair value of the financial instrument, which generally corresponds to the related purchase cost, including directly chargeable transaction costs or income.
After the initial recognition, these assets are measured at amortised cost by using the effective interest method, as well as net of impairment loss.
Debt securities or loans, fulfilling both conditions, are recognised in this category:

The initial recognition of these financial assets is carried out at the date in which the Group becomes a party in the contractual terms of the financial instrument, which usually coincides with the date of settlement. The value of the initial recognition is equal to the fair value of the instrument, which generally corresponds to the related purchase cost, including transaction costs or income that are directly chargeable to the same.
After the initial recognition, these assets continue to be measured at fair value. The interest component resulting from the application of the amortised cost method, as well as impairment losses resulting from the measurement of credit risk, are included in the income statement, while gains and losses resulting from changes in fair value are recognised directly in Shareholders' equity under "Gains or losses on financial assets (other than equity instruments) at fair value through other comprehensive income".
In the event the asset is cancelled, accrued gains and losses due to changes in fair value are recognised through profit or loss.
As regards details on determining of impairment losses, reference is made to the previous section on "Impairment".
Equity instruments that meet the following conditions are also classified under the category Financial assets at fair value through other comprehensive income:
an irrevocable option was exercised for their designation at fair value through other comprehensive income.
Any gains or losses consequent to the change in fair value are disclosed directly in Shareholders' equity under the item "Gains or losses on equity instruments at fair value through other comprehensive income".
Specifically, the accounting of equity instruments, classified under category FVOCI, is different from the one applicable to debt securities classified under the same category, for the following reasons:
Investments in this category are recognised at fair value and the differences (positive or negative) between fair value and carrying amount are recognised through profit or loss.
Information on how the fair value is determined is provided in the section "Fair value measurement criteria – IFRS 13".
There are three further sub-items:
The initial recognition of such financial assets is carried out at the date in which the entity becomes a party of the contractual terms related to the financial instruments, usually coinciding with the settlement date for the debt securities and equity instruments, and at the subscription date for derivatives, for a value equal to the fair value of the financial instrument, without considering transaction costs or income that are directly recognised in the income statement.
After the initial recognition, these assets are measured at fair value and changes in value are recognised in the income statement.
3 Definitions and accounting methods envisaged in IFRS 9 for financial assets at fair value and held-for-trading financial assets (sub-items 4.6.1 and 4.6.2 in the Consolidated Statement of Financial Position) are substantially consistent with those already envisaged in IAS 39.

The item includes financial assets not included in the item "Investments", such as trade receivables and tax receivables. These assets are recognised at their nominal value and subsequently measured at their estimated realisable value.
Other financial assets include, inter alia, receivables deriving from insurance and reinsurance transactions not included, in application of the provisions of IFRS 17, in the cash flows taken into account for the calculation of Insurance assets and liabilities and tax receivables.
This item includes Non-current assets held for sale and any discontinued operations as defined by IFRS 5.
Assets held for sale are recognised at the carrying amount or fair value, whichever is the lower, less costs to sell. If an investment in a subsidiary consolidated using the line-by-line method is to be sold within the time limit set by IFRS 5, all the assets of the company to be sold are reclassified as "Non-current assets or assets of a disposal group held for sale" in the consolidated statement of financial position (item 6.1 of the Assets) and the liabilities are similarly reclassified under the single item "Liabilities associated with disposal groups held for sale" (item 6.1 of the Liabilities). Both items appear in the consolidated financial statements net of intragroup transactions with the company to be sold.
If a group continues to operate in the business of the company to be sold, income statement items relating to the assets held for sale or disposal groups are recognised in accordance with the normal rules of consolidation on a lineby-line basis.
The item includes current and deferred tax assets, defined and governed by IAS 12.
In particular, deferred tax assets are calculated on the deductible temporary differences between the carrying amounts and the amounts for tax purposes of the assets and liabilities of the individual consolidated companies and on the consolidation adjustments. If there are any tax losses, deferred tax assets are also recognised provided there is a probability that taxable income for which they can be used will be available in future.
Deferred taxes are based on the tax rates applied at the end of the year or on the rates that are expected to be applied in the future according to the information available at the end of the financial year.
If assets are revalued solely for tax purposes and relate neither to a revaluation of the carrying amount for a previous year nor to one that is to be carried out in a subsequent year, the tax effects of the adjustment for tax purposes must be recognised in the income statement.
Deferred tax assets and liabilities, distinguished by type of tax, are offset at the level of single Group company or at the consolidated level, within the limits of the scope of the tax consolidation agreement set up by Unipol.
The item includes assets not attributable to other statement of financial position asset items.
This item includes, inter alia, prepayments and accrued income and deferred commission expense connected to investment contracts not falling within the scope of application of IFRS 17, as these are additional costs incurred to acquire the contract and amortised on a straight-line basis over the whole life of the contract. As recommended by Bank of Italy/Consob/IVASS document no. 9 of the Coordination Group on the application of IAS/IFRS, this item also includes tax credits relating to tax subsidies (such as the ecobonus and the sismabonus) acquired from third parties (direct beneficiaries or previous purchasers) and recoverable by offsetting future payments according to methods and timing established in the reference regulation.

Cash and cash equivalents include cash on hand, cash in current accounts available on demand, and term deposits for periods not exceeding 15 days.
The item includes the share capital of the consolidating company.
This item includes perpetual regulatory capital instruments issued by the Parent that qualify as Restricted Tier 1, which do not envisage in any case any obligation on the part of the issuer to reimburse the principal or interest to subscribers (without prejudice to cases of liquidation or the exercise of the right to early redemption by the issuer). These instruments are recognised at the issue value, net of issue expenses and the relative tax benefits. In line with this classification, coupon payments to subscribers are recognised, similar to what takes place for the payment of dividends, as a direct reduction from the equity reserves. Note that similar perpetual capital instruments issued by subsidiaries (if not held by the Parent and therefore eliminated in the consolidation process) are recognised in item 1.2.1 Share capital and reserves attributable to non-controlling interests.
This item includes in particular the share premium reserve of the company that carries out the consolidation. It includes the direct costs of issuing equity instruments, net of tax, and any commission income, net of tax, received for the sale of option rights not exercised by shareholders.
In addition to the income-related and other reserves of the consolidating company, this item includes in particular gains or losses arising from the first-time application of IAS/IFRS (IFRS 1), gains or losses resulting from changes in accounting standards or accounting estimates (IAS 8), provisions arising from equity-settled share-based payment transactions (IFRS 2) and consolidation reserves.
This item includes the equity instruments of the undertaking that draws up the consolidated financial statements owned by the undertaking itself and the consolidated companies. The item was negative. The gains or losses resulting from their subsequent sale are recognised as changes in shareholders' equity.
The Valuation reserves include the exchange rate differences from translation to be charged to shareholders' equity pursuant to IAS 21, whether they arise from transactions in foreign currency or from conversion into the currency of presentation of the financial statements stated in foreign currency.
This item includes, inter alia, gains or losses on cash flow hedges, revaluation reserves of property, plant and equipment and intangible assets and gains or losses on financial assets at fair value through other comprehensive income.
This item also includes the valuation reserves relating to insurance contracts issued and reinsurance contracts held with regard to the impacts deriving from financial variables, as well as the share of valuation reserves of equity investments valued using the equity method.
Provisions are made for risks and charges only when they are deemed necessary to meet an obligation arising from a past event and when it is likely that the amount of resources required can be reliably estimated. The item mainly consisted of provisions for litigation, various disputes, charges relating to the sales network, provisions for salary policies and personnel leaving-incentive schemes.
Insurance contracts according to IFRS 17 are those contracts whereby the issuer assumes significant insurance risk and agrees to compensate a beneficiary in the event of an uncertain adverse event concerning the policyholder. An insurance risk is significant if and only if the insured event could cause the issuer to pay additional amounts that are significant in any scenario with economic substance.
The uncertainty, on the other hand, concerns the occurrence of the insured event, the timing of the insured event, as well as the amount that must be paid to the policyholder.
Specifically, the Group applies IFRS 17 to all products featuring significant insurance risk and to investments contracts with discretionary participation features. Based on that criterion, the scope of application included Non-Life contracts and, with reference to the Life business, all products in class I, IV and V and a limited portion of products in class III, where they contain a significant insurance risk higher than the investment risk.
In detail, as for the Non-Life segment, all the policies in the portfolio were classified as insurance contracts.
As regards the Life segment, the principal criteria used for classifying Life products as insurance policies were:
Direct participation contracts are those insurance contracts whose cash flows are dependent on the underlying assets and which therefore establish:
Contracts with discretionary participation features (DPF), on the other hand, establish the right to receive, in addition to the basic benefits provided by the guarantee, additional services:
In particular, contracts subject to revaluation and linked to segregated funds were classified as investment products with DPF and were therefore measured and recognised as insurance contracts.

Investment contracts are those contracts characterised by the presence of an investment component (deposit), defined as the amount that the company pays to the policyholder even if the insured event does not take place. If they do not include significant insurance risk, they fall within the scope of application of IFRS 9 "Financial instruments".
The following types of contract were classified as investment contracts with no DPFs according to the rules of IFRS 9:
In the case of unit-linked products the loading and the acquisition commissions for the asset management service are recognised and amortised separately over the life of the contract. In the case of index-linked policies, which are not managed over time but only administered, these deferments were not necessary.
Without prejudice to any contractual amendments taking place subsequent to the issue, a contract classified as an insurance contract continues to be an insurance contract until terminated, whereas under certain circumstances an investment contract may be subsequently classified as an insurance contract.
Although, based on a general legal-economic principle, a contract should not be separated in order to correctly reflect its "economic substance", an insurance policy may contain various non-insurance components, such as:
These different components must be measured separately from the host contract, as well as accounted for distinctly pursuant to IFRS 9 (for embedded derivatives and investment components) or IFRS 15 (for non-insurance goods/services).
With regard to investment components, which IFRS 17 defines as the amounts that an insurance contract requires the entity to reimburse to the policyholder in all circumstances, regardless of whether or not an insured event occurs, the Group has identified this component by determining the amount that it would be required to reimburse to the policyholder in all scenarios with an impact on commercial substance.
After separating any non-insurance components, the Group applies IFRS 17 to all of the remaining components of the "host" insurance contract.
For the purpose of aggregating insurance contracts, the concept of portfolio ("contracts subject to similar risks and managed together") set out in the standard, was interpreted by the Group as follows:
For the purpose of identifying the unit of account, i.e., the level of aggregation, also defined based on the level of expected profitability of the contracts, to which the accounting criteria set out in the standard are applied, the Group includes in the same UOA all contracts issued during each financial year (period 1/1 – 31/12, corresponding to the "annual cohort" concept).
The Group applies the option set out in Regulation (EU) 2021/2036, which permits, for contracts with direct participation features that are specifically intergenerationally mutualised (identified within the scope of the Unipol

Group as revaluable Life products linked to segregated funds), not applying the breakdown of UOAs into annual cohorts of issue.
By virtue of the provisions of IFRS 17, the entity is required to apply one of the following valuation models to each group of insurance contracts:
Please recall that the classification of contracts based on the valuation model adopted, described in greater detail below, is carried out by the Group exclusively at the time of initial recognition on the basis of the contractual terms and economic context existing at that date and cannot be subsequently revised except in the event of contractual amendments.
The BBA is a standard model that provides for the separate accounting for the components of insurance liabilities/assets, comprised of the present value of expected future cash flows, the explicit adjustment for risk and the CSM, constantly adjusted based on the market conditions, specifically:
The PAA is an optional and simplified model applicable to contracts with coverage equal to or less than 12 months and, only under specific conditions, also to contracts with a longer duration. This model provides for the recognition of a single liability ("Liability for Remaining Coverage" or LRC) without explicitly distinguishing between the relative components identified in the previous sections, different to the BBA. Generally, at the reporting date, the LRC in the PAA corresponds to the amount of the premiums initially received from the policyholder net of acquisition costs. The LRC is also recognised in the Income Statement according to systematic logic on a time basis or, if significantly different, based on the expected risk distribution pattern in the contractual coverage period. In any case, the BBA valuation model remains applicable for the measurement of liabilities for incurred claims (LIC).
It should be noted that the Group, also taking into consideration the scope of insurance contracts to which this valuation model has been applied, relies on the option, established in par. 56 of IFRS 17, not to adjust the LRC to reflect the time value of money. On the other hand, the Group does not rely on the option established by IFRS 17 par. 59 b), if specific conditions are met, not to adjust FCFs for the time value of money in order to determine the LIC. Lastly, it should be noted that the Group does not make use of the option established by Art. 59 a) of IFRS 17 to recognise the cash flows associated with the acquisition of insurance contracts as costs when they are incurred. The economic burden of these acquisition costs is therefore reversed to the income statement in line with the period during which the insurance services are provided.

The Variable Fee Approach ("VFA") is a mandatory accounting model that constitutes a variation of the BBA applicable to cases of insurance contracts with direct participation and investment contracts with discretionary participation features which require that the policyholder obtain from the insurance company remuneration based on a substantial share of the returns of a portfolio of clearly identifiable financial assets. This valuation model does not include contracts without direct participation as well as reinsurance policies issued and held. Under this approach, the CSM substantially represents the fee for the financial management service provided by the insurer which must be recognised in the Income Statement over the term of the service.
On initial recognition, there is valuation consistency between the general BBA model and the VFA (with the exception of groups of insurance contracts that do not apply the annual cohort requirement). On the other hand, in the subsequent valuation phase, different from that set out for the BBA, any changes in the estimate of the CSM that derive from the performance of the underlying financial assets and therefore are due primarily to changes in fair value that have an impact on fees for the management service, result in a change in the CSM without generating direct impacts on the Income Statement or Comprehensive Income Statement. Finally, in the VFA, financial charges on the CSM are calculated at the market rate (and not at the locked-in rate). In summary, the CSM does not explicitly accrue any interest but is adjusted in each period by an amount equal to the difference between the change in the fair value of the assets and the change in fulfilment cash flows due to the effect of the time value of money, financial risks and the changes that have affected it.
For insurance and reinsurance contracts taken out since the transition date, the Group generally applies the following accounting models:
By virtue of the principle of consistency, these accounting models were also applied to contracts signed prior to the transition date, with the exception of Non-Life business, accounted for on the basis of:
Consistent with the accounting standards applied, for the estimation of future cash flows, which IFRS 17 defines as cash flows that are expected to arise with the fulfilment of the insurance contract, the Group adopts all reasonable and available information at the reporting date.
Specifically, the cash flows attributable to the group of insurance contracts include, for example, the premiums of policyholders, the payment of claims (including those reported and all future claims for which there is a substantive obligation to provide services net of recoveries), expenses and commissions and costs relating to investment activities carried out for the benefit of policyholders (including investment return services). In addition, the cash flows deriving from the acquisition or underwriting of a group of insurance contracts must be directly attributable to the portfolio of insurance contracts to which the group in question belongs.
Depending on the type of services provided, the other costs incurred for the fulfilment of the contracts could also include:
To determine the discount rate to apply to future cash flows, in the absence of regulatory provisions on the matter, the Group applies a bottom-up approach. This approach provides for the identification of a "risk free" curve adjusted on the basis of a factor ("Illiquidity Premium") that expresses the illiquidity characteristics of insurance contracts. To identify the risk free curve, the Group has adopted a methodology similar to the one used in the area of prudential supervision. The Illiquidity Premium is determined using an approach analogous to that designed in the context of the

revision of the Solvency II standard formula, but using the characteristics of the real asset portfolio underlying insurance liabilities. In other words, the Illiquidity Premium is differentiated based on the liquidity characteristics of the cash flows being discounted, distinguishing, for example, between flows that are dependent on the returns of a portfolio of underlying financial assets and those that are not.
The weighted average discount rates adopted at the end of December 2023 and 2022 are summarised below.
Discount rates (zero coupon rate) for cash flows not dependent on underlying assets
| Years | 31/12/2023 | 31/12/2022 |
|---|---|---|
| 1 | 3.68% | 3.62% |
| 2 | 3.02% | 3.74% |
| 3 | 2.77% | 3.65% |
| 4 | 2.68% | 3.60% |
| 5 | 2.65% | 3.58% |
| 10 | 2.72% | 3.54% |
| 15 | 2.80% | 3.47% |
| 20 | 2.73% | 3.21% |
| 30 | 2.80% | 3.09% |
Discount rates (zero coupon rate) for cash flows dependent on underlying assets
| Years | 31/12/2023 | 31/12/2022 |
|---|---|---|
| 1 | 3.87% | 3.79% |
| 2 | 3.20% | 3.91% |
| 3 | 2.95% | 3.82% |
| 4 | 2.86% | 3.77% |
| 5 | 2.83% | 3.74% |
| 10 | 2.90% | 3.71% |
| 15 | 2.98% | 3.64% |
| 20 | 2.91% | 3.38% |
| 30 | 2.94% | 3.22% |
The Group has adopted a method of determining the Risk Adjustment based on metrics derived from the Solvency II framework based on the probability distributions of the set of risks to which the cash flows are subject, also taking into account the diversification benefits existing between the different UOAs. In particular, the diversification effect is applied between the insurance portfolios of the same entity, but not between different sectors or between legal entities. With reference to the confidence level on the basis of which the amount of the Risk Adjustment is determined, the Group has generally adopted a level equal to the 75th percentile which may be supplemented with a prudential buffer up to the 98th percentile in the event of situations of particular uncertainty in the reference context.
Please recall that, based on the BBA general accounting model, the "Contractual Service Margin" (CSM) is the difference between the cash flows due to the company (i.e., premiums) and the aggregate contract charges undertaken, including risk adjustment. If the CSM is positive, it will be suspended under liabilities with the aim of recognising it in the Income Statement throughout the entire insurance coverage period.
If the CSM is negative, on initial recognition or even subsequently in the event of adverse changes in expected profitability, the implicit loss deriving from the insurance contract cannot be deferred and will need to be recognised in the Income Statement. Specifically, at each subsequent reporting period, the CSM must be adjusted due to changes in expected future cash flows caused, for example, by changes in technical assumptions (death, morbidity, longevity, redemptions, expenses, future premiums, etc.) or the financial interest deriving from the locked-in discount rate used on initial recognition to determine the present value of estimated cash flows.

Specifically, the CSM will be gradually recognised in the Income Statement under the item "Insurance revenue" during the insurance coverage period due to a particular calculation mechanism, introduced by IFRS 17, which aims to reflect the insurance services provided by the company on the basis of "coverage units".
In this regard, to determine the coverage units of the entire Non-Life business, the Unipol Group has chosen to use a method based on "incurred undiscounted" claims in order to best represent the risk exposure of the UOAs.
On the other hand, as regards the Life Business, the CSM is released through the Coverage Units determined on the basis of insured capital and any correction to take into account the actual margins achieved during the period.
The Group has adopted the options to reduce accounting mismatches deriving from the methods of valuation of liabilities and assets subject to IFRS 17 and/or IFRS 9. Specifically, the options set out in paragraphs 88, 89 and 90 of IFRS 17 allow for recognising as an offsetting entry in the Comprehensive Income Statement, rather than in the Income Statement, a portion of the finance income or expenses relating to insurance contracts. That option makes it possible:
Pursuant to IFRS 17, an insurance contract is removed from the group of contracts to which it belongs in the event of its expiry, transfer or amendment of conditions so that a new contract can be recognised in a new group. In terms of accounting impacts, the derecognition of insurance contracts entails the adjustment of the respective FCF and CSM of the group of contracts, in line with the reasons underlying the derecognition, without generating a direct and immediate effect on the Income Statement (unless the group of contracts becomes onerous or is extinguished).
IFRS 17 calls for the identification of two separate insurance liabilities based on when the insured event takes place:
This item includes insurance contracts issued as defined and governed by IFRS 17 - insurance and reinsurance contracts, and investment contracts issued with discretionary participation features - belonging to groups of contracts (UoA) whose net positions at year end constitute liabilities.
This item includes reinsurance contracts held defined and governed by IFRS 17, belonging to groups of contracts (UoA) whose net positions at year end constitute liabilities.

This item includes the financial liabilities at fair value through profit or loss and the financial liabilities at amortised cost pursuant to IFRS 9.
The financial liabilities in this category are subdivided into two further sub-items:
held-for-trading financial liabilities, which include negative items on derivatives;
financial liabilities to be measured at fair value through profit or loss, which include the financial liabilities related to contracts issued by insurance companies where the investment risk is borne by the policyholders, when the insurance risk is not significant, and where there is no discretionary participation feature.
This item includes debt securities issued, financial liabilities for future payments to lessors following the recognition of right of use on property, plant and equipment in application of IFRS 16 and other loans obtained.
The item Payables includes:
Payables are recognised at their nominal value.
Post-employment benefits accrued by 31 December 2006 that were not transferred to external bodies in accordance with the provisions of Italian Legislative Decree 252/05 on supplementary pension schemes come under the category of employee benefits classified as a defined benefits plan. The amount due to employees is therefore calculated using actuarial techniques and discounted at the reporting date, using the "Projected unit credit method" (a method based on benefits accrued in proportion to length of employment).
The same method is used to establish the effects of other defined benefits for employees for the post-employment period.
Actuarial gains and losses relating to obligations deriving from defined benefit plans are recorded under Other comprehensive income (expense).
Future cash flows are discounted on the basis of the market yield curve, recorded at the end of the year, for corporate bonds issued by issuers with high credit standing.
The service cost and net interest are recognised in the Income statement.
Net interest is calculated by applying to the net value of liabilities for defined benefits existing at the start of the year the one-year interest rate taken from the yield curve used to discount the liability at the end of the previous year.
Please see above for the corresponding asset item.

The item includes tax payables for current taxes as well as deferred tax liabilities, which are recognised whenever there is a taxable temporary difference, except in the cases provided for in paragraph 15 of IAS 12. Deferred tax liabilities must be measured using the tax rates that are expected to apply during the year in which the
tax liability will be paid off, based on the ruling tax rates (and tax legislation) or those in force at the reporting date. If tax rates change, despite being prior year items, the deferred taxes recalculated in accordance with the new rates are recognised under Income tax in the income statement or under equity reserves to which the temporary variations in question apply.
With regard to the offsetting of deferred tax assets and liabilities, reference should be made to the previous paragraph "6.2 Current tax assets and deferred tax assets - IAS 12" in the section on Assets.
The item includes non-financial liabilities which by their nature cannot be classified under other liability items. The item includes, inter alia, accrued expense and deferred income, liabilities relating to defined benefits and other long-term benefits for employees and deferred commission income relating to investment contracts without discretionary participation in profits, therefore not falling within the scope of scope of application of IFRS 17.
Revenues from insurance contracts issued consist of the fees due to the Company for the insurance services it provides, which pursuant to IFRS 17 are recognised in the income statement in proportion to the share of services provided in the reference period.
The methods whereby fees are reflected in the item "Insurance revenue" vary depending on the accounting model applied. With regard to the general BBA model (and the relative VFA variant), a value is recognised under insurance revenue, corresponding to the benefits that the Group had estimated to provide in the same period and incorporated into the estimate of the LRC at the beginning of the period (or initial recognition in the case of new contracts), plus the related risk adjustment and the share of the margin on contractual services rendered during the period. In detail, the portion of the fee allocated to revenue in the income statement incorporates:
On the other hand, with regard to contracts valued according to the Premium Allocation Approach ("PAA"), the recognition of insurance revenue, therefore the release of the LRC, must be carried out in relation to the distribution of insurance risk over the life of the contracts; in particular, the distribution can be carried out:
The item includes expenses actually incurred in the period deriving from insurance contracts issued and relating to claims occurring during the year (net of investment components) and other expenses directly attributable to the contracts, estimated losses and the respective changes in relation to groups of onerous insurance contracts and the amortisation of expenses for the acquisition of insurance contracts issued.

It also includes the management expenses of investments underlying the insurance contracts to which the VFA is applied.
With regard to groups of insurance contracts with direct participation features and investment contracts with DPF, this item includes changes in the amount of the share of the fair value pertaining to the company that do not change the CSM.
Any positive or negative balance is also included among other technical charges and other technical income connected with insurance contracts issued, for the part of these charges and income not included in FCFs.
This item includes the amount recovered from reinsurers such as, for example, the amount of expenses and losses recovered on the underlying insurance contracts, as well as the positive balance between write-backs and value adjustments connected with the expected losses deriving from the reinsurer's risk of default.
The item includes the share of premiums ceded for the year, net of the amounts expected to be received from reinsurers not associated with claims relating to the underlying insurance contracts.
Lastly, it includes the negative balance between write-backs and value adjustments connected with expected losses deriving from the reinsurer's risk of default and the positive or negative balance between other technical charges and other technical income connected with reinsurance, for the part of these charges and income not included in Fulfilment Cash Flows (FCFs).
This item includes realised gains and losses, interest, dividends, charges and positive and negative changes in value of financial assets and liabilities at fair value through profit or loss.
In particular, the item includes profits and losses relating to non-hedging derivative contracts, other than those included under interest. Income deriving from units of UCITS - Undertakings for Collective Investment - is also incorporated.
This item includes gains and losses on investments in associates and interests in joint ventures recognised in the corresponding asset item.
This item includes gains and losses on investment property, equity investments and financial instruments not measured at fair value through profit or loss.
Specifically, gains mainly include other investment income, including dividends and rental income from investment property, and realised gains on the sale of financial assets or liabilities and investment property.
As regards losses, on the other hand, these include other investment expense, costs relating to investment property such as condominium expenses and maintenance expenses that do not increase the value of the investment property, losses realised as a result of the derecognition of financial assets or liabilities and investment property, amortisation/depreciation and impairment losses.
These items include interest income and expense, as well as income and similar charges relating, respectively, to financial assets at amortised cost, financial assets at fair value through other comprehensive income (Asset items 4.3 and 4.4) and financial liabilities at amortised cost (Liability item 4.2).

The item includes dividends on equity instruments in the portfolio, including those designated at fair value through other comprehensive income, other than equity investments measured at equity, as well as those relating to "Discontinued operations".
The item also includes income and charges deriving from the third party use of investment property, and, in particular, condominium expenses and maintenance and repair costs not added to their value.
The item includes realised gains and losses from the sale of a financial asset at amortised cost or at fair value through other comprehensive income, as well as investment property.
This item includes positive changes deriving from the reversal of impairment and the subsequent valuation of investment property measured at fair value, hedging instruments and financial assets and liabilities subject to hedging, other than equity instruments designated at fair value through other comprehensive income, and negative changes deriving from depreciation, impairment and the measurement subsequent to the initial recognition of investment property measured at fair value, hedging instruments and financial assets and liabilities subject to hedging, other than equity instruments at fair value through other comprehensive income.
The item also includes value adjustments and write-backs connected to changes in credit risk of financial assets at amortised cost and FVOCI, as well as value adjustments/write-backs on other financial assets (item 5) and on financial assets included in "cash and cash equivalents" (item 7) in the Statement of Financial Position.
The item includes changes in the estimated value of insurance contracts issued due to changes in the time value of money and financial risks, net of those recognised in the statement of comprehensive income.
Net financial income or charges deriving from insurance and reinsurance contracts are presented in the Group Income Statement with a distinction between insurance contracts issued and reinsurance contracts held.
Specifically, the items include changes in the estimated value of groups of contracts deriving from financial risks, such as:
The Unipol Group has relied on the option established by IFRS 17 ("FVOCI Option") to recognise the effects of the change in market rates on the value of insurance liabilities and assets as a balancing entry to items of other comprehensive income, thus reducing Income Statement volatility.
Taking into account the above accounting option, financial income/charges relating to insurance and reinsurance contracts are systematically recognised in the income statement according to different methods based on the accounting model applied; in particular:

This item includes the net balance of revenue and costs from the sale of goods, the provision of services other than those of an insurance and financial nature and the use by third parties of the company's property, plant and equipment other than investment property and other assets. Also included are exchange rate differences to be recognised in the income statement pursuant to IAS 21, as well as realised gains relating to property, plant, equipment and intangible assets, other than investment property and "Discontinued operations".
The item includes personnel expenses and overheads directly or indirectly relating to the management of financial instruments, investment property and equity investments. This item does not include expenses calculated by the company in order to estimate insurance assets and liabilities such as, for example, the management costs of investments relating to insurance contracts accounted for on the basis of the VFA.
The item includes personnel expenses and overheads not included in the calculation of insurance liabilities and assets and not allocated to insurance contract acquisition costs and investment management expenses. The item includes, in particular, overheads and personnel expenses incurred for the acquisition and administration of investment contracts issued by the company without discretionary participation features and not falling within the scope of application of IFRS 17.
The item includes the provisions and any releases to the income statement of item 2 "Provisions for risks and charges" under statement of financial position liabilities. Provisions deriving from commitments and financial guarantees issued are also included.
The item includes impairment losses, depreciation and write-backs relating to property, plant and equipment, other than in relation to investment property, including those relating to assets granted under operating leases and rights of use acquired through leases and for the use of property, plant and equipment.
The item also includes the results of the valuations of property, plant and equipment classified as "Non-current assets or assets of a disposal group held for sale" pursuant to IFRS 5.
The item includes impairment losses, amortisation and write-backs relating to intangible assets, including those relating to assets granted under operating leases and rights of use acquired through leases and for the use of intangible assets.
The item also includes the results of the valuations of property, plant and equipment classified as "Non-current assets or assets of a disposal group held for sale" pursuant to IFRS 5.
The item includes costs and revenues not attributable to other items indicated previously.

For the 2021-2023 three-year period, UnipolSai has opted for the Group tax regime regulated by Art. 117 et seq. of Italian Presidential Decree no. 917/86, under the tax consolidating company Unipol Gruppo, together with its own subsidiaries that meet the regulatory requirements.
An agreement was signed between the consolidating company and the respective consolidated companies, regulating the financial and procedural aspects governing the option in question.
Tax for the year is calculated according to current tax regulations and recognised among costs for the year. It represents:
the amounts of deferred tax assets and liabilities arising during the year and usable in future years;
for the portion due for the year, the deduction of deferred tax assets and liabilities generated in previous years.
Deferred tax assets and liabilities are calculated on the basis of the temporary differences (arisen or deducted during the year) between the profit (loss) for the year and the taxable income and on the consolidation adjustments. IRAP for the year is also recognised under Income tax.
The item includes:
Items expressed in foreign currencies are treated in accordance with the principles of multicurrency accounting. Monetary elements in foreign currency (units of currency owned and assets or liabilities that must be received or paid in a fixed or ascertainable number of units of currency) are translated using the exchange rate applicable at the end of the year.
Non-monetary elements measured at historical cost in foreign currency are translated using the exchange rate applicable on the date of the transaction.
Non-monetary elements measured at fair value in a foreign currency are translated using the exchange rates applicable on the date on which the fair value is determined.
Exchange rate differences arising from the settlement of monetary elements are recognised in the income statement. Exchange rate differences arising when non-monetary elements are measured are allocated to the profit (or loss) for the year or to other comprehensive income (expense) depending on whether the profit (or loss) to which they relate is recognised in the profit (loss) for the year or in other comprehensive income (expense), respectively.
The Group pays additional benefits to senior executives under a closed share-based compensation plan under which Unipol Ordinary shares and UnipolSai Ordinary shares are granted if specific targets are achieved (Performance shares). As laid down by IFRS 2 – Share-based payments, these plans form part of the beneficiaries' remuneration. The charge must be recognised through profit or loss, with a balancing item - for UnipolSai Ordinary shares only recognised directly in equity (Reserve arising from equity-settled share-based payment), on the basis of the fair value of the instruments allocated on the grant date, the charge being spread over the period provided for in the scheme.
Basic earnings per share are calculated by dividing the profit allocated to holders of ordinary shares in the Parent UnipolSai by the weighted average number of ordinary shares outstanding during the year.
Diluted earnings per share are calculated by dividing the profit allocated to holders of ordinary shares in the Parent UnipolSai by the weighted average number of any additional ordinary shares that would be outstanding if all the

potential ordinary shares with dilutive effect were converted. If the result is negative, the loss (basic and diluted) per share is calculated.
The application of certain accounting standards implies significant elements of judgment based on estimates and assumptions which are uncertain at the time they are formulated.
It is believed that the assumptions made are appropriate and, therefore, that the financial statements have been drafted clearly and give a true and fair view of the statement of financial position, income statement and statement of cash flows.
In order to formulate reliable estimates and assumptions, reference has been made to past experience, and to other factors considered reasonable for the case in question, based on all available information. However, we cannot exclude that changes in these estimates and assumptions may have a significant effect on the statement of financial position and income statement as well as on the potential assets and liabilities reported in the financial statements for disclosure purposes, if different elements emerge with respect to those considered originally.
As required by IFRS 17, the Group formulates and uses judgments and estimates that have a very significant impact on the amounts recognised for the classification and measurement of insurance contracts as well as their corresponding level of aggregation. In detail, the most significant judgments concern the data used, the assumptions and the estimation techniques taken into consideration to project future cash flows and reflect underlying uncertainties at the reporting date. In more technical terms, the main assumptions adopted that could lead to substantial changes in the estimate of future cash flows concern estimates of payments for claims and the associated settlement expenses, mortality and longevity rates, the conduct of policyholders (due to terminations and redemptions), the percentages of participation in the returns and general costs directly attributable to the contract.
The use of estimates is also relevant in relation to mainly:
For information on the methods used to determine the items in question and the main risk factors, please refer to the sections containing a description of the measurement criteria.

The UnipolSai Group's Consolidated Financial Statements at 31 December 2023 were drawn up by combining the figures of UnipolSai and those for the 61 direct and indirect subsidiaries (IFRS 10).
There are no jointly-controlled interests.
Associates, in which the investment percentage ranges between 20% and 50% (15 companies), are measured using the equity method (IAS 28) or maintained at the carrying amount. At 31 December 2022, there were 20 associated companies.
The changes to the consolidation scope and the lists of equity investments in subsidiaries and associates are shown below.
On 3 April 2023, UnipolSai Assicurazioni SpA acquired 100% of the share capital of Società e Salute SpA. The company, which operates in the private healthcare segment under the brand Centro Medico Santagostino, holds a 100% interest in Santagostino Servizi e Prodotti Srl, specialised in the sale of sanitary items such as eyewear and hearing aids.
On 30 May 2023, the company Tenute del Cerro Wines Srl was established, wholly owned by UnipolSai Assicurazioni SpA, which will be responsible for marketing the wines of Tenute del Cerro and those of other producers.
On 1 June 2023, the partial, non-proportional asymmetric demerger of Promorest in favour of UnipolSai Finance SpA took effect.
On 22 June 2023, Linear SpA established the limited liability company LinearNext Srl, wholly owned by Linear itself, to be entrusted with the mandate for the distribution of "LinearNext" insurance policies.
In execution of the Framework Agreement signed on 28 March 2023 between UnipolSai Assicurazioni SpA and UnipolRental SpA, on the one hand, and BPER Banca SpA and SIFÀ Società Italiana Flotte Aziendali SpA on the other, the merger deed was signed on 22 June for the merger by incorporation of SIFÀ Società Italiana Flotte Aziendali SpA into UnipolRental SpA, with legal, tax and accounting effect from 1 July 2023.
On 27 June 2023, with legal effect from 3 July, the deed of merger of Anton Maria Valsalva Srl into Centri Medici Dyadea Srl was signed.
On 3 August 2023, UnipolSai Assicurazioni SpA participated in the establishment of Cronos Vita SpA, the corporate vehicle for the bail-out of the policyholders of the insurance company Eurovita SpA. In order to provide the investee with the resources necessary to purchase the Eurovita insurance business unit, completed at the end of October 2023, UnipolSai made payments in the form of share capital to Cronos Vita for a total of €49.5m, compared to an equity investment of 22.5% at 31 December 2023.
On 30 November, the purchase and sale contract for the equity investments was executed, signed on 7 July 2023 by Unicredit SpA and UnipolSai Assicurazioni SpA, relating to the transfer of the entire equity investment held in Incontra Assicurazioni SpA by UnipolSai Assicurazioni SpA to Unicredit SpA.
On 14 December 2023, UnipolSai Assicurazioni SpA and UnipolRe Dac, in execution of the respective resolutions dated 28 September and 20 March 2023, signed the deed for the cross-border merger by incorporation of UnipolRe Dac into UnipolSai Assicurazioni SpA, with statutory, accounting and tax effects from 31 December 2023. Prior to the

effective date of the merger, UnipolSai had directly acquired 100% of UnipolRe Dac share capital, having received it in assignment as a result of the voluntary liquidation procedure of UnipolSai Nederland Bv, which was cancelled from the Dutch Chamber of Commerce register with effect from 19 December 2023.
On 14 December 2023, the deed for the merger by incorporation of Centri Medici Dyadea Srl into Società e Salute SpA was signed with legal and accounting effects from 1 January 2024.
On 29 December 2023, on conclusion of the voluntary liquidation process launched on 23 October 2023, the companies Garibaldi SCA and Isola SCA were cancelled from the Luxembourg Register of Commerce and Companies.
| Name | Country of registered office |
Country of operations (1) |
Method (2) |
Business activity (3) |
Type of relationship (4) |
% Direct holding |
% Total participating interest (5) |
% Votes available at ordinary General Meetings (6) |
% Consolidation |
|---|---|---|---|---|---|---|---|---|---|
| Arca Assicurazioni SpA | 086 - Italy | G | 1 | 1 | 98.12% | 62.20% | 100.00% | ||
| Arca Direct Assicurazioni Srl | 086 - Italy | G | 11 | 1 | 100.00% | 63.39% | 100.00% | ||
| Arca Inlinea Scarl | 086 - Italy | G | 11 | 1 | 100.00% | 62.92% | 100.00% | ||
| Arca Sistemi Scarl | 086 - Italy | G | 11 | 1 | 100.00% | 63.19% | 100.00% | ||
| Arca Vita International Dac | 040 - Ireland | G | 2 | 1 | 100.00% | 63.39% | 100.00% | ||
| Arca Vita SpA | 086 - Italy | G | 1 | 1 | 63.39% | 63.39% | 100.00% | ||
| Athens R.E. Fund | 086 - Italy | G | 10 | 1 | 89.59% | 89.59% | 100.00% | ||
| BeRebel SpA | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| BIM Vita SpA | 086 - Italy | G | 1 | 1 | 50.00% | 50.00% | 100.00% | ||
| Cambiomarcia Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Casa di Cura Villa Donatello - SpA | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Centri Medici Dyadea Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Centro Oncologico Fiorentino Casa di | |||||||||
| Cura Villanova Srl in Liquidazione | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Compagnia Assicuratrice Linear SpA | 086 - Italy | G | 1 | 1 | 100.00% | 100.00% | 100.00% | ||
| Consorzio Castello | 086 - Italy | G | 10 | 1 | 99.57% | 99.57% | 100.00% | ||
| Consorzio tra Proprietari Centro | |||||||||
| Commerciale Porta Marcolfa | 086 - Italy | G | 11 | 1 | 68.46% | 68.46% | 100.00% | ||
| DaVinci Healthcare Srl | 086 - Italy | G | 11 | 1 | 77.06% | 77.06% | 100.00% | ||
| Ddor Auto - Limited Liability Company | 289 - Serbia | G | 3 | 1 | 100.00% | 100.00% | 100.00% | ||
| Ddor Novi Sad | 289 - Serbia | G | 3 | 1 | 100.00% | 100.00% | 100.00% | ||
| Ddor Re | 289 - Serbia | G | 6 | 1 | 100.00% | 100.00% | 100.00% | ||
| Finsai International Sa | 092 - Luxembourg | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Florence Centro di Chirurgia | |||||||||
| Ambulatoriale Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Fondazione Unipolis | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Fondo Emporion | 086 - Italy | G | 10 | 1 | 100.00% | 100.00% | 100.00% | ||
| Fondo Landev | 086 - Italy | G | 10 | 1 | 100.00% | 100.00% | 100.00% | ||
| Fondo Oikos | 086 - Italy | G | 10 | 1 | 100.00% | 100.00% | 100.00% | ||
| Gratia et Salus Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Gruppo UNA SpA | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| I.Car Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Immobiliare C.S. Srl | 086 - Italy | G | 10 | 1 | 100.00% | 100.00% | 100.00% | ||
| IRMA Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Ital H&R Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Leithà Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| LinearNext Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Marina di Loano SpA | 086 - Italy | G | 10 | 1 | 100.00% | 100.00% | 100.00% | ||
| Meridiano Secondo Srl | 086 - Italy | G | 10 | 1 | 100.00% | 100.00% | 100.00% | ||
| Midi Srl | 086 - Italy | G | 10 | 1 | 100.00% | 100.00% | 100.00% | ||
| Nuove Iniziative Toscane - Societa' a | |||||||||
| Responsabilita' Limitata | 086 - Italy | G | 10 | 1 | 100.00% | 100.00% | 100.00% |

| Name | Country of registered office |
Country of operations (1) |
Method (2) |
Business activity (3) |
Type of relationship (4) |
% Direct holding |
% Total participating interest (5) |
% Votes available at ordinary General Meetings (6) |
% Consolidation |
|---|---|---|---|---|---|---|---|---|---|
| Nuove Terme Petriolo Srl | 086 - Italy | G | 11 | 1 | 100.00% | 89.59% | 100.00% | ||
| Santagostino Servizi e Prodotti Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Siat-Societa' Italiana Assicurazioni e Riassicurazioni - per Azioni |
086 - Italy | G | 1 | 1 | 94.69% | 94.69% | 100.00% | ||
| Società e Salute SpA | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Tantosvago Srl | 086 - Italy | G | 11 | 1 | 75.00% | 75.00% | 100.00% | ||
| Tenute del Cerro SpA - Societa' Agricola |
086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Tenute del Cerro Wines Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Tikal R.E. Fund | 086 - Italy | G | 10 | 1 | 100.00% | 100.00% | 100.00% | ||
| UniAssiTeam Srl | 086 - Italy | G | 11 | 1 | 65.00% | 65.00% | 100.00% | ||
| Unicasa Italia SpA | 086 - Italy | G | 11 | 1 | 70.00% | 70.00% | 100.00% | ||
| UnipolAssistance Scrl | 086 - Italy | G | 11 | 1 | 100.00% | 99.86% | 100.00% | ||
| UnipolGlass Srl | 086 - Italy | G | 11 | 1 | 70.00% | 70.00% | 100.00% | ||
| UnipolHome SpA | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| UnipolPay SpA | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| UnipolRental SpA | 086 - Italy | G | 11 | 1 | 100.00% | 80.01% | 100.00% | ||
| UnipolSai Finance SpA | 086 - Italy | G | 9 | 1 | 100.00% | 100.00% | 100.00% | ||
| UnipolSai Motor Partner Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| UnipolSai Servizi Previdenziali Srl | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| UnipolService SpA | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| UnipolTech SpA | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% | ||
| Unisalute Servizi Srl | 086 - Italy | G | 11 | 1 | 100.00% | 98.99% | 100.00% | ||
| UniSalute SpA | 086 - Italy | G | 1 | 1 | 98.99% | 98.99% | 100.00% | ||
| WelBee SpA | 086 - Italy | G | 11 | 1 | 100.00% | 100.00% | 100.00% |
(1) This disclosure is required only if the country of operations is different from the country of the registered office
(2) Consolidation method: G=on a line-by-line basis; U=on a line-by-line basis as per unitary management
(3) 1 = Italian insurance companies; 2 = EU insurance companies; 3 = Non-EU insurance companies; 4 = insurance holding companies; 4.1 = mixed financial holding companies. 5 = EU reinsurance companies; 6 = Non-EU reinsurance companies; 7 = banks; 8 = asset management companies; 9 = other holding companies; 10 = real estate companies; 11 = other companies;
(4) Type of relationship:
1 = majority of voting rights at ordinary shareholders' meetings
2 = dominant influence at ordinary shareholders' meetings
3 = agreements with other shareholders
4 = other forms of control
5 = unitary management pursuant to Art. 96, paragraph 1 of "Legislative Decree 209/2005"
6 = unitary management pursuant to Art. 96, paragraph 2 of "Legislative Decree 209/2005"
(5) The product of investment relations concerning all companies positioned in the investment chain.
(6) Availability of votes at ordinary shareholders' meetings, distinguishing between actual votes and potential votes. The availability of votes is indicated only if different from the direct shareholding.

Equity investments in wholly-owned subsidiaries with material non-controlling interests: noncontrolling interests, availability of non-controlling votes, dividends distributed to non-controlling interests, profit (loss) for the year and shareholders' equity of non-controlling interests
| Amounts in €m | |||||
|---|---|---|---|---|---|
| Name | % Non-controlling interests |
% Votes available to non-controlling interests at ordinary |
Dividends distributed to non-controlling interests |
Consolidated profit (loss) attributable to non-controlling |
Shareholders' Equity attributable to non controlling interests |
| Arca Vita | 36.61% | General Meetings | 17 | interests 47 |
230 |
Equity investments with significant third-party interests: accounting information
| Amounts in €m | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Investmen ts |
Other assets |
Cash and cash equivalents |
Insurance liabilities |
Financial liabilities |
Shareholde rs' equity |
Total revenue |
Pre-tax profit (loss) from continuing operations |
Profit (loss) from continuing operations after taxes |
Profit (loss) from discontinue d operations after taxes |
Profit (loss) for the year (1) |
Other income items net of taxes (2) |
Comprehen sive Income Statement (3) = (1) + (2) |
| 1. Arca Vita | 15,138 | 333 | 117 | 11,877 | 2,895 | 618 | 493 | 181 | 127 | 127 | 16 | 142 |
Equity investments in wholly-owned subsidiaries - other information
On 3 April 2023, UnipolSai Assicurazioni SpA acquired 100% of the share capital of Società e Salute SpA, which operates in the healthcare sector under the brand name "Centro Medico Santagostino" which, in turn, holds 100% of the share capital of Santagostino Servizi e Prodotti Srl. Below are the values of the assets and liabilities acquired determined on the basis of the financial statements of Società e Salute and its subsidiary Santagostino Servizi e Prodotti Srl at 31 March 2023.
Amounts in €k
| 31/3/2023 | |
|---|---|
| Intangible assets | 1,952 |
| Property, plant and equipment | 40,951 |
| Investments | 390 |
| Other financial assets | 1,792 |
| Other assets | 2,784 |
| Cash and cash equivalents | 4,917 |
| Provisions for risks and charges | (446) |
| Financial liabilities | (38,308) |
| Payables | (13,333) |
| Other liabilities | (24) |
| Total Net identifiable assets | 675 |
On the basis of these values, the difference between the acquisition cost (equal to €105.4m corresponding to the total amount due to the seller including the best estimate of future price adjustment) and the net identifiable assets led to the recognition of goodwill for €104.7m.
On 1 July 2023, the legal effects entered into force for the merger by incorporation of SIFÀ Società Italiana Flotte Aziendali SpA, a member of the BPER Group operating in the long-term rental business, into UnipolRental SpA, the merger deed for which was signed on 22 June 2023.
As a result of the merger, the share capital of the merging entity UnipolRental SpA increased from €25,000,000.00 to €31,244,899.00 through the issue of 6,244,899 new ordinary shares with a nominal value of €1 each, assigned to the

sole shareholder of the Merged Entity and, therefore, the share capital of UnipolRental SpA, divided into 31,244,899 ordinary shares with a nominal value of €1 each, is broken down between the two shareholders as follows:
• UnipolSai Assicurazioni SpA, holder of 25,000,000 ordinary shares, representing 80.013% of the share capital;
• BPER Banca SpA, holder of 6,244,899 ordinary shares, representing 19.987% of the share capital.
The values of the assets and liabilities acquired of SIFÀ Società Italiana Flotte Aziendali SpA at 1 July 2023, are reported below.
UnipolSai and BPER have mutually agreed a call and put option on the UnipolRental shares held by BPER.
Amounts in €k
| 1/7/2023 | |
|---|---|
| Intangible assets | 10,273 |
| Property, plant and equipment | 625,307 |
| Investments | 4,091 |
| Other financial assets | 58,028 |
| Other assets | 33,145 |
| Cash and cash equivalents | 86 |
| Provisions for risks and charges | (1,555) |
| Financial liabilities | (622,192) |
| Payables | (111,313) |
| Other liabilities | (4,248) |
| Total Net identifiable assets | (8,377) |
On the basis of these values, the difference between the acquisition cost on the basis of the UnipolRental shares issued in connection with the merger by incorporation (equal to €50m) and the net identifiable assets led to the recognition of goodwill for €58.4m.
The UnipolSai Group is not exposed to changes deriving from the performance of unconsolidated structured entities. The UnipolSai Group has promoted transactions with the following structured entities:
The aforementioned SPVs are not consolidated as the UnipolSai Group does not have control of the entity nor is it exposed to their significant variable returns.

Carrying amount of assets and liabilities of structured entities and maximum exposure to the risk of loss
| Amounts in €m | |||||||
|---|---|---|---|---|---|---|---|
| Name of the structured entity/ Financial statement items |
Revenue received by the structured entity in the reference year |
Carrying amount (at the date of transfer) of assets transferred to the structured entity in the reference year |
Carrying amount of assets recognised in the financial statements and relating to the structured entity |
Corresponding asset item in the statement of financial position |
Carrying amount of liabilities recognised in the financial statements and relating to the structured |
Correspondin g liability item in the statement of financial position |
Maximum exposure to the risk of loss |
| Azzurro RE II DAC series 2020-01 | 5 | entity | |||||
| Mercurio Fleet 2022 Srl | 2 | 479 |
During the year, there were no transfers between portfolios of financial assets following a change in the business model.
IFRS 13 provides guidelines to the measurement at fair value of financial instruments and non-financial assets and liabilities already required or permitted by other accounting standards (IFRS). This standard:
The standard defines fair value as the sale price of an asset based on an ordinary transaction or the transfer price of a liability in an ordinary transaction on the main reference market at terms applicable at the measurement date (exit price).
Fair value measurement assumes that the transaction relating to the sale of assets or transfer of liabilities can take place:
When a market price is not observable, the measurement methods which maximise the use of observable parameters and minimise the use of non-observable parameters must mainly be used.
IFRS 13 also defines a fair value hierarchy based on the level of observability of the inputs contained in measurement techniques used to measure fair value.
IFRS 13 governs the fair value measurement and the associated disclosure also for assets and liabilities not measured at fair value on a recurring basis in the statement of financial position. For these assets and liabilities, fair value is calculated for financial statement disclosure purposes. Also note that, as these assets and liabilities are not typically traded, their fair value is largely based on the use of internal parameters that cannot be directly observed in the market, with the sole exception of listed securities classified as Financial assets at amortised cost.

The table below summarises the methods to calculate the fair value for the different macro categories of financial instruments, receivables and property.
| Mark to Market | Mark to Model and other | ||||
|---|---|---|---|---|---|
| Bonds | CBBT contributor - Bloomberg | Mark to Model | |||
| Other contributor - Bloomberg | Counterparty valuation | ||||
| Listed shares and investments, ETFs | Reference market | ||||
| Financial Instruments |
Unlisted shares and investments | DCF DDM Multiples |
|||
| Listed derivatives | Reference market | ||||
| OTC derivatives | Mark to Model | ||||
| UCITS | Net Asset Value | ||||
| Receivables | Trade receivables (Mark to Model) Other receivables (carrying amount) |
||||
| Property | Appraisal value |
In compliance with IFRS 13, the market price is used to determine the fair value of financial instruments, in the case of instruments traded in liquid and active markets (Mark to Market).
"Liquid and active market" means:
In the absence of available prices on a liquid active market, valuation methods are used which maximise the use of observable parameters and minimise the use of non-observable parameters. These methods can be summarised in Mark to Model valuations, valuations by counterparty or valuations at the carrying amount in connection with some non-financial asset categories.
With reference to shares, listed investments, ETFs and listed derivatives, the Mark to Market valuation corresponds to the official valuation price of the market.
For bonds, the sources used for the Mark to Market valuation of financial assets and liabilities are as follows:
For UCITS the Net Asset Value is the source used.
The Group uses valuation methods (Mark to Model) in line with the methods generally used by the market.
The objective of the models used to calculate the fair value is to obtain a value for the financial instrument consistent with the assumptions that market participants would use to quote a price, assumptions that also concern the risk inherent in a particular valuation technique and/or in the inputs used. To ensure the correct Mark to Model valuation of each category of instrument, adequate and consistent valuation models must be defined beforehand as well as reference market parameters.

The list of the main models used within the UnipolSai Group for Mark to Model pricing of financial instruments is provided below:
Securities and interest rate derivatives:
Securities and inflation derivatives:
Securities and share, index and exchange rate derivatives:
Securities and credit derivatives:
The main observable market parameters used to perform Mark to Model valuations are as follows:
The main non-observable market parameters used to perform Mark to Model valuations are as follows:
With reference to bonds in those cases when, even on the basis of the results of the Scoring Model, it is not possible to measure an instrument using the Mark to Market method, the fair value is obtained on the basis of Mark to Model type valuations. The different valuation models referred to above are chosen according to the instrument characteristics.
For OTC derivative contracts, the models used are consistent with the risk factor underlying the contract. The fair value of OTC interest rate derivatives and OTC inflation-linked derivatives is calculated on the basis of Mark to Model type valuations, acknowledging the rules set in IFRS 13.
As regards derivatives on which a collateralisation agreement is provided (Credit Support Annex) between the companies of the UnipolSai Group and the authorised market counterparties, the EONIA (Euro OverNight Index Average) discount curve is used.
As regards uncollateralised derivatives, CVA (Credit Valuation Adjustment) and DVA (Debit Valuation Adjustment) adjustments are made. It should be noted that, at 31 December 2023, almost all derivative positions represented collateralised contracts for which CSA agreements are in place with the counterparties involved in the trading.

As regards unlisted shares and investments for which a market price or an appraisal by an independent expert is not available, the valuations are performed mainly on the basis of (i) equity methods, (ii) methods based on the discounting of future profit or cash flows, i.e. Discounted Cash Flow (DCF) or Dividend Discount Model (DDM), (the socalled "excess capital" version) (iii) if applicable, methods based on market multiples.
As regards unlisted UCITS, Private Equity Funds and Hedge Funds, the fair value is calculated as the Net Asset Value (NAV) at the financial statement date provided directly by the fund managers. The NAV is constructed on the basis of stringent valuation policies defined by the fund and is based on valuation of the underlying assets using updated inputs and more appropriate measurement approaches. Based on these considerations and taking into account sector market practices, this value was used to express the instrument's fair value.
The carrying amount is used for other loans.
With reference to properties, the fair value is measured on the basis of the appraisal value provided by independent experts, in compliance with current legal provisions.
For financial assets and liabilities which do not fall into the categories of instruments valued on a Mark to Market basis and for which there are no consistent and validated valuation models available for the purposes of measuring fair value, the valuations provided by the counterparties that could be contacted to liquidate the position are used.
Bond issues that incorporate a derivative contract which modifies the cash flows generated by the host contract are considered structured bonds. The measurement of structured bonds requires the representation and separate valuation of the host contract and of embedded derivative contracts.
The measurement of structured bonds makes use of models consistent with the breakdown into elementary components (host contract and embedded derivatives) and with the risk factor underlying said contract.
For structured bonds, the valuation of elementary components follows the criteria defined above for the calculation of fair value, which makes provision for use of Mark to Market valuation if available, or of the Mark to Model approach or counterparty price in the case in which the Mark to Market-type price is not available.
Bonds issued by a Special Purpose Vehicle secured by collateral and whose flows paid are generated by an interest rate swap contract in place between the vehicle and the swap counterparty (usually the arranger of the transaction) are considered SPV structured bonds. The measurement of SPV structured bonds requires the representation and separate valuation of the following elements:
interest rate swap agreement between the vehicle and arranger;
any other optional components or CDS agreements included in the vehicle.
For SPV structured bonds the valuation of collateral follows the criteria defined previously for the calculation of the fair value, which makes provision for the use of the Mark to Market approach if available, or the Mark to Model approach or the counterparty price in the case in which the Mark to Market type price is not available.
The valuation of the interest rate swap agreement provides for the discounting of future cash flows on the basis of the different discount curves, based on the existence or not of a collateralisation agreement (Credit Support Annex) between the vehicle and swap counterparty. In particular, if the derivative contract is collateralised using available securities included in the SPV's assets, the future cash flows of the interest rate swap agreement are discounted using the EONIA discount curve; while if there is no collateralisation agreement, use is made of CVA (Credit Valuation Adjustment), DVA (Debit Valuation Adjustment) and FVA (Funding Valuation Adjustment), as appropriate.

Assets and liabilities measured at fair value are classified on the basis of the hierarchy defined by IFRS 13. This classification establishes a fair value hierarchy based on the degree of discretionary power used, giving priority to the use of observable market parameters, as these are representative of the assumptions that market participants would use in the pricing of assets and liabilities.
Assets and liabilities are classified on the basis of the criterion used to determine fair value (Mark to Market, Mark to Model, Counterparty) and on the basis of the observability of the parameters used, in the case of the Mark to Model valuation:
The measurement of financial instruments is a preliminary activity for risk monitoring, integrated asset and liability management and the drafting of the financial statements for the year.
The fair value measurement of financial instruments on a recurring basis is structured into different stages and is carried out, in compliance with the principles of separateness, independence and responsibility of the departments, at the same time, and independently, by the Finance Department and the Risk Management Department of Unipol Gruppo, using the measurement criteria defined in the previous paragraph.
When the independent valuations of financial assets and liabilities have been carried out by the two Departments involved in the pricing process, a check is performed for significant deviations, which refer to deviations of more than 3% in terms of absolute value. In the event of deviations of more than 3%, the reasons for the differences identified are analysed and, when the outcomes of the comparison are known, the price to be used for financial statement valuation purposes is determined.
The classification of financial assets and liabilities at Level 3 adheres to a prudential approach; this category mainly includes the following types of financial instruments:

Consistent with the provisions of IFRS 13, fair value is measured also for assets and liabilities not measured at fair value on a recurring basis in the statement of financial position and when the disclosure on fair value has to be provided in the Notes to the financial statements in compliance with other international accounting standards. Since these assets and liabilities are usually not exchanged, the calculation of their fair value is based primarily on the use of internal parameters not directly observable on the market. This category mainly includes the following types of financial instruments:
The table below shows a comparison between the assets and liabilities measured at fair value on a recurring basis, broken down by fair value hierarchy level.
| Amounts in €m | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Level 1 | Level 2 | Level 3 | Total | ||||||
| 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | ||
| Assets and liabilities at fair value | |||||||||
| Financial assets at fair value through OCI | 37,649 | 34,972 | 2,607 | 2,207 | 611 | 523 | 40,867 | 37,126 | |
| Financial assets at fair value through profit or loss | 12,457 | 12,162 | 214 | 394 | 3,738 | 3,414 | 16,410 | 15,899 | |
| a) | Held-for-trading financial assets | 7 | 9 | 44 | 215 | 22 | 57 | 72 | 281 |
| b) | Financial assets at fair value | 10,578 | 8,692 | 101 | 93 | 10,679 | 8,786 | ||
| c) | Other financial assets mandatorily at fair value |
1,872 | 3,461 | 171 | 178 | 3,616 | 3,264 | 5,659 | 6,832 |
| Investment property | |||||||||
| Property, plant and equipment | |||||||||
| Intangible assets | |||||||||
| Total | 50,106 | 47,135 | 2,822 | 2,601 | 4,349 | 3,936 | 57,277 | 53,025 | |
| Financial liabilities at fair value through profit or loss |
9 | 7 | 80 | 142 | 10,418 | 8,573 | 10,507 | 8,723 | |
| a) | Held for trading financial liabilities | 9 | 7 | 80 | 142 | 5 | 5 | 95 | 155 |
| b) | Financial liabilities at fair value through profit or loss |
10,412 | 8,568 | 10,412 | 8,568 | ||||
| Total | 9 | 7 | 80 | 142 | 10,418 | 8,573 | 10,507 | 8,723 |

Details of changes in Level 3 financial assets and liabilities in the same period are shown below.
| Amounts in €m | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Financial assets at | Financial assets at fair value through profit or loss |
Investment property |
Property, | Intangible | Financial liabilities at fair value through profit or loss |
|||||
| fair value through OCI |
held for trading |
at fair value through profit or loss |
mandatorily at fair value |
plant and equipmen t |
assets | held for trading |
at fair value through profit or loss |
|||
| 1. | Opening balance | 523 | 57 | 93 | 3,264 | 5 | 8,568 | |||
| 2. | Increases | 90 | 14 | 680 | 1 | 1,844 | ||||
| 2.1 | Acquisitions | 80 | 10 | 474 | ||||||
| 2.2 | Gains recognised through: |
|||||||||
| 2.2.1 Profit and Loss | 4 | 206 | ||||||||
| of which gains | ||||||||||
| of which losses | ||||||||||
| 2.2.2 Other Comprehensive Income |
11 | |||||||||
| 2.3 | Transfers to other levels |
|||||||||
| 2.4 | Other increasing changes |
1 | 1,844 | |||||||
| 3. | Decreasee | (2) | (36) | (6) | (328) | (1) | ||||
| 3.1 | Sales | |||||||||
| 3.2 | Repayments | (6) | (177) | |||||||
| 3.3 | Losses recognised through: |
|||||||||
| 3.3.1 Profit and Loss | (150) | (1) | ||||||||
| of which losses | ||||||||||
| of which gains | ||||||||||
| 3.3.2 Other Comprehensive Income |
(2) | |||||||||
| 3.4 | Transfers to other levels |
|||||||||
| 3.5 | Other decreasing changes |
(36) | (1) | |||||||
| 4. | Closing balance | 611 | 22 | 101 | 3,616 | 5 | 10,412 |
The transfers from Level 1 to Level 2, which occurred during the reference period, were irrelevant.
The table below shows, for Level 3 financial assets and liabilities measured at fair value, the effects of the change in the non-observable parameters used in the fair value measurement.
With reference to "assets at fair value on a recurring basis" and belonging to Level 3, the stress test of non-observable parameters is performed with reference to financial instruments valued on a Mark to Model basis and on which the measurement is carried out through one or more non-observable parameters.
The portion of securities subject to analysis had a market value of €363m at 31 December 2023.
The non-observable parameters subject to a shock are benchmark spread curves constructed to assess bonds of issuers for which the prices of the bonds issued or Credit Default Swap curves are unavailable.

The following table shows the results of the shocks:
| Amounts in €m | Curve Spread | ||||
|---|---|---|---|---|---|
| Fair Value | |||||
| Shock | +10 bps | -10 bps | +50 bps | -50 bps | |
| Fair Value delta | (3.00) | 3.06 | (13.60) | 13.89 | |
| Fair Value delta % | (0.83) | 0.84 | (3.75) | 3.83 |
IFRS 13 governs the fair value measurement and the associated disclosure also for assets and liabilities not measured at fair value on a recurring basis.
For these assets and liabilities, fair value is calculated only for the purpose of market disclosure requirements. Furthermore, since these assets and liabilities are not typically traded, their fair value is largely based on the use of internal parameters that cannot be directly observed in the market, with the sole exception of listed securities classified as Financial assets at amortised cost.
| Amounts in €m | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Carrying amount | Level 1 | Level 2 | Level 3 | Total | ||||||
| 31/12/2023 31/12/2022 | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | ||
| Assets | ||||||||||
| Financial assets at amortised cost | 2,149 | 2,076 | 91 | 56 | 965 | 910 | 1,064 | 1,007 | 2,120 | 1,973 |
| Investments in associates and j-v | 170 | 162 | 170 | 162 | 170 | 162 | ||||
| Investment property | 2,364 | 2,359 | 2,802 | 2,749 | 2,802 | 2,749 | ||||
| Non-current assets or assets of a disposal group held for sale |
133 | 514 | ||||||||
| Total assets | 4,816 | 5,111 | 91 | 56 | 965 | 910 | 4,036 | 3,918 | 5,092 | 4,883 |
| Liabilities | ||||||||||
| Financial liabilities at amortised cost |
3,064 | 2,171 | 1,284 | 1,260 | 1,777 | 885 | 3,060 | 2,145 | ||
| Liabilities associated with disposal groups held for sale |
360 | |||||||||
| Total Liabilities | 3,064 | 2,531 | 1,284 | 1,260 | 1,777 | 885 | 3,060 | 2,145 |
During the period, the Group did not recognise profits or losses at the date of initial recognition of financial assets and liabilities as there is no evidence that the value recognised to the counterparty at the time of the transaction differed from the fair value of the underlying financial instrument.

Comments and further information on the items in the statement of financial position and the changes that took place compared to balances at 31 December of the previous year are given below (the numbering of the notes relates to the mandatory layout for the preparation of the statement of financial position).
In application of IFRS 5, assets and liabilities held for sale are shown respectively under items 6.1 in Assets and 6.1 under Liabilities. As regards Non-current assets or assets of a disposal group held for sale, please refer to Chapter 4 Other information, paragraph 4.5, for more information on their composition and measurement criteria.
| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| Assets/Values | 31/12/2023 | 31/12/2022 | ||||
| Fixed period | Indefinite period |
Fixed period | Indefinite period |
|||
| A.1 | Goodwill | 765 | 602 | |||
| A.1.1 | attributable to the owners of the Parent | 765 | 602 | |||
| A.1.2 | attributable to non-controlling interests | |||||
| A.2 | Other intangible assets | 602 | 517 | |||
| of which software | 562 | 482 | ||||
| A.2.1 | Assets measured at cost: | 602 | 517 | |||
| a) Internally generated intangible assets |
||||||
| b) Other assets |
602 | 517 | ||||
| A.2.2 | Assets measured at restated value: | |||||
| a) Internally generated intangible assets |
||||||
| b) Other assets |
||||||
| Total | 602 | 765 | 517 | 602 |
The change in Goodwill is attributable to the consolidation difference, provisionally determined as permitted by IFRS 3, arising from the acquisition of the subsidiary Società e Salute SpA and the acquisition, via merger by incorporation, of SIFÀ Società Italiana Flotte Aziendali SpA by UnipolRental SpA. Please refer to the Consolidation scope, "Information about business combinations" section, of these Notes for further details of the accounting method for the aforementioned transactions.
Goodwill with an indefinite useful life recorded in the financial statements was tested for impairment in accordance with the procedure specifically approved by Unipol's Board of Directors. For information on the criteria used for testing purposes, and on the allocation of this goodwill to the CGUs, please refer to Chapter 3.10 "Analysis of recoverability of goodwill with indefinite useful life (impairment test)".
The item, totalling €602m (€517m in 2022), is composed primarily of costs incurred for purchasing software, licences, consultancy and the customisation of software programmes for €562m (€482m in 2022) and other intangible assets for €40m (€35m at 31/12/2022).
Research and development costs incurred by the Group and charged to the income statement in 2023, deriving from Leithà operations, amounted to €16m.

| Goodwill | Other intangible assets: internally generated |
Other intangible assets: other | Total | ||||
|---|---|---|---|---|---|---|---|
| FIN | INDEF | FIN | INDEF | ||||
| A. | Opening balances | 602 | 517 | 1,119 | |||
| A.1 | Total net impairment losses | ||||||
| A.2 | Net opening balances | 602 | 517 | 1,119 | |||
| B. | Increases | 163 | 207 | 370 | |||
| B.1 | Purchases | 163 | 207 | 370 | |||
| of which from business combinations |
163 | 3 | 167 | ||||
| B.2 | Increases in internal intangible assets |
||||||
| B.3 | Write-backs | ||||||
| B.4 | Positive changes in restated value |
||||||
| - Comprehensive Income Statement |
|||||||
| - Income Statement | |||||||
| B.5 | Positive exchange rate differences |
||||||
| B.6 | Other changes | ||||||
| C. | Decreases | (122) | (122) | ||||
| C.1 | Sales | ||||||
| C.2 | Value adjustments | (122) | (122) | ||||
| - Depreciation/amortisation | (122) | (122) | |||||
| - Write-downs | |||||||
| + Comprehensive Income Statement |
|||||||
| + Income Statement | |||||||
| C.3 | Negative changes in restated value |
||||||
| - Comprehensive Income Statement |
|||||||
| - Income Statement | |||||||
| C.4 | Transfers to non-current assets held for sale |
||||||
| C.5 | Negative exchange rate differences |
||||||
| C.6 | Other changes | ||||||
| D. | Net closing balances | 765 | 602 | 1,367 | |||
| D.1 | Total net value adjustments | ||||||
| E. | Gross closing balances | 765 | 602 | 1,367 | |||
| F. | Measurement at cost | 765 | 602 | 1,367 |

At 31 December 2023, Property, plant and equipment, net of accumulated depreciation, amounted to €4,124m (€2,791m in 2022): the breakdown is shown below.
| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| Assets for own use | Inventories from IAS 2 | |||||
| Assets/Values | At cost | At restated value | 31/12/2023 | 31/12/2022 | ||
| 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | |||
| 1. Owned assets | 3,948 | 2,666 | 46 | 41 | ||
| a) land | 63 | 63 | ||||
| b) buildings | 1,335 | 1,355 | ||||
| c) office furniture and machines | 96 | 86 | ||||
| d) plant and equipment | 197 | 152 | ||||
| e) other assets | 2,257 | 1,010 | 46 | 41 | ||
| 2. Rights of use acquired through leasing | 130 | 85 | ||||
| a) land | ||||||
| b) buildings | 106 | 74 | ||||
| c) office furniture and machines | ||||||
| d) plant and equipment | 22 | 8 | ||||
| e) other assets | 1 | 2 | ||||
| Total | 4,078 | 2,750 | 46 | 41 |

| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| Land | Buildings | Office furniture |
Plant and equipment |
Other tangible |
Total | |
| A. Opening gross balances | 71 | 1,981 | 438 | 427 | 1,624 | 4,542 |
| A.1 Accumulated depreciation and impairment | (8) | (551) | (352) | (268) | (572) | (1,751) |
| A.2 Net opening balances | 63 | 1,430 | 86 | 160 | 1,052 | 2,791 |
| B. Increases: | 106 | 36 | 102 | 1,610 | 1,854 | |
| B.1 Purchases | 44 | 36 | 102 | 1,610 | 1,792 | |
| of which from business combinations | 19 | 6 | 26 | 614 | 666 | |
| B.2 Expenses for capitalised improvements | 44 | 44 | ||||
| B.3 Write-backs | ||||||
| B.4 Positive changes in the restated amount charged to: | ||||||
| a) Comprehensive Income Statement | ||||||
| b) Income Statement | ||||||
| B.5 Positive exchange rate differences | ||||||
| B.6 Transfers from investment property | 18 | 18 | ||||
| B.7 Other changes | ||||||
| C. Decreases: | (94) | (25) | (42) | (359) | (520) | |
| C.1 Sales | (6) | (1) | (14) | (73) | (94) | |
| C.2 Depreciation | (52) | (24) | (28) | (285) | (389) | |
| C.3 Value adjustments for impairment charged to: | (1) | (1) | ||||
| a) Comprehensive Income Statement | ||||||
| b) Income Statement | (1) | (1) | ||||
| C.4 Negative changes in the restated amount charged to: | ||||||
| a) Comprehensive Income Statement | ||||||
| b) Income Statement | ||||||
| C.5 Negative exchange rate differences | ||||||
| C.6 Transfers to: | (36) | (36) | ||||
| a) investment property | (32) | (32) | ||||
| b) non-current assets or assets of a disposal group held for sale |
(4) | (4) | ||||
| C.7 Other changes | ||||||
| D. Net closing balances | 63 | 1,442 | 96 | 219 | 2,304 | 4,124 |
| D.1 Accumulated depreciation and impairment | (8) | (593) | (381) | (381) | (934) | (2,297) |
| D.2 Gross closing balances | 71 | 2,035 | 477 | 600 | 3,238 | 6,421 |
| E. Measurement at cost | 63 | 1,442 | 96 | 219 | 2,304 | 4,124 |
The current value of properties for own use, €1,766m, was based on independent expert appraisals.
The main increase in property, plant and equipment is due to the item Movable assets entered in public registers, in relation to UnipolRental activities during the year, and the merger of SIFÀ Società Italiana Flotte Aziendali SpA into UnipolRental.

This section provides information on the reinsurance contracts held that are assets and liabilities (asset item 3.2 and liability item 3.2) that are composed as follows:
| Amounts in €m | ||||||||
|---|---|---|---|---|---|---|---|---|
| Items/Basis of aggregation | BBA | PAA | Total | BBA | PAA | Total | ||
| 31/12/2023 | 31/12/2023 | 31/12/2023 | 31/12/2022 | 31/12/2022 | 31/12/2022 | |||
| 1 | Reinsurance classifiable as assets | 185 | 875 | 1,060 | 241 | 685 | 926 | |
| 2 | Reinsurance transfers classifiable as liabilities | (22) | (70) | (92) | (16) | (117) | (133) | |
| 3 | Net assets on the balance sheet | 163 | 804 | 968 | 225 | 568 | 793 | |
| of which Life segment | 3 | 3 | (4) | (4) | ||||
| of which Non-Life segment | 163 | 802 | 965 | 225 | 572 | 796 |

| Amounts in €m | ||||||||
|---|---|---|---|---|---|---|---|---|
| Items/Breakdown of carrying amount | Assets for residual coverage 31/12/2023 |
Assets for claims incurred 31/12/2023 |
Total 31/12/2023 |
Assets for residual coverage 31/12/2022 |
Assets for claims incurred 31/12/2022 |
Total 31/12/2022 |
||
| Net of the loss recovery component |
Loss recovery component |
Net of the loss recovery component |
Loss recovery component |
|||||
| A. Initial carrying amount | ||||||||
| 1. Reinsurance contracts held that are assets |
92 | 150 | 241 | 114 | 222 | 336 | ||
| 2. Reinsurance contracts held that are liabilities |
(4) | (12) | (16) | (4) | (12) | (16) | ||
| 3. Net carrying amount as at 1 January | 87 | 138 | 225 | 110 | 210 | 320 | ||
| B. Economic effects of reinsurance | (88) | 14 | (74) | (52) | (1) | 13 | (41) | |
| contracts held 1. Cost of reinsurance |
(88) | (88) | (52) | (52) | ||||
| 2. Claims and other costs recovered | 59 | 59 | 56 | 56 | ||||
| 3. Changes in assets for claims incurred | (45) | (45) | (46) | (46) | ||||
| 4. Reinsurance contracts held covering | (1) | (1) | ||||||
| onerous contracts 4.1 Revenue associated with the recognition |
1 | 1 | ||||||
| of onerous underlying insurance contracts 4.2 Releases of the loss recovery component |
||||||||
| other than changes in cash flows from reinsurance contracts held |
(1) | (1) | ||||||
| 4.3 Changes in cash flows from reinsurance contracts held resulting from the onerous underlying insurance contracts |
||||||||
| 5. Effects of the change of the risk of default by reinsurers |
1 | 1 | 2 | 2 | ||||
| 6. Total | ||||||||
| C. Insurance service result (Total B) | (88) | 14 | (74) | (52) | (1) | 13 | (41) | |
| D. Net finance income/expenses | 1 | 9 | 10 | (2) | (24) | (26) | ||
| 1. Relating to reinsurance contracts held | 1 | 9 | 10 | (2) | (24) | (26) | ||
| 1.1. Recorded in the Income Statement | (1) | (1) | ||||||
| 1.2. Recorded in the Comprehensive Income Statement |
1 | 9 | 10 | (2) | (23) | (25) | ||
| 2. Effects associated with changes in exchange rates |
||||||||
| E. Investment components | ||||||||
| F. Total amount recorded in the Income Statement and in the Comprehensive Income Statement (C+D+E) |
(87) | 23 | (64) | (55) | (1) | (11) | (67) | |
| G. Other changes | (1) | (1) | (1) | 1 | (2) | (2) | ||
| H. Cash movements | 50 | (47) | 3 | 33 | (59) | (26) | ||
| 1. Premiums paid net of amounts not related to claims recovered from reinsurers |
50 | 50 | 33 | 33 | ||||
| 2. Amount of claims recovered from | (47) | (47) | (59) | (59) | ||||
| reinsurers I. Net carrying amount as at 31 December (A.3+F+G+H) |
50 | 113 | 163 | 87 | 138 | 225 | ||
| L. Final carrying amount | ||||||||
| 1. Reinsurance contracts held that are assets | 61 | 125 | 185 | 92 | 150 | 241 | ||
| 2. Reinsurance contracts held that are liabilities |
(11) | (11) | (22) | (4) | (12) | (16) | ||
| 3. Net carrying amount as at 31 December | 50 | 113 | 163 | 87 | 138 | 225 |

LIFE SEGMENT
Amounts in €m
| Assets for residual coverage | Assets for claims incurred | Totale | Assets for residual coverage | Assets for claims incurred | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Items/Breakdown of carrying amount 31/12/2023 |
31/12/2023 | 31/12/2023 | 31/12/2022 | 31/12/2022 | Totale 31/12/2022 | ||||||
| Net of the loss recovery component |
Loss recovery component |
Present value of cash flows |
Adjustment for non-financial risks |
Net of the loss recovery component |
Loss recovery component |
Present value of cash flows |
Adjustment for non-financial risks |
||||
| A. Initial carrying amount | |||||||||||
| 1. Reinsurance contracts held that are assets | 9 | 13 | 22 | 12 | (2) | 10 | |||||
| 2. Reinsurance contracts held that are liabilities |
(25) | (25) | 1 | (13) | (12) | ||||||
| 3. Net carrying amount as at 1 January | 9 | (12) | (4) | 13 | (15) | (2) | |||||
| B. Economic effects of reinsurance contracts held |
(20) | 13 | (6) | (20) | 13 | (7) | |||||
| 1. Cost of reinsurance | (20) | (20) | (20) | (20) | |||||||
| 2. Claims and other costs recovered | 13 | 13 | 13 | 13 | |||||||
| 3. Changes in assets for claims incurred | 1 | 1 | |||||||||
| 4. Reinsurance contracts held covering onerous contracts |
|||||||||||
| 4.1 Revenue associated with the recognition of onerous underlying insurance contracts |
|||||||||||
| 4.2 Releases of the loss recovery component other | |||||||||||
| than changes in cash flows from reinsurance contracts held |
|||||||||||
| 4.3 Changes in cash flows from reinsurance contracts held resulting from the onerous |
|||||||||||
| underlying insurance contracts | |||||||||||
| 5. Effects of the change of the risk of default by reinsurers |
|||||||||||
| 6. Total | (20) | 13 | (6) | (20) | 13 | (7) | |||||
| C. Insurance service result (Total B) | |||||||||||
| D. Net finance income/expenses | |||||||||||
| 1. Relating to reinsurance contracts held | |||||||||||
| 1.1. Recorded in the Income Statement | |||||||||||
| 1.2. Recorded in the Comprehensive Income Statement |
|||||||||||
| 3. Total | |||||||||||
| E. Investment components | (20) | 13 | (6) | (20) | 13 | (7) | |||||
| F. Total amount recorded in the Income | (1) | (1) | |||||||||
| Statement and in the Comprehensive Income G. Other changes |
21 | (9) | 12 | 17 | (11) | 6 | |||||
| H. Cash movements | 20 | 20 | 16 | (11) | 5 | ||||||
| 1. Premiums paid net of amounts not related | 2 | (9) | (8) | 1 | 1 | ||||||
| to claims recovered from reinsurers I. Net carrying amount as at 31 December (A.3+F+G+H) |
11 | (8) | 3 | 9 | (12) | (4) | |||||
| L. Final carrying amount | |||||||||||
| 1. Reinsurance contracts held that are assets | 12 | 13 | 24 | 9 | 13 | 22 | |||||
| 2. Reinsurance contracts held that are liabilities | (1) | (21) | (22) | (25) | (25) | ||||||
| 3. Net carrying amount as at 31 December | 11 | (8) | 3 | 9 | (12) | (4) | |||||

| Amounts in €m | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Items/Breakdown of carrying amount | Assets for residual coverage 31/12/2023 |
Assets for claims incurred Totale 31/12/2023 31/12/2023 |
Assets for residual coverage 31/12/2022 |
Assets for claims incurred 31/12/2022 |
Totale 31/12/2022 | ||||||
| Net of the loss recovery component |
Loss recovery component |
Present value of cash flows |
Adjustment for non-financial risks |
Net of the loss recovery component |
Loss recovery component |
Present value of cash flows |
Adjustment for non-financial risks |
||||
| A. Initial carrying amount | |||||||||||
| 1. Reinsurance contracts held that are assets | 313 | 329 | 21 | 663 | 398 | 266 | 19 | 683 | |||
| 2. Reinsurance contracts held that are liabilities |
(72) | (19) | (91) | (58) | (1) | (59) | |||||
| 3. Net carrying amount as at 1 January | 241 | 310 | 20 | 572 | 340 | 265 | 19 | 624 | |||
| B. Economic effects of reinsurance contracts held |
(289) | 604 | 5 | 321 | (286) | (1) | 164 | 2 | (121) | ||
| 1. Cost of reinsurance | (289) | (289) | (286) | (286) | |||||||
| 2. Claims and other costs recovered | 196 | 196 | 92 | 92 | |||||||
| 3. Changes in assets for claims incurred | 412 | 5 | 416 | 75 | 2 | 77 | |||||
| 4. Reinsurance contracts held covering onerous contracts |
(1) | (1) | |||||||||
| 4.1 Revenue associated with the recognition of onerous underlying insurance contracts |
9 | 9 | |||||||||
| 4.2 Releases of the loss recovery component other than changes in cash flows from reinsurance contracts held |
(9) | (9) | |||||||||
| 4.3 Changes in cash flows from reinsurance contracts held resulting from the onerous underlying insurance contracts |
(1) | (1) | |||||||||
| 5. Effects of the change of the risk of default by reinsurers |
(3) | (3) | (3) | (3) | |||||||
| 6. Total | (289) | 604 | 5 | 321 | (286) | (1) | 164 | 2 | (121) | ||
| C. Insurance service result (Total B) | 4 | 4 | 1 | (7) | (1) | (7) | |||||
| D. Net finance income/expenses | 6 | 1 | 6 | (9) | (1) | (10) | |||||
| 1. Relating to reinsurance contracts held | 3 | 4 | (1) | (1) | |||||||
| 1.1. Recorded in the Income Statement | 3 | 3 | (8) | (1) | (9) | ||||||
| 1.2. Recorded in the Comprehensive Income Statement |
(1) | (2) | 1 | 2 | 3 | ||||||
| 3. Total | |||||||||||
| E. Investment components | (289) | 609 | 5 | 325 | (286) | (1) | 156 | 2 | (128) | ||
| F. Total amount recorded in the Income | 3 | (15) | (12) | (79) | 1 | (14) | (92) | ||||
| Statement and in the Comprehensive Income G. Other changes |
157 | (240) | (83) | 265 | (97) | 167 | |||||
| H. Cash movements | 154 | 154 | 265 | 265 | |||||||
| 1. Premiums paid net of amounts not related | 3 | (240) | (237) | (97) | (98) | ||||||
| to claims recovered from reinsurers I. Net carrying amount as at 31 December (A.3+F+G+H) |
112 | 665 | 25 | 802 | 241 | 310 | 20 | 572 | |||
| L. Final carrying amount | |||||||||||
| 1. Reinsurance contracts held that are assets | 140 | 686 | 24 | 850 | 313 | 329 | 21 | 663 | |||
| 2. Reinsurance contracts held that are liabilities | (28) | (21) | 1 | (48) | (72) | (19) | (91) | ||||
| 3. Net carrying amount as at 31 December | 112 | 665 | 25 | 802 | 241 | 310 | 20 | 572 |
NON-LIFE SEGMENT
Amounts in €m
| Items/Features underlying measurement | Adjustment | Present | Adjustment | Contractual | ||||
|---|---|---|---|---|---|---|---|---|
| Present value of cash flows |
for non financial risks |
Contractual service margin |
Total | value of cash flows |
for non financial risks |
service margin |
Total | |
| 31/12/2023 | 31/12/2023 | 31/12/2023 | 31/12/2023 | 31/12/2022 | 31/12/2022 | 31/12/2022 | 31/12/2022 | |
| A. Initial book value | ||||||||
| 1. Reinsurance classifiable as assets | 183 | 7 | 51 | 241 | 265 | 11 | 59 | 336 |
| 2. Reinsurance transfers classifiable as liabilities |
(16) | (16) | (16) | (16) | ||||
| 3. Net value of financial statements as at 1 January |
167 | 7 | 51 | 225 | 248 | 11 | 60 | 320 |
| B. Changes in current services | (18) | (1) | (67) | (86) | (22) | (1) | (21) | (44) |
| 1. Contractual service margin recorded in the income statement |
(67) | (67) | (21) | (21) | ||||
| 2. Change for non-financial risks past due | (1) | (1) | (1) | (1) | ||||
| 3. Changes related to experience | (18) | (18) | (22) | (22) | ||||
| C. Changes relating to future services | (23) | (1) | 24 | (12) | 11 | (1) | ||
| 1. Changes in estimates that modify the Contractual service margin |
(20) | (1) | 21 | (10) | 10 | |||
| 2. Effects of contracts recognised during | (2) | 2 | (2) | 3 | 1 | |||
| the year 3. Adjustment of the Contractual service margin connected with recoveries relating to the initial recognition of onerous underlying insurance contracts |
||||||||
| 4. Releases of the loss recovery component other than changes in cash flows from reinsurance contracts |
(1) | (1) | ||||||
| 5. Changes in cash flows from reinsurance transfers from the underlying onerous insurance contracts |
||||||||
| D. Changes relating to past services | ||||||||
| 1. adjustments to assets for claims incurred | 12 | (1) | 11 | 6 | (3) | 2 | ||
| E. Effects of changes in the default risk of reinsurers |
1 | 1 | 2 | 2 | ||||
| F. Result of insurance services (B + C + D + E) |
(28) | (3) | (43) | (74) | (26) | (5) | (10) | (41) |
| G. Financial revenues/costs | 10 | 10 | (25) | (1) | (26) | |||
| 1. Reinsurance transfers | 10 | 10 | (25) | (1) | (26) | |||
| 1.1 Recorded in the Income Statement | (1) | (1) | ||||||
| 1.2. Recorded in the Comprehensive Income Statement |
10 | 10 | (24) | (1) | (25) | |||
| 2. Effects associated with changes in exchange rates |
||||||||
| H. Total amount recorded in the Income Statement and in the Comprehensive Income Statement (F + G) |
(18) | (2) | (43) | (64) | (51) | (6) | (10) | (67) |
| I. Other changes | (2) | 1 | (1) | (4) | 1 | 1 | (2) | |
| L. Cash movements | 3 | 3 | (26) | (26) | ||||
| 1. Premiums paid net of amounts not related to claims recovered from reinsurers |
50 | 50 | 33 | 33 | ||||
| 2. Amounts recovered from reinsurers | (47) | (47) | (59) | (59) | ||||
| M. Net value of financial statements as at the reporting date (A.3 + H + I + L) |
150 | 6 | 7 | 163 | 167 | 7 | 51 | 225 |
| N. Final book value | ||||||||
| 1. Reinsurance classifiable as assets | 173 | 5 | 7 | 185 | 183 | 7 | 51 | 241 |
| 2. Reinsurance transfers classifiable as liabilities |
(23) | 1 | (22) | (16) | (16) | |||
| 3. Net value of financial statements as at the reporting date |
150 | 6 | 7 | 163 | 167 | 7 | 51 | 225 |

| Amounts in €m | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | |||||||||||
| New contracts and contracts measured at the transition date with the full retrospective approach |
Contracts measured at the transition date with the modified retrospective approach |
Contracts measured at the transition date with the fair value approach |
Contract s subject to carve out |
Total | New contracts and contracts measured at the transition date with the full retrospective approach |
Contracts measured at the transition date with the modified retrospective approach |
Contracts measured at the transition date with the fair value approach |
Contract s subject to carve out |
Total | |||
| Contractual service margin - Opening balances |
2 | 49 | 51 | 60 | 60 | |||||||
| Changes relating to current services |
(3) | (65) | (67) | (1) | (20) | (21) | ||||||
| - Contractual service margin recognised in the income statement to reflect services received |
(3) | (65) | (67) | (1) | (20) | (21) | ||||||
| Changes relating to future services |
9 | 15 | 24 | 4 | 9 | 13 | ||||||
| - Changes in estimates that adjust the contractual service margin |
6 | 15 | 21 | 1 | 9 | 10 | ||||||
| - Effects of contracts initially recognised in the reference year |
2 | 2 | 3 | 3 | ||||||||
| Finance income/expenses |
||||||||||||
| 1. Relating to reinsurance contracts held 2. Effects associated |
||||||||||||
| with changes in exchange rates |
||||||||||||
| 3. Total | ||||||||||||
| Total changes recognised in the Income Statement and in the Comprehensive Income Statement |
6 | (49) | (43) | 2 | (11) | (9) | ||||||
| Contractual service margin - Closing balances |
8 | (1) | 7 | 2 | 49 | 51 |
| Items/Groups of contracts |
Originated contracts 31/12/2023 | Contracts acquired in business combinations 31/12/2023 |
Contracts transferred from third parties 31/12/2023 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Contracts without loss recovery component |
Contracts with loss recovery component |
Total | Contracts without loss recovery component |
Contracts with loss recovery component |
Total | Contracts without loss recovery component |
Contracts with loss recovery component |
Total | |
| A. Estimate of the present value of future cash outflows |
(6) | (6) | |||||||
| of which: Cash flows associated with the acquisition of insurance contracts |
|||||||||
| B. Estimate of the present value of future cash inflows |
(4) | (4) | |||||||
| C. Estimate of the net present value of future cash flows (A-B) |
(2) | (2) | |||||||
| D. Estimate of adjustment for non-financial risks |
|||||||||
| E. Derecognition of previously recognised cash flows |
|||||||||
| F. Contractual service margin |
2 | 2 | |||||||
| G. Increase in reinsurance contract assets recorded during the year due to the recognition of new contracts (C+D+E+F) |
| Items/Groups of contracts | Originated contracts 31/12/2022 | Contracts acquired in business combinations 31/12/2022 |
Other contracts acquired 31/12/2022 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Initial contracts without loss recovery component |
Initial contracts with loss recovery component |
Total | Initial contracts without loss recovery component |
Initial contracts with loss recovery component |
Total | Initial contracts without loss recovery component |
Initial contracts with loss recovery component |
Total | |
| A. Estimate of the present value of future cash outflows |
(4) | (1) | (6) | ||||||
| of which: Cash flows associated with the acquisition of insurance contracts |
|||||||||
| B. Estimate of the present value of future cash inflows |
(2) | (1) | (3) | ||||||
| C. Estimate of the net present value of future cash flows (A-B) |
(2) | (2) | |||||||
| D. Estimate of adjustment for non-financial risks |
|||||||||
| E. Derecognition of previously recognised cash flows |
|||||||||
| F. Contractual service margin |
2 | 1 | 3 | ||||||
| G. Increase in reinsurance contract assets recorded during the year due to the recognition of new contracts (C+D+E+F) |
1 |
Amounts in €m
Amounts in €m

| Amounts in €m | ||||
|---|---|---|---|---|
| 0-3 years | 4-10 years | >10 years | Total | |
| Non-Life Segment | 7 | 1 | 7 |
At 31 December 2023, total Investments amounted to €61,960m (€57,622m at 31/12/2022) and are shown by type in the table below:
| Amounts in €m | |||||
|---|---|---|---|---|---|
| 31/12/2023 | % comp. | 31/12/2022 | % comp. | % var. | |
| Investment property | 2,364 | 3.8 | 2,359 | 4.1 | 0.2 |
| Investments in associates and interests in joint ventures | 170 | 0.3 | 162 | 0.3 | 4.6 |
| Financial assets at amortised cost | 2,149 | 3.5 | 2,076 | 3.6 | 3.5 |
| Financial assets at fair value through OCI | 40,867 | 66.0 | 37,126 | 64.4 | 10.1 |
| Financial assets at fair value through profit or loss | 16,410 | 26.5 | 15,898 | 27.6 | 3.2 |
| Held-for-trading financial assets | 72 | 0.1 | 281 | 0.5 | (74.2) |
| Financial assets at fair value | 10,679 | 17.2 | 8,786 | 15.2 | 21.5 |
| Other financial assets mandatorily at fair value | 5,659 | 9.1 | 6,832 | 11.9 | (17.2) |
| Total Investiments | 61,960 | 100.0 | 57,622 | 100.0 | 7.5 |
At 31 December 2023, Investment property, net of the related accumulated depreciation, amounted to €2,364m (€2,359m in 2022): the breakdown is shown below.
| Amounts in €m | ||||
|---|---|---|---|---|
| At cost | At fair value | |||
| Assets/Values | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/202 |
| 1. Owned assets | 2,359 | 2,356 | 2 | |
| a) land | 74 | 77 | ||
| b) buildings | 2,284 | 2,280 | ||
| 2. Rights of use acquired through leasing | 5 | 3 | ||
| a) land | ||||
| b) buildings | 5 | 3 | ||
| Total | 2,364 | 2,359 |

| Amounts in €m | |||
|---|---|---|---|
| Land | Buildings | Total | |
| A. Opening gross balances | 120 | 3,113 | 3,233 |
| A.1 Accumulated depreciation and impairment | (44) | (830) | (874) |
| A.2 Net opening balances | 77 | 2,282 | 2,359 |
| B. Increases | 164 | 164 | |
| B.1 Purchases | 92 | 92 | |
| of which from business combinations | |||
| B.2 Expenses for capitalised improvements | 40 | 40 | |
| B.3 Positive changes in fair value | |||
| B.4 Write-backs | |||
| B.5 Positive exchange rate differences | |||
| B.6 Transfers from properties for own use | 32 | 32 | |
| B.7 Other changes | |||
| C. Decreases | (2) | (157) | (159) |
| C.1 Sales | (2) | (66) | (68) |
| C.2 Depreciation | (52) | (52) | |
| C.3 Negative changes in fair value | |||
| C.4 Value adjustments for impairment | (15) | (15) | |
| C.5 Negative exchange rate differences | |||
| C.6 Transfers to | (24) | (24) | |
| a) properties for own use | (18) | (18) | |
| b) non-current assets or assets of a disposal group held for sale | (6) | (6) | |
| C.7 Other changes | |||
| D. Net closing balances | 74 | 2,290 | 2,364 |
| D.1 Accumulated depreciation and impairment | (46) | (878) | (924) |
| D.2 Gross closing balances | 120 | 3,168 | 3,288 |
| E. Measurement at fair value |

At 31 December 2023, Investments in associates and interests in joint ventures amounted to €170m (€162m at 31/12/2022).
| Name | Country of operations (1) |
Country of registered office |
Business activity (2) |
Type of relationship (3) |
% Direct holding |
% Total participating interest (4) |
% Votes available at ordinary General Meetings (5) |
|---|---|---|---|---|---|---|---|
| Associates | |||||||
| Assicoop Bologna Metropolitana SpA | 086 - Italy | 11 | b | 49.19% | 49.19% | ||
| Assicoop Emilia Nord Srl | 086 - Italy | 11 | b | 50.00% | 50.00% | ||
| Assicoop Modena & Ferrara SpA | 086 - Italy | 11 | b | 43.75% | 43.75% | ||
| Assicoop Romagna Futura SpA | 086 - Italy | 11 | b | 50.00% | 50.00% | ||
| Assicoop Toscana SpA | 086 - Italy | 11 | b | 49.77% | 49.77% | ||
| Borsetto Srl | 086 - Italy | 10 | b | 44.93% | 44.93% | ||
| Cronos Vita SpA | 086 - Italy | 1 | b | 22.50% | 22.50% | ||
| Ddor Garant | 289 - Serbia | 11 | b | 40.00% | 40.00% | ||
| Fin.Priv. Srl | 086 - Italy | 11 | b | 28.57% | 28.57% | ||
| Funivie del Piccolo San Bernardo SpA | 086 - Italy | 11 | b | 23.55% | 23.55% | ||
| Pegaso Finanziaria SpA | 086 - Italy | 9 | b | 45.00% | 45.00% | ||
| SCS Azioninnova SpA | 086 - Italy | 11 | b | 42.85% | 42.85% | ||
| Uci - Ufficio Centrale Italiano | 086 - Italy | 11 | b | 38.40% | 38.38% | ||
| UnipolReC SpA | 086 - Italy | 11 | b | 14.76% | 14.76% | ||
| UnipolSai Investimenti Sgr SpA | 086 - Italy | 8 | b | 49.00% | 49.00% |
(1) This disclosure is required only if the country of operations is different from the country of the registered office.
(2) 1=Italian insurers; 2=EU insurers; 3=non-EU insurers; 4=insurance holding companies; 4.1=mixed financial holding companies; 5=EU reinsurers; 6=non-EU reinsurers; 7=banks; 8=asset management companies; 9=other holding companies; 10=real estate companies; 11=other.
(3) b = associates; c = joint ventures.
(4) The product of investment relations concerning all companies positioned in an investment chain.
(5) Availability of votes at ordinary shareholders' meetings, distinguishing between actual votes and potential votes. The availability of votes is indicated only if different from the direct shareholding.
| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| Name | Carrying amount of equity investments |
Profit (loss) from continuing operations after taxes |
Profit (loss) from discontinued operations after taxes |
Profit (loss) for the year (1) |
Other income items net of taxes (2) |
Comprehensive Income Statement (3) = (1) + (2) |
| Società collegate | ||||||
| 31/12/2023 | 170 | 9 | 9 | 9 | 18 | |
| 31/12/2022 | 162 | 2 | 2 | (5) | (4) |
The activity of the associate Cronos Vita, as specifically envisaged in the agreements between the parties involved in the bail-out of Eurovita policyholders, is limited to managing the run-off of the former Eurovita portfolio for the time strictly necessary (i) for the precise identification of the distinct business units making up the company complex to be assigned to the shareholder companies and (ii) the subsequent transfer of these units to them. In this context, it was considered that the investment held in Cronos Vita qualifies, from the acquisition date, as held for sale on the basis of the provisions of IFRS 5. In fact, from the outset, the intention was to sell the equity investment in order to acquire a business unit of the investee, to be identified according to criteria to be defined between the parties and characterised by a potentially different risk/reward profile, in the individual components, from that implicit in the investment.
As a result of the above classification, the equity investment held in Cronos Vita was measured at cost, as it was lower than the estimated realisable value net of costs to sell.

Amounts in €m
Also note in this regard that, as part of the transaction of UnipolSai and the other participating insurance companies, a pro rata guarantee was issued for the benefit of the banks that granted loans to the associate Cronos Vita to cover part of the early redemptions relating to policies associated with the segregated funds distributed by the banks and included in the business complex acquired by Cronos Vita in October 2023. This surety, which can be activated in the event of default by Cronos Vita, subordinate to a separate pledge by Cronos Vita on assets included in the segregated funds portfolio, was issued by each of the shareholders of Cronos Vita in proportion to their percentage interest in the share capital. The maximum amount guaranteed by UnipolSai is €1,094m, calculated on the basis of the maximum amount of commitments to grant loans from the financial institutions. At the end of 2023, the loans already disbursed by financial institutions to Cronos Vita for these commitments amounted to €204m, insofar as the portion guaranteed by Unipol is concerned. The surety will become void when the business unit of the investee company assigned to each of the shareholder companies of Cronos Vita is transferred to them.
Financial assets at amortised cost: product breakdown, percentage composition and fair value hierarchy
| 31/12/2023 | 31/12/2022 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carrying amount |
% comp. |
L1 | L2 | L3 | Total fair value |
Carrying amount |
% comp. |
L1 | L2 | L3 | Total fair value |
|
| 1) Debt securities | 1,282 | 59.6 | 91 | 965 | 196 | 1,253 | 1,262 | 60.8 | 56 | 910 | 193 | 1,159 |
| Government bonds | 192 | 8.9 | 196 | 9.4 | ||||||||
| a) listed | 54 | 2.5 | 77 | 3.7 | ||||||||
| b) unlisted | 138 | 6.4 | 118 | 5.7 | ||||||||
| Other debt securities | 1,090 | 50.7 | 1,067 | 51.4 | ||||||||
| a) listed | 37 | 1.7 | 2 | 0.1 | ||||||||
| b) unlisted | 1,053 | 49.0 | 1,065 | 51.3 | ||||||||
| 2) Loans and receivables |
868 | 40.4 | 868 | 868 | 814 | 39.2 | 814 | 814 |
| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | |||||
| First stage | Second stage | Third stage | First stage | Second stage | Third stage | |
| Government bonds | 192 | 197 | ||||
| Other debt securities | 1,090 | 1,065 | ||||
| Loans and Receivables | 868 | 814 | ||||
| a) to banks | 49 | 52 | ||||
| b) to customers | 818 | 762 | ||||
| - Mortgage loans | ||||||
| - Policy loans | 10 | 12 | ||||
| - Other loans and receivables | 808 | 750 | ||||
| Total | 2,149 | 2,076 |
Other loans and receivables include amounts due from agents as reimbursement of indemnities for €449m (€460m at 31/12/2022).

| Amounts in €m | ||||||||
|---|---|---|---|---|---|---|---|---|
| Gross value | Total value adjustments | |||||||
| First stage | Of which assets with low credit risk |
Second stage | Third stage | First stage | Of which assets with low credit risk |
Second stage | Third stage | |
| Government bonds | 192 | 19 | ||||||
| Other debt securities |
1,093 | 976 | (3) | (3) | ||||
| Loans and receivables |
885 | 1 | (17) | (1) | ||||
| - banks | 49 | |||||||
| - customers | 835 | 1 | (17) | (1) | ||||
| Total 31/12/2023 | 2,170 | 995 | 1 | (21) | (3) | (1) | ||
| Total 31/12/2022 | 2,097 | 1,084 | 1 | (21) | (3) | (1) |
Financial assets at fair value through other comprehensive income: product breakdown and percentage composition
| Amounts in €m | |||||
|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | ||||
| Book value | % Comp. | Book value | % Comp. | ||
| Equity instruments | 2,174 | 5.3 | 2,186 | 5.9 | |
| a) listed | 1,876 | 4.6 | 1,887 | 5.1 | |
| b) unlisted | 298 | 0.7 | 299 | 0.8 | |
| Debt securities | 38,693 | 94.7 | 34,940 | 94.1 | |
| Government bonds | 25,649 | 62.8 | 24,034 | 64.7 | |
| a) listed | 24,464 | 59.9 | 22,994 | 61.9 | |
| b) unlisted | 1,185 | 2.9 | 1,039 | 2.8 | |
| Other debt securities | 13,044 | 31.9 | 10,906 | 29.4 | |
| a) listed | 11,309 | 27.7 | 9,530 | 25.7 | |
| b) unlisted | 1,736 | 4.2 | 1,376 | 3.7 | |
| Other financial instruments | |||||
| Total | 40,867 | 100.0 | 37,126 | 100.0 |

Amounts in €m
Financial assets at fair value through other comprehensive income: gross value and total value adjustments
| Amounts in €m | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross value | Total value adjustments | ||||||||
| First stage | Of which assets with low credit |
Second stage |
Third stage | First stage | Of which assets with low credit |
Second stage |
Third stage | ||
| Government bonds | 25,672 | risk 25,423 |
(23) | risk (22) |
|||||
| Other debt securities | 12,895 | 10,976 | 197 | (41) | (30) | (7) | |||
| Other financial | |||||||||
| instruments Total 31/12/2023 | 38,567 | 36,398 | 197 | (64) | (53) | (7) | |||
| Total 31/12/2022 | 34,745 | 33,650 | 281 | (75) | (63) | (12) |
Financial assets at fair value through profit or loss: product breakdown and percentage composition
| Items/Values | Held-for-trading financial assets | Financial assets at fair value through | profit or loss | Other financial assets mandatorily at fair value |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | ||||||||
| Book | % | Book | % | Book | % | Book | % | Book | % | Book | % | ||
| value | Comp. | value | Comp. | value | Comp. | value | Comp. | value | Comp. | value | Comp. | ||
| Equity instruments | 157 | 1.5 | 132 | 1.5 | 3 | 0.1 | 3 | 0.0 | |||||
| a) listed | 157 | 1.5 | 132 | 1.5 | 3 | 0.1 | 3 | 0.0 | |||||
| b) unlisted | |||||||||||||
| Treasury shares | |||||||||||||
| Own financial liabilities | |||||||||||||
| Other debt securities | 5,357 | 50.2 | 4,061 | 46.2 | 1,527 | 27.0 | 2,753 | 40.3 | |||||
| a) listed | 5,357 | 50.2 | 4,061 | 46.2 | 1,285 | 22.7 | 2,501 | 36.6 | |||||
| b) unlisted | 0.0 | 242 | 4.3 | 252 | 3.7 | ||||||||
| UCITS units | 4,861 | 45.5 | 4,316 | 49.1 | 4,128 | 73.0 | 4,076 | 59.7 | |||||
| Non-hedging derivatives | 42 | 58.7 | 99 | 35.2 | |||||||||
| Hedging derivatives | 30 | 41.3 | 182 | 64.8 | |||||||||
| Other financial | |||||||||||||
| instruments | 304 | 2.9 | 277 | 3.2 | |||||||||
| Total | 72 | 100.0 | 281 | 100.0 | 10,679 | 100.0 | 8,786 | 100.0 | 5,659 | 100.0 | 6,832 | 100.0 |

Amounts in €m
| Hedging instrument | |||||||
|---|---|---|---|---|---|---|---|
| Line item in the statement of financial position including the hedging instruments |
Nominal amount | Carrying amount (*) | Change in fair value |
||||
| 4.1 a) Financial liabilities held-for trading | 218 |
(*) value equal to zero, as the instruments are margined daily through a clearing broker
| Hedged item | ||||
|---|---|---|---|---|
| Line item in the statement of financial position including the hedged instruments |
Nominal amount | Carrying amount | Change in fair value |
Accumulated amount of fair value hedge adjustments on the hedged item included in the carrying amount of the hedged item recognised in the statement of financial position |
| 4.4 Financial assets at fair value through OCI | 218 | 153 | 1 | (2) |
| Hedge ineffectiveness | |
|---|---|
| 6 Gains/losses on financial assets and liabilities at fair value through profit or loss |
|
| 8.5 Unrealised gains/losses | 1 |
During 2023, no new transactions were carried out concerning fair value hedging. Outstanding fair value hedges concern fixed rate bonds held by Unipolsai, for which the interest rate risk was hedged through Interest Rate Swaps.
Existing positions at 31 December 2023 related to IRS contracts for a nominal value of €218.2m, to hedge fixed rate bond assets classified as FVOCI, with a hedged synthetic notional value of the same amount. At 31 December 2023, the fair value change relating to the hedged bonds came to a positive €1.3m, while the fair value change in IRSs amounted to a negative €0.1m, with a positive net economic effect of €1.2m, including the tax effect of €0.4m.
In relation to the hedges entered into through Interest Rate Swaps, note that during the year some contracts in place at 31 December 2022 for a nominal value of €975.0m to hedge bond assets were terminated early, for a synthetic notional value of €970.1m, classified as FVOCI.
The fair value change in IRSs between 31 December 2022 and the closing date of the hedging instruments, was a positive €17.5m, offset by a negative change of €16.6m, booked through profit or loss based on the fair value change of the synthetic asset hedged during the same period. The hedged bonds were not sold.

| Amounts in €m | ||||||||
|---|---|---|---|---|---|---|---|---|
| Hedging instrument | ||||||||
| Line item in the statement of financial position including the hedging instruments |
Nominal amount | Carrying amount | Change in fair value |
Balance in the cash flow hedge reserve |
Hedging gains or (losses) of the reporting period that were recognised in other comprehensive income |
|||
| 4.1 a) Financial liabilities held-for trading | 452 | (77) | 54 | 18 | 54 |
The objective of the existing hedges is to transform the interest rate on financial assets from a floating rate to a fixed rate, stabilising the cash flows.
These relate to:
With regard to cash flow hedges on bonds recorded in the FVOCI portfolio, note that in the third quarter of 2023 a number hedging derivatives for a notional amount of €137m expired.
Amounts in €m
| 31/12/2023 | 31/12/2022 | % var. | |
|---|---|---|---|
| Receivables from intermediaries and companies | 580 | 605 | (4.2) |
| Other receivables | 1,853 | 1,866 | (0.7) |
| Total Other financial assets | 2,433 | 2,470 | (1.5) |
The item Other receivables included, inter alia:
• tax receivables amounting to €1,165m (€1,116m at 31/12/2022);

Amounts in €m
| 31/12/2023 | 31/12/2022 | % var. | |
|---|---|---|---|
| Non-current assets or assets of a disposal group held for sale | 133 | 514 | (74.1) |
| Deferred tax assets | 408 | 856 | (52.3) |
| Current tax assets | 3 | 36 | (91.7) |
| Other assets | 2,592 | 1,482 | 74.9 |
| Total other assets | 3,136 | 2,888 | 8.6 |
Non-current assets or assets of a disposal group held for sale include assets primarily represented by investment properties and the investment held in Cronos Vita. For more information reference is made to paragraph 3.4 of these Notes to the financial statements.
The item Deferred tax assets is shown net of the offsetting carried out, pursuant to IAS 12, with the corresponding taxes (IRES or IRAP) recorded in Deferred tax liabilities, as described in chapter "Main accounting standards".
The item Other assets includes €2,164m in "Ecobonus" and "Sismabonus" tax credits, purchased from direct beneficiaries or their assignees, which can be recovered by offsetting them against future payments.
At 31 December 2023, Cash and cash equivalents amounted to €978m (€826m at 31/12/2022).

Shareholders' equity, excluding non-controlling interests, is composed as follows:
| Amounts in €m | |||
|---|---|---|---|
| 31/12/2023 | 31/12/2022 | variation in amount |
|
| Share capital | 2,031 | 2,031 | |
| Other equity instruments | 496 | 496 | |
| Capital reserves | 347 | 347 | |
| Income-related and other equity reserves | 3,240 | 3,260 | (20) |
| (Treasury shares) | (3) | (3) | |
| Valuation reserves | 215 | (91) | 306 |
| Reserve for foreign currency translation differences | 4 | 4 | |
| Gains/(losses) on financial assets at fair value through OCI | (837) | (2,470) | 1,633 |
| Financial revenues/(costs) relating to insurance/reinsurance contracts | 1,059 | 2,428 | (1,369) |
| Other gains or losses recognised directly in equity | (11) | (53) | 42 |
| Profit (loss) for the year | 700 | 418 | 282 |
| Total shareholders' equity attributable to the owners of the Parent | 7,026 | 6,458 | 568 |
Movements in shareholders' equity recognised during the year with respect to 31 December 2022 are set out in the attached statement of changes in shareholders' equity.
The main changes in the Group's shareholders' equity were as follows:
At 31 December 2023, the Parent UnipolSai's fully paid-up share capital amounted to €2,031m, and was made up of 2,829,717,372 ordinary shares (unchanged compared to 31/12/2022).
At 31 December 2023, the treasury shares held directly or indirectly by UnipolSai totalled 1,087,879 (1,162,312 at 31/12/2022), of which 947,782 shares were held directly and 140,097 shares held by the following subsidiaries:
During the year, 924,433 UnipolSai shares were allocated to UnipolSai Group Executives in implementation of the Share-based compensation plans.

| Items/Types | Ordinary | Other |
|---|---|---|
| A. Shares at the beginning of the year | 2,829,717,372 | |
| - fully paid-up | 2,829,717,372 | |
| - not fully paid-up | ||
| A.1 Treasury shares (-) | 1,162,312 | |
| A.2 Shares outstanding: opening balance | 2,828,555,060 | |
| B. Increases | 924,433 | |
| B.1 New issues | ||
| - for a fee | ||
| - business combinations | ||
| - conversion of bonds | ||
| - exercise of warrants | ||
| - other | ||
| - free of charge | ||
| - for employees | ||
| - for directors | ||
| - other | ||
| B.2 Sale of treasury shares | 924,433 | |
| B.3 Other changes | ||
| C. Decreases | (850,000) | |
| C.1 Cancellation | ||
| C.2 Purchase of treasury shares | (850,000) | |
| C.3 Sales of businesses | ||
| C.4 Other changes | ||
| D. Shares outstanding: closing balances | 2,828,629,493 | |
| D.1 Treasury shares (+) | 1,087,879 | |
| D.2 Shares at the end of the year | 2,829,717,372 | |
| - fully paid-up | 2,829,717,372 | |
| - not fully paid-up |
The increase in the number of shares included in item B.2 Sale of treasury shares was due to the assignment of shares during the year as part of the incentive plans for executive personnel described in more detail in section 3.8 Information on personnel.
Shareholders' equity attributable to non-controlling interests amounted to €281m (€275m at 31/12/2022). The main changes over the year related to:
a decrease of €31m for payment of dividends to third parties;
an increase of €66m due to profit attributable to non-controlling interests.

The item "Provisions for risks and charges" totalled €519m at 31 December 2023 (€596m at 31/12/2022) and mainly consisted of provisions for litigation, various disputes, charges relating to the sales network, provisions for salary policies and personnel leaving-incentive schemes.
At the end of December 2023, tax demands and penalties were received for 2018 relating to the application of VAT on delegation fees for coinsurance transactions entered into with other companies in the insurance sector. Taking into account decisions already made for previous years, the companies will negotiate settlement agreements to finalise payments before the appeal deadline.
The dispute is pending for 2013 and 2017 for IRES and IRAP purposes resulting from the notices of assessment issued following general inspections carried out by the Veneto Regional Department.
In October 2023, a settlement agreement was reached pursuant to Art. 15 of Italian Legislative Decree 218/97 on the IRES notice of assessment for 2017 relating to a finding on the deduction of a portion of a change in technical provisions.
The dispute relating to the notices of assessment for stamp duty on vehicles for the years 2017-2019 issued by the Emilia Romagna Region was settled through judicial conciliation, with payment of a fractional amount with respect to the amount originally assessed for higher taxes, without the application of penalties.
In April, the dispute with the Florence Provincial Department of the Italian Revenue Agency was settled concerning the restatement of the tax value of the area underlying the healthcare complex in Florence. The tax value attributed to the area was redefined on the basis of a method agreed upon with the office.
The dispute relating to the notices of assessment issued for the years 2014 to 2017 for IRES, IRAP and VAT purposes, deriving from the Report on Findings of the Italian Tax Police of Turin drawn up in March 2018, is pending.
By means of communications dated 19 April 2013, Consob commenced two separate sanction proceedings against Fondiaria-SAI and Milano Assicurazioni for charges relating to their respective 2010 consolidated financial statements.
Pursuant to Art. 187-septies, paragraph 1 of the Consolidated Law on Finance, Consob notified Ms. Jonella Ligresti and Mr. Emanuele Erbetta, for the offices held in Fondiaria-SAI at the time of the events, of the violation set forth in Art. 187-ter, paragraph 1, of the Consolidated Law on Finance. Fondiaria-SAI is also charged with this violation as a party bearing joint and several liability. It is also charged with the offence set forth in Art. 187-quinquies, paragraph 1, letter a), of the Consolidated Law on Finance for the aforementioned violation of Art. 187-ter, paragraph 1 of the Consolidated Law on Finance by Ms. Jonella Ligresti and Mr. Emanuele Erbetta, acting in the above mentioned capacities.
Consob also made the same charge against Milano Assicurazioni. In this regard, pursuant to Art. 187-septies, paragraph 1 of the Consolidated Law on Finance, the Commission charged Mr. Emanuele Erbetta, for the role he held in the subsidiary at the time of the events, with the violation established in Art. 187-ter, paragraph 1, of the Consolidated Law on Finance. Milano Assicurazioni is also charged with this violation as a party bearing joint and several liability. It is also charged with the offence set forth in Art. 187-quinquies, paragraph 1, letter a), of the

Consolidated Law on Finance for the aforementioned violation of Art. 187-ter, paragraph 1 of the Consolidated Law on Finance by Mr. Emanuele Erbetta, acting in the above mentioned capacity.
Fondiaria-SAI and Milano Assicurazioni (currently UnipolSai), assisted by their lawyers, presented their conclusions, asking that the administrative penalties set out in Articles 187-ter, 187-quinquies and 187-septies of the Consolidated Law on Finance not be imposed on the companies. On 20 March 2014 the Consob issued a resolution whereby, not deeming that the parties' defences deserved to be accepted, it ordered:
UnipolSai provided for the payment of the fines, and also filed an appeal against Ms. Ligresti. Mr. Erbetta directly paid the penalty imposed on him. In any case, UnipolSai challenged the decision before the Court of Appeal of Bologna, which rejected the appeal on 6 March 2015. The Company, assisted by its lawyers, challenged the decision before the Court of Cassation which, on 6 December 2018, rejected the appeal and confirmed the Consob sanctions.
In March 2019, the Company challenged the decision before the European Court of Human Rights (ECHR), asking for the cancellation of the sanction for the breach of the ne bis in idem principle, according to which a person should not be submitted to sanction or judicial proceedings several times for the same fact. The ECHR declared the appeal admissible but has not yet scheduled the hearing.
On 26 November 2020, the Antitrust Authority notified UnipolSai Assicurazioni of the initiation of preliminary proceedings concerning MV TPL claims settlement, characterised by an alleged hindrance of the right of consumers to access the relevant deeds and the failure to specify the criteria for the quantification of damages in the phase of formulating the compensation offer. On 16 April 2021, the Antitrust Authority then notified the objective extension of these proceedings, claiming failure to comply with the terms of Art. 148 of the Private Insurance Code for the settlement/challenge of MV TPL claims.
UnipolSai deems these charges to be completely unfounded and, to protect its rights, has appointed its lawyers to represent it in the proceedings, which closed with a decision received by UnipolSai on 8 August 2022, whereby the Antitrust Authority imposed a penalty of €5m. Since UnipolSai does not deem the conclusions of the Authority to be acceptable in any way, it appealed against this decision before the Lazio Regional Administrative Court (TAR).
The case was suspended by order dated 13 September 2023 of the Lazio Regional Administrative Court, pending a ruling by the European Court of Justice, as part of another case, on a preliminary issue relevant to the Lazio Regional Administrative Court decision concerning the Antitrust Authority's failure to comply with the terms for launch of the investigation.
By notice served on the Company on 11 October 2021, IVASS ordered the initiation of inspections intended, in relation to MV TPL underwriting and settlement processes, to ascertain the adoption of recent regulatory provisions, respect for the CARD agreement and the related governance and control aspects. After the inspections, which were completed on 21 January 2022, IVASS, with an inspection report notified on 22 June 2022, formulated some findings, to which UnipolSai replied with a Notes to the Income of 4 August 2022 containing its considerations in relation to the findings, also representing, against a "partially favourable" opinion on the results of the assessments conducted, the implementation of specific improvement actions to further refine and perfect certain processes. At present, the final decisions of IVASS have not yet been disclosed.
From 2003 onwards, a number of La Fondiaria Assicurazioni shareholders initiated a series of legal proceedings claiming, albeit on different legal grounds and justifications, compensation for damages allegedly suffered due to failure to launch the takeover bid on Fondiaria shares by SAI Società Assicuratrice Industriale in 2002.
On the whole, 16 proceedings were brought against the Company; 14 of these were settled at various degrees and stages of the proceeding, while one was extinguished when the first instance court's decision handed down in favour of the Company became definitive, as the opposing party failed to appeal it.
At 31 December 2023, only one case was still pending before the Court of Cassation, following the decision issued by the Milan Court of Appeal after resumption by the plaintiff. An appropriate provision has been allocated to cover this pending dispute.
UnipolSai Assicurazioni SpA has for some time been a party in legal proceedings referring to events occurring during the previous management of Fondiaria-SAI and Milano Assicurazioni. As described in greater detail in the financial statements of previous years, the criminal proceedings were all settled with acquittal or dismissal. Two civil proceedings also ended with final judgments for the acquittal of UnipolSai with respect to all compensation claims.
At 31 December 2023, five civil proceedings were still pending, lodged by several investors which, in brief, claimed that they had purchased and subscribed Fondiaria-SAI shares as they were prompted by the information in the prospectuses published by Fondiaria-SAI on 24 June 2011 and 12 July 2012 in relation to the increases in share capital under option resolved by the company on 14 May 2011, 22 June 2011 and 19 March 2012 respectively, and in the financial statements of Fondiaria-SAI relating to the years 2007-2012. UnipolSai (formerly Fondiaria-SAI) appeared in all civil proceedings and disputed the plaintiffs' claims.
Specifically, on 18 May 2017 the Court of Milan partially upheld the compensation claims of one shareholder. The Company appealed against the sentence before the Milan Court of Appeal, which only partially accepted the appeal. The Company therefore appealed against the sentence before the Court of Cassation, which has not yet scheduled the hearing for the discussion of the case.
The Court of Rome, with a sentence published on 12 May 2020, vice versa fully rejected the compensation claims submitted by another investor with respect to the share capital increases noted above. The sentence was challenged before the Court of Appeal of Rome which, with a judgment dated 2 May 2022, rejected the investor's appeal in full, confirming the first instance judgment. The shareholder first served the Company with a summons for revocation of the judgment of the Rome Court of Appeal (hearing scheduled for 25 April 2024 for admission of the facts) and subsequently challenged the judgment before the Court of Cassation, for which a discussion hearing is still pending.
In another case pending on the same issues, the Court of Milan accepted the compensation claims of another investor, with a judgment dated 20 March 2019. The judgment, following an appeal by the Company, was fully reversed by the Court of Appeal of Milan with a judgment dated 22 October 2020. The opposing party has appealed to the Court of Cassation, which has not yet scheduled a hearing.
On 15 February 2021, the Court of Milan partially upheld the compensation claims of other shareholders. After being appealed by the Company, the judgment was overruled in full by the Milan Court of Appeal with a judgment dated 14 April 2023.
The appeal judgment has been challenged by the opposing parties before the Court of Cassation, which has not yet scheduled a hearing.
Two other judgments, which relate to the same issues, are still pending before the Court of Milan, which has set a hearing for closing arguments for 21 May 2024.
Provisions deemed suitable were made in relation to the disputes with investors described above.

This section provides information on the insurance contracts issued that are liabilities and assets (liability item 3.1 and asset item 3.1) that are composed as follows:
| Amounts in €m | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Items/Basis of aggregation | VFA | BBA | PAA | Total | VFA | BBA | PAA | Total | |
| 31/12/2023 31/12/2023 31/12/2023 31/12/2023 31/12/2022 | 31/12/2022 | 31/12/2022 | 31/12/2022 | ||||||
| 1. | Insurance contracts issued that are liabilities | 37,419 | 6,466 | 7,223 | 51,108 | 34,388 | 7,835 | 4,972 | 47,194 |
| 2. | Insurance contracts issued that are assets | (51) | (12) | (63) | (29) | (25) | (54) | ||
| 3. | Net liabilities on the balance sheet | 37,419 | 6,415 | 7,211 | 51,045 | 34,388 | 7,806 | 4,947 | 47,141 |
| of which Life segment | 37,419 | 123 | 1 | 37,544 | 34,388 | 114 | 2 | 34,503 | |
| Contracts issued with direct participation features - Life segment |
37,419 | 37,419 | 34,388 | 34,388 | |||||
| Contracts issued without direct participation features - Life segment |
123 | 1 | 125 | 114 | 2 | 116 | |||
| of which Non-Life segment | 6,291 | 7,210 | 13,501 | 7,692 | 4,945 | 12,637 | |||
| Contracts issued without direct participation features - Non-Life Motor segment |
2,533 | 3,995 | 6,529 | 3,494 | 3,001 | 6,496 | |||
| Contracts issued without direct participation features - Non-Life Non-MV segment |
3,758 | 3,215 | 6,973 | 4,198 | 1,944 | 6,142 |

| Amounts in €m | ||||||||
|---|---|---|---|---|---|---|---|---|
| Liabilities for residual coverage | Liabilities for claims incurred |
Total | Liabilities for residual coverage | Liabilities for claims incurred |
Total | |||
| Net of loss | Loss | 31/12/2023 | Net of loss | Loss | 31/12/2022 | |||
| A. Initial carrying amount | ||||||||
| 1. Insurance contracts issued that are liabilities | 34,119 | 5 | 263 | 34,388 | 41,345 | 3 | 280 | 41,628 |
| 2. Insurance contracts issued that are assets | ||||||||
| 3. Net carrying amount as at 1 January | 34,119 | 5 | 263 | 34,388 | 41,345 | 3 | 280 | 41,628 |
| B. Insurance revenue | (476) | (476) | (423) | (423) | ||||
| C. Insurance service expenses | 13 | 2 | 295 | 310 | 5 | 2 | 245 | 252 |
| 1. Claims incurred and other directly attributable costs |
295 | 295 | 246 | 246 | ||||
| 2. Changes in liability for claims incurred | (1) | (1) | ||||||
| 3. Losses and related recoveries on onerous contracts |
2 | 2 | 2 | 2 | ||||
| 4. Amortisation of contract acquisition costs | 13 | 13 | 5 | 5 | ||||
| D. Insurance service result (B+C) | (463) | 2 | 295 | (166) | (418) | 2 | 245 | (170) |
| E. Net finance expenses/income | 3,083 | 3,083 | (7,231) | (7,231) | ||||
| 1. Relating to insurance contracts issued | 3,083 | 3,083 | (7,232) | (7,232) | ||||
| 1.1 Recorded in the Income Statement | 1,216 | 1,216 | 909 | 909 | ||||
| 1.2 Recorded in the Comprehensive Income Statement |
1,867 | 1,867 | (8,141) | (8,141) | ||||
| 2. Effects associated with changes in exchange rates |
1 | 1 | ||||||
| F. Investment components | (3,636) | 3,636 | (2,643) | 2,643 | ||||
| G. Total amount recorded in the Income Statement and in the Comprehensive Income Statement (D+E+F) |
(1,016) | 2 | 3,931 | 2,917 | (10,293) | 2 | 2,889 | (7,402) |
| H. Other changes | 35 | 35 | (19) | 1 | (18) | |||
| I. Cash movements | 3,999 | (3,920) | 79 | 3,086 | (2,906) | 180 | ||
| 1. Premiums received | 4,067 | 4,067 | 3,142 | 3,142 | ||||
| 2. Payments associated with contract acquisition costs |
(67) | (67) | (56) | (56) | ||||
| 3. Claims paid and other cash outflows | (3,920) | (3,920) | (2,906) | (2,906) | ||||
| L. Net carrying amount as at 31 December (A.3+G+H+I) |
37,137 | 7 | 275 | (3,908) | 34,119 | 5 | 263 | (2,782) |
| M. Final carrying amount | ||||||||
| 1. Insurance contracts issued that are liabilities | 37,137 | 7 | 275 | 37,419 | 34,119 | 5 | 263 | 34,388 |
| 2. Insurance contracts issued that are assets | ||||||||
| 3. Net carrying amount as at 31 December | 37,137 | 7 | 275 | 37,419 | 34,119 | 5 | 263 | 34,388 |
LIFE SEGMENT - Insurance contracts issued with direct participation features and Investment contracts issued with discretionary participation features

| Liabilities for residual coverage | Total | Liabilities for residual coverage | Liabilities for claims incurred |
Total | |||||
|---|---|---|---|---|---|---|---|---|---|
| Net of loss | Loss | 31/12/2023 | Net of loss | Loss | 31/12/2022 | ||||
| A. Initial carrying amount | |||||||||
| 1. Insurance contracts issued that are liabilities | 102 | 38 | 141 | 86 | 36 | 121 | |||
| 2. Insurance contracts issued that are assets | (49) | 23 | (27) | (81) | 23 | (58) | |||
| 3. Net carrying amount as at 1 January | 53 | 61 | 114 | 4 | 59 | 63 | |||
| B. Insurance revenue | (147) | (147) | (126) | (126) | |||||
| C. Insurance service expenses | 10 | 55 | 66 | 5 | 64 | 69 | |||
| 1. Claims incurred and other directly attributable costs |
60 | 60 | 61 | 61 | |||||
| 2. Changes in liability for claims incurred | (5) | (5) | 3 | 3 | |||||
| 3. Losses and related recoveries on onerous contracts |
|||||||||
| 4. Amortisation of contract acquisition costs | 10 | 10 | 5 | 5 | |||||
| D. Insurance service result (B+C) | (136) | 55 | (81) | (121) | 64 | (56) | |||
| E. Net finance expenses/income | (11) | (11) | 23 | 23 | |||||
| 1. Relating to insurance contracts issued | (11) | (11) | 23 | 23 | |||||
| 1.1 Recorded in the Income Statement | 1 | 1 | |||||||
| 1.2 Recorded in the Comprehensive Income Statement |
(12) | (12) | 23 | 23 | |||||
| 2. Effects associated with changes in exchange rates |
|||||||||
| F. Investment components | (10) | 10 | (1) | 1 | |||||
| G. Total amount recorded in the Income Statement and in the Comprehensive Income Statement (D+E+F) |
(157) | 66 | (92) | (99) | 65 | (34) | |||
| H. Other changes | |||||||||
| I. Cash movements | 164 | (62) | 101 | 147 | (62) | 85 | |||
| 1. Premiums received | 215 | 215 | 200 | 200 | |||||
| 2. Payments associated with contract acquisition costs |
(52) | (52) | (53) | (53) | |||||
| 3. Claims paid and other cash outflows | (62) | (62) | (62) | (62) | |||||
| L. Net carrying amount as at 31 December (A.3+G+H+I) |
59 | 64 | 123 | 53 | 61 | 114 | |||
| M. Final carrying amount | |||||||||
| 1. Insurance contracts issued that are liabilities | 134 | 39 | 173 | 102 | 38 | 141 | |||
| 2. Insurance contracts issued that are assets | (75) | 26 | (49) | (49) | 23 | (27) | |||
| 3. Net carrying amount as at 31 December | 59 | 64 | 123 | 53 | 61 | 114 |

| Amounts in €m | ||||||||
|---|---|---|---|---|---|---|---|---|
| Liabilities for residual coverage | Liabilities for claims incurred |
Total | Liabilities for residual coverage | Liabilities for claims incurred |
Total | |||
| Net of loss | Loss | 31/12/2023 | Net of loss | Loss | 31/12/2022 | |||
| A. Initial carrying amount | ||||||||
| 1. Insurance contracts issued that are liabilities | 226 | 1 | 3,267 | 3,494 | 1,490 | 4,542 | 6,031 | |
| 2. Insurance contracts issued that are assets | ||||||||
| 3. Net carrying amount as at 1 January | 226 | 1 | 3,267 | 3,494 | 1,490 | 4,542 | 6,031 | |
| B. Insurance revenue | (179) | (179) | (1,711) | (1,711) | ||||
| C. Insurance service expenses | 12 | 5 | (137) | (119) | 61 | 1 | 1,129 | 1,191 |
| 1. Claims incurred and other directly attributable costs |
911 | 911 | 2,127 | 2,127 | ||||
| 2. Changes in liability for claims incurred | (1,048) | (1,048) | (998) | (998) | ||||
| 3. Losses and related recoveries on onerous contracts |
5 | 5 | 1 | 1 | ||||
| 4. Amortisation of contract acquisition costs | 12 | 12 | 61 | 61 | ||||
| D. Insurance service result (B+C) | (167) | 5 | (137) | (298) | (1,650) | 1 | 1,129 | (520) |
| E. Net finance expenses/income | 7 | 111 | 118 | (13) | (277) | (290) | ||
| 1. Relating to insurance contracts issued | 7 | 111 | 118 | (13) | (277) | (290) | ||
| 1.1 Recorded in the Income Statement | 1 | 1 | 2 | (4) | (16) | (20) | ||
| 1.2 Recorded in the Comprehensive Income Statement |
6 | 110 | 116 | (8) | (261) | (269) | ||
| 2. Effects associated with changes in exchange rates |
||||||||
| F. Investment components | ||||||||
| G. Total amount recorded in the Income Statement and in the Comprehensive Income Statement (D+E+F) |
(159) | 5 | (26) | (180) | (1,663) | 1 | 852 | (810) |
| H. Other changes | 1 | |||||||
| I. Cash movements | 130 | (911) | (781) | 399 | (2,127) | (1,727) | ||
| 1. Premiums received | 166 | 166 | 469 | 469 | ||||
| 2. Payments associated with contract acquisition costs |
(36) | (36) | (69) | (69) | ||||
| 3. Claims paid and other cash outflows | (911) | (911) | (2,127) | (2,127) | ||||
| L. Net carrying amount as at 31 December (A.3+G+H+I) |
197 | 7 | 2,330 | 2,533 | 226 | 1 | 3,267 | 3,494 |
| M. Final carrying amount | ||||||||
| 1. Insurance contracts issued that are liabilities | 197 | 7 | 2,330 | 2,533 | 226 | 1 | 3,267 | 3,494 |
| 2. Insurance contracts issued that are assets | ||||||||
| 3. Net carrying amount as at 31 December | 197 | 7 | 2,330 | 2,533 | 226 | 1 | 3,267 | 3,494 |

| Amounts in €m | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities for residual coverage | Liabilities for claims incurred |
Total | Liabilities for residual coverage | Liabilities for claims incurred |
Total | |||||
| Net of loss | Loss | 31/12/2023 | Net of loss | Loss | 31/12/2022 | |||||
| A. Initial carrying amount | ||||||||||
| 1. Insurance contracts issued that are liabilities | 788 | 18 | 3,393 | 4,199 | 1,607 | 3,990 | 5,597 | |||
| 2. Insurance contracts issued that are assets | (2) | (2) | ||||||||
| 3. Net carrying amount as at 1 January | 786 | 18 | 3,394 | 4,197 | 1,607 | 3,990 | 5,597 | |||
| B. Insurance revenue | (1,145) | (1,145) | (2,033) | (2,033) | ||||||
| C. Insurance service expenses | 183 | 13 | 742 | 938 | 244 | 20 | 1,394 | 1,658 | ||
| 1. Claims incurred and other directly attributable costs |
1,252 | 1,252 | 1,637 | 1,637 | ||||||
| 2. Changes in liability for claims incurred | (510) | (510) | (243) | (243) | ||||||
| 3. Losses and related recoveries on onerous contracts |
13 | 13 | 20 | 20 | ||||||
| 4. Amortisation of contract acquisition costs | 183 | 183 | 244 | 244 | ||||||
| D. Insurance service result (B+C) | (962) | 13 | 742 | (207) | (1,789) | 20 | 1,394 | (375) | ||
| E. Net finance expenses/income | 58 | 1 | 136 | 195 | (69) | (351) | (419) | |||
| 1. Relating to insurance contracts issued | 58 | 1 | 136 | 195 | (69) | (351) | (419) | |||
| 1.1 Recorded in the Income Statement | 11 | 1 | 3 | 14 | (6) | (15) | (21) | |||
| 1.2 Recorded in the Comprehensive Income Statement |
48 | 133 | 181 | (62) | (336) | (398) | ||||
| 2. Effects associated with changes in exchange rates |
||||||||||
| F. Investment components | ||||||||||
| G. Total amount recorded in the Income Statement and in the Comprehensive Income Statement (D+E+F) |
(904) | 14 | 878 | (12) | (1,858) | 20 | 1,044 | (795) | ||
| H. Other changes | (74) | 1 | (1) | (73) | (85) | (2) | (2) | (89) | ||
| I. Cash movements | 897 | (1,252) | (355) | 1,122 | (1,637) | (516) | ||||
| 1. Premiums received | 1,179 | 1,179 | 1,490 | 1,490 | ||||||
| 2. Payments associated with contract acquisition costs |
(282) | (282) | (369) | (369) | ||||||
| 3. Claims paid and other cash outflows | (1,252) | (1,252) | (1,637) | (1,637) | ||||||
| L. Net carrying amount as at 31 December (A.3+G+H+I) |
706 | 33 | 3,019 | 3,758 | 786 | 18 | 3,394 | 4,198 | ||
| M. Final carrying amount | ||||||||||
| 1. Insurance contracts issued that are liabilities | 708 | 33 | 3,019 | 3,760 | 788 | 18 | 3,393 | 4,199 | ||
| 2. Insurance contracts issued that are assets | (2) | (2) | (2) | (2) | ||||||
| 3. Net carrying amount as at 31 December | 706 | 33 | 3,019 | 3,758 | 786 | 18 | 3,394 | 4,198 |

Changes in the carrying amount of insurance contracts issued - PAA - liabilities for residual coverage and for claims incurred
| Amounts in €m | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Items/Breakdown of carrying amount | Liabilities for Liabilities for claims residual coverage incurred |
Total | Liabilities for residual coverage |
Liabilities for claims incurred |
Total | ||||||
| Net of loss |
Loss | Present value of cash flows |
Adjustment for non financial risks |
31/12/2023 | Net of loss |
Loss | Present value of cash flows |
Adjustment for non financial risks |
31/12/2022 | ||
| A. Initial carrying amount | |||||||||||
| 1. Insurance contracts issued that are liabilities |
1 | 1 | 2 | 1 | 1 | ||||||
| 2. Insurance contracts issued that are assets |
|||||||||||
| 3. Net carrying amount as at 1 January | 1 | 1 | 2 | 1 | 1 | ||||||
| B. Insurance revenue | |||||||||||
| C. Insurance service expenses | 1 | 1 | |||||||||
| 1. Claims incurred and other directly attributable costs |
1 | 1 | |||||||||
| 2. Changes in liability for claims incurred |
|||||||||||
| 3. Losses and related recoveries on onerous contracts |
|||||||||||
| 4. Amortisation of contract acquisition costs |
|||||||||||
| D. Insurance service result (B+C) | 1 | ||||||||||
| E. Finance expenses/income | |||||||||||
| 1. Relating to insurance contracts issued |
|||||||||||
| 1.1 Recorded in the Income Statement | |||||||||||
| 1.2 Recorded in the Comprehensive Income Statement |
|||||||||||
| 2. Effects associated with changes in exchange rates |
|||||||||||
| F. Investment components | |||||||||||
| G. Total amount of changes recorded in the Income Statement and in the Comprehensive Income Statement (D+E+F) |
1 | ||||||||||
| H. Other changes | |||||||||||
| I. Cash movements | 1 | (1) | |||||||||
| 1. Premiums received | 1 | 1 | |||||||||
| 2. Payments associated with contract acquisition costs |
|||||||||||
| 3. Claims paid and other cash outflows | (1) | (1) | |||||||||
| L. Net carrying amount as at 31 December (A.3+G+H+I) |
1 | 1 | 1 | 1 | 2 | ||||||
| M. Final carrying amount | |||||||||||
| 1. Insurance contracts issued that are liabilities |
1 | 1 | 1 | 1 | 2 | ||||||
| 2. Insurance contracts issued that are assets |
|||||||||||
| 3. Net carrying amount as at 31 December |
1 | 1 | 1 | 1 | 2 |

| Amounts in €m | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Items/Breakdown of carrying amount | Liabilities for residual coverage |
Liabilities for claims incurred |
Total | Liabilities for residual coverage |
Liabilities for claims incurred |
Total | |||||
| Net of loss |
Loss | Present value of cash flows |
Adjustment for non financial risks |
31/12/2023 | Net of loss |
Loss | Present value of cash flows |
Adjustment for non financial risks |
31/12/2022 | ||
| A. Initial carrying amount | |||||||||||
| 1. Insurance contracts issued that are liabilities |
1,267 | 48 | 1,520 | 166 | 3,001 | 165 | 25 | 746 | 83 | 1,020 | |
| 2. Insurance contracts issued that are assets |
|||||||||||
| 3. Net carrying amount as at 1 January | 1,267 | 48 | 1,520 | 166 | 3,001 | 165 | 25 | 746 | 83 | 1,020 | |
| B. Insurance revenue | (3,991) | (3,991) | (2,150) | (2,150) | |||||||
| C. Insurance service expenses | 704 | (31) | 3,366 | 108 | 4,147 | 369 | 23 | 1,835 | 93 | 2,321 | |
| 1. Claims incurred and other directly attributable costs |
2,282 | 2,282 | 980 | 980 | |||||||
| 2. Changes in liability for claims incurred |
1,084 | 108 | 1,192 | 855 | 93 | 948 | |||||
| 3. Losses and related recoveries on onerous contracts |
(31) | (31) | 23 | 23 | |||||||
| 4. Amortisation of contract acquisition costs |
704 | 704 | 369 | 369 | |||||||
| D. Insurance service result (B+C) | (3,287) | (31) | 3,366 | 108 | 156 | (1,780) | 23 | 1,835 | 93 | 171 | |
| E. Finance expenses/income | (1) | 88 | 8 | 96 | (5) | (80) | (10) | (95) | |||
| 1. Relating to insurance contracts issued |
87 | 8 | 95 | (62) | (8) | (70) | |||||
| 1.1 Recorded in the Income Statement | 56 | 4 | 60 | (1) | (1) | ||||||
| 1.2 Recorded in the Comprehensive Income Statement |
31 | 4 | 34 | (61) | (8) | (68) | |||||
| 2. Effects associated with changes in exchange rates |
(1) | 1 | 1 | 1 | (5) | (18) | (2) | (25) | |||
| F. Investment components | |||||||||||
| G. Total amount of changes recorded in the Income Statement and in the Comprehensive Income Statement (D+E+F) |
(3,288) | (31) | 3,454 | 116 | 252 | (1,785) | 23 | 1,754 | 84 | 77 | |
| H. Other changes | 1 | 2 | 3 | 18 | (1) | 17 | |||||
| I. Cash movements | 3,021 | (2,282) | 739 | 2,868 | (980) | 1,889 | |||||
| 1. Premiums received | 3,700 | 3,700 | 3,535 | 3,535 | |||||||
| 2. Payments associated with contract acquisition costs |
(679) | (679) | (667) | (667) | |||||||
| 3. Claims paid and other cash outflows | (2,282) | (2,282) | (980) | (980) | |||||||
| L. Net carrying amount as at 31 December (A.3+G+H+I) |
1,002 | 17 | 2,694 | 283 | 3,995 | 1,267 | 48 | 1,520 | 166 | 3,001 | |
| M. Final carrying amount | |||||||||||
| 1. Insurance contracts issued that are liabilities |
1,002 | 17 | 2,694 | 283 | 3,996 | 1,267 | 48 | 1,520 | 166 | 3,001 | |
| 2. Insurance contracts issued that are assets |
|||||||||||
| 3. Net carrying amount as at 31 December |
1,002 | 17 | 2,694 | 283 | 3,995 | 1,267 | 48 | 1,520 | 166 | 3,001 |
NON-LIFE MOTOR SEGMENT

| Amounts in € | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Items/Breakdown of carrying amount | Liabilities for residual coverage |
Liabilities for claims incurred |
Total | Liabilities for residual coverage |
Liabilities for claims incurred |
Total | ||||
| Net of loss |
Loss | Present value of cash flows |
Adjustment for non financial risks |
31/12/2023 | Net of loss |
Loss | Present value of cash flows |
Adjustment for non financial risks |
31/12/2022 | |
| A. Initial carrying amount | ||||||||||
| 1. Insurance contracts issued that are liabilities |
696 | 66 | 1,152 | 56 | 1,969 | 409 | 17 | 903 | 48 | 1,376 |
| 2. Insurance contracts issued that are assets |
(26) | 1 | (25) | (20) | (20) | |||||
| 3. Net carrying amount as at 1 January | 670 | 66 | 1,153 | 56 | 1,944 | 389 | 17 | 903 | 48 | 1,356 |
| B. Insurance revenue | (3,632) | (3,632) | (2,106) | (2,106) | ||||||
| C. Insurance service expenses | 978 | 21 | 2,986 | 78 | 4,063 | 527 | 49 | 1,218 | 20 | 1,815 |
| 1. Claims incurred and other directly attributable costs |
1,703 | 1,703 | 920 | 11 | 931 | |||||
| 2. Changes in liability for claims incurred |
1,283 | 78 | 1,361 | 298 | 9 | 307 | ||||
| 3. Losses and related recoveries on onerous contracts |
21 | 21 | 49 | 49 | ||||||
| 4. Amortisation of contract acquisition costs |
978 | 978 | 527 | 527 | ||||||
| D. Insurance service result (B+C) | (2,654) | 21 | 2,986 | 78 | 431 | (1,578) | 49 | 1,218 | 20 | (291) |
| E. Finance expenses/income | 30 | 2 | 32 | (2) | (28) | (1) | (30) | |||
| 1. Relating to insurance contracts issued |
34 | 2 | 37 | (29) | (1) | (31) | ||||
| 1.1 Recorded in the Income Statement | 23 | 2 | 25 | (2) | (3) | |||||
| 1.2 Recorded in the Comprehensive Income Statement |
12 | 12 | (27) | (1) | (28) | |||||
| 2. Effects associated with changes in exchange rates |
(4) | (4) | (2) | 2 | ||||||
| F. Investment components | ||||||||||
| G. Total amount of changes recorded in the Income Statement and in the Comprehensive Income Statement (D+E+F) |
(2,655) | 21 | 3,016 | 80 | 463 | (1,580) | 49 | 1,191 | 19 | (321) |
| H. Other changes | 64 | (4) | 59 | (242) | (20) | (12) | (274) | |||
| I. Cash movements | 2,451 | (1,703) | 748 | 2,103 | (920) | 1,183 | ||||
| 1. Premiums received | 3,370 | 3,370 | 2,932 | 2,932 | ||||||
| 2. Payments associated with contract acquisition costs |
(918) | (918) | (829) | (829) | ||||||
| 3. Claims paid and other cash outflows | (1,703) | (1,703) | (920) | (920) | ||||||
| L. Net carrying amount as at 31 December (A.3+G+H+I) |
530 | 87 | 2,462 | 136 | 3,215 | 670 | 66 | 1,153 | 56 | 1,944 |
| M. Final carrying amount | ||||||||||
| 1. Insurance contracts issued that are liabilities |
543 | 87 | 2,460 | 136 | 3,226 | 696 | 66 | 1,152 | 56 | 1,969 |
| 2. Insurance contracts issued that are assets |
(13) | 2 | (12) | (26) | 1 | (25) | ||||
| 3. Net carrying amount as at 31 December |
530 | 87 | 2,462 | 136 | 3,215 | 670 | 66 | 1,153 | 56 | 1,944 |

Amounts in €m
| Features underlying the measurement of the book value of insurance contracts issued | ||||||||
|---|---|---|---|---|---|---|---|---|
| Items/Features underlying measurement | Present value of cash flows |
Adjustment for non financial risks |
Contractual service margin |
Total 31/12/2023 |
Present value of cash flows |
Adjustment for non financial risks |
Contractual service margin |
Total 31/12/2022 |
| 31/12/2023 | 31/12/2023 | 31/12/2023 | 31/12/2022 | 31/12/2022 | 31/12/2022 | |||
| A. Initial book value | ||||||||
| 1. Insurance contracts issued that are liabilities | 32,254 | 146 | 1,988 | 34,388 | 39,610 | 130 | 1,889 | 41,628 |
| 2. Insurance contracts issued that are assets | ||||||||
| 3. Net book value as at 1 January | 32,253 | 146 | 1,988 | 34,388 | 39,610 | 130 | 1,889 | 41,628 |
| B. Changes in current services | 9 | (13) | (174) | (178) | 10 | (11) | (171) | (173) |
| 1. Contractual service margin recorded in the income statement |
(174) | (174) | (171) | (171) | ||||
| 2. Change for non-financial risks past due | (13) | (13) | (11) | (11) | ||||
| 3. Changes related to experience | 9 | 9 | 10 | 10 | ||||
| C. Changes relating to future services | (171) | 18 | 154 | 2 | (296) | 28 | 271 | 2 |
| 1. Changes in the Contractual service margin | 20 | 5 | (25) | (214) | 19 | 196 | ||
| 2. Losses on groups of onerous contracts and related recoveries |
2 | 2 | 2 | 2 | ||||
| 3. Effects of the contracts initially recognised in the reference year |
(193) | 14 | 179 | (1) | (84) | 9 | 75 | |
| D. Changes relating to past services | 10 | 10 | ||||||
| 1. Adjustments to liabilities for claims incurred | 10 | 10 | ||||||
| E. Result of insurance services (B + C + D) | (152) | 5 | (19) | (166) | (286) | 17 | 99 | (170) |
| F. Financial costs/revenues | 3,083 | 3,083 | (7,231) | (7,231) | ||||
| 1. Relating to insurance contracts issued | 3,083 | 3,083 | (7,232) | (7,232) | ||||
| 1.1 Recorded in the Income Statement | 1,216 | 1,216 | 909 | 909 | ||||
| 1.2 Recorded in the Comprehensive Income Statement | 1,867 | 1,867 | (8,141) | (8,141) | ||||
| 2. Effects associated with changes in exchange rates | 1 | 1 | ||||||
| G. Total amount of changes recorded in the Income Statement and in the Comprehensive Income Statement (E + F) |
2,932 | 5 | (19) | 2,917 | (7,518) | 17 | 99 | (7,402) |
| H. Other changes | 35 | 35 | (18) | (18) | ||||
| I. Cash movements | 79 | 79 | 180 | 180 | ||||
| 1. Premiums received | 4,067 | 4,067 | 3,142 | 3,142 | ||||
| 2. Payments associated with contract acquisition costs | (67) | (67) | (56) | (56) | ||||
| 3. Claims paid and other cash outflows | (3,920) | (3,920) | (2,906) | (2,906) | ||||
| L. Net book value as at the reporting date (A.3 + G + H + I) | 35,299 | 151 | 1,968 | 37,419 | 32,253 | 146 | 1,988 | 34,388 |
| M. Final book value | ||||||||
| 1. Insurance contracts issued that are liabilities | 35,299 | 151 | 1,968 | 37,419 | 32,254 | 146 | 1,988 | 34,388 |
| 2. Insurance contracts issued that are assets | ||||||||
| 3. Net book value as at the reporting date | 35,299 | 151 | 1,968 | 37,419 | 32,253 | 146 | 1,988 | 34,388 |

Amounts in €m
| LIFE SEGMENT - Insurance contracts issued without direct participation features |
|---|
| Features underlying the measurement of the book value of insurance contracts issued | ||||||||
|---|---|---|---|---|---|---|---|---|
| Items/Features underlying measurement | Present value of cash flows |
Adjustment for non financial risks |
Contractual service margin |
Total 31/12/2023 |
Present value of cash flows |
Adjustment for non financial risks |
Contractual service margin |
Total 31/12/2022 |
| 31/12/2023 | 31/12/2023 | 31/12/2023 | 31/12/2022 | 31/12/2022 | 31/12/2022 | |||
| A. Initial book value | ||||||||
| 1. Insurance contracts issued that are liabilities | 21 | 2 | 117 | 141 | 22 | 4 | 96 | 121 |
| 2. Insurance contracts issued that are assets | (189) | 2 | 160 | (27) | (210) | 4 | 148 | (58) |
| 3. Net book value as at 1 January | (168) | 5 | 277 | 114 | (188) | 8 | 244 | 63 |
| B. Changes in current services | (6) | (1) | (59) | (66) | 7 | (1) | (51) | (45) |
| 1. Contractual service margin recorded in the income statement |
(59) | (59) | (51) | (51) | ||||
| 2. Change for non-financial risks past due | (1) | (1) | (1) | (1) | ||||
| 3. Changes related to experience | (6) | (6) | 7 | 7 | ||||
| C. Changes relating to future services | (108) | 2 | 106 | (83) | (2) | 86 | ||
| 1. Changes in the Contractual service margin | (39) | 2 | 37 | (10) | (3) | 13 | ||
| 2. Losses on groups of onerous contracts and related recoveries |
||||||||
| 3. Effects of the contracts initially recognised in the reference year |
(69) | 1 | 68 | (74) | 1 | 73 | ||
| D. Changes relating to past services | (14) | (14) | (12) | (12) | ||||
| 1. Adjustments to liabilities for claims incurred | (14) | (14) | (12) | (12) | ||||
| E. Result of insurance services (B + C + D) | (129) | 2 | 46 | (81) | (88) | (3) | 35 | (56) |
| F. Financial costs/revenues | (14) | 3 | (11) | 24 | (1) | 23 | ||
| 1. Relating to insurance contracts issued | (14) | 3 | (11) | 24 | (1) | 23 | ||
| 1.1 Recorded in the Income Statement | (2) | 3 | 1 | 1 | (1) | |||
| 1.2 Recorded in the Comprehensive Income Statement | (12) | (12) | 23 | 23 | ||||
| 2. Effects associated with changes in exchange rates | ||||||||
| G. Total amount of changes recorded in the Income Statement and in the Comprehensive Income Statement (E + F) |
(143) | 2 | 49 | (92) | (64) | (3) | 34 | (34) |
| H. Other changes I. Cash movements |
101 | 101 | 85 | 85 | ||||
| 1. Premiums received | 215 | 215 | 200 | 200 | ||||
| 2. Payments associated with contract acquisition costs | (52) | (52) | (53) | (53) | ||||
| 3. Claims paid and other cash outflows | (62) | (62) | (62) | (62) | ||||
| L. Net book value as at the reporting date (A.3 + G + H + I) |
(209) | 6 | 326 | 123 | (168) | 5 | 277 | 114 |
| M. Final book value | ||||||||
| 1. Insurance contracts issued that are liabilities | 64 | 4 | 105 | 173 | 21 | 2 | 117 | 141 |
| 2. Insurance contracts issued that are assets | (273) | 3 | 221 | (49) | (189) | 2 | 160 | (27) |
| 3. Net book value as at the reporting date | (209) | 6 | 326 | 123 | (168) | 5 | 277 | 114 |

Amounts in €m
| NON-LIFE MOTOR SEGMENT - Insurance contracts issued without direct participation features | ||
|---|---|---|
| -- | ------------------------------------------------------------------------------------------- | -- |
| Features underlying the measurement of the book value of insurance contracts issued | ||||||||
|---|---|---|---|---|---|---|---|---|
| Items/Features underlying measurement | Present value of cash flows |
Adjustment for non-financial risks |
Contractua l service margin |
Total 31/12/2023 |
Present value of cash flows |
Adjustment for non financial |
Contractual service margin |
Total 31/12/2022 |
| 31/12/2023 | 31/12/2023 | 31/12/2023 | 31/12/2022 | risks 31/12/2022 |
31/12/2022 | |||
| A. Initial book value | ||||||||
| 1. Insurance contracts issued that are liabilities | 3,012 | 338 | 144 | 3,494 | 5,233 | 524 | 275 | 6,031 |
| 2. Insurance contracts issued that are assets | ||||||||
| 3. Net book value as at 1 January | 3,012 | 338 | 144 | 3,494 | 5,233 | 524 | 275 | 6,031 |
| B. Changes in current services | 64 | (4) | (99) | (39) | 118 | (75) | (103) | (60) |
| 1. Contractual service margin recorded in the income statement |
(99) | (99) | (103) | (103) | ||||
| 2. Change for non-financial risks past due | (4) | (4) | (75) | (75) | ||||
| 3. Changes related to experience | 64 | 64 | 118 | 118 | ||||
| C. Changes relating to future services | (13) | 4 | 15 | 5 | 23 | 4 | (26) | 1 |
| 1. Changes in the Contractual service margin | (17) | 2 | 15 | 25 | 1 | (26) | ||
| 2. Losses on groups of onerous contracts and related recoveries |
5 | 5 | 1 | 1 | ||||
| 3. Effects of the contracts initially recognised in the reference year |
(1) | 2 | 1 | 1 | (2) | 3 | ||
| D. Changes relating to past services | (133) | (131) | (265) | (375) | (86) | (461) | ||
| 1. Adjustments to liabilities for claims incurred | (133) | (131) | (265) | (375) | (86) | (461) | ||
| E. Result of insurance services (B + C + D) | (83) | (131) | (84) | (298) | (234) | (157) | (129) | (520) |
| F. Financial costs/revenues | 104 | 13 | 118 | (260) | (29) | (1) | (290) | |
| 1. Relating to insurance contracts issued | 104 | 13 | 118 | (260) | (29) | (1) | (290) | |
| 1.1 Recorded in the Income Statement | 2 | 2 | (18) | (2) | (1) | (20) | ||
| 1.2 Recorded in the Comprehensive Income Statement | 103 | 13 | 116 | (242) | (27) | (269) | ||
| 2. Effects associated with changes in exchange rates | ||||||||
| G. Total amount of changes recorded in the Income Statement and in the Comprehensive Income Statement (E + F) |
21 | (118) | (83) | (180) | (494) | (185) | (130) | (810) |
| H. Other changes | 1 | |||||||
| I. Cash movements | (781) | (781) | (1,727) | (1,727) | ||||
| 1. Premiums received | 166 | 166 | 469 | 469 | ||||
| 2. Payments associated with contract acquisition costs | (36) | (36) | (69) | (69) | ||||
| 3. Claims paid and other cash outflows | (911) | (911) | (2,127) | (2,127) | ||||
| L. Net book value as at the reporting date (A.3 + G + H + I) |
2,252 | 221 | 61 | 2,533 | 3,012 | 338 | 144 | 3,494 |
| M. Final book value | ||||||||
| 1. Insurance contracts issued that are liabilities | 2,252 | 221 | 61 | 2,533 | 3,012 | 338 | 144 | 3,494 |
| 2. Insurance contracts issued that are assets | ||||||||
| 3. Net book value as at the reporting date | 2,252 | 221 | 61 | 2,533 | 3,012 | 338 | 144 | 3,494 |

Amounts in €m
| NON-LIFE NON-MV SEGMENT - Insurance contracts issued without direct participation features | |
|---|---|
| Features underlying the measurement of the book value of insurance contracts issued | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Items/Features underlying measurement | Present value of cash flows |
Adjustment for non financial risks |
Contractual service margin |
Total 31/12/2023 |
Present value of cash flows |
Adjustment for non financial risks |
Contractua l service margin |
Total 31/12/2022 |
|
| 31/12/2023 | 31/12/2023 | 31/12/2023 | 31/12/2022 | 31/12/2022 | 31/12/2022 | ||||
| A. Initial book value | |||||||||
| 1. Insurance contracts issued that are liabilities | 3,305 | 258 | 636 | 4,199 | 4,340 | 400 | 857 | 5,597 | |
| 2. Insurance contracts issued that are assets | (4) | 2 | (2) | ||||||
| 3. Net book value as at 1 January | 3,302 | 258 | 638 | 4,198 | 4,340 | 400 | 857 | 5,597 | |
| B. Changes in current services | 436 | (34) | (388) | 14 | 195 | (95) | (347) | (248) | |
| 1. Contractual service margin recorded in the income statement |
(388) | (388) | (347) | (347) | |||||
| 2. Change for non-financial risks past due | (34) | (34) | (95) | (95) | |||||
| 3. Changes related to experience | 436 | 436 | 195 | 195 | |||||
| C. Changes relating to future services | (267) | 29 | 251 | 13 | (190) | 38 | 171 | 20 | |
| 1. Changes in the Contractual service margin | (142) | 2 | 140 | (96) | 13 | 83 | |||
| 2. Losses on groups of onerous contracts and related recoveries |
(10) | (10) | (12) | (12) | |||||
| 3. Effects of the contracts initially recognised in the reference year |
(115) | 28 | 110 | 24 | (81) | 26 | 88 | 32 | |
| D. Changes relating to past services | (210) | (24) | (234) | (89) | (58) | (147) | |||
| 1. Adjustments to liabilities for claims incurred | (210) | (24) | (234) | (89) | (58) | (147) | |||
| E. Result of insurance services (B + C + D) | (41) | (29) | (137) | (207) | (84) | (115) | (176) | (375) | |
| F. Financial costs/revenues | 179 | 13 | 4 | 195 | (389) | (27) | (3) | (419) | |
| 1. Relating to insurance contracts issued | 179 | 13 | 4 | 195 | (389) | (27) | (3) | (419) | |
| 1.1 Recorded in the Income Statement | 9 | 1 | 4 | 14 | (17) | (1) | (3) | (21) | |
| 1.2 Recorded in the Comprehensive Income | 169 | 12 | 181 | (373) | (26) | (398) | |||
| Statement 2. Effects associated with changes in exchange rates |
|||||||||
| G. Total amount of changes recorded in the Income Statement and in the Comprehensive Income Statement (E + F) |
138 | (16) | (133) | (12) | (473) | (142) | (180) | (795) | |
| H. Other changes | (35) | 4 | (41) | (73) | (50) | (39) | (89) | ||
| I. Cash movements | (355) | (355) | (516) | (516) | |||||
| 1. Premiums received | 1,179 | 1,179 | 1,490 | 1,490 | |||||
| 2. Payments associated with contract acquisition costs |
(282) | (282) | (369) | (369) | |||||
| 3. Claims paid and other cash outflows | (1,252) | (1,252) | (1,637) | (1,637) | |||||
| L. Net book value as at the reporting date (A.3 + G + H + I) |
3,049 | 246 | 463 | 3,758 | 3,302 | 258 | 638 | 4,198 | |
| M. Final book value | |||||||||
| 1. Insurance contracts issued that are liabilities | 3,051 | 246 | 463 | 3,760 | 3,305 | 258 | 636 | 4,199 | |
| 2. Insurance contracts issued that are assets | (2) | (2) | (4) | 2 | (2) | ||||
| 3. Net book value as at the reporting date | 3,049 | 246 | 463 | 3,758 | 3,302 | 258 | 638 | 4,198 |

Amounts in €m
| 31/12/2023 | 31/12/2022 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| New contracts and contracts measured at the transition date with the full retrospective approach |
Contracts measured at the transition date with the modified retrospective approach |
Contracts measured at the transition date with the fair value approach |
Contracts subject to carve-out |
Total | New contracts and contracts measured at the transition date with the full retrospective approach |
Contracts measured at the transition date with the modified retrospective approach |
Contracts measured at the transition date with the fair value approach |
Contracts subject to carve-out |
Total | ||||
| Insurance revenue | 1 | 5 | 471 | 476 | 1 | 6 | 415 | 423 | |||||
| Contractual service margin - Opening balances |
1 | 1,987 | 1,988 | 1 | 1,888 | 1,889 | |||||||
| Changes relating to current services |
(174) | (174) | (171) | (171) | |||||||||
| Contractual service margin recognised in the income statement to reflect services provided |
(174) | (174) | (171) | (171) | |||||||||
| Changes relating to future services |
154 | 154 | 271 | 271 | |||||||||
| - Changes in estimates that adjust the contractual service margin |
(25) | (25) | 7 | 189 | 196 | ||||||||
| - Effects of contracts initially recognised in the reference year |
179 | 179 | (7) | 82 | 75 | ||||||||
| Finance income/expenses |
|||||||||||||
| 1. Relating to insurance contracts issued |
|||||||||||||
| 2. Effects associated with changes in exchange rates |
|||||||||||||
| 3. Total | |||||||||||||
| Total changes recognised in the Income Statement and in the Comprehensive Income Statement |
(19) | (19) | 100 | 99 | |||||||||
| Other movements | |||||||||||||
| Contractual service margin - Closing balances |
1,968 | 1,968 | 1 | 1,987 | 1,988 |

Amounts in €m
| 31/12/2023 | 31/12/2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| New contracts and contracts measured at the transition date with the full retrospective approach |
Contracts measured at the transition date with the modified retrospective approach |
Contracts measured at the transition date with the fair value approach |
Contracts subject to carve-out |
Total | New contracts and contracts measured at the transition date with the full retrospective approach |
Contracts measured at the transition date with the modified retrospective approach |
Contracts measured at the transition date with the fair value approach |
Contracts subject to carve-out |
Total | |
| Insurance revenue | 62 | 81 | 4 | 147 | 39 | 83 | 4 | 126 | ||
| Contractual service margin - Opening balances |
60 | 210 | 7 | 277 | 235 | 9 | 244 | |||
| Changes relating to current services |
(25) | (33) | (1) | (59) | (17) | (33) | (1) | (51) | ||
| Contractual service margin recognised in the income statement to reflect services provided |
(25) | (33) | (1) | (59) | (17) | (33) | (1) | (51) | ||
| Changes relating to future services |
93 | 15 | (2) | 106 | 77 | 9 | 86 | |||
| - Changes in estimates that adjust the contractual service margin |
25 | 15 | (2) | 37 | 4 | 9 | 13 | |||
| - Effects of contracts initially recognised in the reference year |
68 | 68 | 73 | 73 | ||||||
| Finance income/expenses |
||||||||||
| 1. Relating to insurance contracts issued |
3 | 3 | (1) | (1) | ||||||
| 2. Effects associated with changes in exchange rates |
||||||||||
| 3. Total | 3 | 3 | (1) | (1) | ||||||
| Total changes recognised in the Income Statement and in the Comprehensive Income Statement |
70 | (18) | (3) | 49 | 60 | (25) | (1) | 34 | ||
| Other movements | ||||||||||
| Contractual service margin - Closing balances |
130 | 192 | 4 | 326 | 60 | 210 | 7 | 277 |

NON-LIFE MOTOR SEGMENT - Insurance contracts issued without direct participation features
Amounts in €m
| 31/12/2023 | 31/12/2022 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| New contracts and contracts measured at the transition date with the full retrospective approach |
Contracts measured at the transition date with the modified retrospective approach |
Contracts measured at the transition date with the fair value approach |
Contracts subject to carve-out |
Total | New contracts and contracts measured at the transition date with the full retrospective approach |
Contracts measured at the transition date with the modified retrospective approach |
Contracts measured at the transition date with the fair value approach |
Contracts subject to carve-out |
Total | |||
| Insurance revenue | 3,968 | 59 | 142 | 4,170 | 1,934 | 221 | 1,706 | 3,861 | ||||
| Contractual service margin - Opening balances |
8 | 137 | 144 | 275 | 275 | |||||||
| Changes relating to current services |
(4) | (95) | (99) | (1) | (102) | (103) | ||||||
| Contractual service margin recognised in the income statement to reflect services provided |
(4) | (95) | (99) | (1) | (102) | (103) | ||||||
| Changes relating to future services |
3 | 12 | 15 | 8 | (35) | (26) | ||||||
| - Changes in estimates that adjust the contractual service margin |
2 | 12 | 15 | 8 | (35) | (26) | ||||||
| - Effects of contracts initially recognised in the reference year |
1 | 1 | ||||||||||
| Finance income/expenses |
||||||||||||
| 1. Relating to insurance contracts issued |
(1) | (1) | ||||||||||
| 2. Effects associated with changes in exchange rates |
||||||||||||
| 3. Total | (1) | (1) | ||||||||||
| Total changes recognised in the Income Statement and in the Comprehensive Income Statement |
(1) | (83) | (83) | 8 | (138) | (130) | ||||||
| Other movements | ||||||||||||
| Contractual service margin - Closing balances |
7 | 54 | 61 | 8 | 137 | 144 |

Amounts in €m
| 31/12/2023 | 31/12/2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| New contracts and contracts measured at the transition date with the full retrospective approach |
Contracts measured at the transition date with the modified retrospective approach |
Contracts measured at the transition date with the fair value approach |
Contracts subject to carve-out |
Total | New contracts and contracts measured at the transition date with the full retrospective approach |
Contracts measured at the transition date with the modified retrospective approach |
Contracts measured at the transition date with the fair value approach |
Contracts subject to carve-out |
Total | |
| Insurance revenue | 3,795 | 301 | 681 | 4,778 | 1,623 | 640 | 1,876 | 4,138 | ||
| Contractual service margin - Opening balances |
53 | 584 | 638 | 857 | 857 | |||||
| Changes relating to current services |
(66) | (322) | (388) | (19) | (328) | (347) | ||||
| Contractual service margin recognised in the income statement to reflect services provided |
(66) | (322) | (388) | (19) | (328) | (347) | ||||
| Changes relating to future services |
183 | 68 | 251 | 112 | 59 | 171 | ||||
| - Changes in estimates that adjust the contractual service margin |
73 | 68 | 140 | 25 | 59 | 83 | ||||
| - Effects of contracts initially recognised in the reference year |
110 | 110 | 88 | 88 | ||||||
| Finance income/expenses |
||||||||||
| 1. Relating to insurance contracts issued |
4 | 4 | (3) | (3) | ||||||
| 2. Effects associated with changes in exchange rates |
||||||||||
| 3. Total | 4 | 4 | (3) | (3) | ||||||
| Total changes recognised in the Income Statement and in the Comprehensive Income Statement |
121 | (255) | (133) | 93 | (272) | (180) | ||||
| Other movements | ||||||||||
| Contractual service margin - Closing balances |
133 | 330 | 463 | 53 | 584 | 638 | ||||

LIFE SEGMENT - Insurance contracts issued with direct participation features and Investment contracts issued with discretionary participation features
Amounts in €m
| Items/Groups of contracts | Originated contracts 31/12/2023 |
Contracts acquired in business combinations 31/12/2023 |
Contracts transferred from third parties 31/12/2023 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Onerous contracts |
Non-onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | |
| A. Estimate of the present value of future cash outflows | |||||||||
| 1. Contract acquisition costs | 39 | 40 | |||||||
| 2. Amount of claims and other directly attributable costs | 19 | 2,898 | 2,917 | ||||||
| 3. Total | 19 | 2,938 | 2,957 | ||||||
| B. Estimate of the present value of future cash inflows | 17 | 3,133 | 3,150 | ||||||
| C. Estimate of the net present value of future cash flows (A-B) | 2 | (196) | (193) | ||||||
| D. Estimate of adjustment for non-financial risks | (3) | 17 | 14 | ||||||
| E. Derecognition of previously recognised assets against cash flows associated with insurance contracts issued |
|||||||||
| F. Contractual service margin | 179 | 179 | |||||||
| G. Increase included in liability for insurance contracts issued during the year (C+D+E+F) |
(1) | (1) |
| Items/Groups of contracts | Originated contracts | Contracts acquired in business combinations |
Contracts transferred from third parties 31/12/2022 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Onerous contracts |
31/12/2022 Non-onerous contracts |
Total | Onerous contracts |
31/12/2022 Non onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | |
| A. Estimate of the present value of future cash outflows | |||||||||
| 1. Contract acquisition costs | 31 | 31 | |||||||
| 2. Amount of claims and other directly attributable costs | 30 | 2,130 | 2,160 | ||||||
| 3. Total | 31 | 2,161 | 2,191 | ||||||
| B. Estimate of the present value of future cash inflows | 31 | 2,245 | 2,276 | ||||||
| C. Estimate of the net present value of future cash flows (A-B) | (84) | (84) | |||||||
| D. Estimate of adjustment for non-financial risks | 9 | 9 | |||||||
| E. Derecognition of previously recognised assets against cash flows associated with insurance contracts issued |
|||||||||
| F. Contractual service margin | 75 | 75 | |||||||
| G. Increase included in liability for insurance contracts issued during the year (C+D+E+F) |

Amounts in €m
| Items/Groups of contracts | Originated contracts 31/12/2023 |
Contracts acquired in business combinations 31/12/2023 |
Contracts transferred from third parties 31/12/2023 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Onerous contracts |
Non-onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | |
| A. Estimate of the present value of future cash outflows | |||||||||
| 1. Contract acquisition costs | 42 | 42 | |||||||
| 2. Amount of claims and other directly attributable costs | 93 | 93 | |||||||
| 3. Total | 135 | 135 | |||||||
| B. Estimate of the present value of future cash inflows | 204 | 204 | |||||||
| C. Estimate of the net present value of future cash flows (A-B) | (69) | (69) | |||||||
| D. Estimate of adjustment for non-financial risks | 1 | 1 | |||||||
| E. Derecognition of previously recognised assets against cash flows associated with insurance contracts issued |
|||||||||
| F. Contractual service margin | 68 | 68 | |||||||
| G. Increase included in liability for insurance contracts issued during the year (C+D+E+F) |
| Items/Groups of contracts | Originated contracts 31/12/2022 |
Contracts acquired in business combinations 31/12/2022 |
Contracts transferred from third parties 31/12/2022 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Onerous contracts |
Non-onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | |
| A. Estimate of the present value of future cash outflows | |||||||||
| 1. Contract acquisition costs | 4 | 32 | 36 | ||||||
| 2. Amount of claims and other directly attributable costs | 22 | 76 | 98 | ||||||
| 3. Total | 26 | 108 | 134 | ||||||
| B. Estimate of the present value of future cash inflows | 26 | 181 | 207 | ||||||
| C. Estimate of the net present value of future cash flows (A-B) | (73) | (74) | |||||||
| D. Estimate of adjustment for non-financial risks | 1 | 1 | |||||||
| E. Derecognition of previously recognised assets against cash flows associated with insurance contracts issued |
|||||||||
| F. Contractual service margin | 73 | 73 | |||||||
| G. Increase included in liability for insurance contracts issued during the year (C+D+E+F) |

NON-LIFE MOTOR SEGMENT - Insurance contracts issued without direct participation features
Amounts in €m
| Items/Groups of contracts | Originated contracts 31/12/2023 |
Contracts acquired in business combinatio ns 31/12/2023 |
Contracts transferre d from third parties 31/12/2023 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Onerous contracts |
Non-onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | |
| A. Estimate of the present value of future cash outflows | |||||||||
| 1. Contract acquisition costs | 3 | 4 | 7 | ||||||
| 2. Amount of claims and other directly attributable costs | 15 | 10 | 26 | ||||||
| 3. Total | 19 | 14 | 32 | ||||||
| B. Estimate of the present value of future cash inflows | 19 | 15 | 34 | ||||||
| C. Estimate of the net present value of future cash flows (A-B) | (1) | (1) | |||||||
| D. Estimate of adjustment for non-financial risks | 1 | 1 | 2 | ||||||
| E. Derecognition of previously recognised assets against cash flows associated with insurance contracts issued |
|||||||||
| F. Contractual service margin | 1 | 1 | |||||||
| G. Increase included in liability for insurance contracts issued during the year (C+D+E+F) |
1 | 1 |
| Items/Groups of contracts | Originated contracts 31/12/2022 |
Contracts acquired in business combinatio 31/12/2022 |
Contracts transferred from third parties 31/12/2022 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Onerous contracts |
Non-onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | |
| A. Estimate of the present value of future cash outflows | |||||||||
| 1. Contract acquisition costs | 10 | 2 | 12 | ||||||
| 2. Amount of claims and other directly attributable costs | 40 | 7 | 47 | ||||||
| 3. Total | 50 | 9 | 59 | ||||||
| B. Estimate of the present value of future cash inflows | 51 | 10 | 61 | ||||||
| C. Estimate of the net present value of future cash flows (A-B) | (2) | (1) | (2) | ||||||
| D. Estimate of adjustment for non-financial risks | 2 | 1 | 3 | ||||||
| E. Derecognition of previously recognised assets against cash flows associated with insurance contracts issued |
|||||||||
| F. Contractual service margin | |||||||||
| G. Increase included in liability for insurance contracts issued during the year (C+D+E+F) |

Amounts in €m
| Items/Groups of contracts | Originated contracts | Contracts acquired in business combinations 31/12/2023 |
Contracts transferred from third parties 31/12/2023 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Onerous contracts |
Non-onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | |
| A. Estimate of the present value of future cash outflows | |||||||||
| 1. Contract acquisition costs | 63 | 170 | 233 | ||||||
| 2. Amount of claims and other directly attributable costs | 153 | 399 | 553 | ||||||
| 3. Total | 216 | 569 | 786 | ||||||
| B. Estimate of the present value of future cash inflows | 207 | 693 | 900 | ||||||
| C. Estimate of the net present value of future cash flows (A-B) | 9 | (124) | (115) | ||||||
| D. Estimate of adjustment for non-financial risks | 15 | 13 | 28 | ||||||
| E. Derecognition of previously recognised assets against cash flows associated with insurance contracts issued |
|||||||||
| F. Contractual service margin | 110 | 110 | |||||||
| G. Increase included in liability for insurance contracts issued during the year (C+D+E+F) |
24 | 24 |
| Items/Groups of contracts | Originated contracts | Contracts acquired in business combinations |
Contracts transferred from third parties | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 31/12/2022 | 31/12/2022 | ||||||||
| Onerous contracts |
Non-onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | Onerous contracts |
Non onerous contracts |
Total | |
| A. Estimate of the present value of future cash outflows | |||||||||
| 1. Contract acquisition costs | 69 | 141 | 210 | ||||||
| 2. Amount of claims and other directly attributable costs | 202 | 279 | 481 | ||||||
| 3. Total | 271 | 420 | 691 | ||||||
| B. Estimate of the present value of future cash inflows | 255 | 517 | 772 | ||||||
| C. Estimate of the net present value of future cash flows (A-B) | 16 | (97) | (81) | ||||||
| D. Estimate of adjustment for non-financial risks | 16 | 10 | 26 | ||||||
| E. Derecognition of previously recognised assets against cash flows associated with insurance contracts issued |
|||||||||
| F. Contractual service margin | 88 | 88 | |||||||
| G. Increase included in liability for insurance contracts issued during the year (C+D+E+F) |
32 | 32 |

| Amounts in €m | ||||
|---|---|---|---|---|
| 0-3 years | 4-6 years | >6 years | Total | |
| Life Segment | 597 | 459 | 1,239 | 2,295 |
| 0-3 years | 4-10 years | >10 years | Total | |
| Non-Life Segment | 492 | 27 | 5 | 524 |

Amounts in €m
| Claims/Time bands | Year T-9 Year T-8 Year T-7 | Year T-6 Year T-5 Year T-4 Year T-3 Year T-2 | Year T-1 | Year T | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| A. Cumulative claims paid and other directly attributable costs paid | |||||||||||
| 1 At the end of the year of occurrence | 2,318 | 1,996 | 2,077 | 2,242 | 2,261 | 2,405 | 1,944 | 2,144 | 2,340 | 2,689 | |
| 2. One year later | 4,034 | 3,497 | 3,602 | 3,876 | 3,963 | 4,163 | 3,332 | 3,715 | 3,962 | ||
| 3. Two years later | 4,613 | 3,977 | 4,122 | 4,399 | 4,524 | 4,682 | 3,721 | 4,222 | |||
| 4. Three years later | 4,864 | 4,198 | 4,364 | 4,619 | 4,758 | 4,905 | 3,882 | ||||
| 5. Four years later | 5,022 | 4,324 | 4,485 | 4,741 | 4,878 | 5,042 | |||||
| 6. Five years later | 5,127 | 4,404 | 4,564 | 4,823 | 4,970 | ||||||
| 7. Six years later | 5,198 | 4,464 | 4,626 | 4,877 | |||||||
| 8. Seven years later | 5,252 | 4,502 | 4,664 | ||||||||
| 9. Eight years later | 5,284 | 4,532 | |||||||||
| 10. Nine years later | 5,310 | ||||||||||
| Total cumulative claims paid and other directly attributable costs paid (Total A) |
5,310 | 4,532 | 4,664 | 4,877 | 4,970 | 5,042 | 3,882 | 4,222 | 3,962 | 2,689 | 44,149 |
| B. Estimate of the ultimate cost of cumulative claims (amount gross of reinsurance and not discounted) |
|||||||||||
| 1 At the end of the year of occurrence | 5,718 | 6,932 | |||||||||
| 2. One year later | 5,239 | 5,652 | |||||||||
| 3. Two years later | 4,644 | 5,195 | |||||||||
| 4. Three years later | 5,597 | 4,591 | |||||||||
| 5. Four years later | 5,413 | 5,542 | |||||||||
| 6. Five years later | 5,198 | 5,370 | |||||||||
| 7. Six years later | 4,921 | 5,157 | |||||||||
| 8. Seven years later | 4,704 | 4,889 | |||||||||
| 9. Eight years later | 5,485 | 4,684 | |||||||||
| 10. Nine years later | 5,473 | ||||||||||
| Estimate of the ultimate cost of gross cumulative claims not discounted at the reporting date (Total B) |
5,473 | 4,684 | 4,889 | 5,157 | 5,370 | 5,542 | 4,591 | 5,195 | 5,652 | 6,932 | 53,484 |
| C. Liabilities for claims incurred, gross not discounted - year of occurrence from T to T-9 (Total B – Total A) |
163 | 152 | 225 | 280 | 400 | 500 | 709 | 973 | 1,690 | 4,243 | 9,335 |
| D. Liabilities for claims incurred, gross not discounted - years prior to T-9 | 1,483 | ||||||||||
| E. Discounting effect | (706) | ||||||||||
| F. Effect of adjustment for non-financial risks | 811 | ||||||||||
| G. Liabilities for claims incurred gross of insurance contracts issued | 10,923 |

Amounts in €m
UnipolSai Assicurazioni 2023 Consolidated Financial Statements
| Claims/Time bands | Year T-9 Year T-8 Year T-7 | Year T-6 Year T-5 Year T-4 Year T-3 Year T-2 | Year T-1 | Year T | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| A. Cumulative claims paid and other directly attributable costs paid net of reinsurance |
|||||||||||
| 1 At the end of the year of occurrence | 2,274 | 1,961 | 2,045 | 2,159 | 2,208 | 2,310 | 1,914 | 2,111 | 2,310 | 2,602 | |
| 2. One year later | 3,914 | 3,451 | 3,497 | 3,719 | 3,814 | 3,934 | 3,228 | 3,634 | 3,867 | ||
| 3. Two years later | 4,460 | 3,922 | 4,000 | 4,184 | 4,297 | 4,423 | 3,585 | 4,086 | |||
| 4. Three years later | 4,736 | 4,133 | 4,236 | 4,398 | 4,517 | 4,635 | 3,737 | ||||
| 5. Four years later | 4,890 | 4,252 | 4,353 | 4,511 | 4,629 | 4,753 | |||||
| 6. Five years later | 4,991 | 4,327 | 4,428 | 4,591 | 4,717 | ||||||
| 7. Six years later | 5,059 | 4,384 | 4,489 | 4,641 | |||||||
| 8. Seven years later | 5,109 | 4,421 | 4,525 | ||||||||
| 9. Eight years later | 5,140 | 4,451 | |||||||||
| 10. Nine years later | 5,165 | ||||||||||
| Total cumulative claims paid and other directly attributable costs paid net of reinsurance (Total A) |
5,165 | 4,451 | 4,525 | 4,641 | 4,717 | 4,753 | 3,737 | 4,086 | 3,867 | 2,602 | 42,545 |
| B. Estimate of the ultimate cost of cumulative claims (amount net of reinsurance and not discounted) |
|||||||||||
| 1 At the end of the year of occurrence | 5,511 | 6,271 | |||||||||
| 2. One year later | 5,066 | 5,457 | |||||||||
| 3. Two years later | 4,470 | 5,011 | |||||||||
| 4. Three years later | 5,283 | 4,407 | |||||||||
| 5. Four years later | 5,124 | 5,223 | |||||||||
| 6. Five years later | 4,947 | 5,086 | |||||||||
| 7. Six years later | 4,767 | 4,903 | |||||||||
| 8. Seven years later | 4,615 | 4,730 | |||||||||
| 9. Eight years later | 5,331 | 4,590 | |||||||||
| 10. Nine years later | 5,321 | ||||||||||
| Estimate of the ultimate cost of net cumulative claims not discounted at the reporting date (Total B) |
5,321 | 4,590 | 4,730 | 4,903 | 5,086 | 5,223 | 4,407 | 5,011 | 5,457 | 6,271 | 51,000 |
| C. Liabilities for claims incurred, net not discounted - year of occurrence from T to T-9 (Total B – Total A) |
156 | 139 | 205 | 261 | 370 | 470 | 670 | 925 | 1,590 | 3,669 | 8,456 |
| D. Liabilities for claims incurred, net not discounted - years prior to T-9 | 1,402 | ||||||||||
| E. Discounting effect | (653) | ||||||||||
| F. Effect of adjustment for non-financial risks | 781 | ||||||||||
| G. Liabilities for claims incurred net of insurance contracts issued | 9,985 |
It should be noted that the amount reported under item G Liabilities for claims incurred, net of insurance contracts issued, does not include, for an amount of €134 million, the deposits received for reinsurance transfers.
It is also specified that the extrapolation of judgments of adequacy or inadequacy of the reserves, from the results of the following table, must be done with the utmost caution, in particular with reference to their use as input for actuarial models such as the Chain Ladder.

Financial liabilities, at 31 December 2023, were €13,571m (€10,894m at 31/12/2022).
| Amounts in €m | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial liabilities held-for trading | Financial liabilities at fair value | Total | ||||||||||
| Items/Values | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | ||||||
| Book value |
% Comp | Book value |
% Comp | Book value | % Comp | Book value |
% Comp | Book value |
% Comp | Book value |
% Comp | |
| Liabilities from financial contracts issued in accordance with IFRS 9: |
10,412 | 100.0 | 8,568 | 100.0 | 10,412 | 99.1 | 8,568 | 98.2 | ||||
| a) From contracts with services linked to indexes |
10,361 | 99.5 | 4,184 | 48.8 | 10,361 | 98.6 | 4,184 | 48.0 | ||||
| and UCITS units b) Pension fund |
51 | 0.5 | 4,384 | 51.2 | 51 | 0.5 | 4,384 | 50.3 | ||||
| c) Other financial contracts issued |
||||||||||||
| Non-hedging derivatives | 9 | 9.0 | 3 | 1.7 | 9 | 0.1 | 3 | 0.0 | ||||
| Hedging derivatives | 86 | 91.0 | 152 | 98.3 | 86 | 0.8 | 152 | 1.7 | ||||
| Other financial liabilities | ||||||||||||
| Total | 95 | 100.0 | 155 | 100.0 | 10,412 | 100.0 | 8,568 | 100.0 | 10,507 | 100.0 | 8,723 | 100.0 |
.
Please refer to the comments on asset item 4.5.
Financial liabilities at amortised cost: product breakdown, percentage composition and fair value hierarchy
| Amounts in €m L2 L3 |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Items/Values | 31/12/2022 | ||||||||||||||
| Book value |
% Comp | L1 | L2 | L3 | Total Fair |
Book value |
% Comp | L1 | Total Fair |
||||||
| Liabilities | Value | Value | |||||||||||||
| Equity instruments | |||||||||||||||
| Subordinated liabilities | 1,287 | 42.0 | 1,284 | 1,284 | 1,367 | 63.0 | 1,260 | 81 | 1,341 | ||||||
| Debt securities issued | 5 | 0.2 | 5 | 5 | |||||||||||
| Other loans obtained | 1,772 | 57.8 | 1,772 | 1,772 | 804 | 37.0 | 804 | 804 | |||||||
| a) from banks | 261 | 8.5 | 196 | 9.0 | |||||||||||
| b) from customers | 1,511 | 49.3 | 608 | 28.0 | |||||||||||
| Total | 3,064 | 100.0 | 1,284 | 1,777 | 3,060 | 2,171 | 100.0 | 1,260 | 885 | 2,145 |

| Issuer | Nominal amount outstanding |
Subord. level |
Year of maturity |
call | Rate | L/NL |
|---|---|---|---|---|---|---|
| UnipolSai | €750.0m | tier I | in perpetuity | every 3 months from 18/06/2024 |
fixed rate 5,75% (*) | Q |
| UnipolSai | €500.0m | tier II | 2028 | fixed rate 3,875% | Q |
(*) from June 2024 floating rate of 3M Euribor + 518 b.p.
The subordinated liabilities issued by UnipolSai Assicurazioni SpA amounted to €1,287m and relate for €1,250m to hybrid bonds.
Other loans, amounting to €1,772m (€804m at 31/12/2022), mainly referred to:
The item also includes the financial liabilities deriving from the present value of future lease payments due on lease agreements accounted for on the basis of IFRS 16 for a total of €137m.
| Amounts in €m | |||
|---|---|---|---|
| 31/12/2023 | 31/12/2022 | % var. | |
| Payables to intermediaries and companies | 207 | 195 | 6.5 |
| Policyholders' tax due | 159 | 168 | (5.4) |
| Sundry tax payables | 49 | 42 | 18.5 |
| Trade payables | 553 | 463 | 19.4 |
| Post-employment benefits | 41 | 46 | (11.1) |
| Social security charges payable | 42 | 44 | (3.1) |
| Sundry payables | 222 | 397 | (44.1) |
| Total payables | 1,273 | 1,353 | (5.9) |
..
| Amounts in €m | |||
|---|---|---|---|
| 31/12/2023 | 31/12/2022 | % var. | |
| Current tax liabilities | 16 | 12 | 33.3 |
| Deferred tax liabilities | 89 | 376 | (76.3) |
| Liabilities associated with disposal groups held for sale | 360 | (100.0) | |
| Accrued expense and deferred income | 60 | 63 | (4.4) |
| Other liabilities | 1,086 | 983 | 10.5 |
| Total other liabilities | 1,251 | 1,794 | (30.3) |
The item Deferred tax liabilities is shown net of the offsetting carried out, pursuant to IAS 12, with the corresponding taxes (IRES or IRAP) recorded in Deferred tax assets.

Comments and further information on the items in the income statement and the variations that took place compared with the previous year are given below (the numbering of the notes relates to the mandatory layout for the preparation of the income statement).
| Amounts in €m | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Basis A1 | Basis A2 |
Basis A3 |
Basis A4 |
Total | Basis A1 | Basis A2 | Basis A3 | Basis A4 | Total | ||
| Items/Business combination basis | 31/12/2023 | 31/12/2023 | 31/12/2023 | 31/12/2023 | 31/12/2023 | 31/12/2022 | 31/12/2022 | 31/12/2022 | 31/12/2022 | 31/12/2022 | |
| A. Insurance revenues from insurance contracts issued, valued on the basis of GMM and VFA |
|||||||||||
| A.1 Amounts associated with changes in liabilities for residual coverage |
467 | 136 | 167 | 962 | 1,732 | 418 | 121 | 1,650 | 1,789 | 3,978 | |
| 1. Claims incurred and other costs for expected insurance services |
280 | 76 | 64 | 540 | 960 | 236 | 69 | 1,472 | 1,347 | 3,123 | |
| 2. Changes in the adjustment for non-financial risks | 13 | 1 | 4 | 34 | 52 | 11 | 1 | 75 | 95 | 182 | |
| 3. Contractual service margin recorded in the income statement for services provided |
174 | 59 | 99 | 388 | 720 | 171 | 51 | 103 | 347 | 673 | |
| 4. Other amounts | |||||||||||
| A.2 Acquisition costs of recovered insurance contracts |
9 | 10 | 12 | 183 | 215 | 5 | 5 | 61 | 244 | 315 | |
| A.3 Total insurance revenues from insurance contracts issued, valued on the basis of GMM and |
476 | 147 | 179 | 1,145 | 1,947 | 423 | 126 | 1,711 | 2,033 | 4,293 | |
| VFA A.4 Total insurance revenues from insurance contracts issued valued on the basis of PAA |
7,624 | 4,256 | |||||||||
| Life segment | |||||||||||
| Non-life segment - Motor | 3,991 | 2,150 | |||||||||
| Non-life segment - Non-MV | 3,632 | 2,106 | |||||||||
| A.5 Total insurance revenues from insurance contracts issued |
476 | 147 | 179 | 1,145 | 9,571 | 423 | 126 | 1,711 | 2,033 | 8,549 | |
| B. Costs for insurance services from insurance contracts issued under GMM and VFA |
|||||||||||
| 1. Claims incurred and other directly attributable costs |
(295) | (60) | (911) | (1,252) | (2,519) | (246) | (61) | (2,127) | (1,637) | (4,072) | |
| 2. Changes in liability for claims incurred | 5 | 1,048 | 510 | 1,563 | 1 | (3) | 998 | 243 | 1,239 | ||
| 3. Losses on onerous contracts and recovery of these losses |
(2) | (5) | (13) | (20) | (2) | (1) | (20) | (23) | |||
| 4. Amortisation of insurance contract acquisition costs |
(13) | (10) | (12) | (183) | (219) | (5) | (5) | (61) | (244) | (315) | |
| 5. Other amounts | |||||||||||
| B.6 Total costs for insurance services from insurance contracts issued under GMM and VFA |
(310) | (66) | 119 | (938) | (1,195) | (252) | (69) | (1,191) | (1,658) | (3,171) | |
| B.7 Total insurance costs from insurance contracts issued, valued on the basis of PAA |
(8,210) | (4,136) | |||||||||
| - Life segment | (1) | ||||||||||
| - Non-life segment - Motor | (4,147) | (2,321) | |||||||||
| - Non-life segment - Non-MV | (4,063) | (1,815) | |||||||||
| C. Total net costs/revenues from insurance contracts issued |
166 | 81 | 298 | 207 | 166 | 170 | 56 | 520 | 375 | 1,242 |
Insurance revenue and costs from insurance contracts issued – Breakdown
Basis of aggregation 1 = Insurance contracts issued with direct participation features and investment contracts issued with discretionary participation features - Life segment Basis of aggregation 2 = Insurance contracts issued without direct participation features - Life segment
Basis of aggregation 3 = Insurance contracts issued without direct participation features - Non-Life MV segment
Basis of aggregation 4 = Insurance contracts issued without direct participation features - Non-Life Non-MV segment
.

| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| Items/Business combination basis | Basis A1 | Basis A2 | Total | Basis A1 | Basis A2 | Total |
| 31/12/2023 31/12/2023 31/12/2023 | 31/12/2022 | 31/12/2022 | 31/12/2022 | |||
| A. Allocation of premiums paid relating to reinsurance transfers valued on the basis of GMM |
(88) | (88) | (53) | (53) | ||
| A.1 Amounts associated with changes in assets by residual coverage | (88) | (88) | (53) | (53) | ||
| 1. Amount of claims and other expected recoverable costs | (20) | (20) | (30) | (30) | ||
| 2. Changes in the adjustment for non-financial risks | (1) | (1) | (1) | (1) | ||
| 3. Contractual service margin recorded in the income statement for services received |
(67) | (67) | (21) | (21) | ||
| 4. Other amounts | ||||||
| A.2 Other directly attributable costs specific to reinsurance transfers |
||||||
| A.3 Allocation of premiums paid relating to reinsurance transfers valued on the basis of PAA |
(20) | (288) | (308) | (20) | (286) | (306) |
| B. Total reinsurance transfers costs (A.1 + A.2 + A.3) | (20) | (377) | (396) | (20) | (338) | (358) |
| C. Effects of changes in the risk of default by reinsurers | (2) | (2) | ||||
| D. Amount of claims and other expenses recovered | 13 | 255 | 267 | 13 | 148 | 161 |
| E. Changes in assets due to claims incurred | 1 | 371 | 372 | 30 | 31 | |
| F. Other recoveries | (1) | (1) | ||||
| G. Total net costs/revenues from reinsurance (B + C + D + E + F) | (6) | 247 | 240 | (7) | (162) | (168) |
| Basis A.1 = Life segment |
Basis A.2 = Non-Life segment
| Amounts in €m | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | |||||||||||||||||
| Costs/Business combination basis |
Basis A1 – with DFP |
Basis A2 – without DFP |
Basis A1 + Basis A2 |
Basis A3 |
Basis A4 |
Basis A3 + Basis A4 |
Other | Basis A1 – with DFP |
Basis A2 – without DFP |
Basis A1 + Basis A2 |
Basis A3 | Basis A4 | Basis A3 + Basis A4 |
Other | ||||
| Costs attributed to the acquisition of insurance contracts |
(13) | (10) | (24) | (716) | (1,161) | (1,877) | (5) | (5) | (10) | (431) | (771) | (1,202) | ||||||
| Other directly attributable costs |
(297) | (55) | (352) | (3,312) | (3,840) | (7,152) | (248) | (65) | (313) | (3,081) | (2,701) | (5,783) | ||||||
| Investment management expenses |
(6) | (47) | (22) | (15) | (49) | (27) | ||||||||||||
| Other costs | (81) | (571) | (291) | (186) | (846) | (182) | ||||||||||||
| Total | (310) | (66) | (463) | (4,028) | (5,001) | (9,647) | (312) | (252) | (70) | (523) | (3,512) | (3,473) | (7,880) | (209) |
Basis A1 – with DPF = Insurance contracts issued with direct participation features – Life segment Basis A2 – without DPF = Insurance contracts issued without direct participation features – Life segment
Basis A1 + Basis A2 = Life segment
Basis A3 = Insurance contracts issued without direct participation features – Non-Life segment – MV
Basis A4 = Insurance contracts issued without direct participation features – Non-Life segment – Non-MV
Basis A3 + Basis A4 = Non-Life segment

| Amounts in €m | |||||
|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | % var. | |||
| Net gains/losses:: | |||||
| on other financial assets mandatorily at fair value | 428 | (361) | n.s. | ||
| on financial assets/liabilities at fair value through profit or loss | 32 | 42 | (23.9) | ||
| Total net gains/losses | 460 | (318) | n.s. |
At 31 December 2023, they amounted to €38m (€15m at 31/12/2022).
| Amounts in €m | ||||
|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | % var. | ||
| Interests | ||||
| on financial assets at amotised cost | 148 | 72 | 106.1 | |
| on financial assets at fair value through OCI | 1,285 | 1,329 | (3.3) | |
| Other income | ||||
| from investment property | 123 | 107 | 15.6 | |
| from financial assets at fair value through OCI | 103 | 85 | 21.0 | |
| Realised gains | ||||
| on investment property | 15 | 2 | n.s. | |
| on financial assets at amortised cost | (83.1) | |||
| on financial assets at fair value through OCI | 56 | 293 | (80.8) | |
| on financial liabilities at amortised cost | ||||
| Unrealised gains and reversals of impairment losses | ||||
| on financial assets at fair value through OCI | 29 | 5 | 508.4 | |
| on other financial liabilities | 1 | 2 | (26.8) | |
| Total | 1,762 | 1,896 | (7.1) |

| Amounts in €m 31/12/2023 31/12/2022 (126) (51) (2) (2) (1) (69) (70) (48) |
|||
|---|---|---|---|
| % var. | |||
| Interests: | |||
| on other financial liabilities | (76) | 66.4 | |
| Other charges: | |||
| from investment property | (29) | 73.0 | |
| from financial assets at amortised cost | (99.3) | ||
| from financial assets at fair value through OCI | (1) | 123.2 | |
| from other financial liabilities | (2) | 34.5 | |
| Realised losses: | |||
| on investment property | (6) | (88.0) | |
| on financial assets at fair value through OCI | (301) | (77.3) | |
| Unrealised losses and impairment losses: | |||
| on investment property | (76) | (8.8) | |
| on financial assets at fair value through OCI | (302) | (84.2) | |
| on other financial assets | (7) | (10) | (25.8) |
| on other financial liabilities | (4) | (3) | 58.5 |
| Total | (379) | (806) | (53.0) |
The Unrealised losses and impairment losses relating to investment property refer to depreciation for €52m and impairment for €15m (at 31/12/2022, they referred to depreciation for €51m and impairment for €23m).
| Amounts in €m | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Value adjustments | Write-backs | ||||||||
| First stage | Of which assets with low credit risk |
Second stage | Third stage | First stage | Of which assets with low credit risk |
Second stage | Third stage | ||
| Government bonds | (1) | (1) | 7 | 7 | |||||
| Other debt securities | (10) | (8) | (1) | (7) | 7 | 4 | 2 | ||
| Loans and receivables | (4) | (7) | 1 | 3 | |||||
| - banks | |||||||||
| - customers | (4) | (7) | 1 | 3 | |||||
| Total 31/12/2023 | (15) | (9) | (1) | (14) | 15 | 10 | 2 | 3 | |
| Total 31/12/2022 | (42) | (30) | (10) | (8) | 6 | 6 | 5 |
The item includes net expenses of €1,286m (-€838m at 31/12/2022) and relate:

| Net finance expenses and income relating to insurance contracts issued | |
|---|---|
| ------------------------------------------------------------------------ | -- |
| Amounts in €m | ||||||||
|---|---|---|---|---|---|---|---|---|
| Basis A1 | Basis A2 | Basis A3 | Total | Basis A1 | Basis A2 | Basis A3 | Total | |
| Items/Basis of aggregation | 31/12/2023 | 31/12/2023 31/12/2023 31/12/2023 31/12/2022 | 31/12/2022 | 31/12/2022 | 31/12/2022 | |||
| 1. Interest accrued | 26 | (1) | (101) | (76) | 45 | 45 | ||
| 2. Effects of changes in interest rates and other financial assumptions |
||||||||
| 3. Changes in the fair value of assets underlying contracts measured under the VFA |
(1,216) | (1,216) | (909) | (909) | ||||
| 4. Effects of the change in exchange rates | 4 | 4 | (1) | 26 | 26 | |||
| 5. Other | 1 | 2 | 1 | 1 | ||||
| 6. Total net finance income/expenses relating to insurance contracts issued, recognised in the income statement |
(1,190) | (1) | (96) | (1,286) | (910) | 72 | (838) |
Basis A1 = Insurance contracts issued with direct participation features – Life segment - VFA
Basis A2 = Insurance contracts issued without direct participation features – Life segment - BBA
Basis A3 = Insurance contracts issued without direct participation features – Non-Life segment – BBA/PAA
As mentioned previously, the Group has adopted options that make it possible to limit accounting mismatches deriving from the method of valuation of assets and liabilities subject to IFRS 17 and/or IFRS 9. As a result, in addition to net finance expenses and income relating to insurance contracts issued and recognised in the income statement shown in the table above, net expenses of €1,526m were recognised in the statement of comprehensive income.
Net finance expenses relating to reinsurance contracts held came to €3m (net expenses of €2m at 31/12/2022).
| Amounts in €m | |||||||
|---|---|---|---|---|---|---|---|
| Items/Basis of aggregation | Basis A1 | Basis A2 | Total | Basis A1 | Basis A2 | Total | |
| 31/12/2023 | 31/12/2023 | 31/12/2023 | 31/12/2022 | 31/12/2022 | 31/12/2022 | ||
| 1. Interest accrued | 4 | 4 | (2) | (2) | |||
| 2. Effects of changes in interest rates and other financial assumptions |
|||||||
| 3. Effects of the change in exchange rates | (3) | (3) | 2 | 2 | |||
| 4. Other | (1) | (3) | (3) | (1) | (2) | ||
| 5. Total net finance income/expenses relating to reinsurance contracts held |
(1) | (2) | (3) | (1) | (2) |
Basis A1 = Life segment Basis A2 = Non-Life segment
As mentioned previously, the Group has adopted options that make it possible to limit accounting mismatches deriving from the method of valuation of assets and liabilities subject to IFRS 17 and/or IFRS 9. As a result, in addition to net finance income and expenses relating to reinsurance contracts held and recognised in the income statement shown in the table above, net income of €14m was recognised in the statement of comprehensive income.

| Amounts in €m | ||||||||
|---|---|---|---|---|---|---|---|---|
| Life segment | Non-Life segment |
Total | Life segment | Non-Life segment |
Total | |||
| Items\Operating segments | 31/12/2023 | Of which DPF |
31/12/2023 | 31/12/2023 | 31/12/2022 | Of which DPF |
31/12/2022 | 31/12/2022 |
| A. FINANCIAL RESULT OF INVESTMENTS |
3,890 | 3,057 | 1,265 | 8,212 | (8,262) | (7,234) | (1,332) | (16,828) |
| A.1 Interest income from financial assets at amortised cost and at fair value through other comprehensive income |
1,032 | 970 | 397 | 2,398 | 1,062 | 1,012 | 338 | 2,412 |
| A.2 Net gains/losses on assets at fair value through profit or loss |
828 | 174 | 246 | 1,248 | (1,194) | (260) | 9 | (1,444) |
| A.3 Net value adjustments/write-backs for credit risk |
(3) | 4 | (6) | (5) | (26) | (25) | (19) | (70) |
| A.4 Other net income/costs | 34 | 42 | (42) | 34 | 184 | 180 | (412) | (49) |
| A.5 Net capital gains/losses on financial assets at fair value through other comprehensive income |
1,999 | 1,867 | 670 | 4,536 | (8,289) | (8,141) | (1,247) | (17,677) |
| B NET CHANGE IN INVESTMENT CONTRACTS ISSUED IFRS 9 |
(614) | (614) | 866 | 866 | ||||
| C. NET FINANCIAL RESULT - OTHER | 3,276 | 3,057 | 1,265 | 7,597 | (7,396) | (7,234) | (1,332) | (15,962) |
| of which: recognised in the Income Statement |
1,277 | 1,190 | 594 | 3,061 | 893 | 907 | (84) | 1,715 |
| of which: recognised in the Comprehensive Income Statement |
1,999 | 1,867 | 670 | 4,536 | (8,289) | (8,141) | (1,247) | (17,677) |
| Amounts in €m | |||||||
|---|---|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | ||||||
| Summary of results/Operating segments | Life segment |
Non-Life segment |
Total | Life segment |
Non-Life segment |
Total | |
| A. Financial results | 203 | 840 | 1,043 | (8,183) | (1,318) | (9,500) | |
| A.1 Amounts recognised in the Income Statement | 86 | 497 | 582 | (18) | (14) | (31) | |
| 1. Total net financial result of investments | 1,277 | 594 | 1,871 | 893 | (84) | 808 | |
| 2. Net finance income/expenses relating to insurance contracts | (1,191) | (97) | (1,289) | (910) | 71 | (840) | |
| 3. Total | 86 | 497 | 582 | (18) | (14) | (31) | |
| A2. Amounts recognised in the Comprehensive Income Statement |
117 | 343 | 461 | (8,165) | (1,304) | (9,469) | |
| 1. Total net financial result of investments | 1,999 | 670 | 2,669 | (8,289) | (1,247) | (9,536) | |
| 2. Net finance income/expenses relating to insurance contracts | (1,881) | (327) | (2,208) | 123 | (57) | 67 | |
| 3. Total | 117 | 343 | 461 | (8,165) | (1,304) | (9,469) | |
| B. Net insurance and financial result | 610 | 1,592 | 2,202 | (6,721) | (584) | (7,305) | |
| 1. Net insurance service result | 407 | 752 | 1,159 | 1,461 | 734 | 2,195 | |
| 2. Total net financial result of investments | 3,276 | 1,265 | 4,540 | (7,396) | (1,332) | (8,728) | |
| 3. Net financial result of insurance contracts | (3,073) | (424) | (3,497) | (787) | 14 | (773) | |
| 4. Total | 610 | 1,592 | 2,202 | (6,721) | (584) | (7,305) |

The breakdown of the fair value of the net assets underlying insurance contracts with direct participation features and investment contracts with discretionary participation features is provided below.
| Amounts in €m | |||||
|---|---|---|---|---|---|
| Category | 31/12/2023 | 31/12/2022 | |||
| Government bonds | 21,048 | 19,804 | |||
| Corporate bonds | 10,051 | 8,578 | |||
| Equity instruments | 145 | 164 | |||
| Investment funds/UCITS | 2,547 | 2,393 | |||
| Property | 1,213 | 1,205 | |||
| Structured bonds | 77 | 73 | |||
| Cash and cash equivalents | 184 | 165 | |||
| Tax receivables | 894 | 577 | |||
| Derivatives | (65) | (129) | |||
| TOTAL | 36,092 | 32,829 |
| Amounts in €m | ||||
|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | % var. | ||
| Exchange rate differences | (10) | (4) | 136.7 | |
| Extraordinary gains | 18 | 16 | 13.2 | |
| Other income | 1,522 | 1,091 | 39.5 | |
| Other costs | (471) | (626) | (24.8) | |
| Total Other revenue/costs | 1,059 | 476 | 122.4 |
These amounted to €520m (€436m at 31/12/2022), of which €74m relating to investment management expenses (€91m at 31/12/2022) and €446m relating to other administrative expenses not included in the calculation of insurance liabilities and assets and not allocated to insurance contract acquisition costs and investment management expenses (€345m at 31/12/2022).
These amounted to €375m (€282m at 31/12/2022) and mainly relate to depreciation of property, plant and equipment.
These amounted to €133m (€97m at 31/12/2022) and relate to amortisation of intangible assets.

In accordance with the provisions of IAS 12 the following table shows, at consolidated level, the deferred taxes utilised and accrued.
| Amounts in €m | |||||||
|---|---|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | ||||||
| Ires | Irap | Total | Ires | Irap | Total | ||
| Current taxes | 194 | 39 | 233 | 69 | 21 | 90 | |
| Deferred assets and liabilities: | 12 | 9 | 20 | 110 | 27 | 136 | |
| Use of deferred tax assets | 175 | 21 | 195 | 127 | 14 | 141 | |
| Use of deferred tax liabilities | (14) | (14) | (41) | (7) | (48) | ||
| Provisions for deferred tax assets | (276) | (48) | (324) | (136) | (24) | (160) | |
| Provisions for deferred tax liabilities | 127 | 36 | 163 | 159 | 44 | 203 | |
| Total | 205 | 48 | 253 | 178 | 48 | 226 |
Against pre-tax profit of €1,019m, taxes for the period of €253m were recorded. The overall tax rate was 24.8% (32.7% at 31/12/2022).
The actual tax rate for the year was affected by the following:

The following statement illustrates the breakdown of deferred tax assets and liabilities recognised, with separate indication of offsetting performed for adjusted financial statements presentation purposes.
| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| 31/12/2023 | ||||||
| Total | Ires/Corp. tax | Irap | Total | Ires/Corp. tax | Irap | |
| DEFERRED TAX ASSETS | ||||||
| Intangible assets and property, plant and equipment |
284 | 246 | 38 | 298 | 254 | 44 |
| Insurance Assets | 403 | 348 | 56 | 433 | 364 | 69 |
| Investment property | 72 | 63 | 10 | 73 | 63 | 10 |
| Financial instruments | 353 | 280 | 74 | 888 | 697 | 191 |
| Sundry receivables and other assets | 54 | 47 | 6 | 81 | 73 | 8 |
| Provisions | 242 | 213 | 29 | 257 | 226 | 31 |
| Insurance liabilities | 43 | 39 | 4 | 47 | 47 | 1 |
| Financial liabilities | 7 | 4 | 2 | |||
| Payables and other liabilities | 14 | 14 | 9 | 9 | 1 | |
| Other deferred tax assets | 26 | 22 | 4 | 26 | 26 | 1 |
| Netting as required by IAS 12 | (1,084) | (915) | (169) | (1,263) | (993) | (270) |
| Total deferred tax assets | 408 | 357 | 51 | 856 | 768 | 88 |
| DEFERRED TAX LIABILITIES | ||||||
| Intangible assets and property, plant and equipment |
(111) | (93) | (18) | 135 | 113 | 23 |
| Insurance Assets | ||||||
| Investment property | (16) | (13) | (3) | 9 | 5 | 3 |
| Financial instruments | (253) | (198) | (55) | 118 | 96 | 23 |
| Sundry receivables and other assets | 1 | 1 | ||||
| Provisions | (18) | (14) | (4) | 18 | 14 | 4 |
| Insurance liabilities | (754) | (585) | (169) | 1,348 | 1,049 | 299 |
| Financial liabilities | (1) | (1) | 4 | 2 | 2 | |
| Payables and other liabilities | (3) | (3) | 2 | 2 | ||
| Other deferred tax liabilities | (17) | (10) | (8) | 6 | 5 | 1 |
| Netting as required by IAS 12 | (1,263) | (993) | (270) | |||
| Total deferred tax liabilities | (1,173) | (915) | (258) | 377 | 293 | 84 |
Net tax assets are deemed to be recoverable on the basis of the provisional plans of Group companies.
In application of Regulation (EU) 2023/2468 with which the European Commission implemented the IASB amendments to IAS 12, including the introduction of a temporary exception to the recognition of deferred taxes in relation to the application of Pillar Two provisions, note the following.
Italian Legislative Decree no. 209 of 27 December 2023, implementing the reform on international taxation, envisaged the introduction for Italy of a global minimum tax regime from 1 January 2024.
Title II of the aforementioned Legislative Decree contains provisions for the implementation of Law no. 111 of 9 August 2023, transposing Council Directive (EU) no. 2022/2523 of 14 December 2022, aimed at ensuring a global minimum level of taxation for large multinational enterprise groups and large-scale domestic groups in the European Union.
The aforementioned Directive transposes the main core of the global Pillar Two agreement reached at the OECD/G20. To this end, a coordinated system of rules has been devised to ensure that large groups of companies are subject to a minimum tax level of at least 15% in relation to each of the countries in which these groups operate and generate income.

The objective of the Global Minimum Tax is to achieve a level of competitive parity between companies at global level, stop the race to the bottom of tax rates and promote efficient decisions on investments and business locations. In order to guarantee a minimum tax level for multinational or domestic enterprise groups based on the OECD common approach taken up by the EU, Art. 9, paragraph 1, of Italian Legislative Decree no. 209/2023 states that the minimum tax level can be achieved through the application of a top-up tax (TUT) if the effective tax rate (ETR) in each jurisdiction is below 15%. The top-up tax will be collected through:
The entry into force of the GloBE rules will have a substantial impact on business groups, mitigated by the transitional safe harbours (or "Simplified schemes" in the definition of Art. 39 of the Legislative Decree) introduced by the OECD to exclude certain jurisdictions in which a group operates from the scope of application of the GloBE rules. In this regard, two types of safe harbour can be identified:
From a taxpayer perspective, pursuant to Art. 10 of the Legislative Decree, the Unipol Group is subject to provisions relating to the Global Minimum Tax since its consolidated revenues have exceeded €750m in at least two of the four years prior to the year under review.
As the regulation was not in force at the reporting date, no current taxes were recognised.
Outside Italy, in 2023 the Unipol Group operated in Serbia, Ireland, the Netherlands and Luxembourg.
For EU countries, the Group entities will be subject to the Qualified Domestic Minimum Top-Up Tax (QDMTT), unless the aforementioned transitional safe harbour rules apply. In this case, no top-up tax will be payable by the Group in the countries concerned.
Art. 56 of the Legislative Decree4 also envisages the elimination of top-up taxes in the first five years of business start-up of a multinational group (to be verified on the basis of the group's international projection level and the value of fixed assets). At present, the actual scope of application of the aforementioned provision has yet to be clarified.
Taking into account information known or that can be reasonably estimated at year end - although such information has thus far not reflected all the specific provisions of the Pillar II legislation related to the location and operations of all the Group companies in all the individual jurisdictions in which the Group operates - and considering that at year end certain information was not yet known or could not be reasonably estimated, the Unipol Group's Pillar II income tax exposure at year end, also on the basis of the simplified system (the transitional safe harbour from country-bycountry reporting), was considered immaterial.
In particular, on the basis of information already known or that can be reasonably estimated:
With the support of external consultants, the Group is organising and preparing for the Pillar II-related obligations, also in order to manage the exposure in subsequent periods, through the creation of suitable systems and procedures to:
4 "Reference country" means the country in which the companies of the multinational group have the highest total value of tangible assets in the year in which the multinational group falls within the scope of this Title for the first time. The total value of tangible assets in a country corresponds to the sum of the net carrying amounts of all tangible assets of all companies in the multinational group that are located in that country.

• identify, locate and characterise all Group companies, also on a continuous basis, for the purpose of Pillar II legislation, and

In order to allow an evaluation of the actual or potential effects of netting agreements on the UnipolSai Group, the information relating to the financial instruments involved in master netting arrangements is reported below, which at 31 December 2023 consisted exclusively of derivative instruments.
With reference to derivatives, the ISDA Master agreements which regulate transactions in such instruments, make provision, in the cases of the insolvency of one of the contractual parties, for the offsetting between receivables and payables including any cash deposits or financial instruments pledged as guarantee.
| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| Type | Gross amount |
Total financial liabilities offset in the financial |
Net total financial assets recognised in the financial statements |
Related amounts not subject to offsetting in the financial statements |
Net total | |
| (A) | statements (B) |
(C)= (A) - (B) | Financial instruments (D) |
Cash deposits received as guarantees (E) |
(F)=(C )-(D)-(E) | |
| Derivative transactions (1) |
104 | 104 | 83 | 21 | ||
| Repurchase agreements (2) |
||||||
| Securities lending | ||||||
| Other | ||||||
| Total | 104 | 104 | 83 | 21 |
| Amounts in €m | ||||||
|---|---|---|---|---|---|---|
| Gross Total financial amount assets offset Type in the financial statements (B) (A) |
Net total financial liabilities recogni sed in the financial statements |
Related amounts not subject to offsetting in the financial statements |
Net total | |||
| (C)= (A) - (B) | Financial instruments (D) |
Cash deposits given as guarantees (E) |
(F)=(C )-(D)-(E) | |||
| Derivative transactions (1) |
110 | 110 | 24 | 79 | 6 | |
| Repurchase agreements (2) |
||||||
| Securities lending | ||||||
| Other | ||||||
| Total | 110 | 110 | 24 | 79 | 6 |
(1) The amounts indicated include the fair value in the financial statements of the derivatives involved in the offsetting agreements and any cash deposits given or received as guarantee.
(2) The amounts indicated include the financial receivable/payable relating to the repurchase agreement and the value of the financial asset involved in the forward purchase.

| Amounts in €m | ||
|---|---|---|
| Amounts in €m | 31/12/2023 | 31/12/2022 |
| Profit/loss allocated to ordinary shares (€m) | 676 | 394 |
| Weighted average of shares outstanding during the year (no./m) | 2,828 | 2,827 |
| Basic and diluted earnings (loss) per share (€ per share) | 0.24 | 0.14 |
.
The UnipolSai SpA Shareholders' Meeting held on 27 April 2023, in view of the positive financial result at 31 December 2022 amounting to €145m (as shown in the financial statements drawn up in accordance with national accounting standards), resolved, taking into account treasury shares held, to distribute dividends for a total of approximately €453m, corresponding to € 0.19 per share.
The Shareholders' Meeting also set the dividend payment date for 24 May 2023 (ex-dividend date 22/5/2023 and record date 23/5/2023).
At 31 December 2023, reclassifications carried out in application of IFRS 5 to Asset item 6.1 amounted to €133m, of which €83m related to properties held for sale and €50m relating to the equity investment in Cronos Vita Assicurazioni (€514m at 31/12/2022, of which €100m related to properties held for sale and €415m relating to assets held by the company Incontra Assicurazioni, sold during the current year); liabilities reclassified to item 6.1 Liabilities associated with disposal groups held for sale were eliminated following the disposal of the investment in Incontra Assicurazioni (€360m at 31/12/2022, referring entirely to Incontra Assicurazioni).
Note that the sale of the investment in Incontra Assicurazioni was finalised on 30 November 2023: the contribution to the 2023 economic result amounted to €48m including consolidation of the investee's profit for the period and the economic effects of the sale (realised capital gain and reversal of OCI reserves existing at the date of sale).

UnipolSai Assicurazioni provides the following services to companies of the Group:
Finance;
Innovation;
UniSalute provides the following services:
The services provided by UniSalute to its subsidiary UniSalute Servizi mainly concerned the following areas:
SIAT performs the following services in favour of UnipolSai:

UnipolService provides car repair services for certain Group companies, while UnipolGlass provides glass repair services.
UnipolSai Servizi Previdenziali performs administrative management of open pension funds on behalf of a number of Group companies.
UnipolRe DAC, merged into UnipolSai at 31 December 2023, carried out administrative and accounting services for inwards and outwards reinsurance with reference to treaties in run-off on behalf of UnipolSai.
UnipolSai Investimenti SGR administered, on behalf of UnipolSai, the units of real estate funds owned by UnipolSai. However, this service is no longer provided from 1 April 2023 as the activity was insourced to UnipolSai and, consequently, the contract with the asset management company was terminated.
UnipolTech guarantees competitiveness to the Group insurance companies through continuous technological innovation and the evolution of ITC and mobile payment services. In particular:
The Company has developed products and services that are offered through the UnipolSai agency network, the UnipolSai multi-channel system and on the free market such as:
To supplement the electronic toll service, it continues to support UnipolSai in the development of mobile payment solutions to offer customers an integrated model of distinctive services, complementary to the insurance business. The first services available on the UnipolSai and UnipolMove Apps offer the opportunity to pay car parking fees, "blue line" parking slips, for access to certain Limited Traffic Zones (such as Milan Area C), fines and road tax, as well as fuel. From 2023, it also joined the MaaS (Mobility as a Service) NRRP calls for proposals and offers integrated payment services for micro-mobility and public transport, complementary to cars, in the cities of Rome and Milan.
Leithà designs, develops and provides to Group companies services, applications, data-intensive components and innovative, high-tech tools based primarily on Artificial Intelligence, Machine Learning, Process Automation and Computer Vision solutions. It also studies and analyses data in support of the development of new insurance solutions (both in actuarial and product application distribution terms), processes and business development. This includes the necessary preparatory and instrumental activities for the implementation of commissioned research projects and the development of operating system software, operating systems, applications and database management concerning and functional to such projects.
The main project areas covered include:

UnipolAssistance provides the following services for the Companies of the Consortium and to non-insurance third parties:
• organisation, provision and 24/7 management of services provided by the Class 18 assistance insurance coverage, by taking the action requested and managing relations with professionals and independent suppliers to which the material execution of the action is assigned, also including settlement of the related remuneration. Analogous activities are also provided to Consortium members not in the insurance business.
As part of the Tourism claims management solely for consortium members carrying out insurance activities, in addition to the provision of normal Assistance services, at the request of an individual consortium member UnipolAssistance can advance medical expense payments on behalf of that member.
Arca Vita provides the following services to its subsidiaries:
An agreement with Arca Vita International is also in place regarding the licence for use of the "Arca Vita International" trademark owned by Arca Vita.
Arca Inlinea provides sales support services to Arca Assicurazioni, Arca Vita and Arca Vita International and call centre services in favour of UniSalute.
Arca Sistemi provides the following services primarily in favour of the Companies participating in the consortium:
In addition, Arca Sistemi provides IT services to UniSalute.
Arca Direct Assicurazioni has insurance brokerage agreements in place with Arca Vita, Arca Assicurazioni and UnipolSai.
UnipolRental provides medium/long-term vehicle rental services to Group companies.
Cambiomarcia provides services and a digital platform dedicated to the sale of ex-rental vehicles of UnipolRental on the B2C channel (Business to Consumer) and provides electric bicycles to several Group companies.
UnipolHome provides repair services to UnipolSai for insurance products that include this solution.
Welbee designs, develops and provides welfare plans for UnipolSai employees, made available through a digital platform, which focus primarily on flexible benefits in the welfare and health sectors.

Tantosvago provides Welbee with content services and corporate welfare experiences; in addition, the company designs, develops and provides incentive, loyalty and prize competition programmes for UnipolSai.
UniSalute Servizi provides remote assistance services on behalf of UniSalute.
Moreover, it is noted that the Group companies conduct the following regular transactions with each other:
There is also a partnership agreement between UnipolSai and UnipolTech with the aim of strengthening their reciprocal positions in the reference markets: in this sense, the agreement calls for advertising on the UnipolSai website and App, and in particular through the agency network as well, the services offered by UnipolTech.
No atypical or unusual transactions were carried out in the execution of these services.
Fees are mainly calculated on the basis of the external costs incurred, for example the costs of products and services acquired from suppliers, and the costs resulting from activities carried out directly, i.e. generated by their own staff, and taking account of:
The following elements are specifically taken into consideration:
As regards services rendered by Leithà, the consideration was determined to the extent equal to costs, as previously defined, to which a mark-up was applied, which is the operating margin for the service rendered.
The costs for financing activities are calculated by applying a fee on managed volumes. The services provided by UniSalute (except for operating services provided to UniSalute Servizi for which the costs are split), UniSalute Servizi, UnipolService, UnipolSai Investimenti SGR and UnipolRe involve fixed prices.
Unipol, UnipolSai, Arca Vita and Arca Assicurazioni, second their staff to other Group companies to optimise the synergies within the Group.
It should be noted that, in accordance with Art. 2497 et seq. of the Italian Civil Code, none of the shareholders of the Parent Unipol exercises management and coordination activities over the Company.
The Parent Unipol exercised the Group tax consolidation option governed by Title II, Chapter II, Section II of Italian Presidential Decree 917/86 (the Consolidated Income Tax Act, Articles 117 et seq.) as consolidating entity, jointly with the companies belonging to the Unipol Group meeting the established regulatory requirements over time. The option has a three-year duration and is renewed automatically unless cancelled.
Unipol Gruppo and the subsidiaries for which there are economic, financial and organisational restrictions established by regulations in force exercised the joint option of establishment of the Unipol VAT Group pursuant to Arts. 70-bis et seq. of Italian Presidential Decree no. 633/1972 and Ministerial Decree of 6 April 2018. Initially valid for the three-year period 2019-2021, the option renews each year until cancelled.
_____________________________________________________________________________________________________________________________________________________________________________

The following table shows transactions with related parties (holding company, associates and others) carried out during 2023, as laid down in IAS 24 and in Consob Communication DEM/6064293/2006. It should be noted that the application scope of the Procedure for related party transactions, adopted pursuant to Consob Regulation no. 17221 of 12 March 2010, as amended, also includes some counterparties that are included, on a voluntary basis, pursuant to Art. 4 thereof.
Transactions with subsidiaries have not been recognised since in drawing up the Consolidated Financial Statements transactions among Group companies consolidated using the line-by-line method have been eliminated as part of the normal consolidation process.
| Information on transactions with related parties | Amounts in €m | ||||
|---|---|---|---|---|---|
| Holding company |
Associates and Others |
Total | % inc. (1) | % inc. (2) | |
| Financial assets at amortised cost | 293 | 25 | 318 | 0.4 | 12.6 |
| Financial assets at fair value through OCI | 84 | 84 | 0.1 | 3.3 | |
| Other financial assets | 126 | 74 | 200 | 0.3 | 7.9 |
| Other assets | 13 | 13 | 0.0 | 0.5 | |
| Cash and cash equivalents | 851 | 851 | 1.2 | 33.7 | |
| TOTAL ASSETS | 418 | 1,045 | 1,463 | 2.0 | 57.9 |
| Financial liabilities at amortised cost | 476 | 113 | 589 | 0.8 | 23.3 |
| Payables | 115 | 103 | 218 | 0.3 | 8.6 |
| Other liabilities | 11 | 6 | 17 | 0.0 | 0.7 |
| TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES | 602 | 226 | 828 | 1.1 | 32.8 |
| Insurance service expenses from insurance contracts issued | (16) | (136) | (152) | (17.4) | (6.0) |
| Interest income calculated with the effective interest method | 10 | 3 | 13 | 1.5 | 0.5 |
| Interest expense | (17) | (3) | (20) | (2.3) | (0.8) |
| Other income/Charges | 1 | 11 | 12 | 1.4 | 0.5 |
| Other revenue/costs | 7 | 39 | 46 | 5.3 | 1.8 |
| Operating expenses: | (2) | (11) | (13) | (1.5) | (0.5) |
(1) Percentage based on total assets in the consolidated statement of financial position recognised under shareholders' equity, and on pre-tax profit/(loss) for income statement items.
(2) Percentage on total net cash flow from operating activities mentioned in the statement of cash flows.
The item Financial assets at amortised cost from the holding company relates to the receivable due to some subsidiaries from the holding company Unipol as part of the centralised cash pooling agreement, for the purpose of centralising at Unipol the management of the available funds of the non-insurance companies of the Unipol Group.
Financial assets at amortised cost with associates and others included €11m of time deposits above 15 days held by the companies of the Group with BPER Banca, €8m relating to receivables from insurance brokerage agencies for agents' reimbursements and €6m of interest-free loans disbursed by UnipolSai to the associate Borsetto.
Available-for-sale financial assets and Financial assets at fair value through other comprehensive income from associates and others relate to the subscription of listed debt securities issued by BPER Banca and Banca Popolare di Sondrio subscribed by Group companies.
Other financial assets from the holding company comprised amounts related to the tax consolidation and for services rendered.
The item Other financial assets from associates and others mainly included €42m in receivables from insurance brokerage agencies for commissions and €23m in receivables from Finitalia for premiums it had advanced for the service concerning the split payment of policies.
Other assets included current accounts, temporarily unavailable, that UnipolSai has opened with BPER Banca.
Cash and cash equivalents included the balances of current accounts opened by Group companies with BPER Banca and Banca Popolare di Sondrio.
The item Financial liabilities at amortised cost to the holding company included the loan of €450m granted by Unipol to UnipolRental as part of the acquisition and merger by incorporation of Sifà in addition to the payable of some subsidiaries to Unipol Gruppo as part of the above-mentioned cash pooling agreement.
The item Financial liabilities at amortised cost to associates and others related to loans and mortgages disbursed by BPER Banca and Banca Popolare di Sondrio to Group companies.

Payables comprised: as for relations with the holding company, the payable for IRES of the companies participating in the tax consolidation and the payable for Unipol staff seconded to Group companies; as regards relations with associates and others, payables for commissions to be paid to BPER Banca for the placement of insurance products in addition to payables for other services rendered.
Other liabilities to the holding company essentially referred to the liabilities of the Incentive Plans for Unipol Executives seconded to UnipolSai; Other liabilities to associates and others referred to invoices to be received.
Insurance service expenses from insurance contracts issued included costs for commissions paid to insurance brokerage agencies (€106m) and commissions paid to BPER Banca for the placement of insurance policies issued by Group companies (€25m).
Interest income and expense from the holding company referred to the above-mentioned centralised cash pooling agreement; interest income from associates and others related to interest on securities issued by BPER Banca and subscribed by Group companies.
The item Other revenue/costs includes interest income accrued on current accounts opened by Group companies with BPER Banca and Banca Popolare di Sondrio.
Operating expenses include the costs of managing banking relations with BPER Banca.
Please also note that the contributions payable by the Unipol Group companies paid in the course of 2023 to Unipol Group employee and executive pension funds amounted to €26m.
Remuneration for 2023 due to the Directors, Statutory Auditors and Key Managers of UnipolSai for carrying out their duties within the Company and in other consolidated companies amounted to €17.0m, details of which are as follows:
| Amounts in €m | |
|---|---|
| Directors and General Manager | 4.2 |
| Statutory Auditors | 0.4 |
| Other Key Managers (*) | 12.4 |
(*) The amount mainly comprises compensation of employees and it includes the amount paid to Unipol Gruppo as consideration for the secondment of some Key Managers.
The remuneration of the General Manager and the Key Managers relating to benefits granted under the Share-based compensation plans (performance shares), is duly represented in the Remuneration Report, prepared according to Art. 123-ter of the Consolidated Law on Finance and made available, pursuant to current regulations, on the Company website.
In 2023 the companies in the Group paid Unipol and UnipolSai the sum of €1.9m as remuneration for the activities carried out by the Chairman, the Chief Executive Officer, the General Manager and the Key Managers, eliminated during the consolidation process.

With reference to the regulation on the transparency of public funds introduced by Art. 1, paragraphs 125 and 125-bis of Italian Law 124/2017 and subsequent amendments and supplements, note that the Group collected the following contributions and subsidies subject to the mandatory disclosure in the notes to the financial statements pursuant to the above-cited regulation:
| Amounts in €m | ||||
|---|---|---|---|---|
| Recipient | Name of disbursing party | Amount collected (€) | Reason | |
| Tenute del Cerro SpA | ARTEA | 58,559 | Contributions to the Tuscany Region vineyard restructuring |
|
| Tenute del Cerro SpA | AGEA | 40,713 | Contributions to the Umbria Region vineyard restructuring |
|
| Tenute del Cerro SpA | ARTEA | 60,049 | Contributions to Tuscany Region Rural Development Plan |
|
| Tenute del Cerro SpA | AGEA | 193,828 | Contributions to Umbria Region Rural Development Plan |
|
| Tenute del Cerro SpA | INVITALIA | 1,536,000 | Contributions to Agro-industrial Development Contracts |
|
| Tenute del Cerro SpA | ARTEA | 299,077 | Contributions to Community Agricultural Policy 2022/2023 |
|
| Tenute del Cerro SpA | AGEA | 53,001 | Contribution to promotional expenses incurred in foreign countries |
|
| Tenute del Cerro SpA | AGEA | 16,927 | Individual Insurance Plan Contribution |
|
| Tenute del Cerro SpA | RETE OMEGA | 27,045 | Contributions to Umbria Region Rural Development Plan |
For the sake of comprehensiveness, although such grants are excluded from the transparency obligations established in the regulations cited, any Aid measures and the relative individual Aid granted and recorded in the system by the Granting Authorities directly or indirectly benefitting each of the Group companies are published in the National Register of State Aid, open to the public for consultation on the relative website in the transparency section.
The Unipol Group pays variable benefits (long-term incentives) to the General Manager, Key Managers and other senior executives under closed three-year, share-based compensation plans by which Unipol and UnipolSai shares (performance shares) are granted if specific targets of profitability, creation of value for shareholders and ESG sustainability are achieved.
The 2019-2021 Performance share-based compensation plans, if the prerequisites were met, envisaged for shortterm incentives the assignment of UnipolSai and Unipol shares in the year following the year of accrual. With regard to long-term incentives, if the prerequisites were met, it envisaged the assignment of UnipolSai and Unipol shares in at least three annual tranches starting from 2023.
The 2022-2024 Performance share-based compensation plans, if the prerequisites are met, envisages the assignment of the same shares in at least three annual tranches with effect from 2026.
On 2 January 2023, 1,417,994 UnipolSai shares and 783,877 Unipol shares were granted to eligible executives as a longterm incentive for the 2019-21 financial year.
In addition, on 31 May 2023, 3,671 UnipolSai shares and 1,876 Unipol shares were granted to eligible executives, as a short-term incentive for the years 2020 and 2022.
The Information Documents, prepared pursuant to Art. 114-bis of the Consolidated Law on Finance and Art. 84-bis of Consob Issuer's Regulation no. 11971/1999, are available on the respective websites, in the Governance/Shareholders meetings section.

As part of the 2022-2024 Business Plan implementation activities, on 18 October 2022 and 25 October 2022 trade union agreements were signed (for the companies UnipolSai Assicurazioni SpA, UniSalute SpA, Arca Assicurazioni SpA and Siat Assicurazioni SpA) which - as concerns voluntary pre-retirement arrangements for employees meeting pension requirements by the end of 2027 - are divided into three types:
In this regard, note that the mutually agreed termination of employment relationships of the above-mentioned employees took place with access to the extraordinary benefits of the Solidarity Fund as of:
Therefore, a total of 912 employees were involved in the mutually agreed termination of their employment relationship.
The trade union agreement in question envisaged the early termination of 800 employees (in addition to a higher number of participants up to a maximum 10% more than the number indicated), and therefore the objectives of the Business Plan were achieved with regard to this action considered strategic in terms of generational renewal and cost reduction.
In addition, in December 2022, a trade union agreement was signed on pre-retirement arrangements for executive personnel who will meet pension requirements due to either the number of years of contributions or old age by 31 December 2027. This agreement refers to the provisions of the system governed by Art. 4, paragraphs 1 to 7-ter, of Law no. 92 of 28 June 2012 ("Fornero" law), as amended by Art. 34, paragraph 54, of Law no. 221 of 17 December 2012 and Art. 1, paragraph 160, of Law no. 205 of 27 December 2017.
Senior executives who intend to participate in the plan, subject to mutually agreed termination of the employment relationship, will be paid the "isopensione", i.e. an allowance equal to the pension accrued at the time of termination, until the disbursement of the pension benefit. Payments of the relative contribution also continue until the first pension requirement is met.
To date, 9 UnipolSai executives and 1 UNA Group executive have subscribed to the plan.
In terms of policies and plans, the Group Supplementary Corporate Agreement of 8 June 2021 expired on 31 December 2021 and has not experienced any regulatory or economic modifications in the meantime.
The Academy adopts a development and training strategy based on three main dimensions: Business, to support reorganisations and projects, Culture, to promote digital transformation and People, to support key talents and skills, addressing issues such as development of the managerial model, generational turnover and the enhancement of potential. This strategy is integrated with a vertical approach focused on the specific skills and abilities of the various company professionals.
In parallel, training courses dedicated to the key insurance business occupations are provided to strengthen and enhance current skills and capabilities with the emerging skills of the future, with methods alternating between theory and case studies, on the job training and project work.
Overall, the training offer included the delivery of more than 1,000 courses, involving network employees and collaborators.

Among the initiatives for employees, the professional development programme continued for a group of Officers and Middle Managers, with the aim of strengthening skills and ensuring managerial continuity within the Group. This is a rolling programme that is divided into two distinct paths, one for Mid-Term successors and the other for Potential to be developed in the medium-long term.
In line with the "Tech & People Evolution" strand of the 2022-2024 Business Plan, a procedure was launched to disseminate digital culture by engaging and involving employees as digital transformation accelerators and strengthening an approach based on new skills and digital methods.
After initial assessment, the programme included other initiatives such as newsletters personalised by profile, oneto-one interviews and focus groups and a training course dedicated to Digital Champions as promoters of digital change.
Training activities continued throughout the year on technical, technological, commercial and managerial aspects as well as on mandatory and regulatory courses. In particular, basic and refresher training courses on safety continue and it is worth noting the resumption of courses and practical tests for jobs with medium-high risks. With a view to the evolution of operating models, specialised IT courses are offered that support the goal of digital transformation, such as "Business Continuity Management System", "IFRS17 and IFRS9", "Actuarial Technique and Risk Management", "Machine Learning" and "Sustainable Real Estate Framework".
Lastly, the online course "EticaMente!" continued to be offered, which makes it possible to reflect on situations that could arise in the company in which it is essential to act ethically.
In line with employee training, Sales Network training activities were based on training projects that included managerial development with specialised courses such as IMA5, or with programmes aimed at "generational turnover in the Agency" and training for the new position of "Omnichannel Contact Person".
In addition to training projects, the hybrid courses aimed at the network include "Focus Impresa" for the distribution of the new product aimed at Small and Medium-sized Enterprises. The training involved asynchronous activities aimed at the networks and synchronous activities for colleagues in the Sales Department.
Amongst the online courses aimed at the network, the "Code of Ethics and Charter of Values: updates" is particularly significant, which makes it possible to engage in various situations in which it is essential to act in an ethical manner.
There are no significant non-recurring events or transactions to be reported during the year aside from those reported among the main events of the period.
In 2023 there were no atypical and/or unusual transactions that, because of their significance, importance, nature of the counterparties involved in the transaction, transfer pricing procedures, or occurrence close to the end of the year, could give rise to doubts relating to: the accuracy and completeness of the information in these Consolidated Financial Statements, a conflict of interest, the safeguarding of the company's assets or the protection of noncontrolling shareholders.
As in previous years, in accordance with IAS 36.10, which provides for the Impairment of Intangible Assets that have an indefinite useful life, the impairment test was carried out on the goodwill recognised in the consolidated financial statements with reference to the UnipolSai Consolidated Financial Statements.
In determining the parameters used for the assessments, the criteria adopted were aligned with market practice, taking as a reference, for these and for the economic/financial projections, expected developments in the reference economic scenario and the influence of the effect of climate change, albeit with the uncertainty characterising developments and considering that the effects will likely be appreciable, especially in the long term. In particular, the following should be noted: (i) the increase in the discount rate compared to the previous year, following the trends recorded in 2023 in the various components that lead to its determination and (ii) the increase of the g-rate, taking into account updated macroeconomic scenario estimates, as well as the estimated impact of climate factors.

With respect to this scenario, appropriate Sensitivity Analyses were also developed to test the stability of the recoverable amount of goodwill if there was a variation in the main parameters used in the tests.
During the year, some operations were completed, resulting in the recognition of goodwill: please refer to the "Information about business combinations" section for a description of the individual operations.
The CGU structure did not change compared to the previous year. Consequently, the CGUs to which the residual goodwill was allocated, impairment tested at 31 December 2023, were:
With regard to the valuation methods adopted for estimating the recoverable amount of goodwill, please note that, following the introduction of the accounting standard IFRS 17, which is more oriented towards the estimate of balance sheet items based on prospective flows, in consideration of the availability of economic-financial projections also for the Life segment, it was deemed appropriate to adopt a methodology of the Dividend Discount Model (DDM) type in the "excess capital" version also to verify the recoverability of the goodwill allocated to the Life CGU, similarly to what was done for the Non-Life CGU, rather than use the Appraisal Value methodology adopted last year. In relation to the parameters used, an update was carried out at the end of 2023.
The impairment testing of the Non-Life CGU was performed measuring the recoverable amount of UnipolSai Assicurazioni - Non-Life goodwill using the "excess capital" version of a DDM (Dividend Discount Model).
The impairment testing of the Life CGU was performed measuring the recoverable amount of UnipolSai Assicurazioni-Life goodwill using the "excess capital" version of a DDM (Dividend Discount Model).
The results obtained from application of the impairment procedure show that there is no need to make any value adjustments to the goodwill of the Non-Life CGU and the Life CGU recorded in the consolidated financial statements at 31 December 2023.

| Non-Life CGU/Life CGU | |
|---|---|
| Valuation method used |
The method used was an "excess capital" type of DDM (Dividend Discount Model) and focused on the future cash flows theoretically available for shareholders, without drawing on the assets needed to support the expected growth and in accordance with the capital requirements imposed by the Supervisory Authority on capital requirements. According to this method the value of the economic capital is the sum of the current value of potential future cash flows and the current terminal value. |
| Net profits used | The above net profits were considered. |
| Projection period | Five prospective flows were considered. |
| Non-Life discount rate |
A discount rate of 10.06% was used, broken down as follows: - risk-free rate: 4.38% - beta coefficient: 0.94 - risk premium: 5.40% - specific risk premium: 0.60% The average figure for the 10-year Long-Term Treasury Bond for the last three months (October December) 2023 was used for the risk-free rate. A 2-year adjusted Beta coefficient for a sample of companies listed on the European market operating in the Non-Life segment. The risk premium was defined by taking into account the estimates for this benchmark from leading contributors. An additional specific risk component was considered to take into account, within the Non-Life CGU, the presence of companies operating in diversified sectors. |
| Life discount rate | A discount rate of 10.55% was used, broken down as follows: - risk-free rate: 4.38% - beta coefficient: 1.14 - risk premium: 5.40% The average figure for the 10-year Long-Term Treasury Bond for the last three months (October December) 2023 was used for the risk-free rate. A 2-year adjusted Beta coefficient for a sample of companies listed on the European market operating in the Life segment. The risk premium was defined by taking into account the estimates for this benchmark from leading contributors. |
| Long term growth rate (g factor) |
The g-rate was 1.5% (1.2% the previous year) taking into account the updated macroeconomic scenario net of the estimated impact of climatic factors. |

| Amounts in €m | Allocation of goodwill | Recoverable amount (a) |
Excess |
|---|---|---|---|
| Non-Life CGU | 561 | 2,321 | 1,760 |
| Life CGU | 204 | 565 | 361 |
| Total | 765 | 2,887 | 2,121 |
(a) Recoverable value obtained as the difference between CGU Value and Adjusted Shareholders' Equity
| Parameters used | Non-Life |
|---|---|
| Risk Free | 4.38% |
| Beta | 0.94 |
| Risk premium | 5.40% |
| Specific Risk Premium | 0.60% |
| Discounting rate | 10.06% |
| Range | 9.56% - 10.56% |
| Pass | 0.3% |
| g factor | 1.5% |
| Range | 1% - 2% |
| Pass | 0.25% |
| Parameters used | Life |
|---|---|
| Risk Free | 4.38% |
| Beta | 1.14 |
| Risk premium | 5.40% |
| Discounting rate | 10.55% |
| Range | 10.05% - 11.05% |
| Pass | 0.3% |
| g factor | 1.5% |
| Range | 1% - 2% |
| Pass | 0.25% |
| Amounts in €m | Sensitivity (Value range) | ||||||
|---|---|---|---|---|---|---|---|
| Amounts in €m | Min | Max | |||||
| Recoverable CGU Amount - Goodwill Delta |
Amount | g | ke | Amount | g | ke | |
| UnipolSai Non-Life | 1,760 | 1,476 | 1.00% | 10.56% | 2,110 | 2.00% | 9.56% |
| Amounts in €m | Sensitivity (Value range) | ||||||
|---|---|---|---|---|---|---|---|
| Amounts in €m | Min | Max | |||||
| CGU | Recoverable Amount - Goodwill Delta |
Amount | g | ke | Amount | g | ke |
| UnipolSai Life | 361 | 272 | 2.00% | 11.05% | 453 | 1.00% | 10.05% |

Amounts in €m
UnipolSai Assicurazioni 2023 Consolidated Financial Statements
| Items | 31/12/2023 | 31/12/2022 | |
|---|---|---|---|
| 1 | Profit (Loss) for the period | 766 | 466 |
| 2 | Other income items net of taxes not reclassified to profit or loss | 237 | (31) |
| 2.1 | Portion of valuation reserves of equity investments valued at equity | 9 | 18 |
| 2.2 | Change in the revaluation reserve for intangible assets | ||
| 2.3 | Change in the revaluation reserve for property, plant and equipment | ||
| 2.4 | Financial revenues or costs relating to insurance contracts issued | (32) | 19 |
| 2.5 | Gains and losses on non-current assets or disposal groups held for sale | ||
| 2.6 | Actuarial gains and losses and adjustments relating to defined benefit plans | (7) | 15 |
| 2.7 | Gains or losses on equity instruments at fair value through OCI | 371 | (102) |
| a) change in fair value | 323 | (89) | |
| b) transfers to other shareholders' equity components | 48 | (13) | |
| 2.8 | Reserve deriving from variation on credit risk on financial liabilities at fair value through profit or loss | ||
| a) change in fair value | |||
| b) transfers to other shareholders' equity components | |||
| 2.9 | Altre variazioni: | ||
| a) change in fair value (hedged instrument) | |||
| b) change in fair value (hedging instrument) | |||
| c) other changes in fair value | |||
| 2.10 | Income taxes relating to other revenue components without reclassification in the Income Statement | (104) | 21 |
| 3 | Other income items net of taxes reclassified to profit or loss | 77 | (425) |
| 3.1 | Change in the reserve for foreign currency translation differences | ||
| a) changes in value | |||
| b) reclassification in the Income Statement | |||
| c) other changes | |||
| 3.2 | Gains or losses on financial assets (other than equity instruments) at fair value through OCI | 2,243 | (9,535) |
| a) changes in fair value | 1,827 | (9,197) | |
| b) reclassification in the Income Statement | 415 | (338) | |
| - credit risk adjustments | (27) | 46 | |
| - gains/losses on sale | 442 | (384) | |
| c) other changes | |||
| 3.3 | Gains or losses on cash flow hedges | 54 | 102 |
| a) changes in fair value | 54 | 102 | |
| b) reclassification in the Income Statement | |||
| c) other changes | |||
| 3.4 | Gains or losses on hedges of a net investment in foreign operations | ||
| a) changes in fair value | |||
| b) reclassification in the Income Statement | |||
| c) other changes | |||
| 3.5 | Portion of valuation reserves of equity-accounted investments: | (23) | |
| a) changes in fair value | (23) | ||
| b) reclassification in the Income Statement | |||
| - impairment losses | |||
| - gains/losses on sale | |||
| c) other changes | |||
| 3.6 | Financial revenues or costs relating to insurance contracts issued | (2,196) | 8,865 |
| a) changes in fair value | (2,196) | 8,865 | |
| b) reclassification in the Income Statement | |||
| c) other changes |

| Amounts in €m | |||
|---|---|---|---|
| Items | 31/12/2023 | 31/12/2022 | |
| 3.7 | Financial revenues or costs relating to reinsurance transfers | 19 | (42) |
| a) changes in fair value | 19 | (42) | |
| b) reclassification in the Income Statement | |||
| c) other changes | |||
| 3.8 | Gains and losses on non-current assets or disposal groups held for sale | ||
| a) changes in fair value | |||
| b) reclassification in the Income Statement | |||
| c) other changes | |||
| 3.9 | Other items: | ||
| a) changes in fair value | |||
| b) reclassification in the Income Statement | |||
| c) other changes | |||
| 3.10 | Income taxes relating to other revenue components with reclassification in the Income Statement | (43) | 208 |
| 4 | TOTAL OF OTHER COMPONENTS OF THE COMPREHENSIVE INCOME STATEMENT (Sum of items 2.1 to 3.10) |
314 | (456) |
| 5 | TOTAL CONSOLIDATED COMPREHENSIVE INCOME (Items 1 + 4) | 1,080 | 11 |
| 5.1 | of which: attributable to the owners of the Parent | 1,006 | (16) |
| 5.2 | of which: attributable to non-controlling interests | 74 | 27 |

UnipolSai Assicurazioni 2023 Consolidated Financial Statements

| NON-LIFE BUISINESS | LIFE BUSINESS | ||||
|---|---|---|---|---|---|
| Asset items | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | |
| 1 | INTANGIBLE ASSETS | 1,099 | 858 | 243 | 237 |
| 2 | PROPERTY, PLANT AND EQUIPMENT | 3,225 | 1,921 | 194 | 224 |
| 3 | INSURANCE ASSETS | 1,049 | 931 | 74 | 49 |
| 3.1 | Insurance contracts issued that are assets | 13 | 27 | 49 | 27 |
| 3.2 | Reinsurance transfers classifiable as assets | 1,036 | 904 | 24 | 22 |
| 4 | INVESTIMENTS | 12,481 | 13,274 | 48,266 | 43,194 |
| 4.1 | Investment property | 455 | 472 | 932 | 901 |
| 4.2 | Investments in associates and interests in joint ventures | 97 | 87 | 26 | 25 |
| 4.3 | Financial assets at amortised cost | 1,581 | 1,576 | 414 | 410 |
| 4.4 | Financial assets at fair value through OCI | 8,292 | 7,532 | 32,542 | 29,565 |
| 4.5 | Financial assets at fair value through profit or loss | 2,057 | 3,606 | 14,353 | 12,292 |
| 5 | OTHER FINANCIAL ASSETS | 1,711 | 1,634 | 642 | 771 |
| 6 | OTHER ASSETS | 1,784 | 1,563 | 1,267 | 1,237 |
| 7 | CASH AND CASH EQUIVALENTS | 441 | 402 | 399 | 350 |
| TOTAL ASSETS | 21,791 | 20,583 | 51,085 | 46,062 | |
| 1 | SHAREHOLDERS' EQUITY | 3,463 | 3,379 | 1,919 | 1,485 |
| 2 | PROVISIONS FOR RISKS AND CHARGES | 473 | 545 | 24 | 30 |
| 3 | INSURANCE LIABILITIES | 13,585 | 12,771 | 37,615 | 34,556 |
| 3.1 | Insurance contracts issued that are liabilities | 13,515 | 12,663 | 37,593 | 34,530 |
| 3.2 | Reinsurance transfers classifiable as liabilities | 70 | 108 | 22 | 25 |
| 4 | FINANCIAL LIABILITIES | 2,301 | 1,477 | 11,188 | 9,392 |
| 4.1 | Financial liabilities at fair value through profit or loss | 21 | 17 | 10,486 | 8,706 |
| 4.2 | Financial liabilities at amortised cost | 2,280 | 1,460 | 702 | 687 |
| 5 | PAYABLES | 953 | 1,038 | 172 | 201 |
| 6 | ALTRI ELEMENTI DEL PASSIVO | 1,015 | 1,373 | 168 | 399 |
| TOTAL SHAREHOLDERS' EQUITY AND LIABILITIES | 20,583 | 51,085 | 46,062 |

| Amounts in €m | ||
|---|---|---|
| OTHER BUSINESSES | INTERSEGMENT ELIMINATIONS | TOTAL | ||||
|---|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | |
| 25 | 23 | 1,367 | 1,119 | |||
| 705 | 645 | 4,124 | 2,791 | |||
| 1,123 | 980 | |||||
| 63 | 54 | |||||
| 1,060 | 926 | |||||
| 1,402 | 1,343 | (189) | (188) | 61,960 | 57,622 | |
| 977 | 985 | 2,364 | 2,359 | |||
| 47 | 50 | 170 | 162 | |||
| 344 | 278 | (189) | (188) | 2,149 | 2,076 | |
| 33 | 29 | 40,867 | 37,126 | |||
| 16,410 | 15,899 | |||||
| 123 | 100 | (44) | (34) | 2,433 | 2,470 | |
| 91 | 92 | (5) | (3) | 3,136 | 2,888 | |
| 98 | 74 | 40 | 978 | 826 | ||
| 2,443 | 2,277 | (198) | (226) | 75,121 | 68,696 | |
| 1,927 | 1,871 | 7,307 | 6,733 | |||
| 22 | 22 | 519 | 596 | |||
| 51,200 | 47,327 | |||||
| 51,108 | 47,194 | |||||
| 92 | 133 | |||||
| 271 | 212 | (189) | (188) | 13,571 | 10,894 | |
| 10,507 | 8,723 | |||||
| 271 | 212 | (189) | (188) | 3,064 | 2,171 | |
| 183 | 137 | (35) | (22) | 1,273 | 1,353 | |
| 41 | 35 | 25 | (15) | 1,251 | 1,793 | |
| 2,443 | 2,277 | (198) | (226) | 75,121 | 68,696 |

| NON-LIFE BUSINESS | LIFE BUSINESS | ||||
|---|---|---|---|---|---|
| Items | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | |
| 1 | Insurance revenues from insurance contracts issued | 8,947 | 8,000 | 623 | 549 |
| 2 | Insurance service expenses from insurance contracts issued | (9,029) | (6,985) | (376) | (322) |
| 3 | Insurance revenue from reinsurance contracts held | 623 | 177 | 13 | 13 |
| 4 | Insurance service expenses from reinsurance contracts held | (377) | (338) | (20) | (20) |
| 5 | Result of insurance services | 165 | 854 | 241 | 220 |
| 6 | Gains/losses on financial assets and liabilities at fair value through profit or loss |
246 | 9 | 213 | (328) |
| 7 | Gains/losses on investments in associates and interests in joint ventures | 29 | (2) | 4 | 12 |
| 8 | Gain/losses on other financial assets and liabilities and investment property | 319 | (91) | 1,060 | 1,208 |
| 9 | Balance on investments | 594 | (84) | 1,277 | 893 |
| 10 | Net financial costs/revenues relating to insurance contracts issued | (96) | 72 | (1,191) | (910) |
| 11 | Net financial revenues/costs relating to reinsurance transfers | (2) | (1) | (1) | |
| 12 | Net financial result | 497 | (14) | 86 | (18) |
| 13 | Other revenue/costs | 679 | 252 | 70 | 14 |
| 14 | Operating expenses: | (226) | (186) | (40) | (53) |
| 15 | Altri oneri/proventi | (444) | (310) | (24) | (25) |
| Pre-tax Profit/(Loss)for the period | 671 | 596 | 333 | 138 |

| OTHER BUSINESSES | INTERSEGMENT ELIMINATIONS | TOTAL | |||
|---|---|---|---|---|---|
| 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 | 31/12/2023 | 31/12/2022 |
| 9,571 | 8,549 | ||||
| (9,405) | (7,307) | ||||
| 637 | 190 | ||||
| (396) | (358) | ||||
| 407 | 1,074 | ||||
| 460 | (318) | ||||
| 5 | 5 | 38 | 15 | ||
| 47 | 13 | (42) | (40) | 1,383 | 1,090 |
| 52 | 18 | (42) | (40) | 1,881 | 787 |
| (1,286) | (838) | ||||
| (3) | (2) | ||||
| 52 | 18 | (42) | (40) | 592 | (53) |
| 268 | 170 | 42 | 40 | 1,059 | 476 |
| (255) | (198) | (520) | (436) | ||
| (49) | (33) | (519) | (369) | ||
| 16 | (42) | 1,019 | 692 |
Amounts in €m

The Risk Report aims to provide an overview of the risk management system, the internal risk assessment and solvency assessment process and the UnipolSai Group risk profile, in compliance with the principles of the European Solvency II regulations.
Activities by the competent corporate structures of the Group were carried out in 2023 in compliance with Solvency II regulations and the supervisory provisions issued by IVASS.
The Unipol Group and the UnipolSai Group's Risk Management structure and process are part of the wider internal control and risk management system which operates according to several levels:
The departments responsible for these controls are separate from the operating functions; they help define the risk governance policies and the risk management policy;
• internal review (so-called "third-level controls"), verification of the completeness, functionality and adequacy of the Internal Control and Risk Management System (including the first- and second-level controls) and that business operations comply with the System.

By way of a non-exhaustive example, the Risk and Control Governance model adopted in the Unipol Group is shown below. Governance Legal responsibility of Directors (law compliance) Social Responsibility, Ethics principles Responsibility for the Internal Control and Risk Management System Supervision of OMM implementation Implementation and monitoring of the Internal Control and Risk Management System Verification of efficiency and effectiveness of the Internal Control and Risk Management System Shareholders BoD Board of Statutory Auditors Control and Risk Committee Other Board Committees Supervisory Board CEO/General Manager/ Elected Director Body with management function Top Management Audit Risk Management Compliance Manager in charge of financial reporting , Anti-money laundering and Data Protection Officer Acquisition of information from business lines and the Group, and logical reorganisation for governance requirements Operating controls on individual transactions Monitoring and control of quantifiable risks (Solvency II – Basel 2 - Basel 3) Management of compliance risk Verification the reliability and adequacy of the calculation of technical provisions - Solvency II Control of accounting data and financial communication Management of money laundering risk Management of privacy risk Actuarial Function Business Lines Service Lines Level of control 1st 2nd 3rd
Within UnipolSai:
5 The key Risk Management Function of UnipolSai is known as the Chief Risk Officer.

• The Chief Risk Officer supports the Board of Directors, the General Manager and Top Management in the evaluation of the adequacy and effectiveness of the Risk Management System and reports its conclusions to said bodies, highlighting any deficiencies and suggesting ways of resolving them. The Chief Risk Officer carries out this work as part of the process of "Own Risk and Solvency Assessment" (ORSA), ensuring that the work carried out by the various company departments dealing with risk management is coordinated. This does not exempt the individual operating departments from their specific responsibilities for managing the risks relating to their own work since the departments themselves must have the necessary tools and expertise.
Within the Risk management system, the Chief Risk Officer is in charge of continuously identifying, measuring, assessing and monitoring the current and prospective risks at the individual and aggregated level that the Company is or may be exposed to and their correlations.
In this respect, the Chief Risk Officer also contributes to the dissemination of a risk culture extended to the entire Group.
Some internal company committees have been set up within UnipolSai to support the Chief Executive Officer in implementing and monitoring the policies on guidelines, coordination and operating strategy laid down by the Board of Directors.
The Internal control and risk management system (hereinafter, the "System") is defined in the Group Directives on the corporate governance system ("Directives") - adopted by the UnipolSai Board of Directors most recently on 11 November 2021 - which define, inter alia, the role and responsibilities of the parties involved in the internal control and risk management system. The Directives are complemented by the Key Function Policies - approved at the same board meeting.
The principles and processes of the System as a whole are governed by the following Group policies: "Risk Management Policy", "Current and Forward-looking Own Risk and Solvency Assessment Policy", "Operational Risk Management Policy" and "Group-level Risk Concentration Policy".
The policies setting the principles and guidelines below are an integral part of this System: (i) management of specific risk factors (e.g. Investment Policy with regard to market and liquidity risks, and the "Credit Policy"), (ii) risk management as part of a specific process, (iii) risk mitigation and (iv) risk measurement model management.
A risk management process is defined within the Risk management system to allow for risk identification, measurement, monitoring and mitigation.
The risk identification, assessment and monitoring processes are performed on an ongoing basis, to take into account any changes in their nature, business volumes and market context, and any insurgence of new risks or changes in existing risks.
These processes are carried out using methods that guarantee an integrated approach at Group level. The Parent ensures that the risk management policy is implemented consistently and continuously within the entire Group, taking into account the risks of each company included in the scope of supervision of the Group and their mutual interdependencies.
The Risk Management System is inspired by an enterprise risk management logic. This means that is based on the consideration, with an integrated approach, of all the current and prospective risks the Group is exposed to, assessing the impact these risks may have on the achievement of the strategic objectives and replies on a fundamental element: the Risk Appetite.
In quantitative terms, Risk Appetite is generally determined on the basis of the following elements:
Quality objectives are also defined in reference to compliance, emerging, strategic, reputational, ESG (Environmental, Social and Governance), business continuity and IT risks.

The Risk Appetite is formalised in the Risk Appetite Statement, which indicates the risks that the Company intends to assume or avoid, sets their quantitative limits and the qualitative criteria to be taken into account for the management of unquantified risks.
The Risk Appetite forms part of a reference framework - the Risk Appetite Framework (RAF).
The RAF is defined in strict compliance and prompt reconciliation with the business model, the Strategic Plan, the Own Risk and Solvency Assessment (ORSA) process, the budget, company organisation and the internal control system.
The RAF defines the Risk Appetite and other components ensuring its management, both in normal and stress conditions. These components are:
The activity to set the RAF components is dynamic over time, and reflects the risk management objectives associated with the objectives of the Strategic Plan. Verification is performed annually as part of the process of assigning Budget objectives. Further analyses for preventive control of the Risk Appetite, and capital adequacy in particular, are performed when studying extraordinary transactions (such as mergers, acquisitions, disposals).
The RAF is broken down into several analysis macro areas with the aim of guaranteeing continuous monitoring of risk trends and capital adequacy.
The main analysis macro areas are:
Under its own risk management systems, the Group uses the ORSA process to assess the effectiveness of the risk management system and its capital adequacy as well as liquidity governance and management.
The internal ORSA assessment process allows the analysis of the current and forward-looking risk profile of the Group, based on strategy, market scenarios and business development; in addition, the ORSA is an assessment element to support operational and strategic decisions.
The risk management process involves the following steps:
The process is performed in compliance with the Risk Appetite Framework.

Risk identification consists in identifying the risks considered significant, i.e. those with consequences capable of compromising the solvency or reputation of the Group and of the Company, or constitute a serious obstacle to achieving strategic objectives. These risks are classified according to a methodology that takes into consideration the Group structure, the specific nature of the types of business managed by the various operating Companies and the classifications proposed by Italian and European supervisory regulations.
The categories of risk identified are as follows:
This identification and its constant updating are the result of meticulous and continuous activity performed through:
An assessment is performed at least annually to verify that the risks identified actually represent the risk profile of the Group and its companies.
At least annually and in any event every time circumstances arise that could significantly alter the risk profile, the Group assesses the risks to which the Group and the individual Companies are exposed, at present and prospectively, documenting the methods used and the related results. In the Current and Forward-looking Own Risk and Solvency Assessment Policy, the process for the current and forward-looking assessment of risks is also defined, including risks deriving from companies included in the scope of Group supervision and taking into account the risk interdependencies.
The current and forward-looking assessment also includes stress testing to verify the company's vulnerability to extreme but plausible events.
The current assessment of risks identified is performed through methods envisaged in regulations and best practices as regards risks for which measurement is not regulated or defined by high-level principles.
The Own Risk Solvency Assessment (ORSA) is used to support operational and strategic decisions.
The Group defines and implements procedures that are commensurate with the nature, scope and complexity of the business activities and enable it to identify and assess accurately the risks to which the Group or individual Company is or could be exposed in the short and long term.

The Group and each subsidiary Company conduct stress test, reverse stress test and sensitivity analyses at least annually, in compliance with requirements of the national Supervisory Authority regulations. To this end, the Group has adopted:
With reference to the stress scenarios, as part of the 2023 ORSA Report, the Chief Risk Officer assessed, among others, the impacts of:

defines which energy efficiency measures to be applied in terms of the lowest marginal abatement cost (the maximum reduction of emissions at the lowest cost) and estimates the implementation costs and energy cost savings arising from implementation of these measures.
In order to ensure prompt and constant monitoring of the evolution of the Risk Profile and compliance at the different levels of company responsibility with the defined Risk Appetite, a reporting system was implemented based on the principles of completeness, promptness and disclosure efficiency.
This system guarantees that the quality and quantity of information provided is commensurate with the needs of the various recipients and with the complexity of the business managed, in order for it to be used as a strategic and operating tool in assessing the potential impact of decisions on the company's risk profile and solvency.
In relation to the recipients, reporting is divided into "internal" and "external". "Internal" reporting is addressed to the bodies and internal structures of the Group and its companies, with the aim of steering strategic and business decisions and verifying sustainability over time. "External" reporting is directed to Supervisory Authorities and the market and meets the disclosure and transparency requirements of regulations in force.
With regard to internal reporting, in consideration of the recipients of the various requirements and uses, two types of reporting are provided:
As part of the strategic reporting, the following are provided to the Board of Directors, the Control and Risk Committee and Top Management:
As part of the quarterly monitoring of indicators defined in the Risk Appetite Statement, performed by the Chief Risk Officer for the Board of Directors, any failure to comply with one of the defined thresholds triggers the escalation process described below:
6 In reference to the Parent, at consolidated level and at individual company level.

In order to mitigate existing or prospective levels of risk not in line with the defined risk objectives, the following measures can be adopted:
The Unipol Group, UnipolSai Assicurazioni and Arca Vita are authorised by IVASS to use the Partial Internal Model to calculate the Group and individual solvency capital requirement.
The Partial Internal Model is used to assess the following risk factors, as well as in the aggregation process:
There is a plan for the extension of the Partial Internal Model to include all measurable risk modules and reach a Full Internal Model type configuration.
7 The CSA requires the delivery of a collateral asset when the value of the contract exceeds the set threshold.

Note that in the first quarter of 2024, IVASS authorised the Group to apply a risk assessment model change with reference to Non-Life and Health Underwriting Risks, Life Underwriting Risks and, as part of the Market and Credit Risks, to spread risk.
The methodology adopted by the Group for the assessment of Non-Life and Health underwriting risks (represented by the sub-modules: premium risk, reserve risk, catastrophe risk and lapse risk) calls for the use of internal models for the premium and reserve sub-modules as well as, in the context of catastrophe risks, for earthquake risk and the integration of a probability distribution function calibrated on the basis of the results of the Standard Formula for other risks. The aggregation of risks is calibrated by also taking into account information available on the Italian insurance market.
Life underwriting risk (mortality/longevity risk, lapse risk and expense risk) is measured using the Partial Internal Model based on the Least Square Monte Carlo approach, consistent with the principles indicated in Solvency II regulations, which allow calculation of the Probability Distribution Forecast in relation to Life risk factors. Catastrophe risk, in addition to the Life underwriting risks relating to Unit-Linked and Pension Fund products, are assessed using the Standard Formula.
The market risk of the securities portfolio, for which the investment risk is not borne by the policyholders, is measured using the Partial Internal Model that adopts a Monte Carlo VaR approach. As part of the Internal Market Model, Life liabilities are replicated through cash flows with a maturity equivalent to Life provisions run-off for the guaranteed component and polynomial functions (the Least Square Monte Carlo approach) to represent the Future Discretionary Benefits component. Market risk of the securities portfolio for which investment risk is borne by policyholders and concentration risk are measured using the Market Wide Standard Formula.
The table in the following paragraph analyses the main sensitivities to market risk factors.
Credit risk is measured using the Partial Internal Model that adopts a CreditRisk+ approach. This model makes it possible to measure the risk of default relating to bank counterparties, concerning exposures deriving from available liquidity and financial risk mitigation through derivative contracts, insurance and reinsurance exposures and bonds on which spread risk is calculated. Furthermore, the model allows the risk of default deriving from exposures to intermediaries and policyholders to be measured.
The risk aggregation process, adopted by the Group according to the methods defined in the Partial Internal Model, calls for a bottom-up approach and may be broken down into two phases:
The aggregation of the sub-modules involves three distinct approaches:
Below is additional information on the measurement methods and the main results for each risk at 31 December 2023.
The Investment Policy establishes guidelines for investment activities, the type of assets considered suitable for investment and the breakdown of the medium/long-term investment portfolio, taking into account the risk profile of liabilities held to ensure integrated asset and liability management. It also defines the limits for underwriting and related monitoring methods in such a way as to ensure that total exposure is in line with the risk appetite expressed in the Group's strategic objectives, thus guaranteeing adequate portfolio diversification.

Market risk refers to all risks which have the effect of diminishing investments of a financial or real estate nature as a result of adverse trends in the relevant market variables. The market risk modules are:
In the Partial Internal Model, the Value at Risk method is used to measure the market risk, calculated over a 1-year time period and with a confidence interval of 99.5%. In addition, sensitivity and stress test measurements are determined for each risk factor.
Interest rate risk for ALM purposes is quantified in terms of duration mismatch. The assets falling under the calculation of the duration mismatch include securities, cash, receivables and properties; the liabilities include the financial liabilities and technical provisions. The market value is used for financial assets and liabilities, whilst best estimates are used for the technical provisions. The duration mismatch is calculated as the difference between the duration of assets and the duration of liabilities weighted for the assets value, considering the adjusting effect of the derivatives.
For the UnipolSai Group, at 31 December 2023 the duration mismatch for Life business stood at -0.52, while it was +0.42 for Non-Life business.
Equity risk is the risk connected with a potential variation in the value of share assets, as a result of market volatility of the reference indexes.
Real estate risk is the risk connected with the occurrence of losses as a result of unfavourable changes in the market value of real estate assets.
The assets falling under the calculation of real estate risk include real estate funds, directly-owned properties and direct and indirect investments in real estate projects.
In particular, with reference to directly-owned properties, the value used to calculate the risk (fair value) is that deriving from the estimate made by independent experts.
Exchange rate risk for ALM purposes is defined as the risk of a possible variation in the value of financial statement assets and liabilities and the Net Asset Value as a result of unfavourable changes in exchange rates. Based on the Investment Policy, the total exposure to non-Euro currencies, net of currency hedging, must be limited to 3% of total investments.
The UnipolSai Group's exposure to currency risk was not significant at 31 December 2023.
Spread risk is the risk connected with a variation in the value of bond assets following a change in spreads representing the credit rating of individual issuers. In light of the policies and processes adopted to monitor and manage liquidity risk and the objective difficulty in quantifying the default risk of government bonds issued by European Union Member States, spread risk on government bonds has been excluded from the measurement of the market SCR based on the Partial Internal Model. It is not included because of:
The assessment of spread risk on government bonds is included within Pillar II risks and the relative measurement is carried out based on a stress testing type approach.

Amounts in €m
Liquidity risk is the risk of not having the liquid resources necessary to meet the assumed obligations, in the financial statements and off-balance sheet, pertaining to their business, without undergoing economic losses deriving from forced sales of assets in case of adverse scenarios.
The liquid resources functional for the core business deriving from cash and cash equivalents, from the sale of securities that can be swiftly turned into cash and from any financing activities.
The main principles on which the liquidity risk management model within the UnipolSai Group is based may be summarised as follows:
With reference to contracts falling within the scope of application of IFRS 17, the composition of the net undiscounted cash flows deriving from insurance contracts issued and from reinsurance contracts held that are liabilities broken down by expiry time bands, or in detail for each of the five years after the reporting date and, in aggregate, in the period after the first 5 years, is provided below. The analysis excludes the components of insurance liabilities referring to the contractual service margin and the adjustment for non-financial risks and the entire amount of assets and liabilities for residual coverage deriving from contracts accounted for according to the PAA.
| Net contractual cash outflows/(inflows) Year |
Insurance contracts issued that are liabilities |
Reinsurance contracts held that are liabilities |
|---|---|---|
| 2024 | 6,234 | 135 |
| 2025 | 5,153 | (13) |
| 2026 | 4,392 | (10) |
| 2027 | 3,794 | (7) |
| 2028 | 3,647 | (6) |
| Subsequent years | 33,913 | (17) |
| TOTAL | 57,134 | 81 |
It should be noted that the contractual flows referring to 2024 include €493m in net outflows attributable to the balance of current statement of financial position items relating to relations with policyholders and reinsurers, consisting mainly of receivables from policyholders for premiums to be collected and deposits received from reinsurers.
It should also be noted that amounts payable on demand, mainly relating to revaluable Life contracts linked to segregated funds, totalled €35,386m. This amount was calculated assuming that all policyholders who have the right to do so will exercise the right of early surrender at the reporting date, with resulting determination of the amount due to policyholders on the basis of the conditions set forth in the contract, and therefore, for example, net of any penalties. The methods for calculating the early surrender value therefore differ from those underlying the amounts shown in the table of non-discounted contractual cash flows, which are instead determined in line with the expected distribution over time of future cash flows.

Credit risk (or Counterparty Default Risk) identifies the risk that a debtor or guarantor under an enforcement order may wholly or partially fail to honour its accrued monetary commitment to the Parent or one of the Group companies. Credit risk therefore reflects the potential losses from an unexpected default by counterparties and debtors of the insurance and reinsurance companies in the next twelve months.
As part of the Group's credit risk assessment, from FY23 a change in methodology was applied, expanding the scope of calculation of the internal model to exposures to bonds for which Spread Risk is assessed.
Therefore, default risk also includes, in addition to the exposures to securities indicated above, risk mitigation contracts, e.g. reinsurance agreements, securitisations and derivatives, in addition to any other credit exposure not included in financial risks (credit spread risk). Credit risk management is defined in the Credit Policy, which describes the roles and responsibilities of the players involved, the risk assessment and mitigation principles, and the operational limits monitored.
In relation to credit risk, the Risk Management Department monitors compliance with the limits defined in the Group Credit Policy and prepares reports to the administrative body, Top Management and the operating structures on developments in this risk.
Within the scope of the UnipolSai Group, the credit risk is mainly in the exposures to banks, in the insurance and outwards reinsurance areas.
Existing exposure to banks refers to deposited liquidity and exposures in OTC hedging derivatives. In particular, the derivatives exposure considered for risk management and monitoring purposes is equal to the sum of market values, if positive, of the current individual contracts and takes into account any risk mitigation arrangements (collateralisation) covered in the CSAs signed with individual counterparties. The following table shows the distribution of UnipolSai exposures to banks, broken down by rating class, recognised at 31 December 2023.

This risk is calculated within the technical-insurance risks (see relevant section) and monitored by the Bond and Credit Assignment Committee.
In this area, the existing exposure to credit risk is divided into:

be net of any deposits retained or other collateral guarantees (e.g. Banking LOC, reinsurers' and Parent's commitment, etc.).
Provided below is the table showing the distribution of UnipolSai Group exposure to reinsurers, broken down by rating class, recognised at 31 December 2023 net of intragroup reinsurance.


The credit risk of debt securities is monitored within market risk based on credit spread volatility.
The following table shows the distribution of the UnipolSai Group's bond portfolio, Insurance business and Real Estate and Other Businesses, broken down by rating class (figures at 31/12/2023).


To monitor the sensitivity to risk factors and important events, the Group carried out some sensitivity analyses. Sensitivity analyses on the main economic-financial factors of interest are carried out at least once a year and allow the Company to assess the impact on shareholders' equity set forth in its Market Consistent Balance Sheet (MCBS) established by the SII regulations of changes in the main risk factors to which it is exposed. The sensitivity analyses carried out are listed below, with their description and the results of the analyses in question.
| Impact with respect to central scenario |
Impact on MCBS Amounts in €m |
|
|---|---|---|
| Sensitivities: Upward shift in rate curve | interest rate: +100 bps | 93 |
| Sensitivities: Downward shift in rate curve | interest rate: -100 bps | -174 |
| Sensitivities: Surrender frequencies | +100% of surrender tables | -348 |
| Sensitivities: Combined ratio (net of reinsurance) | combined ratio: +100 bps | -59 |
| Sensitivities: Combined Ratio (gross of reinsurance) | combined ratio: +100 bps | -65 |
It should be noted that, as indicated, the sensitivity analyses were developed within the Solvency II framework, which differs from that in force for the preparation of the consolidated financial statements for (prudential purposes rather than reporting on economic-financial performance) and the resulting calculation metrics. Among the most significant differences, it should be noted that shareholders' equity determined according to international accounting standards tends to be less volatile than shareholders' equity according to the MCBS, in relation to the capacity to absorb the volatility inherent in the mechanisms for determining the CSM with reference to the contracts measured according to the BBA or VFA or the LRC complex with reference to those measured according to the PAA.
To analyse the impact of a (upward/downward) shock to the yield curve, two sensitivity analyses were carried out on the dynamics of the interest rates curve, more precisely, two single financial factor analyses assessing the impact of an upward and downward parallel shift of the entire yield curve (Euro, Serbia, and rest of the world), a shift respectively equal to +100 bps and -100 bps.
To analyse the impact of a shock deriving from the increase in surrender frequencies of the Life portfolio, a sensitivity analysis was carried out in which an increase of +100 bps in the surrender tables was assessed.
With reference to Non-Life technical insurance variables, a sensitivity analysis was developed which consists in an unfavourable change in the combined ratio, such as to determine a significant loss in the income statement of each Group company. In particular, these were two single technical factor analyses in which the impact (gross and net of reinsurance) of a +100 bps increase in the combined ratio was assessed.

In accordance with Consob Communication DEM/11070007 of 5 August 2011 and ESMA document 2011/397 of 25 November 2011, relating to information to be provided in annual and interim financial reports on listed companies' exposures to Sovereign debt securities and current trends in international markets, details are provided of Sovereign exposures (i.e. bonds issued by central and local governments and by government organisations and loans granted to them) held by the UnipolSai Group at 31 December 2023, broken down by type of portfolio, nominal value, carrying amount and fair value.

| Balance at 31 December 2023 | |||
|---|---|---|---|
| Amounts in €m | Nominal value | Carrying amount | Market value |
| Italy | 19,814 | 17,591 | 17,591 |
| Financial assets at fair value through OCI | 19,765 | 17,546 | 17,546 |
| Financial assets at fair value through profit or loss | 40 | 41 | 41 |
| Financial assets at amortised cost | 9 | 4 | 4 |
| Spain | 3,723 | 3,249 | 3,251 |
| Financial assets at fair value through OCI | 3,575 | 3,098 | 3,098 |
| Financial assets at fair value through profit or loss | 20 | 22 | 22 |
| Financial assets at amortised cost | 128 | 128 | 131 |
| France | 2,190 | 1,475 | 1,475 |
| Financial assets at fair value through OCI | 2,190 | 1,475 | 1,475 |
| Germany | 508 | 278 | 278 |
| Financial assets at fair value through OCI | 508 | 278 | 278 |
| Portugal | 369 | 371 | 371 |
| Financial assets at fair value through OCI | 369 | 371 | 371 |
| Belgium | 330 | 237 | 237 |
| Financial assets at fair value through OCI | 330 | 237 | 237 |
| Great Britain | 306 | 300 | 300 |
| Financial assets at fair value through OCI | 306 | 300 | 300 |
| Ireland | 246 | 225 | 225 |
| Financial assets at fair value through OCI | 246 | 225 | 225 |
| Slovenia | 207 | 191 | 191 |
| Financial assets at fair value through OCI | 207 | 191 | 191 |
| Netherlands | 147 | 145 | 145 |
| Financial assets at fair value through OCI | 147 | 145 | 145 |
| Israel | 109 | 103 | 103 |
| Financial assets at fair value through OCI | 109 | 103 | 103 |
| Romania | 104 | 87 | 87 |
| Financial assets at fair value through OCI | 104 | 87 | 87 |
| Serbia | 102 | 99 | 98 |
| Financial assets at fair value through OCI | 43 | 39 | 39 |
| Financial assets at amortised cost | 59 | 60 | 59 |
| Mexico | 99 | 75 | 75 |
| Financial assets at fair value through OCI | 99 | 75 | 75 |
| Slovakia | 98 | 82 | 82 |
| Financial assets at fair value through OCI | 98 | 82 | 82 |
| Cyprus | 88 | 78 | 78 |
| Financial assets at fair value through OCI | 88 | 78 | 78 |

| Balance at 31 December 2023 | |||
|---|---|---|---|
| Amounts in €m | Nominal value | Carrying amount | Market value |
| Chile | 83 | 73 | 73 |
| Financial assets at fair value through OCI | 83 | 73 | 73 |
| China | 84 | 70 | 70 |
| Financial assets at fair value through OCI | 84 | 70 | 70 |
| Latvia | 66 | 56 | 56 |
| Financial assets at fair value through OCI | 66 | 56 | 56 |
| Hong Kong | 50 | 34 | 34 |
| Financial assets at fair value through OCI | 50 | 34 | 34 |
| Turkey | 50 | 43 | 43 |
| Financial assets at fair value through OCI | 50 | 43 | 43 |
| Peru | 31 | 24 | 24 |
| Financial assets at fair value through OCI | 31 | 24 | 24 |
| Austria | 29 | 26 | 26 |
| Financial assets at fair value through OCI | 26 | 23 | 23 |
| Financial assets at fair value through profit or loss | 3 | 3 | 3 |
| USA | 23 | 23 | 23 |
| Financial assets at fair value through OCI | 23 | 23 | 23 |
| South Korea | 20 | 18 | 18 |
| Financial assets at fair value through OCI | 20 | 18 | 18 |
| Poland | 18 | 18 | 18 |
| Financial assets at fair value through OCI | 18 | 18 | 18 |
| Croatia | 16 | 16 | 16 |
| Financial assets at fair value through OCI | 16 | 16 | 16 |
| Lithuania | 16 | 15 | 15 |
| Financial assets at fair value through OCI | 16 | 15 | 15 |
| Greece | 10 | 9 | 9 |
| Financial assets at fair value through OCI | 10 | 9 | 9 |
| TOTAL | 28,932 | 25,007 | 25,009 |
The carrying amount of the sovereign exposures represented by debt securities at 31 December 2023 totalled €25,006.8m, 70%, of which (71% in 2022) was concentrated on securities issued by the Italian State. Moreover, the bonds issued by the Italian State account for 32% of total investments of the UnipolSai Group.

The guidelines of the underwriting and reserving activities of the Life business are defined in the "Underwriting Policy - Life Business" and in the "Reserving Policy - Life Business".
The Underwriting Policy defines the guidelines addressing underwriting activities and the related risk management, governing the assumption principles and logic of UnipolSai Group insurance companies based in Italy and operating in the Life business.
The Reserving Policy defines the guidelines addressing reserving activities for direct business and the related risk management, governing the reserving principles and logic of UnipolSai Group insurance companies based in Italy and operating in the Life business, in compliance with national and international accounting standards and the Solvency II prudential supervisory system.
Technical-insurance risks relating to Life business underwriting are divided into:
The options included in the tariffs that can affect the assessment of risks present in the portfolio are monitored. The most significant of these are illustrated below.
This option allows the customer to surrender the contract and receive the surrender value (does not apply to the purerisk tariffs and annuities currently being distributed). Depending on the contract type, more or less significant penalties can be applied, often based on claim seniority.
In individual products where the benefit is expressed in the form of capital, there is often the option to accept disbursement as an annuity.
Among the individual products portfolio there are products for which the conversion ratios are determined at the time of issue of the contract and others, the majority of which (generally those issued after 2000) with the amount of the annuity determined only at the time of the option. In this case the demographic risk is considerably mitigated.
In the supplementary pensions segment, especially collective, the ratios are often associated with each sum paid in, but the risk is mitigated by the frequency at which the offer conditions can be reviewed.
The portfolio includes individual term life products (not "whole-life") that often provided the option to extend the validity of the contract after its original maturity date. During maturity deferment the payment of further premiums is not normally allowed.
The conditions applied during deferment vary according to the contractual terms, and continuation of the contract's financial guarantees or the application of those used at the time of the option can be granted.
Depending on the conditions, even the duration of the maturity deferment can be determined or extended year by year.
The impact on the portfolio of exercising the maturity deferment option is not particularly significant at present.

With regard to risk assessment relating to the Non-Life portfolio, the reference guidelines are contained in the "Underwriting Policy - Non-Life Business", "Reserving Policy - Non-Life Business" and the "Reinsurance and Other Risk Mitigation Techniques Policy".
The Underwriting Policy defines the guidelines addressing underwriting activities and the related risk management, governing the assumption principles and logic of UnipolSai Group insurance companies based in Italy and operating in the Non-Life business.
The Reserving Policy defines the guidelines addressing reserving activities and the related risk management, governing the reserving principles and logic of UnipolSai Group insurance companies based in Italy and operating in the Non-Life business, in compliance with national and international accounting standards and the new Solvency II prudential supervisory system.
The Reinsurance and Other Risk Mitigation Techniques Policy aims to define the guidelines on outwards reinsurance and other techniques for mitigating risk.
During 2023 the Non-Life underwriting risks were calculated using the Non-Life Partial Internal Model, consistent with the standards of Solvency II.
For the assessment of Non-Life and Health underwriting risks, the Non-Life Internal Model was adopted, characterised by the following modelling approaches:
In 2023, in addition to help in calculating risk capital, this tool also provided support to the Group in the Underwriting and Pricing processes and in defining the reinsurance strategy.
As regards the other perils, a simplified approach was adopted based on integration into the Group simulation model of the methods envisaged by the Standard Formula;

With reference to other Catastrophe Risks, the assessments were performed using the standardised scenario approach proposed by EIOPA, in which the following events are taken into consideration:
Consistent with the internal model expansion plan relating to catastrophe risks, in the course of the last two years, the licences of the Italy Flooding and Italy Severe Convective Storm (SCS) models were acquired from a leading software house specialised in catastrophe modelling.
In order to ensure a complete analysis of company risks, the UnipolSai Group has an "Operational Risk Management Policy", updated annually, and has drafted a framework to identify, measure, monitor and manage Operational Risk. This term means "the risk of losses deriving from the inadequacy or malfunctioning of processes, human resources or systems, or from external events". Based on the Operational Risk Management framework, relations and reciprocal impacts between operational and other risks are also considered, with the objective of understanding the direct and indirect effects of events linked to operational risk. In particular, the analysis schemes adopted are aimed at understanding, based on a causal approach, the risk factors, events and effects, both financial and non-financial, and the impacts these can have on the Group's solvency and on the achievement of the objectives set.
Within the Group governance structure, the monitoring of Operational Risks is entrusted to the Operational Risks function of the Risk Management Department. The objectives assigned to this unit, within the internal control system, are aimed at ensuring the Group's assets are safeguarded and at adequate risk control.
Operational risk identification consists in gathering as much information as possible about the risk event, its possible causes and effects with a view to increasing awareness of the specific exposure of the various company areas. In addition, this activity also aims to assess the adequacy of controls and identify the best management solutions for any critical situations.
The operational risk identification essentially involves carrying out two separate processes.
The organisational model for operational risk governance and control envisages a network of analysts in a number of UnipolSai Assicurazioni SpA Divisions and the main Group companies which, after following a specific training course on operational risk management, provide support to the Risk Management Department in identifying operational risk and monitoring this risk within their own areas of operations.
Operational risk assessment is performed annually by the main Group Companies.
2023 saw the continuation of development activities on the internal model for operational risk assessment and measurement, to determine the distribution of operating losses on a scenario-based approach, taking into account the risk events identified and quantitative information gathered through risk self-assessment.

With regard to Standard compliance risk, the Group's compliance risk management process is transversal and comprises organisational and operating monitoring activities carried out by resources from the various corporate functions. The Compliance Function is tasked with assessing whether the organisation and the internal corporate procedures are suitable to reach the objective of preventing this risk, according to a risk-based approach.
With regard to emerging risks, strategic risk and reputational risk, within the dedicated structure present within the Risk Management Department, a dedicated Observatory was created at Group level, called "Reputational & Emerging Risk Observatory", whose key elements are the involvement of an interfunctional Technical Panel and of all the main Business Departments, the use of a consolidated predictive model and methodologies based on futures studies to ensure a forward-looking view of the medium/long-term in order to anticipate the risks and future opportunities, and a holistic approach aimed at grasping and governing the interconnections, both in reading the external context for an integrated vision of the different emerging macro trends (social, technological, political and environmental), and in the internal response for a unified view of the different corporate areas and of the different steps of the value chain. The purpose of the Observatory is to assure effective monitoring of emerging risks, strategic risk and reputational risk, verifying the constant alignment between stakeholders' expectations and the Group's responses and anticipating the most significant phenomena to catch new business opportunities and prepare for emerging risks.
At Group level, a structured process was developed within the Observatory for the assessment and prioritisation of the main emerging risk areas, identified on the basis of the systemic analysis of macrotrends regarding changes in the external context, currently present in the Observatory's Radar. The process calls for the involvement of a composite panel of external experts to assess emerging risks, on the basis of an "outside-in" perspective, in terms of probability, impact, reference time horizon and level of interconnection with other risks, and the assessment, on the basis of an "inside-out" perspective, of the level of exposure and degree of readiness with respect to emerging risks identified as priorities.
Strategic risk is controlled at Group level through the monitoring of Strategic Plan drivers to verify any deviation from the defined scenarios, also using long-term scenario analyses carried out within the Observatory and involving interfunctional teams, using methodologies based on strategic foresight and on anticipation, with the aim of strengthening the resilience of Group strategy to future possibilities in an external context characterised by accelerating change and growing levels of complexity and uncertainty.
With specific reference to the reputational risk, within the frame of the Observatory, a Reputation Management framework was developed at the Group level, which operates in the dual mode of construction and protection of the reputational capital, through two work sites that rely on dedicated corporate competencies and structures in a path of constant mutual alignment, under the joint leadership of the "Corporate Communication and Media Relations" and "Risk Management" functions, with the goal of stably integrating these assets in the strategic planning processes. In the light of the "Opening New Ways" 2022-2024 Strategic Plan, the reputational scorecard and the reputational risk scenario map of the Group were updated on the basis of external and internal sources and in particular a cycle of interviews with the Group's Top Management. Assessment of the reputational risk scenarios identified was also carried out on two fronts:
The level of awareness reached within the Group on the growing importance of reputation as leverage for business and distinctive market positioning in 2019 led to the definition of an integrated governance model for Reputation, operational from 2020, which envisages the set-up of corporate bodies dedicated to the proactive management of the Group's reputation in terms of both building and protection, such as the Operational Reputation Management Team and the Reputation Network, and the launch of a widespread system for reporting reputational warnings involving all the Group managers.

As part of the ERM Framework, the Group identifies and monitors the ESG risk factors focusing on risks emerging on environmental, social and governance aspects and in terms of potential impact on the main categories of actual risk.
ESG risk monitoring is outlined in the individual risk categories, in such a way as to ensure management at all stages of the value creation process and mitigating any reputational risks associated with ESG risks as they arise. These controls, also designed to prevent exposure concentration to areas and/or sectors significantly exposed to ESG risks, are defined in the management policies for each risk category, where material.
Starting from the process of prioritising emerging risks conducted as part of the Reputational & Emerging Risk Observatory, a structured framework was developed to assess exposure to emerging ESG risks identified as priority through the estimation of exposures to the main categories of actual risk.
Within the scope of ESG risks, a particular focus is dedicated to climate risks, specifically with regard to underwriting and investment activities.
The Group has mapped the risks and opportunities linked to the climate, prepared in accordance with the taxonomy defined by the Task Force on Climate-related Financial Disclosure. This map includes both physical and transition risks. As regards the impact of climate change on physical and transition risks, specific stress test analyses have been implemented and integrated into the Group's stress test framework.
As regards the ESG risks generated, at Group level, a dedicated KRI dashboard has been developed, making it possible to monitor the risk level of each area - environmental, social and governance - while integrating oversight and listening indicators in order to combine the "inside-out" with the "outside-in" view.
The Group's capital management strategies and objectives are outlined in the "Capital management and dividend distribution policy", which describes the reference context and the process for managing capital and distributing dividends also in terms of the roles and responsibilities of the players involved. The document also identifies the principles of capital management and the distribution of dividends or other elements of own funds, in line with the return on capital objectives and the risk appetite defined by the Board of Directors.
The general aims pursued by the "Capital management and dividend distribution policy" are:

The capital management and dividend distribution process is divided into five steps, in close relation with other corporate processes:
Bologna, 21 March 2024
The Board of Directors


BIANOC bianco
no.11971/1999
242



-
-
-
-
-




245
by the Independent
Auditors
5.Summary of fees for the
year for services provided
bianco


247
| Amounts in €k | ||
|---|---|---|
| Type of services | Provider of the service | Recipient | Fees (*) |
|---|---|---|---|
| Legally-required audit | EY SpA | UnipolSai SpA | 1,580 |
| Attestation services | EY SpA | UnipolSai SpA | 460 |
| Other professional services | EY SpA | UnipolSai SpA | 249 |
| Total UnipolSai | 2,289 | ||
| Legally-required audit | EY SpA | Subsidiaries | 874 |
| Legally-required audit | Ernst & Young Ireland Unlimited Company - Ireland | Subsidiaries | 76 |
| Legally-required audit | Ernst & Young DOO - Serbia | Subsidiaries | 98 |
| Legally-required audit | Ernst & Young Société Anonyme - Luxembourg | Subsidiaries | 9 |
| Attestation services | EY SpA | Subsidiaries | 23 |
| Other professional services | EY SpA | Subsidiaries | 27 |
| Other professional services | Ernst & Young Ireland Unlimited Company - Ireland | Subsidiaries | 24 |
| Total subsidiaries | 1,131 | ||
| Grand total | 3,420 |
(*) fees do not include any non-deductible VAT nor charged back expenses



Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.